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Thesis Summary 
There exists a growing and tenacious challenge in the medicine supply chain, to 
manage the consequences of supply chain disruptions. Hospitals experience frequent 
shortages, in a European based study, 45% of respondents indicated that life 
preserving drugs were affected by shortages (Pauwels 2015). This research seeks to 
augment theoretical understanding underlying this significant issue and provide advice 
in the management of shortages which is a critical issue within the pharmaceutical 
industry. Previous research has focused on the antecedents of supply chain 
disruptions; what happens after a disruption has received scant attention. This 
research acknowledges that gap and seeks to build on the Bode et al. (2011), model of 
organisational responses to supply chain disruptions.  
This study uses a research onion design as a stencil to guide the pluralistic 
methodological approach chosen to release the multifaceted dimensions of the 
problem under consideration. Data collection instruments were interviews, an online 
survey, and focus groups. It was based on 318 acute care hospitals in the UK and 
Ireland. Findings indicate there are patterns of responses, and shortage performances 
vary depending on the length of time since the disruption and response mixture 
chosen.   
This research gives new insights into the impact of supply chain disruption response 
behaviour and supply chain performance in shortage management. It provides 
additional empirical tests to the Bode et al. (2011) normative model, providing insights 
into the underlying balanced theories, through examination of three constructs: supply 
chain disruption orientation; supply chain disruption performance and organisational 
response. It extends the concept of supply chain disruption orientation and highlights 
how response behaviour can feed back into the dynamic decision-making process, 
augmenting the Bode et al. (2011) framework. It provides insights to managers taking a 
system-wide view on drug delivery performance.  
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1 Introduction  
 
1.1 Research Background 
 
The occurrence of disturbances that negatively affect a supply chain is an unavoidable 
fact, whereby all supply chains are inevitably at risk (Craighead, Blackhurst, 
Rungtusanatham et al., 2007). It is crucial for supply chain survival that managers 
identify, in a proactive manner, the disturbances that may potentially affect the supply 
chain and take measures, developing, for example, mitigation and/or contingency 
plans that help make the supply chain more resilient (i.e. less vulnerable) (Barroso, 
Machado and Cruz-Machado, 2011). Common pressures and responses exist in 
international industries, such as globalisation, increasing legislation, and a volatile 
economic environment, which can lead to a turbulent dynamic (Christopher and 
Holweg, 2011). In the UK, the economic impact of fuel protests in 2000, followed by the 
outbreak of Foot and Mouth Disease early the following year, influenced policymakers 
and highlighted the need to understand more about the vulnerability of commercial 
supply chains (Peck, 2005).  
 
Globalisation has linked low-cost labour economies with consumer markets and, as a 
result, supply chains have become extended. The uncertainty incumbent in these 
elongated chains has resulted in supply chains strategies balancing inventory with 
service levels (Greening and Rutherford, 2011). In many cases, this trade-off leaves 
the supply chain vulnerable to disturbances, leading to an increased focus on supply 
chain coordination. The geographical extent of the supply chain has also resulted in an 
increased vulnerability to disruptions (as opposed to disturbances), such as natural 
disasters or terrorist attacks (Sheffi and Rice, 2005). A disturbance has a negative 
impact to a limited extent and for a limited period, whereas a disruption has a strong 
negative impact normally of wide scope and long duration or effect (Pfohl, Kohler and 
Thomas, 2010). 
 
Supply chain disruptions are not new, of course; they have existed for as long as 
supply chains have (Snyder, Atan, Peng et al., 2012). Nevertheless, the results of 
disruptions have been widespread and their consequences severe, for example, the 
shortages the pharmaceutical industry has been experiencing as a result of disruptions 
from both controllable and non-controllable factors, such as manufacturing issues and 




Shortages can occur where the disruption causes a breakdown in the smooth running 
of the supply chain, which can generate and accelerate shortages. This can produce 
‘stock out’ situations increasing the order lead time, or failing to fulfill the order 
completely. The result of this may be a loss of future orders or, in the case of a hospital 
pharmacy, not receiving the correct drug on time which can lead to an adverse patient 
outcome. Shortages can also ensue when there is a disruption in the flow of 
information and material. This can be due to prediction inaccuracies, Chopra and 
Sodhi (2004) identified this can result from information distortion within the supply 
chain. Croson and Donohue (2003) explained that all supply chains have two distinct 
lead-time pipelines, firstly the order information transfer pipeline, moving upstream 
from the point of sale to raw material supplier, and secondly the product transfer 
downstream from raw material to customer. 
Where the customer anticipates that supply will not be able to meet demand, they can 
demonstrate purchasing behaviour which Lee, Padmanabhan and Whang (2007) 
describes as shortage gaming. This is where customers place larger than average 
orders, creating an amplification in demand through the supply pipeline, which 
Forrester (1958) described as the bullwhip effect. Significant extra orders being placed 
reduces local inventory for distributors, therefore causing a spread of shortages in the 
market. This distortion of information flow from downstream leads to overproduction 
upstream, which then leads to eventual oversupply as the production exceeds the 
demand from downstream. In this case, the supply structure being in a pipeline form, 
the behaviour of stakeholders throughout the pipeline, in addition to the distortion of 
information, causes a shortage which reverberates through the marketplace causing its 
own dynamic.    
This harsh reality, coupled with the emergence of ongoing natural and man-made 
hazards in a volatile environment of financial instability and ongoing crisis, have put 
concepts that were somehow neglected in the past, such as supply chain resilience 
and vulnerability, in the forefront of supply chain research in the last ten years, 
according to Ponis and Kronis (2012). Bakshi and Kleindorfer (2009) note that the 
primary reason for the increased interest in disruption management and, consequently, 
supply chain resilience and vulnerability issues is the awareness, promoted by recent 
research, regarding the magnitude of losses, both direct and indirect, resulting from 
supply chain disruptions. Supply chains are facing numerous changes that are 
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contributing to increasing their complexity and vulnerability to disturbances, and so to 
survive, supply chains must be resilient (Carvalho, Barroso, Virginia et al., 2012). 
1.2 The General Problem Area 
 
The consistent and unchanging way of business life that many corporate purchasing 
departments once enjoyed has now been increasingly imperilled. Threats of resource 
depletion and the scarcity of raw materials, political turbulence, government 
intervention in supply markets, intensified competition, and globalisation (Kraljic, 1983) 
marked the rise of the concept of supply chain risk management that emerged in the 
early 1980s. This meant that purchasing must become supply chain management, 
which lead to the further development of supply chain management, and as new 
challenges were intensified the development of research literature on supply chain 
resilience management commenced. The increased research focus on supply chain 
resilience has seen it widen in its scope of interest from viewing resilience as merely to 
rebound from adverse situations to a mechanism of a shock absorbing attribute; 
something to be incorporated by firms as an active capability and competitive 
advantage in turbulent times (Lengnick-Hall, Beck and Lengnick-Hall, 2011, Ponis and 
Kronis, 2012).  
 
Supply chain disruption response management considers the organisational response 
repertoire but goes beyond the supply chain risk management focus on cost reduction 
and time-based competition, including early warnings before an event. Production and 
partnership approach strategies to suppliers and customers (Chopra and Sodhi, 2004, 
Tang, 2006) can be effective as an escalation of a disruption to improve the handling of 
catastrophic events (Chadist, 2012, Sodhi and Tang, 2009). However, what effects do 
actions taken after the disruption has occurred really have?  
 
1.3 Aim of the Research 
 
The aim of this research was to examine post supply chain disruption management, 
extending the theoretical framework developed by Bode et al (2011) by using a theory 
testing design that formulates and tests novel propositions to augment the existing 
academic body of work on disruption and risk management and exploring new insights 
into this field of study. The research is set in the challenging environment of the 
pharmaceutical supply chain and specifically examines the post disruption response 
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strategies of buffering and bridging in managing shortages. Where buffering includes 
techniques such as building safety stock and bridging includes for example building 
stronger links with suppliers through intense information exchange. 
In particular, this research's goal is to understand the interplay of post disruption 
actions taken after a supply chain disruption event has occurred and to understand 
how and why those actions are taken and what actually are the subsequent outcomes, 
rather than relying on the existing normative theory framework. The research question 
is: How do the actions of buffering and bridging in response to supply chain disruption 
events affect the performance of shortage management? To answer this question, this 
research employs a set of propositions, which incorporate fresh aspects of the dynamic 
and contextual nature of those actions and the resultant conclusions, providing a 
platform for further study.     
1.4 Potential Contribution 
 
The potential contribution of this research is to extend the previous theoretical 
framework on post supply chain disruption responses to give a deeper understanding 
of the factors underlying disruption response and subsequent performance. By 
providing an empirically-based study, testing the three constructs of: supply chain 
disruption orientation, supply chain disruption performance and organisational 
response, to give new insights into the interplay between supply chain disruption 
response actions to actual disruption events. Based on a thorough literature review, 
including an in-depth 77 journal review on supply disruption resilience and response 
management, the testing of the existing model and development of that framework 
allows other response factors to be newly considered, including feedback, boundary 
rationality, and dynamic action variations, as well as to provide insights and refinement 
to the new concept of supply chain disruption orientation. By uniquely incorporating 
empirically based disruption performance results, it explores the consequences of post 
disruption actions scenarios for both theory development and practical management 
application. 
 
1.5 Thesis Structure 
 
The next section outlines the salient structure of the thesis by giving a brief synopsis by 
chapter as they will appear in this research study, and summarised in the thesis 




                                                 Thesis Structure Diagram 
 
Chapter 1: Provides background information regarding supply chain resilience and 
disruption management to set the scene for the research and to give an overview of 
the thesis. It includes, as well as the context, the research rationale, research problem, 
and objectives of this study. A full review of the academic and practitioner literature 
was conducted to ensure the research is based on current knowledge, is relevant to 
the research problem, and provides a legitimate foundation for the research argument. 
The use of the rational, persuasive argument is the stock-in-trade of the researcher. 
This type of argument uses reasoned discussion or debate to separate fact from fiction 
(Machi and McEvoy, 2009). 
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Chapter 2: Is the literature review of the extant body of work for this research. The use 
of the existing literature on a topic is a means of developing an argument about the 
significance of a research study and where it leads (Bryman and Bell, 2011). Following 
the introduction, the literature review is separated into four sections, of which section 
2.2 is the first and focuses on the supply chain management literature. Section 2.3 
provides a critical overview of the pharmaceutical industry in which this research is 
based. Section 2.3 is divided into three parts, beginning with the main stimuli in the 
pharmaceutical industry, and then drilling down into the two main categories within the 
pharmaceutical industry; the primary manufacturing and the secondary production 
sectors. Section 2.4 gives a detailed outline of the of supply chain disruption literature, 
supply chain risk management, supply chain resilience management, and then supply 
chain disruption response management. The final section 2.5 provides reasons for and 
the impact of pharmaceutical supply chain shortages including economic, regulatory, 
manufacturing and health system management. 
 
Chapter 3: Describes and develops the research question from the literature review for 
this research for the specific area of focus.  A new theory framework is proposed in this 
paper which grows from the current research in resilient supply chain strategic 
management. The lack of the development of the existing knowledge encourages an 
extended appropriate analytical framework, which motivates this research to bridge the 
gap with a new paradigm, including the development of the three main research 
constructs and the nine subsequent propositions which answer the research question 
posed to give new insights in this field and provide opportunities for further study.  
 
Chapter 4: Provides an overview of the relevant research design and methodology for 
this study using the onion research plan (Saunders, Lewis and Thornhill, 2007). Each 
research philosophy is considered and the research approach and relevant research 
philosophy chosen. This study chose a predominately positivism philosophy which was 
balanced with a realism perspective. The research approach chosen was through a 
deductive approach following the hypothetico-deductive model. The theory based 
research testing strategy was then aligned with the appropriate methodology chosen, 
which combined quantitative and qualitative procedures to improve the power of the 
study. The techniques chosen were three main data collection methods; survey, 
interview, and focus groups, which lend themselves well to the capture of supply chain 
post disruption data gathering and analysis. The data collected was then analysed by 
coding through summarisation, reducing substantial amounts of data into similar 
groups for proposition testing and theory building on post supply chain actions and 
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outcomes. A key element of the research, because of its focus on the public health 
arena, was ethical approval and considerations, which are set out in the last section of 
the chapter.  
 
Chapter 5: Presents the data collection and description and background, including the 
details behind the various stages of data collection and justifications. This includes the 
desk research, exploratory interviews, survey design, pilot testing, data coding, 
interview, and focus group research findings.   
 
Chapter 6: Presents the core research data analysis. This is separated into two main 
elements: the data analysis of the qualitative interviews and focus groups, followed by 
the data analysis of quantitative findings, including the descriptive findings, cleaning 
and recoding, the reliability analysis, analysis assumptions, and diagnostic tests. It 
then presents the quantitative findings and results for each of the propositions tested, 
including both time dynamics of immediate and post disruption performance. Lastly, it 
triangulated the data analysis from the research in the cross cutting analysis, bringing 
together each of the data collection methods analysis findings to balance out any of the 
potential weaknesses in each data collection method. 
 
Chapter 7: Provides the discussion of the data analysis findings. This meant going 
back to the literature and grappling with what the research findings mean, including 
how they fit in with previous work, and the contribution to scholarly academia in the 
theoretical implications section. This is executed by considering the research question 
and each of the propositions separately for clear understanding and interpretation. 
Where the research results differ from others' findings, an explanation is given 
suggesting why this is. Then the discussion launches into 'bigger picture' issues; the 
practical real-world implications of the research and giving examples of how this 
study’s findings could be usefully assimilated into day-to-day operational practice as 
advice to practitioners and managers, but also reflecting the wider macro implications. 
 
Chapter 8: Presents the conclusions of this study on post disruption supply chains, 
including what was carried out, the research contributions, and what was learnt to 
expand current knowledge. It then acknowledges research shortcomings in an 
evaluation of the study limitations. It then considers future research areas to highlight 




2 Literature Review  
 
2.1 Introduction  
 
Chapter 2 details the literature that has been reviewed as part of this research project. 
The beginning of this literature review provides an overview of the broad topic of 
supply chain management, providing context and to demonstrate key works and 
concepts. This review then focuses more specifically within the extensive areas of the 
supply chain management literature. By providing a deeper review than just a general 
description of supply chain management, this review will identify relevant subsections 
of the extant literature to provide more effective use of the academic body of work. This 
research review is conducted within the published knowledge of other academic 
authors, and in doing so allows this research to be located within the context of that 
work. Furthermore, this review, by defining the appropriate literature subsections within 
the wider field, enables a focused review of the more relevant work to the topic of 
interest. It then goes on to explore these subsections in greater detail. Through critical 
review of the detail of this subdivision, the gaps in the literature are identified to 
connect this work to that of the current literature to establish an original academic 
contribution to current understanding and knowledge. As noted by Machi and McEvoy 
(2009), the literature review is the foundation for identifying a problem that demands 
original research, and is the basis for the study of a research problem. 
The general process followed in the research methodology for refining this review is 
illustrated below: 
1. Define the search terms 
2. Identify the databases 
3. Determine and apply criteria for inclusion and exclusion 
4. Refer to the reference list of the shortlisted articles 
5. Ensure that the resulting articles are representative 
By following the above steps, it specifies and frames the research topic to enable a 
thorough review.  
The literature review is structured into four sections following the introduction including 
the initial overview of supply chain management in section 2.2, so that each one can 
be looked at in detail. This allows the inclusion of both the relevant academic theory 
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with regards to supply chain disruptions and specific industry knowledge considered 
relevant within the pharmaceutical sector in which this research will be carried out. The 
subsequent three sections in chapter 2 are pharmaceutical industry supply chain 2.3, 
supply chain disruptions 2.4. The intersection shown in the grey circle within Figure 1 
highlights the context for final section 2.5 of the literature review: supply chain 
disruptions in the pharmaceutical industry.  
 
 











Figure 1.  A conceptual outline of the literature review elements describing the overall 
positioning of this research 
The subsections outlined in Figure 1 are to concentrate the review so that the gaps in 
the current understanding can be highlighted to position and justify this study's 
research work, and clearly identify the academic contribution. By inclusion of relevant 
industry-based information, this review avoids the limitations of other reviews solely 
based on the analyses from the point of view of academics while failing to incorporate 
the views of practitioners. An academic literature review demands that the review 
seeks both theoretical and field-based knowledge. The current field-based literature is 
used to decide the issues, significance, and relevance of the study. The theoretical 
literature clearly defines the topic and provides the knowledge base for understanding 
the topic’s breadth and depth (Machi and McEvoy, 2009).  
The search terms were defined, and key word searches included supply chain 
disruptions, risk management, strategic management, strategic resilience 
management, shortage management, and pharmaceutical supply chain management. 
Boolean logic was used to frame the database search. These terms were distilled from 
 
Supply Chain 
Disruptions             





             2.3 
  
   2.5 
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the initial wider search on the supply chain management research literature as they 
were more relevant to the chosen topic. The continuous growth of the supply chain risk 
management literature alone quadrupled between 2003 and 2013, as noted in Ho, 
Zheng, Yildiz et al. (2015), and so filtration was required so that the review remained 
focused on the relevant areas of interest. Several criteria were used to filter the articles 
including resilience, disruptions, risk management methods and research gap 
identification. Articles were excluded if they did not meet one of the filtration criteria. 
The shortlisted articles were carefully examined to ensure that an exhaustive search 
was carried out and that no other articles were omitted from the search. Lastly, the 
reference list was thoroughly evaluated so that the articles fitted the context of search 
criteria.  
Literature search methods used have been varied, including supply chain and 
management journals with for example Supply Chain Management: An International 
Journal, (SCMIJ), International Journal of Logistics Management, (IJLM), International 
Journal of Physical Distribution & Logistics Management, (IJPDLM), Journal of 
Logistics Management, (JLM). These journals were chosen as the most relevant and 
frequently occurring from the above search criteria. The databases, including ISI Web 
of Science, Ingenta (BIDS), and Science Direct, have been utilised. Academic 
databases were utilised to identify the journal articles, including EBSCOhost, Emerald, 
IEEExplore, Ingenta, Metapress, Proquest, ScienceDirect, Springer, Scopus, Taylor 
and Francis and Wiley, have been used for some aspects of the literature searching. In 
addition to searching for academic articles, a large volume of practice material was 
gathered from government and non-government organisations, such as Department of 
Health (PPRS), World Health Organisation (WHO), European Federation of 
Pharmaceutical Industries and Associations (EFPIA), and corporate publications. 
Further to the introduction of the literature review above, the following section outlines 
the wider topic of supply chain management.  
 
2.2 Supply Chain Management  
 
Supply chain management is not a novel management paradigm as such. Instead, it 
represents a new focus on how to link organisational units to best serve customer 
needs and to improve the competitiveness of a supply chain as a whole (Stadtler, 
2005). In this endeavour, supply chain management has drawn knowledge and 
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approaches from a number of disciplines like computer science, logistics, marketing, 
operations research, organisational, theory and many more. To extract, adapt, and 
combine those approaches that best suit a specific supply chain is the challenge of 
managing a supply chain successfully (Simchi-Levi, Kaminsky and Simchi-Levi, 2003). 
Supply chains are defined by Christopher, McKinnon, Sharp et al. (2002) as the 
management of upstream and downstream relationships with suppliers and customers 
in order to create enhanced value in the final marketplace at less cost to the supply 
chain as a whole. As defined by the Supply Chain Council Report (2002), a supply 
chain encompasses every effort involved in producing and delivering a final product 
from the supplier’s supplier to the customer’s customer. 
The origin of the supply chain concept has been inspired by many academic fields 
which Chen and Paulraj (2004) list as: 
1. The quality revolution (Dale, Lascelles and Lloyd, 1994) 
2. Notions of materials, management, and integrated logistics (Carter and Price, 
1993, Forrester, 1961) 
3. A growing interest in industrial markets and networks (Ford, 1990, Jarillo, 1993) 
4. The notion of increased focus (Porter, 1987, Snow, Miles and Coleman, 1992) 
5. Influential industry-specific studies (Womack, Jones and Rood, 1990, Lamming, 
1993) 
Researchers find themselves inundated with terminology such as 'supply chains', 
'demand pipelines' (Farmer and Amstel, 1991), 'value streams' (Womack and Jones, 
1994), 'support chains', and many others. The term supply chain management (SCM) 
was originally introduced by consultants in the early 1980s (Oliver and Webber, 1992) 
and has subsequently gained tremendous attention (Londe, 1998) where supply chain 
management (SCM) is the concept of the management of the entire supply chain, or as 
Drucker (1998) p12. defines in his description of new management paradigms: 
Supply chain management is the integration of key business processes from 
end user through original suppliers that provides products, services, and 
information that add value for customers and other stakeholders. 
A typical supply chain, as shown in Figure 2, is a network of materials, information, and 
services processing links with the characteristics of supply, transformation, and 
demand. Both suppliers (1) and customers (3) are connected to the internal supply 
chain (2) which consists of the purchasing, production, and distribution overlapping 
functions. The term supply chain management has been used to explain the planning 
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and control of materials and information flows as well as the logistics activities, not only 
internally within a company but also externally between companies (Cooper, Lambert 
and Pagh, 1997, Fisher, 1997). 
 
 
Figure 2.  An illustration of a company’s supply chain. Adapted from Chen, I.J., Paulraj, A, 
(2004) 
Improving product and process quality have been well established as ways by which 
organisations can respond to increased global competition. Now, however, the 
challenges facing organisations go beyond improving quality. Organisations are 
increasingly faced with the reality that they cannot exist in isolation, but are one piece 
of a complex chain of business activity. Supply chain management studies support this 
notion and confirm that all three major components of a supply chain, suppliers, 
manufacturers, and customers, must be effectively integrated in order to achieve 
financial and growth objectives (Tan, Kannan, Handfield et al., 1999). Successful 
management of the supply chain is the key to the long-term success of an 
organisation. This cannot occur, however, if organisations implement business 
practices in an arbitrary, uncoordinated manner, or if they direct scarce financial 
resources to initiatives that are unlikely to yield positive outcomes. With product 
lifecycles shrinking, firms must unceasingly pursue new markets, modern technologies, 
and improve cost and delivery performance. Supply chain management provides a 
framework within which to implement a well-conceived market strategy, but it cannot 
undo the effects of a poorly conceived one. It is therefore imperative for managers to 
ensure their quality and procurement implementation strategies, tactics, and 
measurements are correctly aligned with strategies in the areas of finance, operations, 
marketing, new product development, and sales. Tan, Kannan, Handfield et al. (1999) 
noted there is a need to understand how future strategies will unfold and how 




The strategies that organisations use to cope with the new supply chain environment 
are changing. Globalisation and changes demanded by stakeholders have influenced 
the attitudes of supply chain entities. These entities are becoming more professional, 
showing ever increasing levels of complexity, and adopting philosophies and 
management practices with the objective of increasing their levels of competitiveness. 
Competitiveness is a critical factor in the success of a supply chain. Disturbances 
increase supply chain challenges and may reduce its performance and 
competitiveness. It is therefore fundamental for a supply chain to be resilient to 
disturbances (Barroso, Machado and Cruz-Machado, 2011). Today’s supply chains are 
more complex than they used to be. There are various reasons for supply chain 
complexity, such as higher levels of R&D and manufacturing outsourcing, supplier–
supplier relationships in supplier networks, increased dependence on supplier 
capabilities, new technologies (e.g., Internet, RFID), regulatory requirements (e.g., post 
9/11 security regulations such as C-TPAT, or food safety controls), shorter product 
lifecycles due to rapidly changing customer preferences, and international market and 




Section 2.2 & gives an overview of the supply chain literature as an introduction and a 
contextual overview for the literature review. Section 2.3 reviews the specific industry 
perspective of the pharmaceutical supply chain, which has a complex international 
dynamic. Section 2.4 begins by defining and discussing the central concepts of 
resilience and disruptions within the scope of supply chain management to concentrate 
the area of academic research focus. Last section 2.5 reviews supply chain disruptions 
within the context of the highly regulated pharmaceutical supply chain, which has 
experienced the considerable impact of supply chain disturbances. 
 
2.3 Pharmaceutical Supply Chain 
 
Section 2.3 presents an overview of the pharmaceutical supply chain and, following a 
brief introduction, begins with section 2.3.1: drivers in the pharmaceutical industry, 
after which there is a detailed explanation of the two of the main areas of distinction 
within the pharmaceutical supply chain; section 2.3.2, the primary manufacturing, and 
32 
 
2.3.3, the secondary manufacturing. This is followed by 2.3.4, the pharmaceutical 
distribution chain and finally the section summary.   
 
Economic and globalisation trends are having a major impact on the pharmaceutical 
drug manufacturing sector. As multinational drug manufacturers struggle with rising 
costs, expiration of blockbuster drug patents, and changes in government legislation 
within their largest markets, Europe and the United States, opportunities are increasing 
within Asia and South America. These trends have caused manufacturers to re-
engineer their supply chain strategies as a consequence. The global pharmaceutical 
market is expected to reach $1 trillion by 2014 and nearly $1.1 trillion by 2015. 
Although the United States and Europe have led the world in terms of pharmaceutical 
sales for many years, according to some estimates, the US share of global 
pharmaceutical spending is expected to decline from 41% in 2005 to 31% in 2015. As 
sales slow for both regions, emerging countries are demonstrating strong growth as 
their markets continue to open up for investments. During the subsequent five years, 
growth in emerging markets is expected to nearly double to between $285bn and 
$315bn, compared with spending of $151bn in 2010. There is a cluster of large, 
research and development-based multinationals with a global presence in branded 
products, both ethical/prescription and over-the-counter. This group dominates the 
marketplace and, due to the global nature of the enterprises involved, tends to have 
the most challenging supply chain problems (Shah, 2004). 
 
In the past, scant attention was paid to supply chains as manufacturers were focused 
on blockbuster drug sales. The changing government role within the pharmaceutical 
drug industry, especially in the Europe and United States markets, has meant that 
manufacturers are now faced with supply chains that are not effective in a sector that is 
in transformation. With the globalisation of the drug manufacturing sector, 
manufacturers are targeting emerging markets such as China and Brazil as locations 
not only to sell to, but also as locations for outsourcing such operations as 
manufacturing, research and development, and clinical trials. However, an array of 
issues such as security, intellectual property, and knowledge of government legislation 
within these emerging markets has presented challenges to drug manufacturers. China 
is one of the fastest growing markets among the emerging countries (Ni, Zhao, Ung et 
al., 2017). With China’s share of pharmaceutical industry output augmented nearly 
seven‐fold, from 2.5% in 1995 to 18.3% in 2010, it is expected to become the second-
largest pharmaceutical market in the world by 2020 (National Institutes of Health, 
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2015). This changing trend may also apply to the global healthcare innovation 
networks as increased sales performance can better support R&D. 
China has risen to a worldwide leading position at an accelerated pace in terms of 
R&D funding, pharmaceutical publications, and patents in recent years (Gautam and 
Yang, 2014). With the perspective of switching from imitation to innovation, R&D outlay 
in China’s pharmaceutical industry increased from $162.6 million USD in 2000 to 
$3249.2 million USD in 2011 (Qiu, Chen, Lu et al., 2014). 
Figure 3 shows there has been a dramatic rise in research focus in Chinese 
pharmaceuticals. However, it should be noted that despite the increase in innovation 
and creation in academic pharmaceutical research, there is still a time lag in patent 
licensing, The difficulty of patent licensing by universities may imply a considerable gap 
between academic research and innovative products (National Bureau of Statistics 
China, 2015).      
 
 
Figure 3. Granted patents and licensing percentage of Chinese universities. Data source: China 
Universities Statistics Yearbook (2015) 
 
The World Health Organisation (WHO) defines a drug or pharmaceutical preparation 
as any substance or mixture of substances manufactured, sold, offered for sale or 
represented for use in the diagnosis, treatment, mitigation, or prevention of disease, 
abnormal physical state or the symptoms thereof in man or animal; [and for use in] 
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restoring, correcting or modifying organic functions in man or animal. This is a very 
wide definition, and correspondingly, there are a number of key players in the 
pharmaceutical industry, as stated by Shah (2004), including:  
 
1. The large, research and development-based multinationals with a global 
presence in branded products, both ethical/prescription and over-the-counter. 
They tend to have manufacturing sites in many locations. 
2. The large generic manufacturers, who produce out-of-patent ethical products 
and over-the-counter products. 
3. Local manufacturing companies that operate in their home country, producing 
both generic products and branded products under licence or contract. 
4. Contract manufacturers, who do not have their own product portfolio, but 
produce either key intermediates, active ingredients (AI), or even final products 
by providing outsourcing services to other companies. 
5. Drug discovery and biotechnology companies, often relatively new start-ups 
with no significant manufacturing capacity. 
 
A supply chain is defined as a system whose constituent parts include material 
suppliers, production facilities, distribution services, and customers linked together via 
a feed forward flow of materials and feedback flow of information (Naylor, Naim and 
Berry, 1999), and includes the flow of resources and cash through the supply chain 
(Naim, 1997). The pharmaceutical industry is mainly focused on the production or 
manufacturing part of the supply chain network rather than the end delivery to patients, 
which is described as a divided structure (Savage, Roberts and Wang, 2006). One of 
the reasons this may be the case is with nearly $350 billion of pharmaceutical sales in 
2005, logistics costs tend to be far lower against revenue than other industries.  
According to Booth (1999), the high returns on investment and high turnovers from 
'blockbuster' products resulted in the following regime: 
 
1. Good R&D productivity, often creating compounds to treat previously 
untreatable diseases; 
2. Long, effective patent lives of these compounds; 
3. Ability of these patents to provide technological barriers to entry; 
4. A limited number of product substitutes in a given therapeutic area; and 
5. A low-price sensitivity; supported by the separation between 
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6. Prescribing and paying responsibilities. 
 
The resulting corporate strategy was to ensure high margins by exploiting the price 
inelasticity and invest a substantial proportion of the resultant profits in R&D 
(approximately 25% of sales), in order to ensure a healthy product pipeline. The more 
recent circumstances are much more challenging: 
 
1. R&D productivity (in terms of numbers of new chemical entities (NCE) 
registered per unit amount of investment) is declining;  
2. Effective patent lives are shortening; 
3. Even while active, patents provide lower barriers to entry; 
4. There are many product substitutes in many therapeutic areas; either 
alternative compounds ('me-too drugs') or off-patent generics; and 
5. The payers of healthcare are exerting strong price pressure and influencing 
prescribing practices; this means that in order to be approved, new drugs must 
address new therapeutic areas or have very significant cost or health benefits 
over existing treatments. 
 
As shown below in Figure 4, the leading pharmaceutical companies will lose between 
14% and 41% of their existing revenues because of patent expiries, this squeeze on 
revenues has focused attention on all costs in the pharmaceutical industry, including 









Figure 4. Source AXA (Brand name of Assurances du Groupe de Paris) Framlington in 
PricewaterhouseCoopers 
Notes: *Estimate of global sales in 12 months prior to patent signing 
** Value of products losing patent protection as a percentage of total company sales 
over the next five years   
 
On the one hand, the global marketplace has become more liberalised, exposing 
products to competition. On the other, governments and other agencies have tended to 
intervene more as they become concerned at the increasing healthcare costs 
associated with ageing populations. Measures taken include strict controls on the 
prices of new drugs, more cost–benefit analysis, and encouragement of the use of 
generic substitutes or replacements where possible. A further weakness that will 
hamper the large players in the area is the historical dependence on 'blockbuster' 
drugs. As shown in Figure 5, only five of the top pharmaceutical companies for 
example Schering Plough, generate more than 10% of revenues from products that 













BMY Bristol Meyers Squibb 
GSK GlaxoSmithKline 
JNJ Johnson & Johnson 









Figure 5. IMS (Intercontinental Marketing Statistics) Healthcare and PricewaterhouseCoopers 
Analysis 
Patent protection as with other restrictions on the pharmaceutical supply chain can 
create shortages for the downstream market. As highlighted in the preceding sections, 
patented blockbuster drugs can mean high price barriers especially in the launch 
phase of the new effective drug treatment. Governments can place caps on supply or 
simply not sanction their purchase at inflated prices, for example by the instruction of 
authorising bodies such as the National Institute of Clinical Excellence (NICE) in the 
UK. However even when NICE approves product, the Government can still block or 
ration products to the very sickest, e.g. the patented drug Solvaldi, for treating liver 
disease which costs £35,000 for a 12 week course (Wapner, 2017).This causes 
shortages of the drug and alternative treatments sort. In addition, changes to patents 
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by issuing license providers, may reduce the length of the patent, but this may result in 
changes in manufacturing and location by the producers (Breen, 2008). This in turn 
can create downstream shortages, as supply maybe coming from offshore outsources 
as producers push mature or out of patent products which are less profitable to lower 
cost and potentially lower quality primary production (Huq, Pawar and Rogers, 2016). 
This has been particularly evident in terms of the manufacture of generic drugs or 
those coming off patent (Marucheck, Greis, Mena et al., 2011). Patent and license 
management is a key commercial tool for pharmaceutical suppliers, and by restricting 
new suppliers in a specific market it can create an artificial shortage through difficult or 
prohibitive costs in downstream purchasing (Habermann, Blackhurst and Metcalf, 
2015). An example was the shortage of HIV medicines to treat the AIDS epidemic in 
Africa due to the super high pricing by the patent holders. Price campaigners 
eventually succeeded in enlisting the India company Cipla to make low cost versions of 
the HIV triple-drug combinations in 2001 that cost $100 per person a year instead of 
$10,000. Patents normally apply for about 20 years but must be registered in the 
country where the drug is sold. That stops other companies making rival copies that 
might compete to push prices down. India had different intellectual property rules at the 
time, which meant the HIV drugs patent, did not apply there. But the rules have since 
changed and attempts to make cheap copies of new drugs such as the new Hepatitis 
C drug have faced long court battles (Boseley, 2017) 
2.3.1 Drivers in the pharmaceutical industry 
  
Probably the single most important driver in the pharmaceutical industry is the time-to-
market. Companies secure very significant returns in the early life of a successful drug, 
before any competition. In Figure 6 below the life cycle of typical pharmaceutical 
products is shown, taking products eight to 12 years to come to market, with only a 
small percentage of molecules researched actually making it into production launch. 
The industry itself is separated into the discovery, exploratory, and full development 
phases of medicine production in a typical 15-year cycle per new product, with the 
added complication of globalisation and multiple layers of delivery through distributors 
and wholesalers. The pharmaceutical supply chain typically has four tiers at global and 
regional levels; from the fourth tier of API manufacturing, tier three, the processing of 
API into tablet or delivery form, tier two, the packaging stage, and finally the distribution 
and repackaging phase to final customer. As per Figure 6, production ramps up until 
approximately year eight, depending on the product, and the company must maximise 
its profits during this period, as once the product matures and goes towards the 
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generic (GX) production phase, costs are under severe pressure and profitability 
reduces. The profit reduction also often leads to a reduction in production, affecting the 
supply of now established drugs on the market. 
 
Figure 6. Life cysle of pharmaceutical product  
The competition-free early life high-returns period, is, however, shortening, previously 
averaging five years, whereas now it is between one to two years. Competition in this 
sense relates to similar (rather than identical) drugs. For example, Bayer’s anti-
cholesterol drug Baycol was withdrawn in 2001 due to safety concerns, and the two 
later entrants, Pravachol (from BMS) and Lipitor (from Pfizer), are now the biggest 
sellers for their companies (Butler, 2002). Given the significant potential for adverse 
health effects, the industry is subject to very stringent regulation. This starts from the 
processes used to evaluate the safety and efficacy of the chemical compounds, 
through to the details of the process and plant design and manufacturing operations. 
The primary regulator that the companies must satisfy is the US Food and Drug 
Administration (FDA). It may be the case that the existence of regulatory protocols has 
hindered innovation in this sector; with companies blaming regulators for their own 
innate conservatism. 
 
The regulatory process tends to be slow and expensive; both these effects must be 
borne by the industry. Furthermore, the complex chemical compounds involved have 
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more complex manufacturing processes, and the activities of route investigation, 
process development, scale-up plant design/retrofit, commissioning and qualification 
are either increasing in duration or proving stubborn to shorten. It is estimated between 
£200m to £400m is required to launch a new drug, and an average of eight to 12 years 
elapses from patent filing to first sale (Grabowski, 1997). Before the medicines even 
reach this ‘supply stage’, though they have been through multiple regulatory 
frameworks, for example, the 2008 Pharmaceutical Price Regulation Scheme (PPRS) 
and contractual/non-contractual and pricing approvals through government agencies, 
such as the Commercial Medicines Unit (CMU) and the National Institute for Health 
and Care Excellence (NICE) in the UK. Each participant in a drug delivery process has 
their own motivation, access to information, and is regulated and managed in different 





Figure 7. The UK pharmaceutical supply chain map, as identified by the pharmaceutical 
stakeholder group (Breen, 2005) 
Figure 7 shows the UK supply chain map (Breen, 2005), with its multiple layers and 
actors. This map was summarised from inputs by a range of stakeholders at different 
levels within the UK pharmaceutical supply chain as part of the aforementioned 
pharmaceutical supply chain research, looking at the causes of pharmaceutical 
shortages in the UK National Health Service. The map of the pharmaceutical supply 
chain describes the manifold of channels the medicines can flow through in the 
pharmaceutical supply chain. The pharmaceutical supply chain fabric is complex, as 
shown above in Figure 7, and is regulated and monitored by parties such as the 
Department of Health (DOH), National Institute for Health and Clinical Effectiveness 
(NICE), Medicine and Healthcare Products Regulatory Agency (MHRA), Medicines 
Controls Agency, and the National Health Service Purchasing and Supply Agency 
(NHS PASA), to name but a few (Breen, 2008). To further understand the 
pharmaceutical supply chain, it is important to identify the fundamental actors within it. 
As summarised in Table 1 below, the key stakeholders in the UK pharmaceutical 
supply chain can be grouped into seven categories as pharmaceutical shareholders:  
 
1. National Health Service (NHS) 
2. Pharmaceutical Industry 
3. Support Industry 
4. Patients Representatives 
5. Government Agencies 
6. Health Care Professionals 






















Table 1. Key stakeholders in the pharmaceutical supply chain  
These stakeholder actor groups overlay the above supply map representing multiple 
interest groups, each with its own agenda and priorities.  
 
Within each interest group, there are numerous roles that individual managers have 
that can determine their sphere of influence and the decisions that they make. In the 
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case of secondary care pharmaceutical management within the National Health 
Service (NHS), previous work on roles was looked at internally using a focus group 
approach and produced an NHS report  (National Health Service, 2005b) looking at 
NHS processes involved in NHS hospital pharmacy procurement in the area of 
logistics and supply chain management. This work focused on the key roles of 
individuals involved in pharmaceutical delivery within the NHS. It highlighted that there 
was a need to identify a knowledge and skills framework for roles within the 
pharmaceutical management supply chain. It identified several key observations; 
discussion at the focus group indicated that a wide variety of work practices existed 
which would make a detailed analysis difficult to apply to all trusts. A list of work 
processes was developed for each of the three separate functions; procurement, 
distribution, and supply chain management. In reality, different managers at different 
trusts had mixed skills and roles, so that assuming one named role has all or only a set 
number of skills and knowledge could be misleading in reality. 
 
The complexity in the supply chain of medicines and the difficult decisions that result 
from drug choice has led to a new discipline being developed to help understand the 
relevant large data output. Pharmacoeconomics helps in making choices by identifying 
and weighing up the value of pharmaceutical products and services from multiple 
perspectives. Pharmacoeconomic research allows decision-makers to characterise 
and compare alternative treatment options, in terms of primary healthcare outcomes, 
including: (1) clinical (medical events that occur because of disease or treatment); (2) 
economic (including direct, indirect, and intangible costs); and (3) humanistic 
(consequences of the disease or treatment from the patient’s perspective, including 
satisfaction with care, functional status, or quality of life). This expansion in demand for 
pharmacoeconomic data will be spurred on by greater knowledge or sophistication 
among healthcare decision-makers over how such information can be used to greater 
advantage (Thwaites and Townsend, 1998). 
 
The drugs do not flow physically directly from the product manufacturer to the end 
user, in this case the patient, and there are a number of causes for this, including both 
regulatory and the market environment. Instead, the routes taken are convoluted in the 
UK and are similar to pharmaceutical supply chains in other countries and similar 
issues exist, such as counterfeit medications and product shortages (World Health 
Organisation, 2006). Research has indicated that in Europe medicines can travel 
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through as many as 20 to 30 pairs of hands before it finally reaches the patient (Haigh, 
2004).  
 
There is a general trend for companies to divest excess capacity that came about from 
having many local manufacturing sites, and move towards a global supply chain (Shah, 
2004). This brings with it many complex coordination issues and much tighter capacity 
constraints. Currently, the logistics cost in the sector is relatively high (Booth, 1999). 
Research efficiency is declining in the sense that the cost of each new chemical entity 
is increasing. Although growth in investment in R&D has exceeded inflation over the 
last 30 years, the global trends are as follows: 844 New Chemical Elements (NCE) 
were registered in 1961–1970, 665 in 1971–1980 and 506 in 1981–1990 (Ballance, 
Pogany and Forstner, 1992). This has been one of the main drivers behind the recent 
series of mergers and acquisitions in the industry, the long-term benefits of which will 
probably not be felt for some time yet as R&D activities continue to be consolidated. As 
such, several drug manufacturers have acquired competitors with newer products to fill 
their own sales gaps. In the last two years, Pfizer paid $68bn for Wyeth, Merck paid 
$4bn for Schering-Plough, Roche paid $46bn for Genentech, and Sanofi-Aventis paid 
$20bn for Genzyme (Transport Intelligence, 2011).  
 
Historically, most management attention has been paid to drug discovery and sales 
and marketing (the extreme ends of the supply chain), but now much more attention is 
being paid to supply chain optimisation as a means of delivering value. There is a 
welcome move away from viewing the supply chain as merely having to deliver 
security of supply at minimum cost, to a recognition of its ability to generate both value 
for the customer and hence to the shareholder, and restructuring of the supply chain 
along regional and global lines will require massive reductions in capacity, which was 
acquired in many cases to propitiate national interest in return for sympathetic pricing 
(Booth, 1999). 
 
There are several components of the pharmaceutical industry manufacturing and 
distribution chain. A typical pharmaceutical supply chain will consist of one or more of 
the following nodes: 
 
1. Primary manufacturing (possibly including contractor sites); 
2. secondary manufacturing (possibly including contractor sites); 






These five components are explained in more detail in the following three sub sections; 
section 2.3.2 and 2.3.3, concentrating on the industry manufacturing, and section 2.3.5 
commenting on the pharmaceutical distribution chain.  
 
2.3.2  Primary manufacturing   
 
The primary manufacturing site is responsible for the production of the active 
ingredient (AI or API). This normally involves either several chemical synthesis and 
separation stages to build up the complex molecules involved, or fermentation and 
product recovery and purification in the case of biochemical processes. The 
manufacturing process is characterised by long task processing times, often rounded 
to multiples of shifts. Where multistage processes are operated, considerable 
inventories are often held between stages. Furthermore, material from an intermediate 
stage must often pass some form of quality control check before being approved for 
use downstream in the process. This can introduce additional delays into the system. 
The traditional process technology involves batch equipment and flexible pipe work. 
The relatively low production volumes result in multipurpose plants to spread the 
capital cost between products. The need to avoid cross-contamination of products and 
requirements for validated cleaning, plus changeovers, results in long downtimes 
between products. These have been of the order 4 weeks in the past, but the 
application of techniques is similar to the single-minute exchange of die (SMED) 
methods that (Moser, Calderari and Morini, 2000) applied to the car industry have 
reduced these times somewhat. These downtimes, in turn, imply that long campaigns 
are the norm; otherwise equipment utilisation is too low. It is not unusual for one year’s 
production of a product to be produced in a single campaign, and the material 
produced being stored until the next campaign in the following year. Since most 
complex pharmaceuticals are produced through multistage processes, the same often 
holds true for the stable intermediates (stage products). This mode of operation does 
not lend itself well to responsiveness, and contributes significantly to some of the poor 
supply chain metrics exhibited by this industry. A further source of complexity (and 
convenience) is the use of contractors to manufacture some, or indeed all, of the active 
ingredient stages. This process of outsourcing is a growing one, as research-oriented 
companies concentrate on the discovery and development activities and rely on third 
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parties’ manufacturing competence. This gives rise to extended supply chain co-
ordination problems. 
 
2.3.3  Secondary manufacturing 
 
This is concerned with taking the active ingredient produced at the primary site and 
adding 'excipient' inert materials, along with further processing and packaging, to 
produce the final products, usually in SKU form. For example, a product that is sold in 
pill form would undergo: 
 
1. Granulation: with addition of all the excipient materials; 
2. compression: forming the pills; 
3. coating; 
4. quality control; and 
5. packaging. 
 
The secondary manufacturing locations are often geographically separate from the 
primary manufacturing locations. This is frequently the outcome of tax and transfer 
price optimisation within the enterprise. There are often many more secondary 
manufacturing sites than primary ones, serving local or regional markets. 
Transportation between sites is of the order of one or two weeks if by ship (usually the 
default mode), and of the order of one or two days if by air.  
 
2.3.4 Pharmaceutical Distribution Chain 
 
Wholesalers play a significant role in this sector. They tend to be large and few. About 
80% of demand flows through this channel in the UK (with three large players 
accounting for almost all the demand), with the large part of the remainder going to 
hospitals. In the US, another intermediary is growing; the managed care organisation 
(MCO), or healthcare maintenance organisation (HMO) (Shah, 2004). 
However, as the market shifts towards personalised healthcare, an increasing focus is 
on a narrower group of individuals. Many of these newer drugs require more complex 
manufacturing and distribution processes than shelf-stable pills. Also, the push for 
safety in the supply chain is a factor in requiring backward visibility to manufacturers’ 
suppliers and suppliers’ suppliers in a robust and real-time way. Market warehouses 
and distribution centres, whether run by third party logistic companies or through 
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dedicated or multi-user distributor, are at the centre of the distribution chain, however, 
these can be missed out in a direct to market model favoured by some larger pharma 
companies. 
Fluctuation in demand for branded and generic products, and changes in distribution 
channels, are also driving the continued evolution of supply chain models. For 
example, the loss of patent protection is impacting the supply chains of both 
manufacturers and large retailers. For generic drugs, 70% are now delivered direct to 
retailers in the US, compared with just 10% of brand-name drugs. This volume of 
generic drugs now sold through the retail channel is leading many large retailers to 
work directly with manufacturers to integrate products into their own distribution 
network for less complexity and cost. New direct-to-patient, high-cost specialty 
therapies are also causing manufacturers to reconsider how they take products to 
market to better respond to consumer demand. As well as retailers, hospitals 
themselves are involved in the distribution chain in several ways including supply to 
other hospitals and groups, and to logistics companies and to and from the parallel 
trade and, in some cases, urgent specials and reformulations. 
Pharmaceutical companies are businesses, not public health agencies; they are not 
obligated to make certain types of drugs, for example, vaccines. To determine where 
they should invest research and development (R&D) dollars, pharmaceutical 
companies evaluate a product’s potential to contribute to their bottom line. Among the 
four large companies that are still making vaccines, these account for less than 1% of 
the worldwide vaccine industry. None has revenue from vaccines that exceeds 10 
percent of total revenue (Offit, 2005). 
The growth in emerging markets adds another level of complexity. Global 
pharmaceutical outsourcing has become increasingly prevalent, but is creating a 
complex and risky supply chain environment. This global expansion is making it more 
difficult for pharmaceutical manufacturers to manage their supply chain. The need for a 
flexible supply chain is great as the industry undergoes changes in product mix, 
manufacturing routes, and distribution channels for different kinds of products 









In summary, section 2.3 introduces the drivers in the pharmaceutical industry, including 
the primary and secondary manufacturing aspects of the supply chain as it is complex 
and interlinked, so that a disruption in just one aspect can create downstream havoc. It 
ends with the distribution chain for pharmaceuticals review, including the remote and 
widespread outsourcing, and financial factors. Section 2.4 presents a comprehensive 
understanding of the current knowledge on the topic of supply chain disruptions, 
including risk management, resilience management, distribution response, and 




2.4 Supply Chain Disruptions 
 
This section outlines the process followed in the literature review of supply chain 
disruptions, highlights the areas of selected focus, provides the context and 
background about the current knowledge of the topic, and lays out the argument for 
further research. 
 
The literature review followed a six step process, as recommended by Machi and 
McEvoy (2009), from topic selection which then specified and framed an initial search 
of the literature. The review then explored and catalogued related topics. Next, the 
review developed the argument to refine the area of interest, and then organised and 
formed the basis of the literature survey. The review then documented and discovered 
evidence for the next step, which was the critique of the literature which then 
advocated and defined the written review. The following topics were selected from the 
extensive literature in the field of supply chain management, as introduced in section 2, 
as most relevant from the review process. 
 
The focus of the review of the extant literature considering supply chain disruptions will 
include the relevant management literature, as well as the following main related 
topics: 
 
1. Supply Chain Risk Management 
2. Supply Chain Resilience Management 
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3. Supply Chain Disruption Response Management 
 
This is to concentrate the review so that the gaps in the current understanding can be 
highlighted to position and justify this study's research work and clearly identify the 
academic contribution.  
A review of the extant literature, focusing on supply chain disruptions, revealed a wide 
range of perspectives have been researched. These include supply chain risk 
management (Vlachos, Iakovou, Papapanagiotou et al., 2012, Pfohl, Kohler and 
Thomas, 2010, Wright, 2013), supply chain strategic management (Tang, 2006, Sheffi 
and Rice, 2005), and strategic resilience management (Teoh and Zadeh, 2013, Jüttner 
and Maklan, 2011). 
The review of supply chain disruptions will examine each of these three perspectives 
and identify gaps in the research, before looking at them in greater detail.   
However, this abundance of research has focused on the antecedents of supply chain 
disruptions, but the question of what happens after a disruption has received scant 
attention. This research acknowledges that academic gap, and seeks to build on the 
Bode et al. (2011) model of organisational responses to supply chain disruptions. This 
important concept is discussed in more detail in section 2.4.3; supply chain disruption 
response management, and further developed in the research question in Chapter 3. 
The globalisation of economic interchange, rising volatility of markets, trends towards 
out and single sourcing, as well as just-in-time concepts, are making today’s supply 
chains ever more complex (Harland, Brenchley and Walker, 2003, Crone, 2006). Flows 
of goods, information, financial resources, rights, and multiple interfaces have to be 
integrated, increasing their vulnerability (Peck, 2006). This is exacerbated by 
numerous events of the previous decade. Supply chains are often triggered by 
disturbances on the supply and the demand side, e.g., terrorist attacks, natural 
disasters, changes in consumer behaviour, technological crises, or bankruptcy. The 
trend to designing lean supply networks that are tightly coupled and operated at 
minimum levels of time and material’s buffers makes them vulnerable to local 
disturbances. These can be an existential threat to global or networked supply chains 
and may have negative effects on costs, quality, flexibility, and reliability on image and, 
ultimately, the valuation of all the participants in the network. Cross-company supply 
chain risk management therefore becomes a critical success factor. There has been a 
fundamental consensus emerging in research, as well as in business practice, that 
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systematic risk management is required to deal with these challenges. However, there 
are different opinions on the necessary elements of successful supply chain risk 
management. Research on the process of supply chain risk management 
implementation has received less focus  (Pfohl, Kohler and Thomas, 2010).  
 
2.4.1 Supply Chain Risk Management 
 
A definition of supply chain risk management is applied, as suggested by Kaju''ter 
(2003) p36:  
Supply chain risk management is a collaborative and structured approach to 
risk management, embedded in the planning and control processes of the 
supply chain, to handle risks that might adversely affect the achievement of 
supply chain goals. 
 
Systemic risks with global geographic scope, cross-industry relevance, uncertainty as 
to how and when they will occur, and elevated levels of economic and/or social impact 
have become a major concern for supply chain operators. Building risk management 
into supply chain governance is essential, but broader measures are also necessary. 
Through greater public and private sector collaboration, including activities such as the 
World Economic Forum Supply Chain Risk Initiative, we are deriving a more 
comprehensive view of supply chain risk and the measures needed to build greater 
resilience, while increasing both the efficiency and the effectiveness of global supply 
(Wright, 2013).  
 
The World Economic Forum conducted a detailed survey across Europe, North 
America, and Asia, via supply chain risk radar; an analytical and self-diagnostic tool 
developed by the World Economic Forum (WEF). The aim of the survey was to 
understand how the risk landscape varied across the three regions and how the top 
risks compared with the top five global risks from 2011. Survey respondents 
considered global risks and their potential to cause system-wide disruptions in global 
supply chains. Four of the top five risks (natural disasters, conflict and political unrest, 
terrorism, and sudden demand shocks) remained unchanged. Extreme weather, 
however, emerged as a more prevalent concern in 2012, with an overall ranking of 




Processes can either amplify or absorb the effect of risks in the supply chain and refer 
to the design and implementation of processes within and between the entities in the 
supply chain. Robust processes are built on a thorough understanding of variability, 
e.g., in manufacturing or forecasting, supply chain bottlenecks or dependencies on IT 
systems, and may need to have planned process redundancies or excess capacities 
where necessary (Mason-Jones and Towill, 1998). For example, the impact of supplier 
insolvency as a supply risk is either amplified or absorbed by the level of excess 
capacity held within the chain. Similarly, supply chain control mechanisms, like 
decision rules and policies regarding order quantities, batch sizes, and safety stocks, 
can either amplify or absorb risk effects. For example, the effect of a sudden trough in 
demand is amplified in the presence of inflexible rules regarding order quantities. It is 
suggested here that a characteristic of supply chain risk sources is that they can be 
inextricably linked to the supply chain structure.  
 
Supply and demand risk sources are supply chain specific and are likely to affect 
several interdependent parties in the chain. Moreover, demand and supply risks, as 
internal supply chain risk sources, imply that any company in the supply chain can be 
responsible for supply chain risk management implementation and become a source of 
risk to the supply chain at the same time. Expanding the idea of supply chain risk, it 
can be argued that a supply chain's risk exposure determines its vulnerability. As 
argued by Jüttner (2005), supply chain vulnerability is defined as an exposure to 
serious disturbance arising from supply chain risks, affecting the supply chain’s ability 
to effectively serve the end customer market. The remit of supply chain risk 
management as a managerial activity can be defined as the identification and 
management of risks for the supply chain, through a co-ordinated approach amongst 
supply chain members to reduce overall supply chain vulnerability. This definition is 
similar to the one proposed by Lindroth and Norman (2001). However, they take a 
more restricted view by stating that supply chain risk management deals with risks 
caused by, or impacting on, logistics-related activities or resources. By contrast, this 
definition adopts the basic tenet of the overarching concept of supply chain 
management that logistics is only one of the functions contained in the concept 
(Guinipero and Brand, 1996, Cooper, Lambert and Pagh, 1997, Ross, 1998, Mentzer, 
Dewitt, Keebler et al., 2001). Hence, supply chain risk management, like supply chain 
management, entails the same multiplicity of business functions and processes.  
 
As the supply chain networks keep on expanding geographically in a globalised 
environment, they are becoming more exposed to risk, even more prone to disruption, 
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and thus more vulnerable (Iakovou, Vlachos and Xanthopoulus, 2007). Increasing 
product and service complexity, outsourcing, and globalisation have led to the growth 
of complex, dynamic supply networks, changing risk and its location (Harland, 
Brenchley and Walker, 2003). Furthermore, business studies confirm that the newly 
shaped market should take under serious consideration the management of supply 
chain risk since disruptions could have an impact not only on a company’s financial 
situation, but also on the stock price performance (Hendricks, Singhal and Zhang, 
2009). 
 
As a result, researchers try to develop new analysis and optimisation models for 
demand planning, production scheduling, transportation network design, inventory 
control, lean initiatives, and other areas along the value chain. This focus on supply 
chain management aspects inevitably turned the spotlight on the extensive study of 
supply chain risk management and vice-versa (Vlachos, Iakovou, Papapanagiotou et 
al., 2012). Either way, the management of risk in supply chains has now become an 
established element in the fields of supply chain management, corporate strategic 
management, and enterprise risk management (Zsidisin and Ritchie, 2008). Risk to 
enterprises research has also incorporated ‘time to response’ reduction, considering, 
for example, key factors in cutting response time. Chadist (2012) stated that 
preparation, partnership, organisation and reserve are all key factors in reducing 
response time. 
 
The problem is that many companies leave risk management and business continuity 
to security professionals, business continuity planners, or insurance professionals. 
However, building a resilient enterprise should be a strategic initiative that changes the 
way a company operates and that increases its competitiveness. Reducing 
vulnerability means reducing the likelihood of a disruption and increasing resilience, i.e. 
the ability to bounce back from a disruption (Sheffi and Rice, 2005). Strategic supply 
chain management is then concerned with planning ahead so that resilience in the 
supply chain can be built in. Khan, Christopher and Creazza (2012) research in the 
retail fashion industry investigated the alignment between product design and the 
supply chain and investigated how this alignment impacts on a firm’s supply chain 
responsiveness and resilience. They considered the alignment of product design and 
the supply chain, such as expanding and internalising the design process to work 
closer to procurement teams and other key business functions. Because of this case, 
an interesting link has been observed between supply chain responsiveness and 
supply chain resilience in that a number of strategies that were implemented to 
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improve supply chain responsiveness have also reduced the impact of supply chain 
risk and improved the company’s resilience. 
 
Tang (2006) also highlighted the requirement for firms to secure their supply chains 
through 'robust' supply chain management strategies. Firstly, these strategies should 
be able to help a firm to reduce cost and/or improve customer satisfaction under 
normal circumstances. Secondly, the same strategies should enable a firm to sustain 
its operations during and after a major disruption. The Tang (2006) work identified 
several robust strategies, as shown below in Table 2, and it is shown how these 
strategies can help a firm to succeed before, during, and after a major disruption. An 
established, robust supply chain strategy would enable a firm to deploy the associated 
contingency plans efficiently and effectively when facing a disruption. Therefore, 
having a robust supply chain strategy could make a firm become more resilient. Table 
2 summarises key features of the nine strategies identified.  
 
 
Table 2. Robust strategies, Tang (2006) 
 
Table 2 sets out nine supply chain strategies with the main objective for each strategy 
employed. It also highlights the perceived benefits for each supply chain strategy 
employed under normal circumstances, and the related benefits after a major 
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disruption. The difference is that while the benefits of strategies employed under 
normal circumstances look at overall capabilities in a predictable environment, the 
benefits that ensue after a disruption have a different focus and dynamic. Various 
strategies and benefits are examined in further detail below. 
 
The postponement strategy, as shown in Table 2, utilises product or process design 
concepts such as standardisation, commonality, modular design and operations 
reversal, to delay the point of product differentiation. Strategic stock strategy involves 
carrying additional 'just in case' safety stock inventories to ensure that the supply chain 
can continue to function smoothly when facing a disruption in supply. Flexible supply 
base strategy negates the use of just a single supplier, instead employing multiple 
suppliers to accommodate regular demand fluctuations but also maintains supply of 
materials when a major disruption occurs. A make-and-buy strategy allows the 
production of certain products in-house, while other products are outsourced to outside 
suppliers. Economic supply incentives strategy uses economic incentives issued by the 
buyer to cultivate additional suppliers where there is limited number of suppliers in the 
market. This strategy was used by the US government to mitigate the lack of flu 
vaccine producers in October 2004. Following a strategy of flexible transportation uses 
a variety of means to transport product from utilising different modes of transport, 
routes, and carriers to spread the risk of disruption. Revenue management by dynamic 
pricing and promotion allows a firm facing a disruption by changing pricing to change 
customer’s behaviour to mitigate the impact. Assortment planning uses product 
placement and mix to influence consumer product choice and demand, commonly 
used, for example, by retailers. Under silent product rollover strategy, new products are 
'leaked' slowly into the market without any formal announcement so that key new 
features on the market do not create unsustainable demand creating a stock-out 
situation.   
 
The occurrence of supply chain disruptions, which have many downstream effects, 
including shortages, have prompted the increased academic research focus on supply 
chain resilience and supply chain disruption management. Resilience engineering is a 
discipline focused on identifying system capabilities and response to disruption threats, 
often focused on, for example, safety and security systems (Hollnagel, Woods and 
Leverson, 2007). Risk analysis, in contrast, concentrates on identifying and 
understanding existing and evolving threats that challenge operations of complex 
systems (Lambert, Keisler, Wheeler et al., 2013). Supply chain resilience, however, is 
a comprehensive view of supply chain robustness and stability. It has a more strategic 
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emphasis on the design of supply chains (Barroso, Machado and Cruz-Machado, 
2011). 
2.4.2 Supply Chain Resilience Management       
 
Supply chain resilience is currently considered a critical component of supply chain risk 
management (Ponomarov and Holcomb, 2011), and a relatively new and yet 
underexplored research area of management as a whole. As Christopher and Peck 
(2004) state, supply chain resilience is a scientific field of research in its ascendancy. 
The significance of supply chain resilience in the context of contemporary global supply 
chains is further validated by Gartner’s Supply Chain Top 25 report (2011), in which 
authors identify resilience as being one of the four major themes for research. The 
literature review revealed the existence of two discrete approaches on organisational 
resilience. Some scholars see organisational resilience as simply an ability to rebound 
from unexpected, stressful, adverse situations and to pick up where they left off, while 
others visualise organisational resilience beyond restoration to include the 
development of new capabilities and an expanded ability to keep pace with and even 
create new opportunities (Lengnick-Hall, Beck and Lengnick-Hall, 2011, Ponis and 
Kronis, 2012). Lengnick-Hall, Beck and Lengnick-Hall (2011) defines organisational 
resilience as the firm's ability to effectively absorb, develop situation-specific responses 
to, and ultimately engage in transformative activities to capitalise on disruptive 
surprises that potentially threaten organisation survival  
 
There have been several studies considering the present literature on supply chain 
resilience in this turbulent disruption-rich world. This literature survey identified 77 
studies which were reviewed from the extant supply chain resilience and disruption 
literature, as per the supply chain disruption resilience table in Appendix 1. As 
described above, the literature review process involved a search of the extant 
academic literature using key word Boolean searches. The search defined the 
investigation terms, identified the databases, then determined and applied criteria for 
inclusion and exclusion. The references were then catalogued by tabulating under 
general headings for review. Reference headings were by date, author, title, 
methodology, perspective, theory, focus, and contribution. The focus content was then 
further summarised by coding, so that frequency and reoccurring themes could be 
quickly identified and described. Lastly, a brief critique of each reference included was 
given so that the limitations of other research could be identified to avoid future 
mistakes but also to help interpret their findings, identify gaps, and consider the 
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inclusion of variables that may not otherwise have been considered, as suggested by 
Bryman and Bell (2011). The three key topics identified and focused on were supply 
chain risk management, supply chain strategic management, and strategic resilience 
management. 
 
However, most of this research focuses on strategies to mitigate or measure the 
disruption impact. For example, taking a strategic management perspective argues for 
increased flexibility to improve resilience (Sheffi and Rice, 2005). Taking a process 
control perspective, Christopher and Peck (2004) suggests a framework for improved 
supply chain risk identification, whereas other researchers using a benchmarking 
approach have endorsed a measurement tool to test proposed resilience (Stephenson, 
Seville, Vargo et al., 2010). Several researchers have used evaluation measurement 
either through gaming quantification of mitigating financing (Bakshi and Kleindorfer, 
2009), or using graph theory to provide supply chain vulnerability indices for industries 
(Wagner and Neshat, 2010). Some researchers have drawn on a control theory based 
approach leading to an optimisation model based framework, (Seferlis, Vlachos, 
Iakovou et al., 2008), building on earlier work which developed a deterministic EOQ-
type inventory control model for a two-stage supply chain that is susceptible to several 
types of production and demand related disruptions (Xia, Yang, Golany et al., 2004).  
 
Few, except for some notable exceptions (Bode, Wagner, Petersen et al., 2011, 
Greening and Rutherford, 2011, Primo and Dooley, 2007, Grewal, Johnson and 
Sarker, 2007), have examined the strategic behaviour of firms in response to the 
supply chain disruption. While the Greening and Rutherford (2011) research focused 
mainly on the network structure post disruption rather than specifically on the 
motivation behind the response. Primo et al's (2007) primary concern was on supplier 
dissatisfaction by manufacturers. Mishra, Sharma, Kumar et al. (2016) considered 
buffering and bridging strategies to minimise risk and improve downstream supply 
chain performance. Their work, however, was based on the classic four firm typology 
approach of prospectors, defenders, analysers, and reactors (Miles, Snow, Meyer et 
al., 1978). Grewal et al. (2007) was concerned with the nature of response both 
location and context. They highlighted two dimensions: response diversity and nature 
of crisis to give a typology of four response patterns; hedging, cautious, focusing, and 
maintenance. Pettit, Fiskel and Croxton (2013), in contrast, took a general supply chain 
research perspective with a focus on supply chain resilience, taking account of both 
capabilities and disruption response. However, only a single method of focus group 
was used, based on a single company in the retail vertical. It was conducted over only 
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a short period with strong conceptual bias. The research of Ponis and Kronis (2012), 
Jüttner and Maklan (2011), Vickers and Kouzmin (2001), Asbjornslett (1999) had both 
a supply chain resilience and vulnerability aspect included in their work, however, only 
Jüttner and Maklan (2011) conducted an empirical study; all, however, did have a 
capability focus. However, Peck (2005) and Greening and Rutherford (2011) focus on 
both capabilities and distribution response. Ivanov, Sokolov and Dolgui (2014) 
observed that quantitative analysis tools are rarely applied in practice, and concluded 
that the ripple effect can be the phenomenon that is able to consolidate research in 
supply chain disruption management and recovery, similar to the bullwhip effect 
regarding demand and lead time ﬂuctuations, where the ripple effect describes the 
impact of a disruption on supply chain performance and disruption-based scope of 
changes in the supply chain structures and parameters. Following a disruption, its 
effect ripples through the chain of supply. The scope of the rippling and its impact on 
economic performance depends both on robustness reserves (e.g., redundancies like 
inventory or capacity buffers) and speed and scale of recovery measures (Hendricks 
and Singhal, 2005, Sheffi and Rice, 2005, Tomlin, 2006, Bode, Wagner, Petersen et 
al., 2011, Kim and Tomlin, 2013). The Ivanov, Sokolov and Dolgui (2014) research, 
however, was an identification of the challenges and suggested solutions as a 
summary, rather than an empirical data-based study from the field. Greening and 
Rutherford (2011) also used a desk-based methodology but conducted an extensive 
literature review of 485 articles, and rather than empirically-based research, it was 
looking at the theory of supply chain disruption with a focus on network structure post 
disruption. Peck (2005) work, in contrast, used an exploratory case study of the military 
aerospace industry and considered the sources and drivers of supply chain 
vulnerability, however, the main purpose of the work was to consider the broader 'why' 
question in supply chain vulnerabilities.  
 
There exists significant research in the extant literature relating to and focusing on 
mitigating and measuring impact, however, this review found there has been scant 
attention on strategic responses to disruptions once they have occurred. Section 2.4.3 
considers supply chain disruption response management. In particular, this part of the 
literature review will give insights into the theoretical background and associated 
findings, articulating the gaps in the literature, and applying findings to the particular 




2.4.3 Supply Chain Disruption Response Management       
 
Bode et al. (2011) presented the first systematic empirical investigation of 
organisational responses to supply chain disruptions. Bode et al. (2011) introduced the 
concept of supply chain disruption orientation, introducing the construct  into the supply 
chain literature, building on earlier organisational orientation works by (Daft and Weick, 
1984) investigating active and passive firms. They examined why, how, and under 
what conditions firms respond to supply chain disruptions. Bode et al. (2011) 
introduced a model of organisational responses to supply chain disruptions, 
underpinned by the dual theoretical lenses. These were resource dependency theory 
(Carroll, 1993) and information processing theory (Galbraithe, 1977, Tushman and 
Nadler, 1978). Pfeffer and Salancik (1978) state in regard to resource dependency 
theory that, although organisations depend on their environment to survive, they seek 
to assert control over the resources they require to minimise their dependence. 
Galbraith (1973) p150, proposed that uncertainty refers to the “difference between the 
amount of information required to perform a task and the amount of information already 
possessed by the organisation”. The more environmental uncertainty a firm faces, the 
more information it needs to gather and process to achieve a given level of 
performance. The importance of the Bode, Wagner, Petersen et al. (2011) research 
was that it provided insights into the mechanisms that shape organisational responses 
to supply chain responses, augmenting resource dependency theory perspective with 
other lenses, as called for by (Hillman, Withers and Collins, 2009). This research will 
build on those insights into factors affecting responses by considering their post 
disruption consequences and extend understanding of the response actions dynamic.   
 
Alternative responses to disruptions and the drivers behind them is a relatively novel 
area of research compared to that of supply chain risk management. Supply chain risk 
management is defined as an inter-organisational collaborative endeavour utilising 
quantitative and qualitative risk management methodologies to identify, evaluate, 
mitigate, and monitor unexpected macro and micro level events or conditions which 
might adversely impact any part of the supply chain (Ho, Zheng, Yildiz et al., 2015). 
Theories that encompass both the striving for stability and the generation of the 
stability motive to react to disruptions, giving two generic responses: that of bridging 
and buffering, which can be built off earlier works on the subject  (Fennell and 
Alexander, 1987, Meznar and Nigh, 1995). Buffering actions are attempts to gain 
stability by establishing safeguards that protect a firm from disturbances that an 
exchange relationship confers, and bridging actions are attempts to manage 
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uncertainty through employing 'boundary-spanning' and 'boundary-shifting' actions with 
an exchange partner. 
Resource dependency theory focuses on control, power, and vulnerability in firms' 
external responses, whereas information processing theory focuses on information and 
smooth internal processes. However, as a supply chain disruption affects both internal 
processes (information processes) and external processes (exchange partnerships), 
Bode et al (2011) identified the need for an integrative view to explain why firms 
respond to these events.   
Models of organisational responses to supply chain disruptions have included trust and 
dependence in the external processes (interfirm) and supply chain orientation and prior 
experience in the internal processes (intrafirm). Trust is considered to be central to 
explaining a firm’s interpretation of and behaviour towards its exchange relationships 
(Morgan and Hunt, 1994). Every firm has learned preferences for the parameters that it 
uses to determine its response in light of the environmental uncertainty it faces (Huber, 
1991), where the experience of such disruptions with an exchange partner establishes 
the amount of trust between them (Anderson and Narus, 1990). Trust then serves as 
the condition under which decision choices are formed. Trust is accepted by this 
research as an important factor in organisational response behaviour and included in 
Figure 9 below. From a resource dependence perspective, a supply chain disruption 
requires a response when it entails a dependence relationship (Pfeffer and Salancik, 
1978). Dependence on an exchange partner implies that a firm needs to maintain the 
relationship with the partner to achieve its desired goals (Emerson, 1962). As the 
degree of dependence increases, so does the likelihood that the firm considers the 
occurrence of a disruption to be important and reflective of its lack of control 
(Buchanan, 1992, Daft, Sormunen and Parks, 1988), thereby arousing the stability 
motive (Green and Welsh, 1988 ). Dependence is accepted as a key factor in 
organisational response behaviour and included in Figure 8. Taking an information 
processing perspective, the occurrence of a supply chain disruption may indicate to a 
firm that its information processing capabilities and information processing needs are 
mismatched. Without relevant prior experiences, the firm has difficulty determining the 
form and the strength of a response that restores fit and, consequently, stability 
(Sinkula, 1994). Prior experience in a firm means that it has likely developed dedicated 
rules and routines for dealing with supply chain disruptions (Green and Welsh, 1988 ). 
Prior experience is accepted by this research as an important parameter in 




The interpretative posture and motivation to act determined then the organisational 
response repertoire (bridging or buffering) to the supply chain disruption, where supply 
chain disruption orientation is defined by Bode, Wagner, Petersen et al. (2011) p837, 
as "a firm's general awareness and consciousness of, concerns about, seriousness 
toward, and recognition of opportunity to learn from supply chain disruption." 
Organisational response research findings indicated that a high supply chain disruption 
orientation makes firms more likely to craft a specific response for reducing the 
likelihood and impact of future supply chain disruptions (Bode, Wagner, Petersen et al., 
2011). Their results are consistent with those of other studies emphasising the 
importance of firm orientations and cultural traits, enhancing a firm’s capability for 
dealing with adverse events  (Edmondson, 1996, Dyck, Frese, Baer et al., 2005, 
Cheng and Lu, 2017). A firm’s ability to effectively respond to adverse events and to 
accommodate latent problems or changes in its environment can be critical to both its 
competitiveness and its long-term success (Child, 1972, Alldred, 2006). This is also in 
line with Li, Wu, Holsapple et al. (2017) who found in a turbulent environment supply 
chain preparedness, supply chain alertness and supply chain agility all aim at 
increasing a firm’s financial outcomes. 
 
Other researchers have also looked at a firm's orientation affecting their actions, 
including Autry and Bobbitt (2008) who did look at how a firm was orientated towards 
risk but there was a focus on disruption from a security perspective, with actors 
changing their actions accordingly, however, their research was qualitatively based on 
risk with operational performance. Narver and Slater (1990), in contrast, chose a 
market perspective to consider the response orientation of a firm, as did Lumpkin and 
Dess (1996) who examined a firm's orientation through an entrepreneurial lens. The 
security orientation perspective has also been studied empirically in the US and Italy in 
a large study (462 firms) considering supply chain security (SCS), classifying practices 
and differential effects on performance (Lu, Koufteros and Lucianetti, 2017) . They 
looked at how supply chain security (SCS) breaches (a form of supply chain risk) are 
distressing supply chains and they have the potential to engender acute pain on the 
society at large. Although they looked at practices and performance, their results 
suggested that detection practices are the most efﬁcacious when SCS performance is 
concerned, however, they were considering action before disruption impact, and 
detection, for example, would be techniques such as closed-circuit television. Although 
they suspected that prevention may have a stronger impact than mitigation and 




Alternative research perspectives also looked at responses to supplier induced 
disruptions for example Reiman (2017) on event system theory and presents an in-
depth qualitative investigation of 60 response processes following supplier-induced 
disruptions in Western–Chinese buyer–supplier relationships. An example was 
defective key components from one of Apple’s China-based suppliers that slowed 
down the release of the Apple Watch (Wakabayshi and Luk, 2015). Event system 
theory characterizes the strength of an event based on its novelty, impact, and 
criticality (Morgeson, Mitchell and Liu, 2015). Behavioural research perspectives have 
also been used to evaluate supply chain disruption response management, as 
individual’s behaviour is a key in understanding response mechanisms. So to better 
understand the behavior of boundedly rational individuals, behavioral supply 
management researchers have recently begun to explore the cognitive underpinnings 
of purchasing managers’ decision-making (Carter, Kaufmann and Michel, 2007). In line 
with this is increasing interest on individual-level based knowledge view in building 
supply chain risk mitigation competency (Ambulkar, Blackhurst and Cantor, 2016).  
 
Research aimed at improving operational performance in supply chain disruptions 
have been framed using information processing theory and the complementarity theory 
suggesting that a combination of external supply chain integration practices with 
traditional risk management practices is superior in in facing risky environments and 
improving operational performance (Kauppi, Longoni, Caniato et al., 2016) 
complementing the work in this area with (Zhao, Huo, Sun et al., 2013, Nooraie and 
Parast, 2016, Ivanov, Pavlov, Dolgui et al., 2016). Although in the Kauppi, Longoni, 
Caniato et al. (2016) study, data collection was limited to the exogenous distribution 
risks. Other orientation based supply chain resilience research in congruence with 
Bode, Wagner, Petersen et al. (2011) has found orientation important, for example 
Cheng and Lu (2017) their findings indicated managers of larger ﬁrms should consider 
facilitating trajectory and absorptive capacity to enhance proactive and reactive 
dimension of supply chain resilience. In contrast to Kauppi, Longoni, Caniato et al. 
(2016) a resource based theory perspective was adopted by Cheng and Lu (2017). 
Although as indicated by Nooraie and Parast (2016)  increasing supply chain resilience 
to risks has its own costs. Busse, Meinlschmidt and Foerstl (2017) took a purely 
information processing perspective and found that in extreme situations though facing 
the same amount of a certain type of uncertainty, apply the fitting information 




This research will build upon and refine the new construct of supply chain disruption 
orientation, by building on existing theory and examining it in greater detail through 
extensive research and rigorous examination. The Bode at al. (2011) model, as shown 
below in Figure 8, contributes to academic knowledge by normatively explaining the 
why, how, and under what circumstances firms respond to disruptions, however, their 
research did not go on to examine the performance implications of the respective 
bridging or buffering strategic response choices. This is important because to make 
effective decisions, managers need to be informed (Pfeffer and Salancik, 1978), as per 
resource dependency theory. Supply chain orientation is a new concept which offers 
new insights in response behaviours which is important in informing strategic 
management thinking, however, it requires further development and empirical 
examination to improve validity and generalisation. The response action outcome 
information not only comes from prior experience, for example, because the 
information may have been forgotten, never documented, or the individual manager 
making that decision could no longer be available. Lack of documentation processes 
and recording results in large complex organisations, where functions and decisions in 
a supply chain can be spread over many individuals, has been identified as a threat to 
performance (Heywood, 2014). As mentioned previously, earlier work on supply chain 
resilience has attracted optimisation-based framework models using quantitative 
methodologies (Seferlis, Vlachos, Iakovou et al., 2008, Falasca, Zobel and Cook, 
2008, Xia, Yang, Golany et al., 2004). Although Bode at al. (2011) developed the 
causal links (as shown in Figure 8) between the actions of buffering and bridging as 
organisational responses to supply chain disruptions, they did not establish the 
benefits of incorporating dynamic feedback performance that has been examined 
through optimisation using a quantitative simulation approach.  
This research will further consider the dynamic feedback on response disruption 
decisions and its effect on performance. This area lacks detailed research, with a 
recent literature survey of more than 200 supply chain researchers presenting three 
gaps in supply chain risk management, one of which was process gap (inadequate 
coverage of responses to risk incidents), (Ho, Zheng, Yildiz et al., 2015). To action this, 
a feedback construct is added to the original model (as shown in Figure 8), to help 
inform and improve the supply chain orientation of an organisation in a continual 
process, which is dynamic rather than static. This will be achieved by capturing and 
understanding the actual outputs of the performance measures used for each 
behavioural response taken after the supply chain disruption, rather than making 
normative recommendations. Detailed analysis of past disruptions and successful 
anticipation, recovery, and adaption efforts will be essential in future research to 
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determine the significant linkages between specific capabilities and inherent 
vulnerabilities (Pettit, Fiskel and Croxton, 2013). 
 
The learning processes organisations go through have been long considered by 
researchers, starting with the original concept of organisational learning, which dates 
back to the 1960s (Fiol and Lyles, 1985). There has been significant growth in the body 
of knowledge on organisational learning (Crossan and Guatto, 1996), with 
organisational learning seen as the process and outcomes of changes to 
organisational level properties such as culture, operational processes, systems, and 
policies. Organisational learning occurs in all organisations as they inevitably evolve 
and change, but it is only sometimes seen as such by members of the organisation, or 
intended by them. There is a common, but not universal, assumption that learning is 
associated with improved performance (Crossan, Lane, White et al., 1995). However, 
despite criticisms of organisational learning empirical inquiry and theory, the concept is 
seen to be valuable. In introducing a compilation of leading texts on the subject, 
(Cohen and Sproull, 1996) suggest that, using the concept of organisational learning, 
the texts’ authors challenge conventional organisation theory in three fundamental 
ways: 
 
1. They focus on action, rather than choice 
2. They emphasise dynamics, with stability interpreted in that context 
3. They explain organisational coherence, rather than assuming it 
 
Learning organisations purposefully construct structures and strategies so that they 
enhance and maximise organisational learning (Dodgson, 1993). There are arguably 
two concepts of organisational learning (Easterby-Smith and Araujo, 1997), firstly as a 
technical process (Huber, 1991), and secondly as a social process (Gherardi, 2000). 
The technical view assumes that organisational learning is about the effective 
processing, interpretation of, and response to, information both inside and outside the 
organisation, whereas the social perspective on organisational learning focuses on the 
way actors make sense of their experiences at work, where learning emerges from 
social interaction. This reflects the cognition-behaviour dimension of the learning 
outcome. A behaviouristic approach underlays reinforcement theory, which says that 
“behaviour is a function of consequences” (Robbins, Judge and Campbell, 2010) p154.  
As noted by Huysman (1999), the how, when and why questions present four biases 
within the literature on organisational learning that were identified. These biases point 
to an individual learning bias, an active agency bias, a purposeful learning bias and an 
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improvement bias. In the research by Huysman (1999), a case story concerning the 
learning of old and new routines used by information systems designers is used to 
demonstrate the alternative approaches to scrutinise organizational learning in different 
organisations.  
 
The supply chain disruption event can have a variety of possible outcomes on a focal 
firm, whether directly or indirectly. Every activity that a supply chain conducts has an 
inherent risk that an unexpected disruption can occur. Disruptions such as the loss of a 
critical supplier, a major fire at a manufacturing plant, or an act of terrorism, have the 
potential to adversely affect both revenue and cost (Ponomarov and Holcomb, 2011). 
Supply chain disruption is captured in this research’s model in Figure 9, and the extent 
of the impact and its relationship with response choices and performance outcome is 
measured as an independent variable.   
 
Previous research on supply chain disruption did not take account of strategic 
orientation and environment when considering the concept of supply chain disruption 
orientation, and were beyond the factors incorporated in their hypothesis. This study 
will, however, take account of boundary conditions, as argued by Carvalho, Barroso, 
Virginia et al. (2012), it is expected that specificities related to the industry context, like 
product type, production process, country, and cultural perspectives can impact on the 
types of resilience and agile practices employed in the supply chain and in the effect 
these practices have on supply chain behaviour. Carvalho, Barroso, Virginia et al. 
(2012) combined agile and resilient approaches developing a new framework to 
demonstrate their influence on performance and competitiveness, but excluded 
boundary reality bias of the manager’s environment. Differing management decisional 
roles means their requirements are determined by the manager’s role, seniority, and 
availability of information (Mintzberg, 1973, Mintzberg, 1975, Hales, 1986). Because 
choices and actions are made by people, who work as part of a team in an 
organisation that is faced with disruptions, this research will include the role and 
knowledge of the decision-making manager, making response decisions post 
disruption to fill this research gap, just as managers are influenced by their roles, 
knowledge, and the organisation they work within and its environment all have an 
impact on response decisions. Fennel and Alexander (1987), in their research on 
organisational boundary spanning in institutionalised environments, found that 
hospitals in systems are more likely to bridge, probably because of corporate policies 
intended to centralise functions and minimise costs. System membership was reported 
by (Fennell and Alexander, 1987) as an important factor in a hospital's selection of 
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bridging or buffering strategies. A hospital that is the sole unit in a hospital trust, as 
opposed to a hospital in a trust which is made up of several trusts, may have a higher 




Figure 8. Bode, Wagner, Petersen, Ellram, Academy of Management Journal (2011:853-856) 
(Vol. 54, No4). 
In Figure 8, the conceptual framework was first developed by Bode, Wagner, Petersen 
et al. (2011), based on the original conceptual model of organisational response to 
supply chain disruptions; the model is focused on the relationships between the impact 
of supply chain disruption and intrafirm and interfirm responses. However, in this 
research, existing knowledge is challenged. Central to this research is the new 
proposed model, Figure 9, which extends and deepens the focus to concentrate on 
how those responses affect performance, how the different organisational responses 
interact (bridging and buffering) and also explores the role of supply chain orientation, 
both through organisational response and response performance outcomes. This 
develops the existing conceptual model and provides new insights into the body of 
work on supply chain disruption management responses. The new model will be 
further explained in the context of the research question, with a trinity of contructs, 
examining further the new concept of supply chain disruption orientation, 
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organisational response and performance, and the corresponding propositions directly 
addressing and testing the underlying theories in Chapter 3.      
 
 
Figure 9. New proposed model of organisational responses to supply chain disruptions 
integrating response action output performance  
Incorporating the boundary rationality bias into the understanding of the manager’s 
decision-making process in response to supply chain disruptions, this research will 
build on the notion of bounded rationality in managerial decision-making (Simon, 1979, 
Tiwana, Wang, Keil et al., 2007). Furthermore, as supply chain disruptions affect the 
environmental certainty in which an organisation must make strategic decisions (Burns 
and Stalker, 1961, Lawrence and Lorsch, 1967), it is important to consider the actors 
that are in constant interaction with that environment. It is essential then to take into 
account managerial roles as the key actors in this interplay (Mintzberg, 1973, 
Mintzberg, 1975) . Hales (1986) looked in detail at what managers do in reality when 














































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





















































to their boundaries. Supply chain management is not a linear activity, rather it is a 
complicated activity and difficult to predict, and these factors need to be accounted for 
to demonstrate exhaustive research into supply chain disruption response. In so doing, 
this research returns to examine the original model of Bode et al (2011), which used 
the combined  lenses of organisational information processing (Galbraithe, 1973, 
Tushman and Nadler, 1978), and resource dependency theory (Pfeffer and Salancik, 
1978) to underpin the stability motive and interpretive postures which determine 
response decisions. It then challenges it with boundary rationality and, in so doing, 
improves the understanding of the decision-making processes in managerial 
responses to supply chain disruption. It is important academically because it adds to 
the body of work on supply chain post disruption response, but also practically for 
managers actively in decision-making. 
 
Section 2.5 introduces the topic of supply chain disruptions in the industry specific 
context of the pharmaceutical industry, where disruptions have had a significant 
impact.   
 
2.5 Supply Chain Disruptions in the Pharmaceutical Industry 
 
This section on supply chain disruptions in the pharmaceutical industry begins with an 
introduction to the complex area of global drugs supply chain. This, as previously 
highlighted at the beginning of the literature review (section 2.1, Figure 1), is where the 
pharmaceutical supply chain intersects with supply chain disruption research. The 
overall literature review brings together academic literature starting within the supply 
chain management area and the pharmaceutical industry review. It then narrows to this 
section, which begins with the introduction in 2.5.1 on the specific topic of supply chain 
disruptions in the context of the pharmaceutical industry, followed by the description of 
the causes of these disruptions (section 2.5.2 to 2.5.6), and then the impact these 
disruptions are having through the supply chain of pharmaceuticals (section 2.5.7). 
Lastly, the attempts at improvements tried in the pharmaceutical supply chain in 
response are then explored in sections 2.5.8 to 2.5.13, including best practice 





A shrinking global economy has multiplied failures at home and abroad, threatening 
supply chain stability. A supply chain breakdown can devastate a company financially 
and cause extensive reputational damage. The increasing trend by manufacturers to 
outsource manufacturing of medical products to areas such as India and China have 
had positive cost benefits for the manufacturers, an important strategic goal for 
improving overall supply chain efficiencies from a supplier perspective. However, the 
elongated supply chains and potential for quality impacts has not improved the 
shortage problem. This is especially important during sustained periods of volatility in 
the global trade, as described by Christopher and Holweg (2011), where organisations 
are using supply chain management to gain a competitive edge.  
 
Developing and sustaining competitive advantage for an organisation through supply 
chain management, as proposed by (Spekman and Kamauff, 1998) in the modern 
pharmaceutical supply chain, is challenging. Central to their analysis was the belief 
that collaboration within a supply chain can be achieved to the extent the trading 
partners share a common 'world view' of supply chain management. With multiple 
agencies involved in the pharmaceutical supply chain, all with conflicting agendas 
spread across often emerging economies, collaboration is difficult and product demand 
is significant compared to the supply, especially with the ongoing disruptions.  
 
For pharmaceutical companies, supply chain breakdown not only brings immediate 
damage to the affected company, but can also threaten human health and well-being 
by causing medical supply shortages (PricewaterhouseCoopers, 2009). In an industry 
study, 75 pharmaceutical companies that reported supply chain failures between 1998 
and 2007 were compared by performance with an unaffected peer group. During the 
two days following a disruption announcement, such as a quality or production 
problem, the share prices of the affected companies tumbled 7% below the 
comparison group. One year later, the affected companies stock prices were still 
underperforming compared to their peers by about 4%. Even after accounting for 
normal industry and economic effects, the average returns on assets for the disrupted 
companies was 5% lower, and sales were 3% lower (PricewaterhouseCoopers, 2008). 
 
Supply chain disruptions are more likely in uncertain economic times. As the ripple 
effects of a shrinking global economy spread through the supply chains of 
pharmaceutical companies, the potential for cascading failures threatens to disrupt 
product development. In the US and Europe, many small biotech companies are 
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struggling to continue operations as they find it increasingly difficult to access venture 
capital and government funding (Wintein, 2009). In China, which is the world’s top 
producer of active pharmaceutical ingredients (APIs), factory cutbacks and closings in 
export-driven coastal regions are quickly spreading inland (McDonald, 2009). In India, 
the world’s third largest API source, many small and medium sized suppliers with 
shrinking orders from overseas find themselves on the brink of failure (Heathcote, 
2008). 
 
No matter where the supply chain breaks down, when a disruption occurs the public 
holds the company that owns the brand accountable or the service provider at point of 
source (for example, the National Health Service in the UK). Supplier management of 
remote suppliers by pharmaceutical companies is not an easy task to prevent 
disruptions despite the serious consequences. For example, in March 2008, 
contaminated batches of an injectable drug (heparin) caused 81 patient deaths and 
785 reports of serious injuries associated by the drug use (Powell, 2008). The deaths 
and severe allergic reactions included difficulty breathing, nausea, vomiting, excessive 
sweating, and rapidly falling blood pressure that, in some cases, led to life-threatening 
shock (Gardiner and Bogdonowich, 2008). The US Food and Drug Administration 
(FDA) traced the contamination to Asian factories that produced the API used in the 
drug. This incident led to a massive product recall and pointed towards weakness in 
supply chain monitoring by the industry and its regulators. The episode resulted in 
negative media attention, public outrage, and numerous lawsuits. The raw material for 
the recalled heparin batches was processed in China from pig’s intestines by the 
American firm Scientific Protein Laboratories (Powell, 2008). 
 
The review found there has been extensive mapping of relationships, influences and 
also information and technology in the supply chain healthcare industry, including 
notably (Whewell, 2010, Savage, Roberts and Wang, 2006, Breen, 2005, Breen, 2008) 
on the former, and (Ling and Collier, 2000, Siska and Tribble, 2011) on the latter. 
Whewell (2010) considered the pharmaceutical supply chain from a practical industry 
based standpoint, which was heavily influenced by the pharmaceutical manufacturer’s 
perspective. His ideas had their antecedents with (Braithwaite, 1993) with a focus on 
demand management, with attention to the customer before the logistics system. He 
did, however, promote the importance of information and recommended using a 
preference share model to understand how to influence sales. Most importantly, he 
noted, as did other observers, the poor state of the pharmaceutical supply chain, the 
70 
 
tendency to overstock product to mitigate against the risk of the supply chain, 
especially in the launch of new products. Furthermore, there are a number of studies 
on the safety and errors in the administration of drugs at the practice end of the supply 
chain, for example, (Armitage, Newell and Wright, 2007), who researched errors in a 
British acute hospital trust, and (Alldred, 2006), who considered a risk assessment of 
purchasing safer medicines.  
In the review of the literature on supply chain disruptions specifically and the 
pharmaceutical industry in general, many different geographically based information 
sources were found. These included predominantly UK, Europe, US and to a lesser 
extent China based academic reviews as well as industry information and reports. As 
will be discussed in more detail in the causes and impacts of supply chain disruptions 
in the pharmaceutical industry in section 2.5.7 drug shortages are a global problem 
(Gray and Manasse, 2012, Bruhc, 2012). In congruence with other pharmaceutical 
based research   non-industry specific elements (e.g. majority of the disturbance 
factors) can be applied and extended to other sectors (Huq, Pawar and Rogers, 2016). 
However, it should be considered that there is no ‘one-size-fits-all’ strategy, and even 
for firms in similar sectors supply chain design differs, owing to unique characteristics. 
For example drug prices vary in each market, in the United States 20mg of Paroxetine 
(antidepressant) costs $6.83, in Canada $2.98, in the UK and Australia  $0.98 and 
$0.70 in Turkey (Miller, 2018). This could be why 19 million adults in America import 
medication to save money, i.e. 8% of the population therefore, it is important to note 
that some of the supply chain configurations presented in this thesis would not be 
appropriate for particular drug types and that the response actions suggested might in 
certain cases not be feasible due to regulatory, market  issues (The Henry J Kaiser 
Family Foundation, 2016) . For example in contexts characterized by high power 
distance, such as China, people accept that power is unequally distributed, and the 
less powerful supply chain partner therefore accepts its weaker position (Zhao, Huo, 
Flynn et al., 2008). Power symmetry results in more cooperative interactions Reiman 
(2017) so that response mitigating strategies can be more effective, for example 
bridging with suppliers.  Drawing information in this review from different regions helps 
understand the common factors causing the shortage phenomena, and the widespread 
impacts. However, although there are common factors affecting both patients as the 
end users, hospitals and healthcare government departments, it should be noted that 
each country have their own healthcare structures, procurement methods, regulation 
and policy structures, and caution is required not to believe a solution in one country 
will automatically be applicable in all. The scope of this review and research study 
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does not provide a fully comprehensive meta-analysis of global policy and delivery 
structures on a macro level.  That said by drawing on sources from different 
geographies both in the more privately based pharmaceutical supply environment of 
the US system for example and the largely publicly funded secondary care sector in 
the UK, allows different perspectives to inform and provide understanding for the 
research in the general problem area of shortage management. In other supply chain 
disruption research (Golgeci and Ponomarov, 2013) used a between subjects 
scenario-based experimental methodology combined with a survey method in US & EU 
manufacturing. Finding from that research showed common understanding of both 
positive outcomes of ﬁrm innovativeness and drivers of supply chain resilience.  
Efforts were made in this systematic review to identify all relevant literature on the 
review topic so the search would not be limited solely to one geography on a single 
electronic database (Crumley, Wiebe and Cramer, 2005). Additional search strategies 
included hand-checking relevant article reference lists and personal communication 
with experts in the field. Searching the ‘grey literature’ is of particular importance for 
pharmacy practice literature reviews because relevant articles written by non-academic 
pharmacists are often not published in traditional academic journals (Charrois, Durec 
and Tsuyuki, 2009)   
  
2.5.2 Reasons and impact of pharmaceutical supply chain disruptions 
Pharmaceutical supply chain disruptions predominantly manifest themselves further 
down the pipeline as shortages in medicines for patients. The reasons for drug product 
shortages are numerous, complex, and interrelated. A shortage is, most fundamentally, 
a lack of adequate supply of a drug product to meet medical need. Shortage situations 
most often originate at the manufacturing level and then reverberate throughout the 
pharmaceutical supply chain and broader healthcare system. Understanding the 
causes and management of the shortages because of supply chain disruptions can 
give insights into the management strategies that can be employed as organisational 
response choices. Recent research on medicine shortage has found a potential link 
between drug shortages and increasing drug prices. Drug shortages can be associated 
with an increase in price, even when there are multiple suppliers of a product (Fox and 
Tyler, 2017). A manufacturer may raise prices for multiple reasons. Where, for 
instance, manufacturers may pass on additional manufacturing costs when the raw 
material costs increase or factory upgrades are required. Expenditure could also 
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increase for commercial drive to increase profits. However, the specific root trigger for 
rises are rarely transparent, similar to reasons for drug shortages. 
There are many stakeholders involved, all with their own agenda, some of which may 
be acting in conflicting directions. They include the producers, distributors, 
wholesalers, the primary and secondary care health systems, governments, through to 
the patient’s themselves. These differences can be as fundamental as how a 
pharmaceutical is viewed, either as a high cost-low margin product by the 
pharmaceutical company to the lifesaving treatment required by the patient. An 
example of this comes from a recent comment from Stephen Whitehead, Chief 
Executive of the Association of British Healthcare Industries, ABPI (October 2012) p78, 
he said: 
It is important we see medicines for what they are, not simply a cost, but an 
investment. An investment not only in the health of patients, but also an 
investment that reduces expensive hospital care, promotes medical research 
and spurs growth in the UK economy. 
Yet we could also interpret this statement as a revenue push on behalf of his members 
from the pharmaceutical industry as ‘spend more on our new drug products’. How 
much push there is by the pharmaceutical industry to reduce shortages of mature or 
discontinued lines, now outsourced to far-off geographies, using relocated 
manufacturing equipment is debatable. From a wholesaler perspective, who distributes 
the medicines once they are received in the local market, they too face difficulties as a 
result of disruptions to the supply chain. Sawer (2014) stated wholesalers distribute as 
much product as they possibly can get hold of as quickly as they can, but it’s very time 
consuming for pharmacists to chase drugs. Pharmacists are in the front line. 
Wholesalers understand that the patient who cannot get hold of a medicine, apart from 
being a tragedy, is not how the supply chain is supposed to work.  
However, some pharmaceutical supply chain stakeholders, in responding to front line 
complaints of medicine shortages caused either wholly or partly by disruptions, deny 
there is a problem. The understanding of generic drug shortages, for example, has not 
been particularly clear. Broeer (2014), chairman of the British Generic Manufacturers 
Association (BGMA), does not consider shortages to exist. In contrast, although the 
wholesalers believe they are providing a good service, they do recognise shortages 
are a real phenomenon. The British Association of Pharmaceutical Wholesalers 
(BAPW) definition of a shortage is a delay over 24 hours (Sawer, 2014) p128: 
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The broader definition of drug shortages used by the UUDIS (University of Utah 
Drug Information Service) A product shortage occurs when: (Total) supply does 
not meet demand for a drug on a nationwide or regional basis for a period of 
time that necessitates changing the practice of treating the patient. 
Drug shortages are not a new phenomenon and span the last 10 years, from Charatan 
(2001) p322, who described "a prescription drug shortage plague," to Mirtallo, 
Holcombe, Kochevar et al. (2012) p390, who described the "crisis in drug shortages". 
Gray and Manasse (2012) reported the medicines shortage is a complex global 
problem. They describe how shortages of essential medicines, among them generic 
injectable chemotherapy agents, are causing increasing concern. Their work revealed 
the problem is far wider than just one product in one country. It is affecting other 
classes of medicines, including injectable anaesthetic agents, such as Propofol, 
intravenous nutrition and electrolyte products, enzyme replacement products, and 
radiopharmaceuticals. 
Medicine shortages are widespread, as Bruhc (2012) p34, described: "supply 
shortages of drugs are a global problem”. Beerteen and Bonheure (2011) p12, also 
claimed that the problem is global “from Afghanistan to Zimbabwe”, listing 21 countries 
affected by a variety of supply problems. A shortage of the injectable antibiotic 
streptomycin was reported in 15 countries in Lancet (2010), with 11 more countries 
predicting their stocks would run out before they could be replenished. 
The number of new drug shortages has tripled since 2006. The University of Utah Drug 
Information Service (UUDIS) and the American Society of Health-System Pharmacists 
(ASHP) reported 267 shortages in 2011 across multiple product categories, including 
anaesthesia drugs, oncology products, oral stimulants, antibiotics, electrolyte and fluid-
balancing drugs, and others, as shown below in Figure 10. Approximately 80 percent 
of newly reported shortages were generic injectable products (Healthcare Distribution 




Figure 10. Adapted from HDMA (Healthcare Distribution Management Association) guidelines 
of report on guidelines for communications for managing product shortages in the healthcare 
supply chain (2012) 
Broadly, the solutions to a product’s availability issues will likely depend on the factors 
that are causing or contributing to the supply disruption problem. A joint working group 
was set up in the UK to research in more detail the risk factors in product shortages. It 
brought together a cross section of the stakeholders to rank the causes of shortages. 
In the research study by (Breen, 2008), a group of 20 stakeholders from the UK 
pharmaceutical supply chain, including a mixed collection of pharmaceutical 
manufacturers, wholesalers and National Health Service personnel, was facilitated by 
pharmaceutical procurement specialists.  
Table 3 summarises the results, showing not only the 35 distinct reasons for shortages 





Table 3. Product shortage factors adapted from Breen (2008)    
The highest ranked factors found in the research (Breen, 2008) for risk factors for 
supply chain disruptions causing shortages include the fragmented and disparate 
supply chain, visibility, demand versus capacity, diversion of production by 
manufacturers, congestion, weather, and lack of adequate information under 
assessment categories, such as impact, occurrence, and controllability. Although 
similarities with other industries causal risks were identified, the workshop group 
established that there are aspects of the product that highlights its uniqueness, for 
example, criticality. 
However, as recently claimed by Blair (2012) referring to drug diversion, although on 
the increase, is not the only problem involving drugs that hospital officials should be 
concerned with in the growing drug shortage situation. However, offshore production, 
counterfeiting, and weaknesses in the drug supply chain in case of a worldwide 
pandemic are even greater causes for concern. In the UK, manufacturers blamed 
shortages on parallel trading that forced them to put quota systems in place. 
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Pharmacies, hospitals, wholesalers, and prescribers pointed to these quotas as the 
main reason for shortages. They also blamed disruptions in the supply chain caused 
by the implementation of restricted wholesaler deals. In the case of generics, 
manufacturing issues was the biggest concern. 
As well as shortages in primary care, there is a growing concern about medicines not 
being delivered on time in secondary care. Hospitals have up to 400 medicines 
exceeding their expected delivery times, although only a few of these are causing 
critical shortages  (Chemist, 2013). 
 
Breen (2005) case study and questionnaire-based research in the North West of 
England on improving the pharmaceutical supply chain had earlier argued that 
improvements in performance could be gained from the introduction of Electronic Data 
Interchange (EDI) and the implementation and use of e-commerce into purchasing 
departments in hospital pharmacies. This earlier research, however, took a local 
practice approach and was based on a national sample basis. Furthermore, it implied 
that the underlying issue is around information and data transfer to affect quality in 
performance, addressing the IT agenda rather than the strategic response to supply 
chain disruptions. They did, however, confirm there was much to learn from alternative 
industries and to adopt best practices where feasible.   
In the research by Breen (2008), disruptions leading to shortages also included 
commercial factors linked to the profits of manufacturers. There has been a general 
decline in manufacturers producing vaccines, for example, due to the costs of research 
and development compared to the relatively small market to generate sales revenue. 
Offit (2005) describes how during the past fifty years, the number of pharmaceutical 
companies manufacturing vaccines has decreased dramatically, and those that still 
make vaccines have reduced resources to make new ones. 
2.5.3 The pharmaceutical manufacturing process 
Pharmaceutical manufacturing is an inherently complex endeavour. In the US, the 
Food and Drug Administration cites product quality and other manufacturing-related 
issues as major reasons for existing shortages (Food and Drug Administration, 2011). 
These issues can include, but are not limited to, any of the following: 
1. Product quality problems, such as contamination with particulate matter or 
precipitates (that may result in cessation of or decrease in production and/or recall 
of existing product); 
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2. Manufacturing issues, such as equipment failures or scheduled downtime to 
upgrade facilities; 
3. Insufficient manufacturing capacity; 
4. Raw material/active pharmaceutical ingredients (API) supply issues, particularly of 
foreign-sourced material where supply could be interrupted due to geopolitical 
factors and/or if API is not available from the sole source; and, 
5. Disruptions in the supply of drug product components or packaging (labelling, 
excipients, etc.) 
Suppliers cite production-related issues and increased demand as the main reasons 
for supply chain disruption related shortages, rather than raw material or quality issues, 
as stated by the Institute of Health Informatics, Institute for Healthcare Informatics 
(2011). Older, sole, or limited-source injectable products are particularly vulnerable to 
shortage situations because of limited production capacity, long manufacturing lead 
times, and the complexity of the manufacturing process. 
2.5.4 Economic factors 
Arguably the premier reasons for the pharmaceutical manufacturers to end or curtail 
production are the economic considerations. Panzitta, Ponti, Bruno et al. (2017) 
developed the concept of manufacturing appraisal, providing a technical overview of 
upcoming challenges; this is a risk based approach and an economic picture of 
shortage costs. They developed an overall quality concept, which was not limited to 
GMP factors but included all elements leading to a robust supply and promoting 
technical innovation. However, this is of potential relevance to new products 
manufacturing, but much of the products in short supply are older, difficult to 
manufacture and not especially profitable. Relevant economic concerns include: 
1. Lack of redundancy — fewer firms making multiple products on existing 
manufacturing lines; 
2. Reallocation of manufacturing resources to other products (including new 
formulations); 
3. Unfavourable economies of scale and/or prohibitively high costs to comply with 
regulatory requirements or inspectional demands; and, 
4. Discontinuation by API or other critical component suppliers which may 
eliminate alternative supply options or cause critical time and resources for 
manufacturers to find approved alternate sources. 




6. Cutting costs in areas where there is wastage and money is not being used 
efficiently. There are always areas in any company that are not working as 
efficiently as they could.  
 
2.5.5 Regulation 
The requirements and decisions by regulatory bodies, such as the National Institute for 
Clinical Excellence (NICE) in the UK or the FDA in the US, can impact product 
availability. For example, most drugs are subject to regulatory pre-approval of an 
application. Furthermore, changes to an existing approved application, such as those 
involving adding new API sources, new equipment, or new manufacturing processes, 
may also require pre-approval, potentially slowing production if approval is delayed. 
Regulatory and enforcement initiatives may also impact product availability, including 
standards and quotas by authorities around the globe, an increasing issue with global 
sourcing driven by cost efficiencies by the manufacturers competing in a global market. 
2.5.6 Other underlying forces impact pharmaceutical supply chain  
Depending on the situation, other factors may result in a short-term disruption, 
amplification, or unnecessary extension of an existing disruption situation Healthcare 
Distribution Management Association (2012b). 
Although not usually the root cause of any shortage, these dynamics are worth 
understanding: 
1. A domino effect, as increased demand for related or alternative product causes 
shortages for those products and there is a delay as manufacturers ramp up 
production to meet sudden increases in demand; 
2. Panic buying/hoarding behaviour that exacerbates a potential shortage, 
creating artificial demand, additional cost and waste in the system if product is 
unused and returned, as shown in Figure 11 below;  
3. Contract awards that produce large demand shifts in a short period of time; 
4. Severe inventory demand disruptions which are exponentially greater than 
predicted normal variation in demand and supply.  
Examples could include: 




2. New product sales significantly exceed expectations;  
3. Inaccurate manufacturer demand forecasting;  
4. Off-label prescribing;  
5. Theft/losses that create temporary 'spot' shortages, and emergency 
preparedness and response;  
6. Natural disasters may disrupt product availability on a local, regional, national 
or global level;  
7. and unusual disease outbreak, pandemic, or other severe public health 
emergencies may impact product availability due to increased demand. 
2.5.7 Impact of pharmaceutical disruptions  
The consequences of product shortages have both health and economic implications. 
In the current economic climate, focus is on costs reduction by governments and 
industry alike. In contrast, healthcare costs are rising; the World Health Organisation 
(Guide and Zone, 2017) reported that the UK spent 18% of its GDP on healthcare. 
Although the consequences of drug shortages may be only a relatively minor part of 
this rise, it has a significant political impact through real-time media reporting.  
The following list gives an overview of the impacts within the secondary healthcare 
system of acute care medical shortages:   
1. Costs of alternatives 
2. Time spent on shortages by pharmacists/cost impact efficiency 
3. Time spent on shortages by non-pharmacists 
4. Additional staff 
5. Patient impact (adverse outcomes and clinical incidence) 
6. Shortage response path (length of time to get the drug to the patient) 
7. Procurement planning, practices, and pricing 
8. Stockpiling of medicines in short supply 
9. Reduced risk assessment to get into clinical practice 
These examples include, for example, direct patient impact, practice management, 
health system management time and labour resources. Offit (2005) p.623, highlights 
the many examples within the vaccines group: 
The flu vaccine shortages of 2003–2005 are just one example of what has been 
a steady, unrelenting series of vaccine shortages. Since 1998, nine of twelve 
vaccines routinely recommended for young children have been in short supply: 
specifically, vaccines to prevent measles, mumps, rubella (German measles), 
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varicella (chickenpox), tetanus, diphtheria, whooping cough (pertussis), 
influenza, and pneumococcal disease.  
These shortages have caused children to miss vaccines that they needed, and some 
children never caught up when the shortages were over.  
It was estimated by Stead (2009) that in the UK, £6 million was tied up in managing 
shortages through the increased need for management time and resources in 
managing hospital trusts, sourcing products, and managing staff. Dorsey, Thompson, 
Dayoub et al. (2009) investigated the September 2007 shortages of generic Selegiline, 
forcing patients to either switch to more expensive alternatives or forego treatment. 
They found the societal cost of substituting generic Selegiline with branded capsules 
was $75,000 over the first four months of the shortage. 
Artificial demand is created by panic buying/hoarding behaviour and exacerbates a 
potential shortage, and causes additional cost and waste in the system if the product is 
unused and returned, as illustrated in Figure 11. 
 
Figure 11. Impact to demand from product recall and supplier backorder, HDMA, (2012) 
Figure 11 shows the impact on ordering patterns resulting from a product recall and the 
domino effect from an anticipated shortage. A product recall of Acyclovir in the Autumn 
of 2009 triggered an unusually large ordering period lasting more than six months 
(Healthcare Distribution Management Association, 2012a). Multiple manufacturers 




launched a similar product, ordering patterns returned closer to previous patterns. In 
this data from one distributor, all of the orders above the red line resulted from artificial 
demand. (These reflect orders received, but not necessarily fulfilled.) 
Any one of these factors may create or exacerbate a shortage situation that requires 
consideration of alternative treatments for the patient, whether long-term or short-term. 
Depending on the patient population undergoing a specific course of treatment, the 
chronic or acute nature of the medical condition and the therapeutic alternatives 
available, certain shortages will have a more severe patient impact. From patients to 
clinicians downstream to raw materials suppliers upstream in the supply chain, the key 
focus is on the duration of the shortage to make the most informed decisions. As noted 
by Chadist (2012) both management skill and employee resources are critical to 
response speed. 
As shown below in the Figure 12, which is a high-level diagram showing the upstream 
and the downstream elements of a pharmaceutical supply chain, there are many 




Figure 12 Pharmaceuticals end to end supply chain map 
and actors within those levels. The upstream includes the raw material from different 
suppliers that make up the finished product the manufacturer produces, and the packaging 
companies output into the downstream supply chain. The distributors with different channels 
can use dispensing logistics then to reach further downstream in the supply chain through the 
hospitals and pharmacies to the patients.  The upstream drug supply chain impacts the end 
sections of downstream hospitals and patients as discussed in section 2.5.2. The upstream 
problems affecting both the raw materials and the production parts of the end to end supply 
chain can often be disrupted causing downstream shortages. For example, the Doxycycline 
shortage of June 2013, where shortages were created by production shortages (Palmer, 2014). 
The interruptions of production at plants, reduced or halted production of doxycycline by 
multiple manufacturers because of raw materials shortages. Prices for doxycycline rose 
dramatically in response with a $5 prescription increasing to $160 and smaller pharmaceutical 
firms began to produce doxycycline, charging higher prices. With the Centres for Disease 
Control and Prevention (CDC) recommendation to use Doxycycline only when other 
interventions were not available. Where the CDC is a public health institute acting as a 
government agency, and part of the regulatory response in the USA to manage pharmaceutical 
disruptions. 
2.5.8 Managing pharmaceutical disruptions  
In the UK, the product shortage crisis has focused the attentions of both the healthcare 
pharmaceutical participants and the government-run National Health Service (NHS). A 
variety of groups have been working together to try and understand and mitigate the 
risks of product shortages in secondary acute care. The NHS has issued guidelines, 
directives, recommendations and best practice through the European Medicines 
Agency as well as coordinating through the group of special pharmacists representing 
the regions across England and the wider pharmacy industry. For example, the 2008 
Best Practice Guidance on joint working between the NHS, pharmaceutical industry, 
and other relevant commercial organisations. The Department of Health and the ABPI 
have also been working together to develop best practice guidelines. However, as the 
Chair of the UK National Pharmacy Supply Group, Alldred (2006)  notes: 
1. Not all pharmaceutical companies are included in the working group 





Drug disruptions in the UK are not always uniformly spread across the regions, 
however, this may be as much to do with the political geo-economics, such as which 
medicines to approve and supply by regional hospitals and trusts, rather than a supply 
chain information issue alone. Government agencies, such as NICE, have recently 
tried to balance medicines' regional availability using a new scorecard. Stephen 
Whitehead, Chief Executive of the Association of the British Pharmaceutical Industry, 
commented (Association of British Healthcare Industries, 2012) that the NHS 
Innovation Scorecard will be a valuable tool for supporting the use of the latest NICE 
recommended medicines across England. On regional differences, he further added 
that there was still a great deal of variation across the country on which treatments 
patients are able to access and was hopeful the Scorecard will help highlight 
discrepancies which can then be addressed. 
Pharmaceutical companies are businesses, not public health agencies nevertheless 
and to deal with the problem of drug shortages, a holistic multi-agent approach is 
required. The challenge has been that relying on a voluntary cooperation between 
parties with different interests has so far not solved the problems of drug shortages, 
rather the problem appears to be getting worse, as shown above in Figure 10, with 267 
reported drug shortages in 2011 compared to 120 in 2001 in the US alone (Healthcare 
Distribution Management Association, 2012a).  
Governments can legislate through specific policies on the issue of drug shortages, but 
in the UK the approach has been to focus on the issuing of guidelines and the 
promotion of working groups, government agencies, and partnership approaches, 
although the legal threat remains. In contrast, in the US, policy making is already 
underway to try and prevent shortages occurring in critical drugs. Chabner (2011) 
records that on October 31, 2011, in response to the shortages, US President Barack 
Obama issued an executive order in which he broadened reporting requirements for 
potential shortages and instructed the FDA to accelerate reviews of new applications 
for marketing of generics and to provide information to the Justice Department about 
possible collusion or price gouging related to the shortages. This action represents a 
step forward in addressing this issue. Earlier draft legislation to address the issue of 
drug shortages has been brought forward in both houses of the United States 
Congress (2011), leading to the Preserving Access to Life-Saving Medications Act. A 
similar resource has been developed for Canada. In Europe, France has led the way 
on regulation in taking action on shortage management through the Health Law of 
January 2016; France acquired new regulatory tools in order to fight against growing 
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shortages and wanted to target the drugs for which they are the most detrimental: the 
major therapeutic interest (MTI) drugs (Bocquet, Degrassat-Theas, Peigne et al., 
2017).  
 
Gray and Manasse (2012), from a US-based perspective, proposed that a longer-term 
solution may lie in careful policy-making that avoids winner-takes-all procurement 
decisions, one that promotes the development of a sustainable local and global phar-
maceutical manufacturing capacity, and that identifies and protects particularly fragile 
markets. While there have been predictable libertarian calls for lifting price controls to 
encourage investment, governments have a responsibility not only to ensure the 
quality of medicines and access to essential medicines, but also to create the 
necessary conditions for a sustainable, productive, and responsible pharmaceutical 
industry. In this case, laissez faire will not suffice. 
 
2.5.9 Improving efficiencies in the pharmaceutical supply chain 
To reduce supply chain disruption impacts, proposals and guidelines have been 
offered through industry journal, such as Pharma IQ (2010), which has focused on 
improvements to the efficiency of the supply chain:   
 
Cutting out the middle man (wholesaler) or disintermediation  
Speed up the distribution process, as the company will be delivering directly to the customer.  
Cut costs by cutting out the middle man.  
Sell more product; with better prices the companies will be more competitive and outsell competitors.  
Improvements in tracking product, to reduce counterfeits and competitors copying product.  
Improve technology in the manufacturing process. This will help:  
The products to be created quickly and efficiently.  
Better technology will help product cost to be reduced and sold at a more competitive price.   
Upgrading manufacturing equipment and processes to make manufacturing product more efficient.  
Quality control will be increased.  
Supply chain analytics should be done...   
Examine which suppliers are the best and most efficient: some suppliers are better than others. The more 
efficient the suppliers are the better, the supply chain will work.  
Impaction of varied factors can affect the supply chain. The impact of various elements like weather or the rise 
and fall of fuel prices on the delivery system will affect cost of supply.  
How much inventory to keep for certain products  
Examining the purchasing team in the company.  
The pharmaceutical industry primary focus and recommendations as private companies are however inevitably 
driven by the company shareholders. But where cost efficiencies can be combined with practices that result in 
reduced shortages it can be of benefit. 
All participants in the healthcare supply chain play a role. The value of communicating information among all 





Table 4. Supply efficiencies improving the pharma supply chain, adapted from Pharma (2010) 
p58. 
Information normally needed by stakeholders includes: 
1. The reason for a shortage; 
2. Estimated duration of the shortage; 
3. Potential alternate sources; 
4. Potential alternate therapies; and, 
5. Allocation parameters (including limits and processes from manufacturer and 
distributor). 
If a manufacturer has instituted an allocation plan for distribution to their customers due 
to a product shortage, how the manufacturer communicates that information to its 
trading partners is also very important.  
Similarly, distributor communication to downstream customers is also important and 
should be consistent, accurate, and timely. Technology can be a valuable tool in 
communicating product availability issues. Although manufacturers must consider the 
potential risk that communications may cause stakeholders downstream to focus on 
protecting and enhancing inventory position, effective communication can assist in 
averting panic-buying and/or hoarding, especially of medically necessary products. 
The challenge has been that all stakeholders do not cooperate efficiently or equally, 
causing the quality of the information communicated to reduce its application in some 
areas of the supply chain and hence a degradation on performance. Frictions exist 
further down the supply chain between industry groups as pharmaceutical disruptions 
impact the drugs supply. In a three-month consultation run by the National Pharmacy 
Association in the UK, over 700 pharmacies expressed their views on the role played 
by wholesalers in a medicine's supply chain that has been criticised for too often failing 
to ensure drugs reach pharmacies and patients in a timely manner. The consultation 
revolved around five issues; fairness, responsiveness, timely communications, 
efficiency and transparency, allowing NPA members to measure how well wholesalers 
are performing and to give the NPA a picture of wholesaler performance across the 
board (Jones, 2014). The British Association of Pharmaceutical Wholesalers reacted to 
the findings by saying they welcomed all feedback on services. Sawer (2014), 
executive director of the BAPW, however, commented that BAPW wholesalers and 
distributors provide a world class, efficient, and resilient service on behalf of two billion 
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different healthcare items per year to all hospitals, pharmacies, and dispensing doctors 
across the United Kingdom.    
The following section illuminate’s steps from a manufacturing perspective in managing 
disruptions that commonly result in product shortages and communication about 
product availability that have been used in the UK and the US. 
2.5.10 Manufacturers Improvements 
In the US, the FDA, and in the UK, the Department of Health, works to communicate 
information about shortages based on information provided by the manufacturers, and 
will work directly with a manufacturer or manufacturers to take appropriate steps to 
address the disruption to quality and regulatory barriers that may have caused or 
contributed to shortage situations. In both geographies, however, this is a voluntary 
arrangement except in certain circumstances for sole-source and medically necessary 
products. However, this information is necessary for stakeholders to manage product 
shortages when disruptions occur and helps determine strategies employed based 
upon the nature of the shortage and how long it is expected to last. 
Pharmaceutical manufacturers can report any information to either drug shortage 
websites in the UK, this is potentially the University College London Hospital (UCLH) 
website, or to the Department of Health (DoH), or in the US the FDA, or the 
Association of British Healthcare Industries (ABHI) websites. In some cases, 
confidential communications with the DoH or FDA is necessary to protect proprietary 
information and reduce the risk of panic-buying in cases where medically necessary 
products may be in short supply until the agency and manufacturer can sort out 
shortage issues. This delayed communication often causes frustrations at a regional 
hospital level and tensions exist between the parties involved. 
In the UK, these tensions and delayed information communication channels have 
resulted in the increasing drive for collaboration. The DoH encourages the setting up of 
working groups where all stakeholders try and work together through cooperation and 
information sharing. Communication strategies for these products may require special 
attention to lessen the impact of a shortage on patient care. To help prevent product 
shortages, manufacturers have been encouraged to focus on accurately forecasting 
demand and maintaining internal quality assurance and other practices that address 
product shortages. Demand forecasting requires certain information from a 
manufacturer’s customers, including distributors, purchasing groups, and chain drug 
and government entities. 
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In the US, a fee-for-service and inventory management agreement to guide distributors 
has been set up, providing inventory level information to manufacturers (often through 
Electronic Data Interchange, or (EDI) so that future manufacturing needs can be met.  
Purchasing agreements, according to the UK Commercial Medical Unit, take account 
of the nature and availability of branded drugs in acute medical care when agreeing 
contracts with manufacturers. They have also used consultants to investigate the 
procurement practices and strategies to allow them to rank the suppliers on 
compliance in their supply of medicines. This has allowed the CMU to negotiate 
service credits based on supply performance. 
The DoH in the UK, and the FDA in the US, have developed other practical distribution 
disruption strategies to cope with the lack of product. Although this may not address 
the root cause of the problem, it has been effective in mitigating the impact, and in 
some cases, reduces the problem. 
2.5.11 Product Shortage Allocation 
The main consideration in using product allocation programmes (Healthcare 
Distribution Management Association, 2012a) are as follows: 
• The launch of the allocation programme for the finished goods inventory as 
close as possible to the communication of a shortage to trading partners (i.e. 
the sharing of the limited supply amongst Trusts and Institution by critical need)  
• To consider the potential benefits of maintaining a central pool of inventory: 
• Also, to ensure allocation programmes are user-friendly, fair and adequately 
communicated to all stakeholders.  
 
2.5.12 Health systems or hospital pharmacy  
By defining the guideline, as proposed by Fox, Birt, James et al. (2009) for the 
decision-making procedure, the response of the healthcare system can try and 
diminish the supply chain disruption impact, as shown in Figure 13. These guidelines 
come from the American Society of Health System Pharmacists (ASHP), the UK has a 





Figure 13. Adapted from ASPH (American Society of Health System Pharmacists) Guidelines 
for drug disruption management in hospitals and healthcare systems (2009:61) 
The ASPH (2009) guidelines recommend that hospital pharmacy staff, which are 
generally a multidisciplinary team of both pharmacy and non-pharmacy staff depending 
on the size of the institution, will take the following actions: 
1. An operational assessment, typically done by the pharmacy department, will 
examine shortage details, determine remaining stock, identify alternative 
sources of the product in shortage, analyse purchase and use history, estimate 
time until impact, and identify supply of alternative drug products; 
2. A therapeutic assessment performed concurrently with the operational 
assessment will determine the primary affected patient population and identify 
any therapeutic alternatives; 
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3. After collecting necessary operational and therapeutic information, the team will 
conduct an impact analysis by examining therapeutic differences, prescribing, 
distribution and administration processes and financial ramifications to estimate 
the impact of the shortage on patient care; 
4. Using the collected information, staff will create a final plan that addresses 
operational, therapeutic, and ethical issues while meeting the institution’s 
patient care standards. This plan is approved by the Pharmacy and 
Therapeutics Committee when the shortage represents a significant impact on 
patient care (e.g., alternative therapies are less effective than the drug in 
shortage); 
5. Sustained communication throughout the health system is necessary for the 
duration of the shortage. The shortage team uses the most effective means 
available to inform all affected staff of the shortage, the date of impact, 
identified therapeutic alternatives, and any temporary guidelines and 
procedures necessary for maintaining patient safety and quality of care. 
Communication means may include email, order-entry and decision support 
systems, staff meetings, or other established internal communication routes; 
and, 
6. Once informed, staff members will ensure that the plan is implemented. This 
includes information technology system changes, technological changes (e.g., 
bar coding), inventory system changes, and new procedures. 
Section 4.4.13 summarises the pharmaceutical supply chain disruption topic, including 
management strategy. 
2.5.13 Medicine supply chain disruption discussion 
The causes of medicine supply chain disruptions are disputed depending on which 
stakeholders are engaged in discussion, but can be categorised under supply chain 
disruption as a result of economic, manufacturing, and regulatory factors. There are 
usually several factors occurring at the same time, combined with a global dynamic. 
The consequences can be catastrophic at a patient level and the problem is growing 
year on year. A variety of preventative measures and approaches have been used in 
different geographies, both at a macro and micro level.  
In some cases, however, because of the nature and structure of the pharmaceutical 
chain, legislative measures designed to improve the drug supply can in fact worsen the 
situation. For example, as described in research looking at the critical challenges for 
generic medicines by Chabner (2011), it was observed that in the US, the problem for 
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cancer treatment stems from a confluence of factors: consolidation of generic drug 
production in the hands of a few manufacturers (Teva, Bedford, APP Pharmaceuticals, 
Hospira), who in turn have experienced both increased demand for drugs and 
production 'problems'. In general, generic drugs are sold for very limited profit, as fixed 
in the US, for example, by Medicare legislation, and therefore are produced as 
inexpensively as possible, using older and less efficient production facilities, and with 
limited inventories to reduce carrying costs for the company. Once these factors were 
combined with the closure of several key plants, i.e. Bedford and Hospira, due to 
contamination of commercial drug vials with particulate or biologic matter, the problem 
becomes critical. Also, legislation to change the behaviour of profit-making 
organisations can have unpredictable consequences, and each country has their own 
laws and interpretations. Countries with low cost legislation for critical drugs can find 
supplies reducing as pharmaceutical companies, or resellers, divert products to more 
profitable markets, therefore disrupting the supply.  
At a country level, the implementation of voluntary communication guidelines and 
examination of other practices could help the healthcare industry mitigate the impact of 
supply chain disruptions and consequential product shortages and, to an extent, 
improve communications when disruptions occur, and encourage coordinated recovery 
from product shortage situations between trading partners. Due to the unique nature of 
each product shortage and the complexities of the underlying causes, it will take strong 
relationships between trading partners, open channels of communication, and 
controlled discipline among supply chain partners to mitigate their effects. Regardless 
of the root cause(s) of any shortage, it is a shared responsibility among all supply chain 
partners to manage available inventory to meet patient need to the fullest extent 
possible and to recover from the shortage in the most expedient manner possible. 
On a wider perspective, (Boscheck, 1996), looking at comprehensive healthcare 
reform and the restricting of the pharmaceutical industry, stated that market 
transparency and the independence of information is the essence of managed care.  
As previously mentioned, management strategy to combat the consequences of 
pharmaceutical supply chain disruptions has offered up a variety of ‘options’ for 
organisations. Those organisations: 
that have been hugely successful…are great not because they were focused 
on cost or flexibility or speed, but because they have the ability to manage 
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transitions, changing market [and environmental] conditions, evolving 
technology, and different requirements as a product moves through its life cycle 
 (Enyinda and Szmerekovsky, 2008) p98.  
Organisations that can adapt are the ones that will be here for the long-term (Beth, 
Burt, Copacino et al., 2003). Possibly, smart supply chains can create customer or 
shareholder value through their abilities to sense and respond to changes in 
environmental conditions and threats in order to meet customers’ value expectations. It 
has been argued that transforming the pharmaceutical industry supply chain through 
sense and response supply chain models will become a matter of adapt or perish. 
Adaptability invokes the ability of organisations to sense early (anticipate) and quickly 
respond to sudden changes in environmental conditions (Haeckel, 1999, Heinrich and 
Betts, 2003). For the pharmaceutical firms, it is the ability to sense and respond swiftly 
to changing business environments that will be required for firms to survive in the 21st 
century global economy and to gain a competitive advantage. Just like other industries, 
the pharmaceutical firms can leverage a sense and respond supply chain model to 
defend against counterfeiting and diversion of legitimate drugs. Every adaptive system 
survives by making sense its internal and external environments and responding with 
appropriate pre-emptive actions. The sense and respond supply chain model, with an 
adaptive value chain network depicted below in Figure 14, presents how 
pharmaceutical firms can mitigate disruptions by sensing what is taking place in its 
environment. Adaptive supply chain networks are communities of customer-centric 
organisations that must first sense what is going on in its environment, share 
knowledge, rapidly seize new business opportunities, and responding to them while 
judiciously adjusting to changing business conditions (Haeckel, 1999). The ability to 
rapidly adapt to uncertain environmental changes is arguably hinged upon sense and 
respond supply chain technologies such as RFID. Possibly, RFID enabled sense and 
respond supply chains can provide near perfect real-world awareness of information 











Figure 14. Sense and respond supply chain with an adaptive value chain network, adapted (and 
modified) from IBM (2005). Transforming the Military through Sense and Respond. IBM 
Consulting Services (Lin and Luby, 2005). 
As described above in Figure 14, RFID adaptive supply chain networks can develop 
beneficial capabilities, including, 1) monitor and sense, 2) detect and interpret, 3) 
analyse, 4) decide, and 5) respond and execute (Lin and Luby, 2005). Fisher (1997) 
p.110, asserted that: “never has so much technology and brainpower been applied to 
improving supply chain performance,” as is the case with RFID technology. Essentially, 
the ability to sense unexpected vulnerabilities and provide near real-time information 
can adapt supply chain processes to respond in the most efficient and/or timely 
fashion, which  is imperative (Ferrari, 2006). Increasingly, because the pharmaceutical 
firms can no longer meet today’s challenges with their current mitigating strategies, 
there are alternative/additional options to look toward developing sense and respond 
supply chain capabilities. With RFID-based send and respond supply chains, firms can 
achieve real-time visibility on the status of products within and across enterprises. For 
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example, according to an FDA report, the pharmaceutical industry has been subjected 
to serious consequences because of the current level of counterfeiting that is 
estimated at 7% to 10% of the total market and growing annually. To reverse this 
trend, the pharmaceutical industry must evolve its supply chains into adaptive networks 
of supply chain partners that use technology to sense and respond in a coordinated 
fashion to changes in their operational environment (Radjou, Orlov and Nakashima, 
2002). 
Not only are firms’ transitions to sense and respond supply chains evolutionary, but it is 
also more urgent than ever if firms want to be less vulnerable, less massive, more 
robust, and more effective. This indicates that firms must evolve along two premier 
trajectories; becoming more collaborative and adaptive (Castano-Pardo, et al., 2006). 
However, this technology-based strategy relies on the easy adoption of RFID, which 
has not been the case in the pharmaceutical industry because of multiple barriers. 
Yao, Chu and Li (2010) showed that most care providers indicated RFID to be 
functional and useful in asset tracking and patient identification. Nevertheless, major 
barriers were also identified to RFID adoption in healthcare, including prohibitive costs, 
technological limitations, and privacy concerns. Other barriers to RFID adoption 
include the lack of organisational support, trust issues, and security concerns. Further 
agreement on universal standards and protocols globally is far from resolved. It can 
possibly assist in identifying counterfeiting and diversion of products, but for disruptions 
caused by production interruption at the manufacturing level, something that is 
common (Breen, 2005), there may also be no product to track. In emerging markets, 
such as Africa, an m-pedigree method has been piloted using mobile phone 
technology to verify the validity of pharmaceutical packs where no other technology is 
prevalent and available. Though tracking and authenticating drug packs may improve 
security, reduce waste (Paik, Chen and Subramanian, 2009), and so reduce supply 
chain disruptions due to counterfeiting, it does not offer an effective management 
strategy for responding to the disruption once it occurs.  
 
Eliminating waste and thus fat from the supply chain does cut costs, but with it also 
comes risks: it makes the supply chain increasingly vulnerable to disruptions and 
unpredictable events as there is no slack to fall back on. In the car industry, which may 
not be such a problem, all it means is the customer will just have to wait a little bit 
longer until the car is ready. Patients, on the other hand, must take their medication 
immediately; sometimes their life depends on having the product available day to day. 
We have the moral obligation to guarantee the best possible treatment to the patients 





Pharma Trade Journal (2011) p89, predicts:  
 
In 10 years’ time, risk management will not only take place on a strategic level, 
but it will have penetrated day-to-day supply chain operations. We will see a 
comeback of operations research, not to cut costs, but to calculate and balance 
the likelihood and impact of risks against the cost of mitigation. Agility will 
become a feature of the industry, and the organisations that succeed in 
implementing this most successfully are best equipped for survival in an 
uncertain 21st century.  
 
Resilience, in turn, can be achieved by either creating redundancy or increasing 
flexibility. Redundancy is the familiar concept of keeping some resources in reserve to 
be used in case of a disruption. The most common forms of redundancy are safety 
stock, the deliberate use of multiple suppliers even when the secondary suppliers have 
higher costs, and deliberately low capacity utilisation rates. It can be argued that 
significantly more leverage, not to mention operational advantages, can be achieved 
by making supply chains flexible and dynamic. Flexibility requires building in organic 
capabilities that can sense threats and respond to them quickly. Adding a dynamic 
aspect to shortage disruption management response actions can improve flexibility and 
actions can be fluid and combined to potentially improve shortage management 
performance. These findings from the literature review will be crystallised in the 
development of the research question in Chapter 3.   
 
2.5.14 Summary 
In summary, this section considered the current knowledge and literature on supply 
chain disruptions, including risk management, response management in general and in 
the distinctive context of the drug industry environment. It described and critiqued the 
current research, including a detailed and focused examination of 77 supply chain 
resilience articles to inform and highlight the gaps in the research to further develop the 
extant research which underpin the development of the research question this study 






3 Development of Research Question and Propositions 
 
3.1 Introduction  
 
The following sections describe the development of the research question for this 
study. The research question is crucial as it guides multiple aspects of the research 
study, from research design, data collection and analysis and focuses the direction of 
how, what, and why the research is conducted (Bryman and Bell, 2011). The research 
development chapter is divided into four sections, firstly introducing the overarching 
research question (3.2). It then elucidates the three constructs: Supply Chain 
Disruption Orientation, Supply Chain Disruption Performance, and Organisational 
Response and each section are followed by their relevant propositions. 
The research question section will refer specifically to the new conceptual model that 
this research will examine in detail. The original and new models are both described 
and contrasted in the literature review in section 2.4.3, supply chain disruption 
response management. In particular, the research question is built from the supply 
chain response management post disruption gaps identified in the literature review.   
A single research question was chosen because, following the in-depth literature 
review, it focuses on the key area of unexplored research extending the previous 
academic work by (Bode, Wagner, Petersen et al., 2011) on understanding responses 
to supply chain disruptions: insights from information processing theory (Galbraithe, 
1973, Tushman and Nadler, 1978) and resource dependence perspectives (Pfeffer and 
Salancik, 1978). That is the interactions of supply chain response alternatives of 
buffering and bridging post disruption event, considering the performance aspect not 
explicitly considered previously in studies and set in the critical and challenging new 
context of the real-world phenomenon of shortage management. As explained in the 
review, buffering actions are attempts to gain stability by establishing safeguards that 
protect a firm from disturbances that an exchange relationship confers, and bridging 
actions are attempts to manage uncertainty through employing 'boundary-spanning' 
and 'boundary-shifting' actions with an exchange partner (Fennell and Alexander, 
1987, Meznar and Nigh, 1995). The critical challenge of shortage management is, 
most fundamentally, a lack of adequate supply of a particular drug product to meet 
medical need (Charatan, 2001, Mirtallo, Holcombe, Kochevar et al., 2012). 
Performance measures are used in supply chains by management to determine the 
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efficiency or effectiveness of a specified supply chain (Swaminathan, Smith and 
Sadeh, 1998).  
 
The measures to be used in this research are taken from the relevant academic and 
practitioner literature, and this research highlights the measurement and the analysis of 
causal relationships between the variables which are developed. The use of 
performance measurement is a novel approach to supply chain disruption response 
decisions. Items included are validated measures used in previous studies on supply 
chain performance (Gruen and Corsten, 2003, Baumer, 2004) and are described and 
justified in detail in the technique and procedures (section 4.6) of the research design. 
The three key constructs explained below were developed to succinctly answer the 
research question and each was defined by the key research areas that are not 
presently explored in-depth in the extant literature on supply chain disruption response, 
as identified in this research's literature review and evidenced in the focused 77 articles 
review in Appendix 1. These constructs extend the previous work on post disruption 
events management strategy, i.e. supply chain disruption orientation, supply chain 
performance, and organisational response, as highlighted in red in the below Figure 
15. The first two constructs, as shown in Figure 15, are drawn from the existing model 
of organisational responses to supply chain disruptions introduced by Bode, Wagner, 
Petersen et al. (2011), and the third construct of performance extends the original 
model. Each of the constructs was further developed into a series of relevant 
propositions which were expanded so that each element of the construct can be 
measured, examined, and defined. The three constructs are highlighted and put into 
context of the overall study in the research design and strategy discussion in Chapter 
4, as shown in Figure 22: the research problem flowchart. This flowchart links the 
research question, constructs, and propositions. Although a research question can 
never fully be answered in completeness, it does allow the generation of fresh insights 
into the subject under examination to contribute to existing and future research.     
As identified in the research literature review (Section 2.4.3), understanding a firm’s 
responses to supply chain disruptions after the event and constructing a holistic theory 
to explain these issues is still developing. This research gap has informed the research 
design of this study which will lead on from the principles of theory-orientated research 
following a deductive approach by testing the below propositions. The objective of 
theory-orientated research is to contribute to the development of theory (Dul and Hak, 
2007). The research question below was formed by the need to build on and give 
further insights into post-disruption management strategy theory, as highlighted in this 
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study's review of the extant literature. It will be explored in the subsequent propositions 
introduced with each construct, which will then be tested by this research to contribute 
to academic theory development.  
 
3.2 Research Question 
 
How do the actions of buffering and bridging in response to supply chain 
disruption events affect the performance of shortage management? 
The specific research question is formulated to define the area of interest and what it is 
the research wants to know. This is to prevent the risk of open-ended research which 
can lead to the collection of too much data, which lacks focus. As noted by Bryman 
and Bell (2011), without the focus of a specific research question the researcher is 
unsure what the research is about and the reason the data is being collected. A series 
of propositions (P1-P3) were designed based on the existing research theory of 
information processing theory (Galbraithe, 1977) and resource dependence theory 
(Pfeffer and Salancik, 1978). However, this research will also include other 
perspectives of organisational learning literature and organisational response 
(Crossan, Lane, White et al., 1995, Crossan and Guatto, 1996, Dodgson, 1993, Cohen 
and Sproull, 1996) incorporating the concept of dynamic resilience (Grewal, Johnson 
and Sarker, 2007, Peck, 2006, Huber, 1991, Edmondson, 1996, Ponomarov and 
Holcomb, 2011) as discussed in the literature review (Section 2.4.3). For each of the 
underlying theory constructs, as shown below in the new proposed model, these 
constructs, highlighted red in Figure 15, were developed and extended from the 
original Bode et al. (2011) model of organisational responses to disruptions, which will 
be tested by examining the propositions using a survey tool and triangulated with 
interviews, focus groups and secondary data described and justified in the research 
design section.  
The following section outlines each construct this research will examine to answer the 
above research question. Each construct is firstly defined from its basis in the extant 
literature and then each subsequent proposition (P1-P3) to be tested by this research 








Figure 15. New proposed model of organisational responses to supply chain disruptions, 
integrating response action and output performance  
 
 
3.3 Supply Chain Disruption Orientation Construct 
 
The first construct that this research will refine and expand to augment understanding 
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orientation, which was first introduced into the supply chain management literature by 
Bode et al. (2011) to fill the gap in the research, as identified in the literature review.  
Supply chain disruption orientation is a new concept and was defined by Bode et al. 
(2011) as an organisation’s general awareness, consciousness of, concerns about, 
seriousness toward, and recognition of the opportunity to learn from supply chain 
disruptions. The stronger the firm’s supply chain disruption orientation, the more 
importance it attaches to the issue of supply chain disruptions and the more 
pronounced its need for stability is. The supply chain orientation concept built on 
previous work in the supply chain risk management literature (Autry and Bobbitt, 2008, 
Christopher and Peck, 2004, Sheffi and Rice, 2005). Autry and Bobbitt (2008) did look 
at how a firm was orientated towards risk but there was an emphasis on the security 
element, with respondents blending their responses to this purely qualitative research 
on security risk with operational performance. The supply chain security (SCS) has 
since developed from the risk management literature with an emphasis on an 
orientation to damage limitation and performance (Lu, Koufteros and Lucianetti, 2017), 
identifying practice against performance in the wake of incidents, such as the 9/11 
attacks, to thwart breaches and restore operations. Supply chain security has an 
emphasis on prevention rather than concentrating on the reasons due to interpretation 
and motivation to act by examining mitigation and response actions. Supply chain 
disruption orientation, in contrast, builds on a firm’s market orientation (Narver and 
Slater, 1990) and entrepreneurial orientation (Lumpkin and Dess, 1996). Supply chain 
disruption orientation draws on Daft and Weick (1984) work which explained how a 
firm’s behaviour was categorised either as active or passive. Whether a firm is active 
or passive then determines their actions as both proactive and assertive, or to accept 
the environment as a given and being reluctant to change, therefore making them 
slower to respond to environmental events.  
This argument indicates that if a firm is an active firm with high awareness of 
disruptions that they would have a strong motivation to act as per resource 
dependency theory (Pfeffer and Salancik, 1978). As examined in the literature review 
(Section 2.3), resource dependency theory states that firms seek to assert control over 
the resources they require to minimise their dependence. So, where a supply chain 
disruption entails a dependence relationship, it requires action. Furthermore, when a 
disruption event occurs there can often be a mismatch between the amounts of 
information available to a firm and its information processing capacity (Huber and Daft, 
1987). As per information processing theory (Galbraithe, 1973) , the greater the 
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uncertainty a firm faces, the more information it needs to gather and process to 
achieve a given level of performance. Organisations may be more active in using 
information to try and influence their environmental stability, and use information 
proactively. In this way, organisations would be high performing in response to a 
disruption event causing shortages by using information more effectively. As informed 
by the literature review, and addressing the first construct of supply chain disruption 
orientation, the below proposition P1a is developed, where the unit is defined as a 
pharmaceutical dispensing operation managed by a pharmaceutical lead within an 
acute secondary care hospital (as described in detail in the Section 6.10 of the 
research design section). The proposition to be tested is: 
Proposition 1a. The stronger the supply chain disruption orientation (SCDO) of a unit, 
the higher the performance in shortage management. 
The original concept of supply chain orientation did not take account of boundary 
conditions in which a firm makes response decisions. Looking at supply chain redesign 
for resilience, Carvalho, Barroso, Virginia et al. (2012) stated it is expected that 
specificities related to the industry context like product type, production process, 
country and cultural perspectives can impact on the types of resilience and agile 
practices employed in the supply chain and the effect these practices have on supply 
chain behaviour; so the decision-making response to disruption is affected by the 
environment the firm operates in. Simon (1979) originally developed the concept of 
boundary rationality and considered rational decision-making in business 
organisations. Bounded rationality refers to the limits experienced by managers in their 
ability to process and interpret a large volume of pertinent information in their decision-
making activities (Simon, 1979). Boundary rationality bias in managerial valuation of 
real options was considered by (Tiwana, Wang, Keil et al., 2007); they noted that real 
options theory unequivocally suggests that uncertainty increases options value. 
Furthermore, the more knowledge supply chain members possess, the greater their 
awareness that additional knowledge can ultimately enhance outcomes (Hult, Ketchen 
and Slater, 2004). Mintzberg (1973, 1975) considered decisional roles of managers. 
He described how decision-making choices and their requirements are determined by 
the manager’s role, seniority, and availability of information. Bounded rationality thus 
describes the process of how managers arrive at their assessments (Simon, 1979). 
Bounded rationality encompasses two central concepts: search and satisfying. Search 
refers to how extensively a decision maker searches for information to guide decision-
making, its perceived organisational benefits, and the technical and business 
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uncertainties that might affect its likelihood for successful completion. The search 
scope is capped by what Simon describes as an aspiration level that defines at the 
outset of the search process what constitutes a good enough solution. As soon as this 
aspiration level is reached, individuals terminate the search process and reach a 
tentative conclusion. Search is guided by heuristics that are tacitly held but consistently 
used to simplify the cognitive decision-making process (Simon, 1979, Tiwana, Wang, 
Keil et al., 2007, Hammond, Keeney and Raiffa, 1998).  
Managers cope with the potentially large volume of contextual information by focusing 
on a few salient cues in forming heuristic-driven judgments under uncertainty 
(Kahneman, 2003, Simon and Houghton, 2003). Individuals then reach a preliminary 
conclusion after assessing a salient subset of the available information that they see as 
being most informative and terminate their search (Miller and Chen, 2004, Hilary and 
Menly, 2006). Management strategy in response to post disruption has to then take 
into account other factors than explained by resource dependency theory. Having 
control over a firm’s resources in traditional strategic management decisions (Child, 
1972) is only one aspect of the contingency approach to organisational behaviour 
(Buchanan and Huczynski, 2004). Taking account of the alternative perspectives using 
the determinists approach to contingency, for example, (Burns and Stalker, 1961, 
Lawrence and Lorsch, 1967) describe ‘contextual’ factors, such as size, ownership, 
technology or environment, imposing constraints on managers' choices as also 
necessary. The environment in which managerial decisions are made in response to 
disruptions affects the decisions made and so influences the outcomes. The extent of 
the disruption, the role, and knowledge of the manager making the decisions will 
influence the response choice and therefore the performance. The next proposition is 
informed by the gap identified in literature review, where the original supply chain 
disruption orientation concept excluded boundary rationality, to test how the contextual 
factors through the role of the actor influence outcome:  
 
Proposition 1b. The lower the role of the actor responsible for making supply chain 
disruption action decisions, the lesser the shortage management performance 
Boundary spanning activities (Thompson, 1967) can either link organisations to other 
organisations or buffer them from environmental disturbances, as noted by Fennell and 
Alexander (1987). Given the problem of hierarchical clustering or multiple levels of 
organisation (Freeman, 1978), organisations can be defined as either independent 
units or members of larger organisational systems. Fennel and Alexander (1987), in 
102 
 
their research on organisational boundary spanning in institutionalised environments, 
found that hospitals in systems are more likely to bridge, probably as a result of 
corporate policies intended to centralise functions and minimise costs. System 
membership was reported by  Fennell and Alexander (1987) as an important factor in a 
hospital's selection of bridging or buffering. A hospital which is the sole unit in a 
hospital trust, as opposed to a hospital in a trust which is made up of a number of 
trusts, may have a higher tendency therefore to bridge within the trust than the sole 
unit does. The concept of supply chain disruption orientation is a novel concept in 
supply chain management research, as discussed in the literature review (Section 
2.4.3), and this research aims to give further insights into this concept to fill this 
academic gap. To develop the concept of supply chain disruption orientation, it is 
important to identify the response spectrum, taking account of the system, a unit is in 
(i.e. whether the pharmaceutical dispensing unit in the acute care hospital has 
opportunity to bridge with other hospitals which are part of the trust or not). The next 
proposition therefore is: 
Proposition 1c. The larger the number of hospitals in a trust, the stronger the supply 
chain disruption orientation of a unit  
 
Organisational performance in response to disruptions they encounter is not uniform 
(Hendricks and Singhal, 2005). Hendricks and Singhal (2005) analysed disruptions, 
including announced shipping delays and other supply chain disruptions reported in the 
Wall Street Journal during the 1990s and showed, based on matched sample 
comparisons, that companies experiencing such disruptions under-perform their peers 
significantly in stock performance as well as in operating performance, as reflected in 
costs, sales, and profits. Firms with a highly developed supply chain orientation should 
therefore not only out perform their contemporaries but also make better response 
decisions when the worst of the disruptions occur. The last proposition to examine this 
construct is: 
 
Proposition 1d. The higher the severity of the disruption, the better the managers with 
higher supply chain disruption orientation perform 
The first construct was concerned with the development of the new concept of supply 
chain disruption orientation; the second construct further develops supply chain 
disruption understanding by considering the performance aspect. Performance 
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implications, as debated in the literature review (Section 2.4.3),  were not considered in 
previous research on disruption orientation, specifically Bode, Wagner, Petersen et al. 
(2011) did not go on to examine the performance repercussions of the respective 
bridging or buffering strategic response choices. 
 
3.4 Supply Chain Disruption Performance Construct 
 
Supply chain management, observed Seferlis, Vlachos, Iakovou et al. (2008), involves 
a number of decisions to be taken at every time period to meet end-customer 
requirements. The overall supply chain performance is multi-dimensional and directly 
or indirectly affected by several factors, such as service quality and overall operating 
costs. Provided that these factors are generally battling with each other, trade-off and 
compromise choices are necessary to achieve the best performance. Inventories at the 
nodes of the network serve as safety stock to handle the stochastic variation of 
demand, anticipate for lead time in ordered quantities, and compensate for abrupt 
shocks (e.g., damaged products during transportation, bad storage conditions, and 
delays in lead times) that would otherwise disrupt the smooth supply of products. 
However, making disruption response decisions that give either a positive or sub 
optimal performance are ‘of the moment’ unless the managers and organisations can 
learn from that performance (Peck, 2006). As highlighted by Daft and Weick (1984), 
overlapping with extant organisational information processing models, gathering, 
processing, and acting on data from the environment is a firm's main task. Taking an 
information processing perspective, it is critical to supply chain success (Bowersox, 
Closs and Stank, 1999, Busse, Meinlschmidt and Foerstl, 2017).  
 
The supply chain disruption performance construct has its grounding in the information 
processing perspective, as did Bode et al. (2011), in developing the organisational 
response framework, as shown in Figure 14, but also draws on the organisational 
learning research, as discussed in the literature review. Two assumptions underpin 
much research on learning in the organisational context; that learning is intended, 
conscious, or purposeful and that ‘successful’ learning leads to better performance. To 
influence employees, as noted by Sims and Lorenzi (1992), successful managers 
require an understanding of a contingency of reinforcements, also called the 
behavioural contingency. The link between learning and performance is explicitly 
addressed in several reviews. Many organisational learning researchers assume a link 
between learning and performance (Huysman, 1999, Crossan, Lane, White et al., 
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1995, Dodgson, 1993). As noted, however, by Huysman (1999), is the learning just a 
new rather than old routine, or is it an ‘active’ agency. Huber (1991) p1001, defined 
learning: “an entity learns if, through its processing of information, the range of 
potential behaviours is changed”. Also as per reinforcement theory noted by Robbins, 
Judge and Campbell (2010), any consequences that, when immediately following 
responses, increase the chances that the behaviour will be repeated. The results of 
Bode et al. (2011) points towards the moderating effect of prior experience making a 
strong case for organisational learning from supply chain disruptions. Hedberg (1981) 
also raised the question of whether firms forget what they have learned from prior 
supply chain disruptions. In encapsulating the literature, Huber (1991) identified four 
key learning elements: knowledge acquisition, information distribution, information 
interpretation, and organisational memory. In a strategic supply chain, memory 
encourages more acquisition knowledge (Hult, Ketchen and Slater, 2004).  
 
Members of chains that possess significant memory are aware that knowledge 
coordination across nodes reduces duplication, waste, and redundancy (Handfield and 
Nichols, 2002). To make effective response decisions to disruptions which lead to, for 
example, stock-out situations, outcome performance information needs a feedback 
loop mechanism. In this way, management making strategic response decisions can 
make informed response choices, with dynamic capabilities drawing a response 
dependence perspective (Pfeffer and Salancik, 1978, Daft and Weick, 1984). Actors 
making independent response decisions may hold diverse views whose interpretation 
may overlap without reaching consensus on meaning (Gioia and Thomas, 1996). But 
diverse interpretations are often a hindrance in the supply chain context (Hult, Ketchen 
and Slater, 2004). Diverse views of concepts can be resolved so that effort can be 
focused on necessary activities. By including the assistance of empirical performance 
data from prior response decisions, strategic supply chains can benefit and individual 
participants learn to think alike. There is a distinction, as discussed in the literature 
review between managerial ‘work’ as a set of actual behaviours and as a set of desired 
(either by managers or others) outcomes (Hales, 1986). The following proposition is 
developed to fill the gap left by previous research by considering the role of feedback 
and supply chain disruption: 
 
Proposition 2e. There is a positive relationship between the performance feedback 




The analysis of buffering and bridging strategies in response to supply chain 
disruptions requires further investigation, leading on from the initial works by Bode et 
al. (2011). An examination of the interplay of buffering and bridging is needed. 
Buffering involves trying to keep the environment from interfering with internal 
operations and trying to influence the external environment (for example, building 
safety stock). Bridging occurs as firms seek to adapt organisational activities so that 
they conform to external expectations (for example, developing new supply sources). 
This response could be a response strategy due to a supply factor risk, for example, as 
a result of having too small a supply base, supplier dependency, inflexibility, or single 
sourcing (Wagner and Neshat, 2010, Ho, Zheng, Yildiz et al., 2015, Tummala and 
Schoenherr, 2011). However, as identified by previous research (Meznar and Nigh, 
1995, Bode, Wagner, Petersen et al., 2011), the interaction of the different strategies 
are still not fully understood.  In particular, there exists a research gap for deeper 
analysis of their comparative efficiency and effectiveness. Buffering and bridging 
choices are not mutually exclusive, as shown in prior work (Meznar and Nigh, 1995, 
Fennell and Alexander, 1987, Bode, Wagner, Petersen et al., 2011). Although the 
Bode et al. (2011) study (based on integrating perspectives; information processing 
and resource dependency theory) did not find significant correlation between the two 
strategies, they did find that there may be a temporal ordering wherein a focal firm 
progresses from less to more intense responses. This dynamic nature of organisational 
responses to supply chain disruptions and their relative efficiency and effectiveness will 
be tested by the following proposition:   
Proposition 2f. Pursuing an initial buffering strategy followed by a bridging strategy 
enhances performance in shortage management 
The dynamic and evolving nature of supply chain risks means that no supply chain 
strategy is ever likely to be risk-free, and no system, however well managed, is 
invulnerable. Therefore, as noted by Peck (2005), it seems that there is slack in the 
system, whether in the form of inventory, capacity, capability, and even time. Mitigating 
strategies and buffering and bridging have been positively related in risk management 
research to consider risk reduction and its relation to improved downstream supply 
chain performance overall, by Mishra, Sharma, Kumar et al. (2016) based on the Miles, 
Snow, Meyer et al. (1978) four firm typology, although constant awareness and 
vigilance are needed if supply chains are to become, and remain, truly resilient. The 
previous two propositions consider whether the use of a combined strategic approach 
of buffering and bridging will deliver improved shortage management performance in 
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response to a disruption. According to resource dependency theory, responses can be 
different on the basis of whether they are internal or external to a current relationship 
(Carroll, 1993). Buffering actions are predominately internal (for example, controlling 
stock an organisation already has on hand or ordered), whereas bridging actions are 
predominately external (for example, sourcing new suppliers or a new organisational 
network). The last proposition to examine supply chain disruption performance is:   
Proposition 2g. Buffering actions in response to supply chain disruption are more 
effective than bridging actions in shortage management performance 
The third construct, following on from supply chain disruption performance, is 
organisational response. 
3.5 Organisational Response Construct 
 
The final construct extends the examination of post supply chain disruption strategic 
management, as highlighted in the literature review (Section 2.4.3), giving new insights 
by considering dynamic response and its effect on performance. Strategic 
management and responses do not operate in a vacuum and at a single point in time, 
instead they change and adapt to the environment they operate in. As described in 
constructs one and two above, organisations can learn from post disruption decisions 
and their performance can vary with the response spectrum. 
 
The organisational response construct incorporates prior work on organisational 
responses to adverse environmental events. These have been investigated in various 
settings and through many theoretical lenses (Chattopadhyay, Glick and Huber, 2001, 
Ford and Baucus, 1987, Meyer, 1982, Grewal, Johnson and Sarker, 2007, Primo and 
Dooley, 2007), and by Bode et al. (2011), who explicitly examined these issues across 
the boundaries of firms and at the dyad level. Taking an information processing 
perspective (Galbraithe, 1977) and resource dependency perspective (Pfeffer and 
Salancik, 1978), the Bode et al. (2011) research developed the organisational 
response construct to encompass the repertoire of disruption response. These include 
the dual strategies of buffering and bridging, building on earlier generic response 
alternatives developed by (Fennell and Alexander, 1987, Meznar and Nigh, 1995). This 
research will build on this construct and will further consider the dynamic nature of 
disruption response management, as previously identified. In the supply chain 
disruption performance construct section, the performance feedback is considered, 
taking into account the effect of organisational learning. But, if an outcome of learning 
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might be the potential to act, the opportunity to deploy this new capability in practice 
might not arise immediately. Furthermore, if the opportunity did arise, one might expect 
a short-term loss of performance as competence in new skills would take time to 
develop. In addition, changes to organisational routines and culture may have an 
enduring detrimental effect on organisational performance (Crossan, Lane, White et 
al., 1995). So, any association between learning and performance could be discernible 
or not; positive or negative; temporarily proximate or distant; clear or equivocal. Whilst 
we may recognise that interest in learning relates to interest in performance, we should 
not assume a simple static relationship exists between them. Many publications about 
organisational learning and learning organisations are not based on robust empirical 
evidence (Easterby-Smith and Araujo, 1997). This research will consider the time 
dynamic of organisational learning in post disruption decision-making integrating 
concepts from organisational management and supply chain management. The 
diversity of disciplines in the research will benefit from the plurality of perspectives. 
 
Supply chain processes are often measured against time (e.g., on time deliveries, 
picking rates, etc.), as opposed to some other physical dimension or quantity (e.g., 
picking accuracy, product tolerances, etc.) as noted by Christopher and Peck (2004). 
Applying a dynamic management approach to enhance performance in strategic 
disruption response where a shift, stabilise, and resynchronise response is varied over 
time offers supply chain resilience. However, as Tang (2006) pointed out, a robust 
strategy is useless unless a firm can execute the strategy in a proactive manner. 
Resilience, as defined by Christopher and Peck (2004), is the ability of a system to 
return to its original (or desired) state after being disturbed. In the context of supply 
chain disruptions, a resilient supply chain must also be adaptable, as the desired state 
may be different from the original. ‘Robust’ processes may be strong but they are not, 
by definition, adaptable, hence a supply chain of robust processes is not necessarily 
going to be resilient. The dynamic management approach to managing disruptions 
proactively is concerned with adjusting the response alternatives over time according 
to the situation presented, and it has been used in resilience optimisation from other 
perspectives, for example, industrial and systems engineering (Ng and Sy, 2014).  
From an information processing theory perspective, a bridge forestalls uncertainty by 
facilitating access to reliable and timely information about looming supply chain 
disruptions and their consequences (Grewal, Johnson and Sarker, 2007). In addition, 
bridging may be associated with investments in collaborative structures or initiatives, 
such as joint risk management systems, or with scanning approaches such as 
monitoring or intensifying information exchanges (Flynn and Flynn, 1999, Pfeffer and 
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Salancik, 1978). These proactive responses, as opposed to static passive reaction, will 
result in strategic action changes post disruption and yield improved performance. The 
second construct supply chain disruption performance, examined through propositions 
P2e-P2g; the interaction of effectiveness of pursuing the alternative strategic 
responses of buffering and bridging. The following propositions, P3h-P3i, offer further 
new insights to contribute to the supply chain management literature by examining the 
dynamic aspect of supply chain resilience through the perspective of dynamic 
organisation response, as explored in the literature review (Chapter 4). Specifically, 
how response decisions to disruptions can vary over time and the subsequent effect of 
those dynamic decision choices on performance. This is a novel research area and 
builds on and expands the previous research of (Bode, Wagner, Petersen et al., 2011). 
 
Proposition 3h. Varying a firm’s supply chain disruption response actions dynamically 
post event improves performance in shortage management 
The original supply chain disruption model did not focus on the specific interplay 
between the buffering and bridging alternative response actions to supply chain 
disruptions. The literature review identified this gap, and to address the aims of this 
research study, as described in Section 1.3, the next proposition is therefore to 
examine not only the differing impacts of each action, but how those actions and 
outcomes unfold or play out over the post action period. It uniquely empirically tests 
this dynamic interchange, which stretches the existing description of supply chain 
organisational resilience as identified in the literature review; for example, of Lengnick-
Hall, Beck and Lengnick-Hall (2011) of situation specific responses to examine the 
blends, suites and chemistry of post responses over time from initial impact. Therefore, 
the last proposition is:  
Proposition 3i. The impact of buffering and bridging actions in response to supply chain 




Chapter 5 developed the research question and propositions for this study, which will 
be answered by the research design and methodology laid out in the following Chapter 
6. The study has a single research question and subsequent nine propositions, which 
are organised into three specific constructs, as highlighted in the new proposed 
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framework model shown in Figure 15, to extend and give further insights to current 
knowledge. By launching a new study which includes performance, boundary 
rationality, feedback and dynamics new perspectives will augment the existing supply 
chain management body of work and underlying theory, as described in the literature 
review, to tackle the gaps identified in current research, by extending the existing 
disruption response model (Bode, Wagner, Petersen et al., 2011) based on information 
processing and resource dependency. Considerable amounts of the literature are 
focused on the mitigation of risk, implicitly assuming that sources of risk can be 
identified, and centres mitigation strategies on organisational preparedness (Greening 
and Rutherford, 2011). However, to deal with the nature of disruptions which often 
have significant impact and result in discontinuities, further understanding is required 
as to the post disruption response mechanisms, and by testing the new conceptual 
disruption framework it allows the incorporation of additional dimensions, including 























4 Research Design and Methodology 
 
4.1 Introduction  
 
Chapter 4 introduces the approach taken to the overall research design. It sets out and 
defines the considerations of the research and then goes on to provide an overview of 
the methodology. A methodology needs to be chosen in order to outline the activities 
that are needed to answer the research questions (Blaikie, 2000). The research design 
is the general plan of how to go about answering the research question. This research 
used the ‘onion’ research plan (Saunders, Lewis and Thornhill, 2003) as a way of 
depicting issues underlying the choice of data collection methods, philosophies, and 
approaches. The way research questions are answered is influenced by the research 
philosophy and approach to theory. As shown in Figure 16, which is based on 
Saunders, Lewis and Thornhill (2003), the philosophical stance (layer 1) and research 
approach (layer 2) will subsequently influence the inner research layers. Those inner 
layers being the research strategy (layer 3), method choices and time horizons (layers 
4 and 5) and techniques and procedures, including data collection and data analysis 
(layer 6).   
 
This research as described and explained in the following section, sets out the 
research design process followed for this research using the research onion as a 
reference roadmap.  These five research headings relate to the research onion used in 
this research: 
 
1. Philosophical Stance (4.2) 
2. Research Approach (4.3) 
3. Research Strategy (4.4) 
4. Research Methodology (4.5) 
5. Techniques and Procedures (4.6) 
 







Figure 16. Research Onion: adapted from original source (Saunders, Lewis, and Thornhill, 
2011: 160). 
Each section will be separated into two parts, the first part setting out the general 
explanation of the research considerations, and the second part setting out the 
proposed choice for this research. 
 
The original research onion diagram, created by Saunders, Lewis and Thornhill (2003), 
included the possible philosophical stance choices of positivism, realism, 
interpretivism, and pragmatism. The model, as shown in Figure 16, excludes the three 
philosophies of Ontology, Epistemology and Axiology from the research onion for 
simplicity, as these are broader terms which include several philosophical approaches. 
Understanding and choosing a philosophy is a key step in planning and carrying out 
research, and these approaches have been included as three additional elements 









4.2 Philosophical Research Considerations 
 
Layer 1 of the research onion, as shown in Figure 16, contains the philosophical 
stances associated with the philosophies. Each of the possible choices at this level 
require careful thought as they provide structure, guidance, and possible limitations to 
following decisions and, ultimately, the way a researcher can collect and analyse data 
to create valid findings 
 
Ontological philosophy is concerned with the nature of reality. It requires researchers 
to ask themselves how they think the world operates, how society is constructed, and 
how this influences everything around us. Ontology talks about the difference between 
reality, our perception of reality, and how this influences people’s behaviour. 
 
There are three philosophical positions commonly agreed to work under an ontological 
worldview. These are objectivism, constructivism, and pragmatism (Phillimore and 
Goodson, 2004).  
  
Epistemology is concerned with addressing the facts by asking what the acceptable 
knowledge is. It asks you to define what acceptable knowledge about your field of 
research is and what information is known to be true after rigorous testing, and 
thereafter is treated as fact. This philosophy is most commonly used in scientific 
research as it searches for facts and information that can be proven without doubt, 
rather than changeable situations and opinions. The epistemology philosophy is about 
understanding the nature of knowledge and how it is acquired. Therefore, it entails the 
most relevant ways of enquiring into the nature of the world (Easterby-Smith, Thorpe 
and Jackson, 2008) and focuses on the data collection processes (research methods). 
The further philosophical positions associated with epistemology are positivism, critical 
realism, and interpretivism (Norris, 2005).  
 
The different combinations of ontological and epistemological philosophies determine 
the methodological perspectives (paradigms) for the investigation of theory and data. 
According to Blaikie (2007) p.79: 
The methodological perspectives are defined in terms of their ontology and 
epistemology, and include reference to the logic of theory construction, what 
counts as data, explanations and theory, criteria of validity, and views on the 




According to Bryman and Bell (Bryman and Bell, 2011) p.102, a paradigm is “a cluster 
of beliefs and dictates which for scientists in a particular discipline influence what 
should be studied, how research should be done, and how results should be 
interpreted”. There is no collective agreement regarding the terms for these paradigms 
to be used and it is common for different names to be used to describe apparently 
similar paradigms. However, three main paradigms that can be identified in the 
literature are namely positivism, critical realism (realism or post positivism), and 
interpretivism (anti-positivism or constructivism) (Boll, 2009, Bryman and Bell, 2011, 
Creswell and Plano Clark, 2011, Denzin and Lincoln, 2000, Easterby-Smith, Thorpe 
and Lowe, 2004).  
In Figure 17, these three paradigms can be identified. Positivism supports that the real 
world exists independent of our knowledge (objective ontology) and the knowledge 
about this world obtained in an objective way (objective epistemology). Objectivism 
recognises that social phenomena and their meanings exist separately to social actors. 
An example of social phenomena could be heavy rain and social actors are people 
wanting to have a picnic outside. The rain exists, it is real and would be acknowledged 
by everyone to exist and is, therefore, independent to the people who have had their 
day out ruined by it. On the other hand, interpretivism and critical realism believe that 
knowledge is socially constructed (subjective epistemology). Concerning ontology, 
interpretivism takes the stance of subjective ontology and qualitative data is mostly 
used, whereas critical realism accepts the objective ontology as positivism does. 
However, positivism can be described as a ‘flat’ ontology': one reality exists and that 
reality can be observed. Critical realism supports that it is impossible to observe 




Figure 17. Positioning the paradigms Positivism, Constructivism and Critical Realism (adapted 
from Bol, 2011:16) 
4.2.1 Positivism 
Positivism generates hypotheses (or research questions) that can be tested and allows 
explanations that are measured against accepted knowledge of the world we live in. 
These could be the laws of gravity applied to an apple falling from a tree. This position 
creates a body of research that can be replicated by other researchers to generate the 
same results. The emphasis is on quantifiable results that lend themselves to statistical 
analysis. Logical positivism is one of the central strands of the fabric of twentieth 
century thought and was entwined with some of the most important scientific 
developments, including the growth and propagation of Einstein's theory of relativity 
(Friedman, 1999).  
 
The first positivist research examples are the work of (Pugh, Hickson, Hinings et al., 
1963) at Aston University when researching into organisational structure that used 
highly structured interviews and questionnaires over a large sample. Thus, the focus is 
on quantitative data, and includes research methods such as simulation, mathematical 
modelling, and structured questionnaires (Bryman and Bell, 2011, Easterby-Smith, 
Thorpe and Jackson, 2008). The positivist position believes that there are ‘absolute 
truths’ about the real world and the researcher is separated from the observed 
phenomena (ontology). Quantitative research searches for general laws and such 
research highlights the measurement and the analysis of causal relationships between 
variables. The positivism paradigm usually tests a set of hypotheses developed from 
existing theory (deductive logic). The theoretical models developed from the positivist 
stance are generalisable and can describe cause and effect relationships (Easterby-
Smith et al., 2008). The main strengths of positivism are that its methods can be fast 
and economical. However, they are inflexible, artificial, and not effective in 
understanding processes or the significance that people attach to actions (Easterby-
Smith, Thorpe and Jackson, 2008). According to Habermas, positivism reaches the 
ideal knowledge and ignores the moral choices, values and judgments researchers 
make (Cohen, Manion and Morrison, 2007)   
4.2.2 Interpretivism 
Interpretivism refers to approaches emphasising the meaningful nature of people's 
participation in social and cultural life. Researchers working within this tradition analyse 
the meanings people confer upon their own and others' actions and take the view that 
cultural existence and change can be understood by studying what people think about, 
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their ideas, and the meanings that are important to them. This position is described 
differently in research such as constructivism, or by (Hatch and Cunliffe, 2006) as anti-
positivist, and by (Blaikie, 2007) as post-positivist. Constructivism argues the opposite 
beliefs as objectivism; it is a standpoint that believes social phenomena are actually 
constructed by social actors. So, if you had a constructive ontological world view, you 
would believe that, for example, a new law is the product of the behaviour of the group 
of people it now has an impact on.  
 
Interpretivist approach starts from data and views reality subjectively (a researcher’s 
knowledge on a specific topic relies on the perceptions of the participants). 
Interpretivism considers the differences between people (Bryman, 2001) and the 
researcher is trying to understand the interpretations of social actors (what they are 
thinking, feeling, et cetera), and the world from their point of view, which is highly 
contextual and hence is not widely generalisable (Easterby-Smith, Thorpe and 
Jackson, 2008, Saunders, Lewis and Thornhill, 2007). Interpretivist researchers look at 
organisations in-depth by using qualitative methods, such as interviews, observations, 
and secondary data analysis in order to overcome generalisability critiques (Bryman 
and Bell, 2011, Easterby-Smith, Thorpe and Lowe, 2004, Eriksson and Kovalainen, 
2008). Constructivism is based on inductive reasoning, where data is collected first and 
then the theory is developed (Saunders, Lewis and Thornhill, 2007). At the centre of 
this paradigm is that all knowledge is socially constructed. One of the limitations to 
interpretive research is that it does not verify the results and thus cannot be 
generalised to other situations (Mack, 2010). Another limitation of this paradigm is the 
subjective nature of it (Mack, 2010).  
4.2.3 Realism 
Realism is similar to positivism in its processes and belief that social reality and the 
researcher are independent of each other and so will not create biased results. 
However, where they differ is that realism thinks that scientific methods are not perfect. 
It believes that all theory can be revised and that our ability to know for certain what 
reality is may not exist without continually researching and leaving our minds open to 
using new methods of research. Realism may, therefore, use several types of research 
methods to triangulate results in its search for a more reliable outcome. 
 
Critical realism offers an alternative position to positivism and interpretivism. It is a 
combination of positivist conceptions of an external world with the recognition of 
interpretive understanding. Thus, the critical realist paradigm combines the strengths 
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and avoids the limitations of positivist and interpretivist paradigms (Easterby-Smith, 
Thorpe and Lowe, 2004). The major advantage of this paradigm is the multiple sources 
of data and perspectives (Easterby-Smith, Thorpe and Lowe, 2004). Events, 
experiences, structures and mechanisms can be interpreted by using qualitative and 
quantitative methods (Sobh and Perry, 2006). Critical realism uses the research 
strategy of ‘retroduction’, which means describing the mechanism that has resulted in 
the current situation (Bhaskar, 1997).  According to (Sayer, 1992) p263, retroduction is 
a: "mode of inference in which events are explained by postulating (and identifying) 
mechanisms which are capable of producing them".  The critical realist entails the 
notion of stratified ontology, which distinguishes between the real domain, the actual 
domain and the empirical domain (Bhaskar, 1978). The real is whatever exists, and it 
consists of objects, structures, and powers (mechanisms). These mechanisms may 
exist unexercised. The activation of these mechanisms and its implications belongs to 
the actual domain. Finally, the empirical refers to the events that entail our experiences 
and perceptions. Realism believes that events are not predetermined to take place, but 
they depend on contingent conditions. However, the same mechanism can lead to 
different outcomes based on the context and spatio-temporal relations with other 
objects (Sayer, 2000).  
Table 5 summarises the main differences seen in positivist, interpretivist, and critical 
realist paradigms regarding their ontology and epistemology. There seems to be a 
stronger polarisation between positivist and interpretivist paradigms, whereas the 
critical realist paradigm appears to be taking a middle view. 
Elements Positivism Critical Realism Interpretivism 
Ontology Reality is real and 
apprehensible 
Reality is real but only 
imperfectly 
Multiple local and 
constructed realities 
Epistemology Findings are true Findings are probably 
true 
Created findings 
based on the 
interpretations of the 
researcher 
Aims Discovery Exposure Invention 









Methodology Outcome and 
verification oriented 
Discovery oriented Observation oriented 
Techniques Measurement Survey Conversation 
Sample Size Large Small Small 
Interview Questions Closed with limited 
probing 
Open with probing Very open 
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Table 5. Research Paradigms (Bryman and Bell, 2011; Easterby-Smith et al., 2004; Sobh and 
Perry, 2006) 
Axiology, in contrast, allows the researcher to understand and recognise the role their 
values and opinions play in the collection and analysis of the research, as opposed to 
eliminating or trying to balance the influence of them. For example, if the researcher is 
a vegetarian and they are researching the availability and range of vegetarian food in 
hotels, this must be declared in their research. How this shapes your investigation of 
the issue and how you analyse the results will need to be detailed and analysed in 
different ways according to the approach you choose. The problems and issues 
axiology investigates have been with us from the moment man began to reflect upon 
conditions of his life, the structure of reality, the order of nature, and man’s place in it 
(Hart, 1971). Pragmatism argues the alternative, that both constructivism and 
objectivism are valid ways to approach research. Pragmatism allows a researcher to 
view the topic from either or both points-of-view regarding the influence or role of social 
actors and uses these to create a practical approach to research. This may be used to 
find solutions to problems (May, 2011). 
 
 
4.2.4 Philosophical Stance Chosen 
This research considered the range of philosophical stances available. In particular, it 
considered critical realism which lends itself to a multi-method research approach 
(Sayer, 1992, Mingers, 2004). Critical realism paradigm includes in-depth interviews, 
focus group methodologies, and case studies (interview protocol, questions), and 
relatively quantitative methodology such as survey and modelling (Healy and Perry, 
2000). Figure 18 below, illustrates that critical realism is a ‘middle-ground’ approach in 
terms of the methodology, the roles of the individual and of context, and the modified 
objectivist epistemological position. Critical realism’s combination of quantitative and 
qualitative methodologies complements the provision of an elaborated view of issues 
and establishes the validity of findings. Qualitative, naturalistic approaches provide 
richness, depth, density, and the contextual embedding of data. Quantitative 
approaches, including those utilising certain forms of statistical analysis, allow for the 
assessment of the capacity for the broader applicability of observed patterns in data. 
Critical realist research may be initially qualitative and inductive, enabling issues, 
propositions, and models to be developed, clarified, and modified, then followed by the 
hypothetico-deductive approach (most commonly used in quantitative accounting 
research) to unearth knowledge concerning broader mechanisms and tendencies. This 
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research will use a predominantly positivist paradigm, however, includes the realism 
perspective to complement and balance the research approach. 
 
Figure 18. A range of methodologies and their related paradigms, adapted from Healy and 
Perry (2000:121) 
 
The research paradigm(s) that a researcher adopts will influence the research method 
chosen (Healy and Perry, 2000), and the research approach is the next step in the 
research design to select the range of dimensions of the research process (Bryman 
and Bell, 2011). Section 4.3, explains the research approach considerations, referred 
to as layer 2 in the research onion (Figure 16) based on Saunders, Lewis and Thornhill 
(2007), and then explains and justifies the research approach chosen for this research. 
4.3 Research Approach Considerations 
  
The research onion in Figure 15 contains the terms deductive and inductive, which are 
forms of logical inference. A decision on this level may be strongly indicated by the 
decisions made at the previous level, or may need to further assess the research aim, 
or limitations and subjective opinions to decide which method will work best for the 
research. A deductive approach means that you start with a statement or question and 
your research sets out to answer it. The aim would be to conclude with a yes or no 
response to the question. Questions may be statements or informed speculation about 




The thought process of deduction moves from theory, to the research question, to data 
collection, findings, to a rejection or confirmation of the research question. This should 
lead onto a revision of the theory and often starts the process over again. Inductive 
means that you are researching to create a theory. The process moves in the opposite 
direction to the deductive approach, taking its focus from the working title of the 
research rather than the existing theory. This means the research goes from research 
question, to observation and description, to analysis, and finally theory. Therefore, if 
little research exists on a topic then an inductive approach may be the best way to 
proceed (Saunders, Lewis and Thornhill, 2007).  
 
Critical realism contends that there are four modes of inference and these have 
different possibilities and limitations in terms of knowledge discovery. These modes are 
deduction, induction, abduction, and retroduction (Blaikie, 2007). The deductive 
reasoning includes conclusions made logically from things already known. That is, it is 
about going from the general to the particular, or applying a general knowledge to a 
particular situation, whereas inductive reasoning can be seen as a process in which 
the outcome, for example, the general rule (or conclusion) is based on individual ideas 
(or facts). In this case, it is about going from the particular to the general, or building a 
general knowledge from particular situations. Furthermore, there is the question of 
abduction and retroduction.  
 
Deduction is generally taken to be the opposite of induction in that it takes its starting 
point from the conclusion of induction, namely a universal or general law. Deduction 
can thus be used to deduce a particular, from a universal law. The key point to make is 
that while deduction and induction are very effective at investigating the empirical level 
of reality, critical realism is also concerned with understanding the generative powers 
and mechanisms which cannot be directly observed at the domain of the empirical 
(Blaikie, 2007).  
A decisive difference between deduction and abduction is that deduction proves 
something must be in a certain way, while abduction shows how something might be 
(Habermas, 1972). Critical realism criticises empiricism for its reduction of reality to the 
observable because it claims there is a distinction between a real world and a 
conceptual one, between our description and the factual reality. Comprehending 
deeper structures and generative mechanisms requires the use of abductive and 
retroductive inference. It is for this reason that the study described in this thesis cannot 
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be conceptualised as a strictly inductive study. Critical realism would argue that 
induction:  
Gives no guidance as to how, from something observable, we can reach 
knowledge of underlying structures and mechanisms; it is limited to conclusions 
of empirical generalisations and regularities. 
(Danermark, Ekstrom, Jakobsen et al., 2002) p70. Critical realism’s notion is that the 
objects of science are not primarily empirical regularities, but structures and 
mechanisms.  
Abductive research has entered numerous streams of research in disciplines such as 
learning, logic, neural networks, and artificial intelligence. More recently, there have 
been pleas for it to be used in SCM in order to break out of the positivist bias which 
has resulted in “a paucity of discussing different research approaches in logistics 
journals” (Kovács and Spens, 2005). The abductive approach stems from the insight 
that most great advances in science follow the pattern of neither pure deduction nor 
pure induction. Creativity in research is necessary to break out of the limitations of 
deduction and induction, as advances in sciences often come from intuitive leaps that 
emerge as a whole and are commonly called abductive reasoning (Kovács and Spens, 
2005, Danermark, Ekstrom, Jakobsen et al., 2002). The introduction of intuition, 
creativity, and imagination into research is what differentiates abduction from the 
dominant research methods. Abduction involves the ability to see something in a 
different context, to 'see something as something else', so to speak. It involves not only 
description but re-description. Re-description is not seen as necessarily providing a 
better description of the object of study; rather, in abductive reasoning, the case 
presents a plausible but not logically necessary conclusion. Therefore, abductive 
conclusions in social science are seldom capable of deciding if something is ultimately 
true or false (Danermark, Ekstrom, Jakobsen et al., 2002).  
The severe limitations of abduction raise the question about why it should be used in 
SCM research. The first point is that abduction seeks to generate new insights by 
examining matters from fresh perspectives and, similarly, SCM is a multidisciplinary 
field, drawing on many perspectives. Secondly, SCM involves investigating social 
issues. Social scientists are not in the business of discovering new events previously 
unknown to anyone; rather, what they discover is connections and relationships that 
are not directly observable. The modes of inference available through abduction will 
assist social research. Finally, abduction is very useful in developing theory in 
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emerging fields, such as SCM, and can lay a platform for subsequent inductive and 
deductive research (Kovács and Spens, 2005).  
Retroduction differs from deduction, induction and abduction in that it is not a 
formalised mode of inference. What it does have in common with these other modes of 
inference is thought operation, whereby it is possible to move one thing to knowledge 
of something else. The core of retroduction is transcendental argumentation. This 
argumentation seeks to clarify the basic prerequisites or conditions for social 
relationships, people’s actions, reasoning, and knowledge. In this context, conditions 
mean the circumstances without which something cannot exist. As intentionality is 
taken as a universal condition for all human activity, retroduction encourages 
investigators to ask questions as to what would happen to social structures if 
intentionality changed. An obvious example in SCM would be what would happen if 
intentionality around the often-cited constructs of trust and collaboration were removed. 
This approach has been severely criticised for being outside what we spontaneously 
experience or observe. Critical realism repudiates such a view on the grounds it 
reduces knowledge to that which is directly given or observable. Retroduction has 
been widely used in social science by researchers who side with and against critical 
realism (Danermark, Ekstrom, Jakobsen et al., 2002). Since it has been established 
that we are dealing with research into open systems, and the more open the system 
the more the complexity around the mechanisms which are cooperating to maintain 
that system, retroduction is well suited to assisting the exploration and possible 
detection of tendencies which maintain the system within a specific context.  
While some researchers treat these interchangeably (two concepts overarching each 
other), others claim the opposite. According to the former type of definition scholars, 
such as abductive or retroductive, reasoning is a process in which explanatory 
hypotheses are formed and tested to give an explanation for a particular situation 
(Paloniemi, 2010). In critical realism, some researchers present the abductive logic 
together with retroduction, while some other scholars (e.g. Blaikie, 2007) want to 
differentiate the latter from the former.  
“The retroductive research strategy involves the building of models in order to explain 
observed regularities.” (Lisle, 2000) p121. The retroductive strategy encompasses 
induction, deduction, and abduction, as well as building and testing models to explain 
the phenomenon (Lisle, 2000). Critical realism is well connected with retroduction 
(Mingers, 2004), which means that mechanisms are proposed that may lead to a 
specific phenomenon (to be investigated) if the mechanism existed.  
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Section 4.3.1 explains the specific research approach chosen for this research. 
4.3.1 Research Approach Chosen 
This research considered various perspectives and approaches prior to choosing the 
research approach, and took into account the relationship between the data and the 
theory as recommended good practice (Easterby-Smith, Thorpe and Jackson, 2008).  
The deductive approach, as discussed above, moves towards hypothesis testing, after 
which the principle is confirmed, refuted, or modified. These hypotheses present an 
assertion about two or more concepts that attempt to explain the relationship between 
them. Concepts themselves are abstract ideas that form the building blocks of 
hypotheses and theories. The first stage, therefore, is the elaboration of a set of 
principles or allied ideas that are then tested through empirical observation or 
experimentation. 
 
This study will follow a predominately positivist paradigm in combination with a realism 
paradigm through a deductive approach following the hypothetico-deductive model 
(Lee and Lings, 2008). The researcher will reduce phenomena to their simplest 
elements, focus on facts and formulate propositions, and then test them, (Easterby-
Smith, Thorpe and Jackson, 2008). The deductive approach, moves towards 
proposition testing, after which the principle is confirmed, refuted, or modified. The 
main research method will use quantitative research through a survey. However, 
qualitative research will also be used in both the initial and final phases of the 
research, using both interviews and focus groups so that multiple sources of data and 
perspectives can be included. This is to make the research study more rigorous, as 
referenced when discussing the considerations of philosophical stances in Section 4.2 
from Easterby-Smith, Thorpe and Lowe (2004). 
 
Table 5 summarises the main differences seen in positivist, interpretivist, and critical 
realist paradigms regarding their ontology and epistemology. Taking account of the 
data required to be measured in this research and that it will be collected from a large 
population, a predominately positivist paradigm is followed. It is important that the 
research design provides a framework for the collection and analysis of data and 
importance should be attached to expressing causal connections between variables, 
and so both factors were built into the research design (Bryman and Bell, 2011). 
Furthermore, three of the most prominent criteria for the evaluation of management 
research are reliability, replication, and validity. Both reliability and measurement 
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validity are essentially concerned with the adequacy of measures, which are most 
obviously a concern of quantitative research. Internal validity is concerned with the 
soundness of findings that specify a causal connection, an issue that is most 
commonly of concern to quantitative research (Bryman and Bell, 2011). This research 
aims to discover causal connections to give new insights into how performance is 
affected by strategic choices in supply chain disruptions.  
However, to address ecological validity, which is concerned with the question of 
whether or not social scientific findings are applicable to what happens in people’s 
everyday lives, e.g., their relevance (Bryman and Bell, 2011, Hammersley, 1992), 
interviews will also be used by this research. Using qualitative research methods will 
help to explain the relationships between variables, in addition to strengthening the 
research to withstand criticism. When a single qualitative research method is used, the 
problem of generality would occur, for example, critics of qualitative research state that 
there is a tendency for findings to be presented in an anecdotal fashion (Bryman and 
Bell, 2011).  
Following a stepwise approach to research design selection, as outlined by (Dul and 
Hak, 2007): 
1. First defining the research topic 
2. General research objective 
3. Determining the specific research objective 
4. Choosing the research strategy 
5. Select instances 
6. Conduct measurement 
7. Conduct data analysis 
8. Discuss results 
9. Report the research 
 
This research will use a theory-testing research design. Theory-testing research is 
aimed at the testing of formulated propositions (Dul and Hak, 2007), and a type of 






Figure 19. Flowchart 1A - Deciding on the type of theory-orientated research, adapted from Dul 











Figure 20. Flow chart 2A - Theory-testing research (initial theory-testing), adapted from Dul and 
Hak (2007: 254). 
This research, following the principles as highlighted by the pathways in Flowchart 1A, 
confirmed following the exploration of theory that related propositions did exist but it 
needs refining and extending, thus the study chooses an initial theory testing approach 
(Flowchart 2A).The first phase involved a detailed and focused literature review, which 
led to the development of the conceptual supply chain disruptions theory framework 
that explains different supply chain responses to disruptions. After the examination of 
the theory and refining of the propositions, the specification of the propositions was of 
a probabilistic proposition; a probabilistic proposition is defined as a proposition which 
expresses a probabilistic relation (Dul and Hak, 2007). A probabilistic relation is a 
relation between an independent concept or variable and a dependent concept or 
variable in which their values, on average, increase or decrease at the same time 
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(positive relation) or in which the value of one, on average, increases as the other 
decreases (negative relation). The survey instrument was selected as an appropriate 
method to test these relationships between concepts and variables. Analytical surveys 
are highly structured and place an emphasis on the careful random selection of 
samples, so that the results can be generalised to other situations or contexts (Gray, 
2013). Analytic surveys emphasise: 
1. A deductive approach 
2. The identification of the research population 
3. The drawing of a representative sample from the population 
4. Control of variables 
5. The generation of both qualitative and quantitative data 
6. Generalisability of results 
  
This research will not use experiments because they are usually used where variables 
can be controlled. Experiments are commonly used methods in physical sciences but 
are not so valuable in management research (Beech, 2005).  Participant observation, 
ethnography, or discourse analyses are commonly conducted over a long period of 
time (longitudinal). Action research cannot be employed due to time, economic, and 
accessibility constraints. Grounded theory and ethnography were excluded as they are 
purely qualitative. Grounded theory uses inductive methods to predict and explain 
behaviour to build theory, whereas this study aims to use a theory testing approach 
(Dul and Hak, 2007).  
 
There are then multiple competing paradigms and associated research approaches 
that can be selected to conduct research to address the research question that the 
investigator is interested in (Bryman and Bell, 2011). Sections 4.4 and 4.5 explain the 
strategy and research method considerations, which are also reflected in Figure 16 
(Saunders, Lewis and Thornhill, 2007). 
4.4 Research Strategy Considerations 
 
Strategy choices refer to the research style that is used to collect and analyse data, 
such as grounded theory. Each one has its benefits and limitations. This needs to be 
thought through, explained, and balanced throughout the research. Choices may be 
more commonly associated with different philosophies and philosophical standpoints, 
as shown in the research onion (Figure 16). Experimental designs are more rigid and 
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scientific in their structure to enable the research to be replicated. These designs test 
the causal effects of phenomena on a group compared to a control group who are not 
subjected to any phenomena. The causal effect is the independent variable on the 
dependent variable. Experimental strategies generate data that can be statistically 
analysed. A survey strategy is often associated with a deductive approach. It offers the 
researcher a highly economical way of collecting large amounts of data to address the 
who, what, where, when, and how of any given topic or issue. This strategy can 
generate both rich and statistical data (Somekh, 2006).  
 
Grounded theory uses inductive methods to predict and explain behaviour to build 
theory. This starts with data being collected from observation and theory. Predictions 
are generated from that data and those predictions are then tested. This strategy, 
although generating new theory, is still grounded by existing theory and literature on 
the topic (Strauss, 1998, Wertz, 2011). Ethnography is rooted in anthropology, which is 
the study of others from a detached point-of-view. However, ethnography requires the 
researcher to be a part of the community or situation they are researching. This may 
be time consuming for the researcher to achieve full integration into a social scene to 
experience and document long-term changes in actions and opinions (Crang and 
Cook, 2007). Archival research strategy centres its data collection on existing data sets 
or archive documents. This allows for exploratory, explanatory, or descriptive analysis 
of changes tracked over a long period of time. However, the accuracy and breadth of 
information available may be an issue for a researcher relying solely on this type of 
secondary data.  
 
4.4.1 Research Strategy Chosen 
This study is seeking to explain how the actions of buffering and bridging in response 
to supply chain disruptions events affect the performance of shortage management, 
and is seeking detailed explanation of the constructs and propositions summarised in 
the Research Question (section 3.2) based on constructs that were developed and 
extended from the original constructs of Bode, Wagner, Petersen et al. (2011). A 
theory testing emphasis approach will be most appropriate (Rao and Perry, 2003), as 
shown in Table 6. Table 6 contrasts the different strategies best employed to approach 
different research problems. As this research addresses the theory testing emphasis, a 
survey strategy choice is appropriate. This research will use a survey strategy which 
will be conducted after the initial interviews, where the aim will be to test the 
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propositions and thus give further novel insights on supply chain response 
management.  
 Theory building 
emphasis 
Theory testing emphasis 
Research Problem What kind of strategies 
are implemented? 
What impact do these 
strategies have on 
performance? 
Literature Review Exploratory Explanatory: constructs 
have been measured 
before 
Paradigm  Interpretive Positivist 
Methodology Case study Survey 
Table 6. Research Approaches (Rao and Perry, 2003) 
 
The overall research strategy is outlined below in Figure 21, which describes the 
research work flow plan from the initial in-depth literature review (both academic and 
industry based), the identification and development of the theory framework (as 
described in the research question, section 3.2), through to the desk research and 
UCLH mining and initial descriptive analysis, followed by interviews and the main 
survey design to test the theory based propositions. The outputs of this are analysed, 
and feedback and further interviews and focus groups are conducted, the results of 
which are critically collated, theory refined, and conclusions and limitations drawn. The 
work flow, which is outlined in Figure 21, follows the theory testing plan (Dul and Hak, 



































Figure 21. Research High Level Design Flow Chart 
 
Figure 21 outlines the research high level design flowchart followed by this research. 
The initial literature review composed three main elements; supply chain management, 
an industry review of the pharmaceutical supply chain, and a literature review of supply 
chain reductions.  
 
This provided the supply chain post disruption theory framework for the research. The 
initial secondary research included desk research which revealed and facilitated the 
data mining of the University College London Hospital (UCLH) shortage management 
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historic database. This and other secondary research provided informed background 
for the exploratory interviews after the initial analysis. The exploratory interviews 
guided the survey tool design, and later provided expert advice in the pilot testing of 
the survey to facilitate a robust final survey online tool. The survey tool was used to 
test the theory propositions extending the existing theory framework. The interviews 
were then conducted after ethical approval was granted. The last data collection 
method used was the focus group, which comprised of three focus groups reflecting 
the spectrum of the target population. The data analysis of each of the data collection 
methods was then carried out, refining and informing the new theory framework 
understanding so the research data analysis findings could be presented and the 
research conclusions drawn and explained. 
 
Section 4.5 is separated into two parts. The first illustrates the research methodology 
considerations, including the time horizons, and then the second part specifies the 
research methodology selected for this research. 
4.5 Research Methodology Considerations 
 
Layer 4 in the research onion diagram is where the researcher defines how to use 
quantitative and qualitative methods in research.  Methods are the ways in which a 
researcher will actually design and collect data. Each choice at this stage has a 
framework of methods and tools. Mono-method research is when either quantitative or 
qualitative data is collected, rather than a combination of both. This may be due to the 
demands of the philosophy, philosophical choices, and strategies employed. It could 
also be used to research an opposing view to existing mono-method research. Mixed-
method research is when the researcher uses quantitative and qualitative research 
methods in the process of their study, data collection, and analysis. It can be argued 
that by combining both types of research, the limitations of each individual method can 
be offset and gaps of data can be filled or predicted (Sandelowski, 2000). A multi 
method is where the researcher uses both quantitative and qualitative data, but the 
researcher’s outlook is rooted in only one of them. So, both types of data are analysed 
from only one point-of-view.  
 
In layer 5 of the research onion, there are only two-time horizon choices for the 
research. These are cross-sectional, which is a short-term study, and longitudinal, 
which is research carried out over a longer period of time. Cross-sectional designs can 
use qualitative and quantitative research, and they measure an aspect or behaviour of 
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many groups or individuals at a single point in time. Longitudinal designs can also use 
qualitative and quantitative research but they study events and behaviours using 
concentrated samples over a longer period. As noted by Collins, Joseph and Bielaczyc 
(2004), certain design research methodology faces other serious challenges, including 
the following: 
 
• Difficulties arising from the complexity of real-world situations and their resistance to 
experimental control 
 • Large amounts of data arising from a need to combine ethnographic and quantitative 
analysis 
 • Comparing across designs 
 
Different aspects of reality lend themselves to different methods of inquiry, so that 
before choosing a research methodology, the problem, the research question and the 
subjects and situations must be considered (Wolfer, 1993, Creswell and Plano Clark, 
2011). Is a combination of methods, rather than a single method, possible to 
strengthen results, and if so is the typology of a mixed method approach going to be 
emergent or fixed? The researcher has the choice to start off with one method, and 
then add in other methods if the first is deemed insufficient; the challenge here is 
reliability, can the study be replicated by others to corroborate findings. One of the key 
drivers that must be considered is if the methodology chosen is achievable and 
practical, this can be both from a time and resource perspective but also from a data 
availability aspect. In addition, is the method under consideration appropriate for the 
environment to be conducted, certain fields have very high barriers of ethical or 
security control to prevent smaller scale research projects with impractically brief time 
spans. Lastly, have previous methods in the same general problem area been 
challenged due to limitations of the research? An example of this is using an action 
research methodology in certain settings (Ritchie, 2002). In that research, it was noted 
that having a research assistant embedded in the environment may have affected the 
validity of results with researcher bias. Staff found this type of working relationship 
confusing, and it was observed that if the research had been less action based, 
potentially more analysis could have been performed but actions may not have been 
initiated, as they were researcher driven, pointing towards possible researcher bias. 
Section 4.5.1 describes the research methodology chosen for this study.     
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4.5.1 Research Methodology Chosen 
A combination of qualitative and quantitative methods will be used in this research. 
Mixed-method research is a dynamic option for expanding the scope and improving the 
analytic power of studies. When done well, mixed-method studies dramatize the 
artfulness and versatility of research design (Sandelowski, 2000). A qualitative 
research method is used to answer questions about the nature of phenomena, with the 
purpose of understanding them from the participants' points-of-view. Quantitative 
approach assisted in testing the theory as it involves variables analysed with statistical 
procedures in order to test if generalisations of the theory hold true (Creswell, 2003). 
This study will use both qualitative and quantitative research methods as 
complementary methods rather than competitive. Yin (2003) argues that quantitative 
and qualitative approaches can be used to complement each other to provide 
methodological triangulation and enhance reliability of the study 
 
Quantitative and qualitative research methods do not have a layer of their own in the 
research onion diagram (Saunders, Lewis and Thornhill, 2007) as they should be 
continually considered as the researcher travels through to the centre. Quantitative 
research involves numbers. It is concerned with quantity and measurements. 
Qualitative research is concerned with rich data, such as personal accounts, opinions, 
and description. 
 
The initial dialogue with the target participants and desk research identified multiple 
sources of data, both in the form of an information database and willing key 
participants from the pharmaceutical suppliers and buyers, including NHS hospital trust 
lead pharmacies, NHS regional procurement specialists, and the Department of 
Health. 
The methodological approach taken in this research is mixed-methodology, with an 
emphasis on quantitative data. Mixed-method research focuses on collecting, 
analysing, and mixing both quantitative and qualitative data in a single study or series 
of studies (Creswell and Plano Clark, 2011). Its central premise is that the use of 
quantitative and qualitative approaches in combination provides a better understanding 
of research problems than either approach alone. Easterby-Smith, Thorpe and 
Jackson (2008) refers to data triangulation as the collecting of data over different times 
or from different sources. This approach is typical of cross-sectional designs. 
Methodological triangulation is also possible, with the use of a combination of methods, 
such as interviews, surveys, and secondary data. All methods have their strengths and 
133 
 
weaknesses, so not only does the use of multiple methods assist in data triangulation, 
it helps to balance out any of the potential weaknesses in each data collection method 
(Gray, 2013). Careful measurements, generalisable samples, experimental control, 
and statistical tools of good quantitative studies are precious assets. When they are 
combined with the up-close, deep, credible understanding of complex real-world 
contexts that characterise good qualitative studies, it produces a powerful mix (Miles, 
Huberman and Saldana, 2014). 
This research will use qualitative techniques in an exploratory phase to uncover hidden 
practices as recommended by Bryman and Hardy (2006), and is explained in more 
detail in Section 6.6. However, the majority of the data will be collected using a 
quantitative self-report questionnaire. Survey research (or ‘the survey’) is research in 
which (1) a single population in the real life context is selected and (2) scores obtained 
from this population are analysed in a quantitative manner (Dul and Hak, 2007). A 
predominately quantitative research methodology was selected using survey research 
that employs a cross-sectional research design. Quantitative survey research has 
previously been successfully used in researching supply chain disruptions and 
resilience (Stephenson, Seville, Vargo et al., 2010, Wagner and Neshat, 2010, Jüttner 
and Maklan, 2011). The cross-sectional design will be used as it is necessary to have 
a systematic and standardised method for gauging variation in order to establish 
variation between cases (and then to examine associations between variables), 
(Bryman, 2012).  
The closing section of the research design chapter describes the techniques and 
procedures considerations, and then finally the techniques and procedures chosen for 
this research. It presents how the research survey design is linked to the research 
question, constructs, and propositions which were first set out in Chapter 3.  
 
4.6 Techniques and Procedures Considerations 
 
The last layer of the research onion moves the research design further into the 
practicalities of data collection and analysis. This is where the researcher needs to 
decide from all the previous decisions made what data collection methods will work 
best and what type of analysis to employ to create the results to answer the research 
question. Data collection and analysis includes decisions on sample groups, 
questionnaire content, and questions to be asked in interviews. All of the decisions and 
tools employed at this final stage must fit in with the philosophies, philosophical 
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stances, strategies, choices, and time horizons already fixed upon if valid results are to 
be created and withstand criticism (Brace, 2008). It is important, however, to be aware 
that all research methods have limitations. As noted by Bryman and Bell (2011), 
quantitative research, for example, teaches us that it is rarely the case that we find 
perfect association between variables. We should not be surprised, therefore, that the 
practice of business research similarly lacks absolute determinism.   
 
Utilising secondary analysis offers numerous benefits to researchers, including saving 
both cost and time and providing high quality data obtained using rigorous sampling 
procedures. This ensures the data is representative, and it often offers national 
samples covering the UK (Bryman and Bell, 2011). By including secondary analysis in 
conjunction with other forms of data collection, this research will avoid the pitfalls of 
relying solely on a single source of data collection (Yin, 2003). 
 
4.6.1 Techniques and Procedures Chosen 
This section firstly describes the overall research problem flowchart in order to put the 
subsequent techniques and procedures into context, and to enable each proposition to 
be linked to the construct it addresses to answer the research question. Processes 
used can be justified and the research will output relevant deliverables which will 
address the research question. Next, the survey research design is outlined, followed 
by the data collection and data analysis subsections, which describe in detail the 
instruments selected and analysis of data to be used in this research study. 
 
The following flowchart, Figure 22, unpacks the path followed within the high-level 
research design to address the research problem, as identified in the research 
question in Chapter 3. In Section 3.2, the research problem was described in the 
research question: how do the actions of buffering and bridging in response to 
supply chain disruption events affect the performance of shortage 
management?  Three constructs were developed as a way of bringing the theory 
down to earth, and helping to explain the different components of theories, as well as 
to measure and observe their behaviour. Constructs are the building blocks of theories, 
helping to explain how and why certain phenomena behave the way that they do 
(Rioux, 1997). The three constructs; supply chain disruption orientation, supply chain 
disruption performance, and organisational response based on the new theory 
framework (Figure 15, Section 3.2), were then translated into nine propositions, P1a to 
P3i, to be tested so that the relationships they describe can be examined to give new 
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insights into post disruption response management. As explained by Rioux (1997), 
constructs must be translated from the abstract  to the concrete (for instance, 
measurable or testable in the form of variables). This requires the re-stating of 
constructs as variables, with variables also having their own attributes. The role of the 
operational definition is to exactly describe how to measure the characteristics of a 
construct. Characteristics are the abstractions/ideas within constructs that are 
ultimately measurable in the form of variables and their attributes. It is these variables 
























Figure 22. Research Problem Flowchart 
In order to address the research problem and answer the research question, the three 
constructs and the nine propositions that test them are categorised in Figure 22, and 
the survey questions that will directly answer them are described below in the broader 
research survey design. It is then followed by the techniques and procedures sections, 
and lastly the ethical considerations.  
4.6.2 Desk Research & Exploratory Interviews 
This research will use desk research as the initial technique following on from the 
literature review. Desk research comprises searching for information using existing 
resources, such as the press, the internet, analytical reports, and statistical 
publications. This is then followed by cross-referencing and the collation of data. Desk 
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research, or secondary research, can serve as a standalone research technique or as 
the initial stage of a project and a precursor to primary research (PMR, 2016). Desk 
research uses secondary analysis, which is the analysis of data that has been 
collected by other organisations in the course of their business (Bryman and Bell, 
2011).  
Interviews were conducted at two stages within the research process, highlighted in 
the high-level research design flowchart (Figure 21). 
An initial exploratory set of semi-structured interviews was conducted on a limited pool 
to include a relevant range of managers involved in the buyer side of the acute 
secondary care pharmaceutical supply chain including:  
1. Pharmacy lead procurement technicians, or hospital pharmacy managers 
2. Regional pharmacist specialists 
3. Commercial Medicines Unit (CMU) 
4. Department of Health (DoH) 
 
The sample pool of exploratory interviews was drawn from two of each of the above 
role types using a purposive sampling technique. Purposive sampling is a non-
probability form of sampling, as participants are not sought on a random basis. The 
goal of purposive sampling is to sample cases/participants in a strategic way so that 
those sampled are relevant to the research question being posed (Bryman and Bell, 
2011). In acute secondary care, the above four categories of teams are involved in the 
procurement side of the pharmaceutical supply chain, representing distinct levels and 
stages, i.e. operational (pharmaceutical leads and specialists), contractual (CMU) and 
policy (DoH). It is recognised as a limitation of this research that using a non-
probability sampling approach whilst employing a purposive approach does not allow 
the researcher to generalise to a population. However, the reason for these initial 
interviews was to deepen the immersion of the interviewer in the topic under 
consideration to discover and guide the later research. 
The exploratory phase was carried out in order to ensure that the measures being 
used in the quantitative survey would be as applicable to the situation as possible. It is 
also designed to give contextual information as to the general issues of supply chain 
disruptions, decision response actions being taken and subsequent performance 
consequences.  Research using a combined methodology with an in-depth focus on 
the pharmaceutical supply chain from a buyer perspective is novel in the supply chain 
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disruption research area and will provide contextual insights as to the phenomena 
under consideration. In particular, it considers the multi-layered nature of buffering and 
bridging decision-making and its effect on shortage performance in secondary care 
acute hospitals.  
 
The exploratory interviews allowed the researcher to gather deeper insights into the 
challenging working environment the operational managers had to face on a day-to-
day basis in managing shortages in response to supply chain disruptions. As this 
research was focusing on the decision-making actions, their interplay, and outcomes, it 
was important to gain industry verification of the proposed quantitative survey 
instrument. For this purpose and to help maximise the research support and exposure, 
including the ethical considerations, an informal research steering committee was set 
up. This consisted of two experienced participants from the exploratory interviews on 
the operational side, i.e. one regional specialist pharmacist and one lead procurement 
pharmacist technician.  
 
The pharmacy lead procurement technician and regional pharmacist specialist were 
asked to review and pilot the survey questions and validate the medicines in the 
shortage frequency sample, as identified in the initial desk research analysis of the 
UCLH database. The survey questions were then piloted before the questionnaire 
content and schedule was finalised, as recommended by Bryman and Bell (2011) for 
conducting a self-completion questionnaire for a social survey. A self-completion 
questionnaire was chosen rather than a structured interview because of the wide 
geographic scope of the respondents, therefore making it cheaper and easier to 
administer. There would also be no interviewer effects, no interviewer variability, as 
well as being convenient for very busy hospital pharmacy leads. It further allowed the 
whole population of acute care hospitals to be targeted and included in the research 
rather than a limited representative sample. However, all methods have limitations and 
it is recognised that there may be a discrepancy between what participants do and 
what they say they do, and what observers see participants doing is generally 
considered a more accurate reflection of reality than self-report (Sandelowski, 2000). 
Following on from the desk research and initial interview phase, the research survey 
will be conducted. 
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4.6.3 Research Survey Design 
A survey strategy is often associated with a deductive approach. It offers the 
researcher a highly economical way of collecting large amounts of data to address the 
who, what, where, when, and how of any given topic or issue. This strategy can 
generate both rich and statistical data. This research used a survey that was designed 
so that the overall research question would be directly addressed by examining the 
constructs through the refined propositions. As detailed in Table 7, each proposition is 




Table 7. Research Survey Design 
The online questionnaire was created following on from the initial exploratory 
interviews. A feasibility enquiry and pilot testing of the research questions and 
measures were carried out within a pharmacy region, previously known as Strategic 
Health Authority areas or SHAs, using the steering committee to ensure that the 
questions were able to be answered by the target audiences, and that the interviewees 
were able to easily understand the measures requested. To ensure content validity, a 
group of practitioners acting as a steering committee were invited to pre-test the 
interview questionnaire. Specifically, they needed to evaluate the appropriateness, 
clarity, and accuracy of questions and their evaluation involved changing the wording 
of some of the questions to comply with these three requirements. Lead pharmacists 
were targeted who were identified by the initial interviews and steering committee to 
have key roles in making operational response decisions to supply chain disruptions 
causing drug shortages. Any discrepancies between their interpretations and 
researcher’s expectations were discussed beforehand and based on their feedback, 
the initial questionnaire was modified. The design of the survey was rigorously 
developed using good procedures of scale development via the general approach 
adapted from DeVellis (2003) and Creswell and Plano Clark (2011). 
1. Determine what you want to measure, and ground yourself in theory and in the 
constructs to be addressed (as well as in the qualitative findings). 
Research Question Do the actions of buffering and bridging in response to supply chain disruption events affect the performance of shortage management?
Construct SCDO Performance Organisational Performance Organisational Performance Organisational SCDO SCDO
Response Response & SCDO Response
Propositions 1a 2e 3h 2f 3i 1d 2g 1c 1b
Survey Questions Section A & B Section A & B Section A & B Section B Section B Section A & B Section A & B Section A & B Section A & B
Questions B.24 to 64 B.24-64 B.24-64 B.24-64 B.24-64 B.24-64 B.24-64 B24-64 B.24-64
A11-23 A18-19 A20-21 A11,13-23 A12 A9
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2. Generate an item pool using short items, an appropriate reading level, and 
questions that ask a single question (based on participant language when 
possible). 
3. Determine the scale of measurement for the items and the physical 
construction of the instrument. 
4. Have the item pool reviewed by experts. 
5. Consider the inclusion of validated items from other scales or instruments. 
6. Administer the instrument to a sample for validation. 
7. Evaluate the items (e.g., item-scale correlations, item variance, and reliability). 
8. Optimise scale length based on item performance and reliability checks. 
 
4.7 Validity and Reliability 
 
The choice of the design reflects the research interests and objectives pursued. The 
goal was to develop and validate a generic instrument that would have reasonable 
predictive power, and can be used to predict individual's behaviour in relation to real 
life. When constructing a scale or using an existing one, it is good practice to analyse 
the data for reliability and dimensionality (Bryman and Bell, 2011). 
Internal consistency reliability was considered as part of the individual scale item 
analysis. Where internal consistency reliability reflects the degree to which each item is 
intercorrelated with other items in the pool, thus it indicates how well the items fit 
together conceptually (Parsian and Dunning, 2009). The Cronbach’s alpha is one of 
the most commonly used procedures for measuring internal consistency reliability 
(Bryman and Cramer, 1999) and this was used in the analysis of this research, detailed 
in Chapter 6. According to Gliem and Gliem (2003), the Cronbach’s alpha is a reliability 
test technique that requires only a single test administration to provide a unique 
estimate of the reliability for a given test. Cronbach’s alpha is the average value of the 
reliability coefficients one would obtain for every possible combination of items when 
split into two half-tests. In this way, Cronbach’s alpha was intended to remove 
‘garbage’ items which displayed low levels of internal consistency reliability (Churchill, 
1979). The Cronbach’s alpha will be calculated based on both all and standardised 
items. A computed alpha coefficient will vary between 1 (denoting perfect internal 
reliability) and 0 (denoting no internal reliability). As noted by Bryman and Bell (2011), 
the figure 0.8 is typically employed as a rule of thumb to denote an acceptable level of 
internal reliability, though many writers accept a slightly lower figure. For example, in 
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the case of the Burnout scale replicated in Schutte, Arbour, Lorenz et al. (2000), the 
alpha was 0.7, which they suggested was a rule of thumb which is considered to be 
efficient. Although reliability and validity are analytically distinguishable, they are 
related because validity presumes reliability. 
 
The survey design included procedural remedies to prevent common method variance 
(Podsakoff, MacKenzie, Lee et al., 2003). Although the survey gave an outline in the 
participants' information sheets of the general objectives of the study, no clues were 
given as to the specific relationships under investigation. The respondents were given 
anonymity to reduce chances of influencing the outcomes, for example, by answering 
in a way the respondents believed the researcher desired. The participants were also 
asked to base their responses on a specific medical shortage situation to improve the 
design of the research instrument (Doty and Glick, 1998). Specifically, they were asked 
to base their answers on the experience of five specific medical lines, or cases, that 
were subject to disruption causing a shortage event which occurred in the previous 12 
months prior to the data collection. The reported instances from the UCLH shortage 
database included supply chain disruptions prompted by quality issues with the 
manufacturing process, batch failure to pass quality control, raw materials issues, 
cargo issues, labelling or packaging problems, short shelf life, regulatory changes, and 
product changes. The selection procedures of the resultant shortages that were 
presented in the survey instrument are detailed below in the survey sampling strategy.  
 
The disruption’s severity was also captured with the exact month in which the 
disruption occurred. This is to ensure that when asking a reflective question about 
historic events, the recency effect, a potential threat to validity, is limited. This is 
particularly important, as validity is the extent to which a research procedure can be 
considered to meaningfully capture its aims (Dul and Hak, 2007). For all cases in the 
survey data set, objective secondary data for the variables' unit size and performance 
was sorted through NHS website, all of which is in the public domain.  
 
4.8 The scaling method  
 
The survey instrument used a combination of question approaches to allow for both a 
clear and understandable presentation to the participants, whilst at the same time 
maximising the response rate. It gave clear instructions on how to respond and kept 
answers and questions together. The online survey also used response sets of closed 
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questions, allowing for pre-coding to expedite computer analysis. Response sets used 
a Likert scale as this is the most appropriate choice for studies exploring attitude 
patterning (Oppenheim, 1992). It uses fixed-choice response formats and measures 
the strength and intensity of attitudes (Rattray and Jones, 2007). In this project, I asked 
subjects to give numerical indication on their degree of preference of the statement by 
selecting from a numerical score range. For example, a score of five equals the most 
favourable attitude, and a score of one equals the least favourable attitude, with three 
as the middle point for an undecided or neutral opinion. The benefit of having a neutral 
point is that it allows respondents to be honest about their choice rather than being 
forced to choose either extreme (Cox and Isham, 1980). 
 
The survey pilot and retesting of subject matter experts from the steering committee 
helped refine the questions so that the response set and answers were likely to provide 
a valid assessment for the participating individual. 
 
4.9 Survey sampling strategy 
 
The survey instrument is the main data collection method for this research. However, 
the discovery and development of the UCLH database of drug shortages provided 
evidence over an uninterrupted time period of six years, reported by hospital 
pharmacists across the country. (Patton, 1990) p201, argues that: “Sample size 
depends on what you want to know, the purpose of the inquiry, what will be useful, 
what will have credibility, and what can be done with available time and resources.” 
Two key decisions were required to select the components of the sampling strategy; 
the target population to be surveyed and the drugs in shortage as a result of supply 
chain disruption. 
4.9.1 Drugs in shortage as a result of supply chain disruption 
The first key decision in the sampling strategy of this research was to choose the drugs 
in shortage as a result of supply chain disruption to be presented to the target 
population via the survey instrument, questioning their decision responses post 
disruption and subsequent performance. Note that although the participants were 
presented with five specific known shortages cases, they were also offered the option 




The UCLH data provided a ready source of drug shortage data which gives credibility 
to the inclusion of a selection from a total list of 2008 different medicines nationally 
reported to have a disruption in the pharmaceutical supply chain. As this data is still in 
a raw state, initial analysis of this research focused on aggregating the records and 
summarising the data. 
 
 A typology of medicines in shortage for sample selection was prepared: 
1. Readily recognised as in shortage over the last seven years 
2. Frequency of occurrence 
3. Severity of impact (meaning there was no substitute readily available) 
 
The high frequency drugs selected from the UCLH drug shortage database were 
further refined in accordance with this typology and additionally verified by the steering 
committee. Typologies provide tools that help researchers design their studies and by 
focusing our attention on the points of interface it facilitates good research design 
(Guest, 2013). Of the UCLH medicine shortages, the following medicines were 
recognised as meeting the above typology criteria by the steering committee and 
selected for inclusion in the research survey instrument as a supply chain disruption 
case from the original item pool of 10, as shown in Figure 23: 
 
1. Lidocaine Injection 
2. Aciclovir Infusion Solution and Powder 
3. Glycopyrronium Bromide Injection 
4. Ketamine Injection 
5. Lorazepam Injection 
 
The original pool of 10 drugs in shortage were selected from the UCLH shortage 
database and ranked by frequency of incidence to distil to a pool of 10, with the other 
drug shortage medicines discarded. The steering committee then distilled it further 
using the specified typology, keeping three of the original 10, discarding the rest, and 












 1 Lidocaine Injection 12 
  2 Metformin Tablets 11 


















Bromide Injection 10 
  10 Ibuprofen Tablets 10 
  
     Figure 23. Pharmaceutical shortages identified by occurrence rank from the UCLH shortage 
database 
4.9.2 Target population to be surveyed 
The target population selected was the largest available within the nations where the 
research was based to take account of the time and resources available to the 
research. This comprised of all the NHS trust and acute care hospitals in England, 
Wales, Northern Ireland, as well as the acute care and general hospitals in the 
Republic of Ireland. Targeting the entire population enabled this research to avoid 
sampling bias, improving the validity of the research method. As noted by Bryman and 
Bell (2011), the researcher needs to ensure that steps are taken to keep bias to an 
absolute minimum. 
 
The survey was aimed at the key individuals responsible for managing shortages in the 
secondary care hospitals, which normally have a dedicated or semi-dedicated 
manager responsible for managing shortages, usually the lead pharmacist. However, 
as was seen from the response from the survey and subsequent interviews, there are 
a range of roles within the pharmacy work environment that share responsibility in 
managing the medicine shortages.  
The total population of 261 acute care hospitals and trusts in the UK, excluding 
Scotland, and 57 hospitals in the Republic of Ireland, gives a total population of 318. 
The population pool excludes ambulance trusts, mental health trusts, and district and 
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community hospitals and clinics. This reduction in the total population pool was 
because initial interviews with senior hospital pharmacists and health departments had 
indicated the high impacts and occurrence of drug shortages were in secondary care 
acute hospitals and trusts. This research recognised that drug shortages also occur on 
a regular basis in primary, community and mental health hospitals, however, as noted 
by the experts and steering committee that provided expert advice for this research, 
the critical nature of the illnesses in acute secondary care means that shortages often 
cause immediate actions to be taken, which is the focus of this research. As noted by 
respondents in the interviews, for example, patients in hospital can be quickly affected 
by a drug shortage given their urgent need for treatment, and this treatment will have 
to be stopped if an alternative cannot be found. Furthermore, the main issues in drugs 
in shortage in secondary care are hospital-only medicines, as drugs that are regularly 
used in primary care are not ordered in large quantities by the secondary care sector, 
meaning they are less in demand.  
There is, however, scope for further research in primary care and this will be discussed 
in more detail in the closing chapter under limitations and further research sections. 
4.9.3 Generating the pool of preliminary items  
Once the overall sampling strategy was defined and a prior dimensional structure 
postulated in the propositions of Chapter 3, it was necessary to generate a pool of 
items that measure each dimension. Within the scaling literature, such dimensions are 
referred to as factors (DeVellis, 2003, Netemeyer, Bearden and Sharma, 2003). In 
order to operationalise factors, items are required to ‘tap’ or ‘cover’ the domain of the 
construct (Netemeyer, Bearden and Sharma, 2003). 
Before experimentation can take place, underlying concepts must be operationalised 
(made measurable) in such a way that they can be observed to confirm that they have 
occurred. Hence, measures and indicators are created (Gray, 2013). The process of 
quantitative research is frequently depicted as one in which theory is employed in order 
to deduce hypotheses which are then submitted to empirical scrutiny (Bryman and 
Hardy, 2006). Within the hypothesis will be two or more concepts that will require 
translation into empirical indicators. These indicators are frequently referred to as 
variables and represent the fundamental focus of all quantitative research.  




Measures constitute direct quantitative assessment of variables (Bryman and Hardy, 
2006). In order to determine the measures to be used in the survey research, an 
extensive review was carried out of the extant academic and practitioner literature and 
exploratory qualitative interviews with pharmaceutical purchasing managers and 
regional pharmaceutical specialist managers. In addition to pre-testing, an in-person 
pilot study was conducted to purify the measurements used. Following the multi-item 
measure approach developed by the scale development, summarised by Creswell and 
Plano Clark (2011), each construct was based on multiple item scales for the 
quantitative tests. Section 4.11-13 outlines all the measures and items used and 
presents the information in table form using the multi-scale measurement scale in 
Table 15, Chapter 6 data analysis. A unit is defined as a pharmaceutical dispensing 
operation, managed by a pharmaceutical lead within an acute secondary care hospital. 
 
The items for each measure used were consistent throughout, depending on the 
construct under consideration. However, to test the propositions and thereby answer 
the research question, the variables did vary from independent, dependent, or 
moderator. Section 4.11-13 explains all the variables used. 
 
4.11 Independent variables 
 
To measure supply chain disruption orientation construct, a scale was developed in 
congruence with prior research using the five scale developed by Bode, Wagner, 
Petersen et al. (2011). Roles within the pharmaceutical hospital environment were also 
allocated a five scale listing the job titles that were refined from the extant literature 
(Ritchie, 2002), and from prior management practice work on roles carried out in the 
National Health Service (2005a). Hospital numbers representing the number of 
hospitals in a given trust was defined by adopting a four point scale based on desk 
research of the current NHS publicly available hospital data, prior research (Baumer, 
2004), and from pilot testing and review from the research steering committee. 
Disruption severity, which encapsulates the extent to which a disruption had an effect 
(positive or negative) on a hospital unit, was measured by using a five-point scale, in 
congruence with the approach of prior research (Chadist, 2012, Ponis and Kronis, 
2012). Feedback is key in establishing learning from past events in disruptions, as in 
the case for urgent shortages during events, as noted by (Hales, 1986, Chadist, 2012). 
A five-point scale was developed to capture both intra-regional and inter-regional 
management feedback, as the public health service environment in which this research 
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was conducted is structured into hospitals, trusts, and health boards within regions, 
and the regions within each nation. 
 
This research measured buffering and bridging as actions taken post supply chain 
disruption causing a medicine shortage by the focal unit. These activities were drawn 
from the extant literature on supply chain risk management and exploratory interviews, 
which were then further adapted and refined in a novel approach by breaking down 
each action into time periods past the disruption. For example, buffering immediately 
after the supply chain disruption causing a shortage was up to eight weeks afterwards, 
with buffering (post) actions taken eight to 16 weeks after the disruption. This 
subdivision allowed the dynamic nature of post disruption actions in real world 
operations to be captured. Being able to adapt actions during events in a dynamic way 
builds on the work on dynamic management by Grewal, Johnson and Sarker (2007) 
and extends and further investigates the initial work on supply chain disruption 
resilience (Bode, Wagner, Petersen et al., 2011). The analysis of the time-critical 
supply chains requires application of dynamic methods (Ivanov and Sokolov, 2013, 
Ivanov, Sokolov, Solovyeva et al., 2016) and the ability to adapt during the course of a 
disruption (Xu, Wang and Zhao, 2014).This is due to the dynamic nature of the 
disruption fall out and need to respond to the specific and changing circumstances 
including for example the severity (Ponomarov and Holcomb, 2011). In pharmaceutical 
shortage management due to the criticality of the supply chain (high patient demand 
and life-threatening circumstances) hospital pharmacists and clinicians need to 
respond to the immediate impact of the disruption causing the shortage, but those 
response action(s) can change after a number of weeks. This can be due to the nature 
of the illness being treated, line inventory levels, alternatives medicine available, 
prescribing protocols, new suppliers (at home and abroad), preparation of the product 
for example, and the expert steering committee recommended that a typical response 
change time division post disruption impact was up to 8 weeks after the shortage 
started, and then from 8 weeks to 16 weeks.      
 
Six item scales were developed for both buffering and bridging for immediately after 
the disruption event and actions taken eight to 16 weeks after the event. These were 
based on prior research on pharmaceutical practice item scales and adapted from 
Baumer (2004). 
 
The extant academic literature on supply chain risk management, supply chain 
resilience management, and boundary spanning organisational behaviours 
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management describe the generic strategic responses of bridging and buffering 
(Fennell and Alexander, 1987, Meznar and Nigh, 1995). However, as pointed out by 
Peck (2006) p130, "No one person manages a whole supply chain", and there is a 
need to understand the multi-layered nature of organisational response. Further 
responses are a process and not an end in itself, so in congruence with the literature, 
the items for buffering and bridging have been extended from Bode, Wagner, Petersen 
et al. (2011) to include information gathered from qualitative pre-testing and items 
validated from earlier studies (Baumer, 2004). These include resources, policies and 
boundary spanning items of inter and intra-organisational relations. The bridging and 
buffering new constructs both included the concept of time from disruption occurrence, 
recognising the dynamic nature of response decisions, and the process nature of 
supply chain risk management. As Aitken (1998) noted, the term 'supply chain' is a 
flow of material and information from suppliers to end users; it is not a static process 
that can be understood by one decision immediately after one disruption. 
 
A five point scale was derived from the supply chain resilience literature and the 
exploratory interviews for the dynamic variable reflecting during event adaption 
(Christopher and Peck, 2004, Tang, 2006) These were further broken down into both 
internal business needs and length of time from the disruption to further examine the 
dynamic nature of the post disruption management behaviour.    
 
4.12 Dependent variables 
 
Performance measures are used in supply chains by management to determine the 
efficiency or effectiveness of a specified supply chain, (Swaminathan, Smith and 
Sadeh, 1998). The performance measures are taken from the relevant academic and 
practitioner literature and pre-test qualitative interviews and steering group pilot study 
review. The use of performance measurement variables is a novel approach to post 
supply chain disruption response decisions. Items reviewed included those validated 
measures used in previous studies on supply chain performance: 
 
1. Fraction of time an item is out of stock, which is similar to out-of-stock used in 
the retail industry (Gruen and Corsten, 2003)  
2. Line fill rate 
3. Time to fulfil order 




From these items, the line fill rate was selected into an item scale. One was for 
immediately after the disruption, and one was for eight to 16 weeks after the disruption 
for each measure, to capture the performance of the focal unit for analysis. The fill rate 
was selected as the most recognisable and the most relevant to the shortages 
captured on an ongoing basis via the pharmacist management systems, as identified 
by the expert steering committee.  
 
Further measures reflected previous industry context studies, such as  Baumer (2004), 
to ensure relevance and impact and from initial qualitative interview feedback: 
1. Procedure change 
2. Patient impact 
3. Suboptimal treatment 
4. Health consequence 
 
Supply chain disruption orientation was also used as the dependent variable to test the 
proposition P1c in further exploring the new concept initially developed by Bode, 
Wagner, Petersen et al. (2011), and extended with regards to the system membership 
aspect based on the extant boundary spanning organisational literature (Fennell and 
Alexander, 1987). 
4.13 Control Variables 
 
The control variables in the analysis phase are set to the context of the dyad but 
included the variable beds for which a four item scale was developed based on 
previous research (Baumer, 2004) as this may affect organisational actions and inertia 
(Chattopadhyay, Glick and Huber, 2001). 
Having collected the completed questionnaire responses, and after cleaning data entry 
errors, the data was input and coded using SPSS. After collating the information, a 
simple check was carried out on the response data for obvious errors such as entries 
falling outside the defined question responses. The data was further visually inspected 
and a descriptive analysis conducted using mean and standard deviation and variation 
in responses to determine general trends in the data prior to the data analysis phase, 
as described in Chapter 6. 
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The next section describes the interviews that were conducted and the process 
followed, including the initial descriptive statistics from the survey. The interviews were 
then followed up by conducting three separate focus groups, as described in 6.17. The 
reason for conducting several contrasting qualitative procedures, in addition to the data 
collected by the quantitative tool of the online survey, was to triangulate the results and 
to enable the better interpretation of the results and the ‘why’ question. The original 
post supply chain disruption model was built by Bode, Wagner, Petersen et al. (2011); 
Bode, Wagner, Petersen et al. (2011) almost exclusively used a survey quantitative 
methodology, with limited exploratory interviews and secondary data. By applying a 
combination of methods approach, as noted by Sandelowski (2000) p251, "Mixed-
method research is a dynamic option for expanding the scope and improving the 
analytic power of studies." Interviews not only allow the investigator to clarify questions 
for the participant, but also probe responses and seek deeper insights in meaning, 
focusing on the research question. For example, not only finding out what 
management actions were taken but why those actions were taken, and often 
examples may be given to further illuminate the issue under consideration and to add 
empirical first-hand information to corroborate the participant information of the subject 
under discussion. However, there is a downside to every method, and interviewees 
can go off the point and start discussing their own experience or answer non-related 
questions of their own; for example, the ethical considerations in treatment decisions, 
although this does give the investigator a wider perspective of the environment, the 
decision-making takes place by their research participants.   
 
4.14 Interviews    
 
The interviews were conducted following on from the self-completed questionnaire in 
order to give meaning to the data collected and to verify and develop the findings. The 
processes followed and the initial outputs of the interviews are described below. The 
full data analysis of the interviews is included in Chapter 6. 
 The main preoccupations of quantitative research are described by Bryman and Bell 
(2011) in terms of four features: measurement, causality, generalisation, and 
replication. The triangulation of this information with the rich source of research data 
through in-depth semi-structured qualitative interviews with a cross section sample of 
the survey participants provided detailed answers to make sense of and challenge the 
quantitative findings. Qualitative interviewing allowed the interviewee to depart from the 
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scheduled and quickly coded answers to accommodate flexibility (Bryman and Bell, 
2011), whilst at the same time focusing on the outlined topic. 
 
4.15 Interview Sampling Strategy 
 
The interviews were conducted on participants drawn from the survey instrument. Due 
to the strict ethical considerations within the public health system ethics procedures, 
highlighted below in Section 4.19, and the approved ethical protocol, the participants in 
the survey were given participant information and consent requests. These included 
indicating whether they would participate in the follow-up interviews. 
 
4.16 Validity and reliability 
 
The application of rules in content analysis is important as it means the analysis is 
done in a consistent manner in order to eliminate bias. The rules can be a reflection of 
the researcher's concerns and interest and these might be subject to bias. The main 
issue for reliability, however, is that once designed and documented they can be 
followed without the intrusion of bias. The eight step process, known as the Weber 
Protocol (Weber, 1990), was followed in formulating the coding scheme, so that the 
process and outputs of the content analysis could be replicated without bias: 
1. Definition of the recording units  
2. Definition of the coding categories 
3. Test of the coding sample of text 
4. Assessment of the accuracy and reliability of the sample coding 
5. Revision of the coding rules 
6. Return to step three until sufficient reliability is achieved 
7. Coding of all the text 





4.17 Focus group 
Following on from the online questionnaire and interviews, three group interviews were 
organised in the form of a focus group. The focus group offers the researcher the 
opportunity to study the ways in which individuals collectively make sense of a 
phenomena and construct meaning around it. It is a central tenant of theoretical 
positions like symbolic interaction that the process of understanding social phenomena 
is not undertaken by individuals in isolation from each other. Instead, it is something 
that occurs in interaction and discussion with others (Bryman and Bell, 2011). Focus 
groups reflect the processes through which meaning is constructed in everyday life and 
to that extent can be regarded as more naturalistic than individual interviews 
(Wilkinson, 1998). 
However, as with all research methods, the focus group approach has limitations. As 
well as the practical challenges of group organisation and the large amount of 
information they quickly generate, there are the potential problems of group effects or 
‘groupthink’. These include reticence to contribute, the tendency, in some cases, for 
agreements rather than disagreements, and the expression of culturally expected 
views in contrast to individual interviews (Janis, 1982, Krueger, 1998).  To overcome 
and reduce these phenomena, the groups were given active encouragement to 
contribute, with the interviewer expressing that there were no right or wrong answers 
and that each interviewee's opinion was valid.  
4.18 Focus group selection 
The focus group has been subject to criticism in a marketing research context, with 
critics stating that a group of 10 or so interviewees, usually chosen haphazardly at a 
single location, cannot be expected to reflect the views of the whole population. 
However, this research is not considering a product in a marketing context and the 
focus groups were conducted for the entire population of regional specialist pharmacist 
managers in England and Wales, with a separate focus group for each. Because focus 
groups are useful for assessing complex concepts, they are ideal for researchers who 
wish to systematically research and include concepts via survey or experimental work 
(Cyr, 2016).  This research also conducted a focus group with a senior cohort group 
from the buyer side of the pharmaceutical acute care secondary supply chain, derived 
from the same teams involved in the exploratory interviews for consistency and wider 
understanding, namely the Commercial Medicines Unit (CMU), and the Department of 
Health (DoH) Supplies Team, who focus on shortages.  
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These groups did not consist of randomly selected managers with limited knowledge of 
supply chain disruptions and shortages in medicines, rather they were the key targeted 
groups of operational experts involved in the operational management, policy, and 
contracting of the buyer side of the pharmaceutical supply chain in acute secondary 
care.  Selecting focus group participants from natural groups of experts in a field has 
been successfully used in other management research, such as Kiely (1998). One of 
the potential criticisms of using natural groups is that the participants can often already 
know each other and take it for granted that topic knowledge is high and this can be 
difficult if a hired moderator is involved to control the group discussion. To counter this 
issue, and for ethical and resource constraints, the focus groups were conducted by 
the researcher and did not include a hired moderator.   
After conducting three separate focus groups in different locations across England and 
Wales, the information and data collected was substantial and varied, however, 
repeated themes were identified. Due to the time, finance, and resource constraints of 
this research and the saturation of the data outcomes, a further focus group to be 
conducted in the Republic of Ireland was deemed beyond this research study and not 
critical to the data integrity due to the repeated theme outputs from the existing focus 
groups, in addition to reducing the complexity of the research overall (Schlesinger, 
Dobash and Weaver, 1992). The focus group sample size was then not predetermined, 
but rather dictated by theoretical saturation; that is, data collection was stopped, when 
no additional concepts or relationships among the concepts emerged, a technique 
used in other qualitative research in disruptions and crisis management by Grewal, 
Johnson and Sarker (2007). The data generated by qualitative methods are 
voluminous, and the sheer quantity of raw data needs to be organised and managed. 
As part of this process, the recognition of ‘sensemaking’ and a goal approach has, at 
its roots, pragmatism (Brinkman, 2014). Livingstone and Lunt (1994) note on this point 
of theoretical saturation that the criteria for selecting the number of focus groups is 
determined by continuing until comments and patterns began to repeat and little new 
material is generated. 
Fern (2001) has argued that the generalisability of focus group findings, as with other 
research methods, depends on the scale of the sample. What the focus group does 
allow the researcher to do is to drill down into the details of an issue, with a group of 




All the focus groups were recorded and transcribed, as were all the individual 
interviews, as it has the following advantages, as described by Heritage (1987): 
1. It helps correct the natural limit of our memories 
2. It allows more thorough examination of what people say 
3. It permits repeated examination of the respondent answers 
4. It opens up the data to public scrutiny 
5. It therefore counters accusations of bias by researcher influence 
6. It allows the data to be reused in other ways 
The focus groups were included in the ethical approval process, along with the 
individual interviews, and focus group protocol guides, including anonymity and data 
integrity, participation information sheets, and consent forms were all approved, 
issued, and collected as part of the focus group research. Each group interview was 
held for approximately one-and-a-half hours, with all participants meeting the criteria 
for participation. The participants were told the session would be audibly recorded and 
subsequently transcribed by the researcher. The same focus group guide was used for 
each of the groups.  
Each focus group followed a six step topic agenda relating back to the research 
question and consequent propositions in order to concentrate on the explanation of the 
subject under consideration: 
1. Current shortage challenges 
2. Supply chain disruption orientation 
3. Buffering and bridging actions 
4. Feedback and dynamics 
5. Size and role 
6. Shortage management performance 
These topics not only reflected the requirement to answer the research question, but 
were also a distillation of the main themes identified by the collective interview results. 
The transcriptions from the focus groups were also uploaded into the NVivo software 
programme. This was to allow the management of the substantial amounts of data 
generated by the focus groups' transcriptions, facilitate easy extraction of quotations in 
the display screen, and to identify the main themes using the Word Cloud function.  
However, the focus group transcripts were not fragmented into nodes and categories 
to allow for wider participant perspectives across the group and to facilitate moving 
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from findings to actions from the group-based discussions and interactions, as 
recommended by Bloomberg and Volpe (2015). 
The next section refers to the ethical considerations for this research, prior to data 
collection and analysis. 
 
 
4.19 Ethical Considerations 
 
When conducting research, the researcher needs to maximise benefits and minimise 
harm, therefore, the researcher must consider the impact of his or her actions before 
conducting them (Barrar, 2002) and so, as with all research conducted, consideration 
had to be given to the ethical and moral implications of the research methodology 
applied. To maximise the validity of the research findings, a number of research 
methods were triangulated, e.g., there was no one area of the research where the 
researcher did not employ more than one method of data collation. This mixed method 
approach meant the research had the potential for ethical repercussions, and so a 
robust action plan was put in place in accordance with the ethical rules of both the 
university and the National Health Service, the latter of which ethical staff involvement 
was required from both organisations.   
Having developed an appropriate and relevant questionnaire, interview and focus 
group participation information sheets and consent forms (as part of the risk 
assessment and gaining the relevant external and internal ethical approvals), the data 
was then collected. The data collection tools for the questionnaire were administered to 
the inter-organisational actors by internet link to protect the identity of the recipient, 
which is important from an ethical aspect but also as this is a self-reporting tool to 
encourage objective participation. The survey was issued with a participant information 
letter outlining the purpose of the research and an individual consent form confirming 
that the research is for academic purposes only and that it has been approved by the 
ethical committee of the university, who will act as sponsors for the research, as were 
the interviews and the focus groups. In parallel to the Research Ethics Committee 
(REC) review, NHS permissions were sought and granted by the appropriate NHS 
Ethics Committee representative. This research did not involve collecting data direct 
from patients but through interviews and surveys of NHS pharmacy staff in aggregate. 
No sensitive personal data (Data Protection Act, 1998) or commercially sensitive data 
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(Freedom of Information Act, 2000) will be gathered or examined. Research protocols 
were developed, reviewed, and approved prior to any data being collected, including a 




In Chapter 4, the research design and methodology plan was initially described 
following the five-step research plan. The first steps of the research plan are the 
philosophical stance and research approach, and considerable attention was given in 
this part of the research plan as this influences the way in which all other elements of 
the later elements of the research plan, i.e., strategy, methodology and techniques and 
procedures, are constructed. It is recognised by this research that there are multiple 
philosophical stances and research approaches available to the researcher in any 
study (Healy and Perry, 2000). However, by using comprehensive criteria, the relative 
merits of each stance and methodical design has to be aligned to an appropriate 
paradigm, in this case positivism, given the theory testing nature of the research. This 
section also included the high-level research flow chart, research problem, constructs 
and propositions flowchart and the research survey design summary table to explain 
how the research question will be answered. The proposed techniques and procedures 
for this research are outlined above, before being described in detail in the next data 
collection sections of Chapter 5.  
 
Chapter 5 is the final layer 6 in the research plan, as described in the Saunders, Lewis 
and Thornhill (2007) research onion in Figure 15. It presents the actual data collection 
process followed using a step by step approach, to clearly set out the method(s) used 












5 Data Collection and Descriptive Presentation 
 
5.1 Introduction  
 
This chapter describes the data collection process in detail and presents the 
descriptive statistics and outputs of the initial results. The data collection instruments, 
as described below, follow the strategy path outlined in the research high level design 
flowchart: Chapter 4.4.1, Figure 20. 
   
5.2 Desk Research    
 
The initial dialogue with the target participants and desk research identified multiple 
sources of data, both in the form of an information database and willing key 
participants from pharmacists representing each of the NHS areas in England, tracking 
the 10 SHA regions, NHS Wales and Health Service Executive (HSE) Hospital Groups 
in Ireland. Each region includes trusts or regions of cooperation, which themselves 
have varying numbers of acute care hospitals, where a lead pharmacist will be 
responsible for the operational delivery of pharmaceuticals to patients. 
 
The desk research identified the UCLH national drug shortage database as a relevant 
and available source to be investigated by this research. 
 
5.3 Drug Shortage Database  
 
The drug shortage database was developed by the University College London Hospital 
NHS Trust (UCLH) in 2001. The site was initially cultivated in-house to provide details 
of manufacturing problems of medical products for departments within the trust. 
 
The idea proved a success within UCLH, and interest became so great that its 
availability was gradually expanded to hospitals on a national basis via e-mail, fax and 
post. The data is uploaded either directly to the site or on a manual basis by the in-
house team, which also administers and supports the site. It became a valuable and 
unique source of drug shortage information in England in the medicine supply chain 
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final mile for practitioners and stakeholders alike. The site progressed to become the 
Solutions website, a valuable resource to its users in the communication and 
management of pharmaceutical supply problems. The site is designed for NHS 
healthcare professionals, and to access and use the site a mandatory account must be 
set up using a username and password. Applicants are first reviewed internally by the 
ULCH solutions website staff. 
 
The raw data includes information relating to over 2,000 medicines that have been in 
shortage in the United Kingdom’s secondary care supply chain, reported as so by a 
variety of sources. Specifically, the data includes the shortage medicines’ generic 
name and preparation, strength, pack size, brand-name, manufacturer, a target date 
for the shortage resolution, the reason for the shortage, and alternative drug source 
information. The 'Product Shortage Information' section is updated daily and has a 
search function available. The most significant pharmaceutical supply shortages are 
readily identifiable at a glance in the 'Critical Drugs' section, which also offers advice 
on how to deal with the problem. 
 
Figure 24 shows there is a frequent incidence of injectable drug shortages from various 
manufacturers, with the top five from four different suppliers. Summary description of 
the data identified the most frequent causes of pharmaceutical shortages are due to 
‘macro’ disruption issues, with the manufacture of the drugs upstream in the 
pharmaceutical supply chain. Note that there are 2008 types and preparation of 
generic drugs recorded in shortage not taking into account pack size, which introduces 
the scale of the complexity involved in managing inventory of shortages. Figure 24 
displays several drugs in shortage, all due to supply chain disruption, over a six-year 




Figure 24. Frequency of pharmaceuticals in shortage incidence by medicine from the UCLH 
shortage database. 
Following on from the desk research and initial analysis of the UCLH drug shortage 
database, exploratory interviews were conducted to give further meaning to the initial 
quantitative data found. The interviews also assisted in guiding and selecting the 
survey design and to help define the survey sampling strategy, including the medicines 
in shortage to be included, so that they are relevant and valid. The need to sample is 
one that is almost invariably encountered in quantitative research (Bryman and Bell, 
2011). 
5.4 Exploratory Interviews  
 
The exploratory interviews conducted identified that disruption response actions and 
the mechanisms that underlie them vary between organisations and responsible 
managers. Initial discussions also indicated that, currently, the pharmaceutical supply 
chain in acute care is underperforming in shortage management, with the ongoing 
disruptions affecting the supply of drugs becoming the norm rather than the exception.  
The preliminary discussions with the range of professionals helped to further illuminate 
the pharmacy supply chain field. The professionals were all aware of shortages in 
medicines, and noted that this was not a new phenomenon. The occurrence of 
shortages was seen as a routine part of the pharmaceutical supply chain. It was also 
seen as getting worse with every passing year, and whilst 95% of secondary care 

















































































































































































100% care availability at the point of use. Pressure was evident from the interviewee’s 
feedback to improve this performance to 100%. The focus, however, was local 
disruption to the supply chain, albeit with an awareness of the global supply chain 
network. The initial discussions with research participants, desk research and literature 
review all identified the ongoing performance issues in shortage management with 
regards to pharmaceutical supply chain disruptions. For example, when discussing 
with a lead procurement technician at one hospital trust regarding medicine line 
samples that had been in shortage over the last 12 months, there were multiple 
examples readily given, including injectables such as insulin. A widespread problem 
identified was medicine contracting and the non-adherence to contracts, for example, 
prematurely pulling out of contracts that were seen as not economically viable. The 
quality and availability of data, such as forecasts, and supply chain flexibility were also 
cited as important. 
In addition to contractual adjustments and risk assessment strategy, Stead’s (2009) 
work was referred to by two of the interviewees, specifically A Framework for 
Managing Medicines Shortages and Product Discontinuations, which involved a multi-
agency approach1 . There was a recognition at an early stage of the need for both 
wider and local bridging actions to complement the local buffering actions. This work 
was a follow-on from the earlier NHS 'Improving pharmaceutical supply chain 
performance: pilot programme'. The thickening of the supply chain for a wide range of 
elevated risk medicines (buffer stocks) and the public healthcare ownership of 
emergency stock was mentioned. Also, the selection criteria of suppliers were not 
solely price focused, but this conflicts with the ‘value based pricing’ current government 
directive, economic climate, and the fact that all secondary care regional pharmacy 
managers have costs reduction targets.  
Access to information and having the right information in the right place at the right 
time was a common theme coming from the interviewees. This included a variety of 
information flows and methods, but it was identified that there was no automatic direct 
real-time flow of data. Pharmacy data was uploaded monthly and held by the CMU. 
Manufacturing companies affected can give inventory forecasts twice weekly as 
required, plus a two-way process of manual alerts. Other drug companies send weekly 
lists. Data and the availability of information to hospital pharmacies is centred around 
the CMU as a gatekeeper. The interviewees stated that the conflicts existing between 
the multiple systems that were in use throughout the process negatively impacted the 
                                                          
1 Agencies included ABPI,BAPW and BGMA 
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efficient use of the data. They identified that a single integrated IT system would 
benefit the supply chain process enormously. The interviewees coded, however, that 
improvements had recently been made. For example, most hospital trusts are now 
using EDI to transfer data, improving the flow of information. 
The preliminary interviews identified that within the NHS system, these are the key 
strategic decision-making areas for supply chain response to disruptions. It was 
mentioned that roles at each hospital trust have different focuses, but often those with 
responsibility for dealing with shortage issues caused by disruptions have multiple 
responsibilities. For example, the pharmacy director or head of pharmacy has focus on 
the overall budget and wider service level agreements to the customer and board 
notifications but also takes a strategic role in responding to shortages. This exploratory 
phase involved face-to-face interviews or telephone interviews (in order of preference) 
depending on the commitments of those taking part. Using pre-existing, readily 
accessible resources and permissions for interviews on a large population is useful 
(Bell and Bryman, 2007) after the typology of the sample is considered (Patton, 1990, 
Miles and Huberman, 1994). However, it is important to note that these exploratory 
interviews were not a convenience sample being simply available by chance; in 
contrast, they were selected with the study's research question in mind. 
5.5 Survey Response  
 
The overall response rate was 125 respondent hospitals, 109 from the UK, excluding 
Scotland, from a possible 261, meaning 42% of the possible population responded, 
and 16 from the Republic of Ireland, from a possible 57, meaning 28% of the possible 
population responded. This gives a strong overall response rate of 39% from the entire 
population of 261 hospitals. There was a limited amount of missing data in the survey 
responses, amounting to 146 data points from a possible 7,875, totaling less than 2%.  
 
5.6 Interview Response  
 
Those in the subsequent candidate pool of consenting interview participants were then 
contacted to request participation in a follow-up interview. An interview candidate list 
was drawn up and from all those contacted with follow-ups, an interview schedule was 
drawn up and conducted. No filtering of the consenting participants was conducted and 
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the total number of interviews conducted was 18, 14% of the available survey 
respondent’s population, which itself was drawn from all the secondary care acute 
hospitals in the UK, excluding Scotland and including the Republic of Ireland. There 
were no missing data items as all questions were answered by each participant during 
the interviews. The interview format allowed participants to clarify questions and the 
examples given by the interviewer were necessary to illuminate the questions posed. 
The pre-testing of the interview's semi-structured protocols by the steering committee 
meant that many of the questions were easily understood by the candidates. 
The data analysis of the interviews was based on the technique of quantitative content 
analysis. This is an approach to the analysis of documents and texts that seeks to 
quantify content in terms of predetermined categories. The approach to content 
analysis is based on categories designed to capture the dominant themes present in 
the text (Franzosi, 1995). Data analysis, or coding, of each of the first two participants, 
before continuing with subsequent interviews, was carried out, as recommended by 
(Saldana, 2013). This ensured the quality of the interviewing process by identifying 
possible leading comments and/or incomplete participant responses. This pause in 
conducting interviews allowed greater confidence that the interviews were conducted 
completely and accurately. A comprehensive definition of 'code'  is given by (Saldana, 
2009) p129, he states:  
 
A code in qualitative inquiry is most often a word or short phrase that 
symbolically assigns a summative, salient, essence-capturing, and/or evocative 
attribute for a portion of language-based or visual data.  
 
In analysing qualitative data, it is essential to keep an open mind, remembering that 
qualitative research is all about discovery (Bloomberg and Volpe, 2015). Although 
content analysis has the advantages of being flexible and transparent, it is recognised 
that inter-coder reliability can never be perfect and it is almost impossible to devise a 
coding manual that does not involve some interpretation on the part of the coders 
through everyday knowledge (Cicourel, 1964).   
 
The interviews were analysed by using the NVivo software. This programme had 
already been applied in the literature review of this research for analysing content; 
codes are created by the researcher, which facilitates the process of analysis.  
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The interviews were all audio-taped, transcribed and entered into the NVivo software 
programme. The researcher also imported field notes from observations, and other 
secondary data collected; for example, standard operating procedures to verify and 
add depth to the meaning of the interviewer’s comments. Documents from each case 
were stored together in order to make individual case analysis easier and more 
efficient (Heritage, 1987). The software was used during initial coding and to develop 
coding categories for each case.  
The NVivo software tool helped organise and manage the large volume of data 
collected in the research process. If data are to be thoroughly analysed, they must be 
well organised (Bloomberg and Volpe, 2015). Although there is still an ongoing debate 
within the field about the utility of CAQDAS (computer-aided software programmes for 
data analysis), they do enable selective monitor display of data and codes in 
configurations to allow the researcher review and apply analytic thinking to the 
research material and their meanings (Miles, Huberman and Saldana, 2014). The 
justification for the interviews and subsequent focus groups to be transcribed by the 
researcher was to allow total immersion in the data, to improve familiarisation, and to 
become familiar with it. The NVivo software allows the storage and organisation of raw 
data in multiple forms, for instance Word and PDF, and so allows a common platform 
for organising the research results and analysing them. 
Although the qualitative and quantitative parts of this research project were conducted 
separately and analysed in different ways, the overall reporting of findings means that 
data from both sources are seamlessly woven together to provide an overall integrated 
and holistic presentation, as recommended by (Bloomberg and Volpe, 2015). After the 
transcripts were entered case-by-case into the NVivo software, they were profiled into 
themes by allocating variables to each theme. 
 
To facilitate the refinement process and ensure a reliable process was documented, a 
two-stage process of coding was followed. 
5.7 First round coding 
 
First round coding was completed in NVivo using nodes. A node is defined in the latest 
release as, "a collection of references about a specific theme, place, person or other 
area of interest" (Bryman and Bell, 2011) p598. Coding was carried out by applying 
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nodes to segments of text. Each theme or variable is allocated a node. This profiling 
method enables the development of coherent descriptions of what and how things 
happen across a number of cases (Miles, Huberman and Saldana, 2014). Next, each 
case, or interview, from the complete collection of 18 interviews was reviewed line by 
line in the NVivo display to allocate first coding by phrase or word most relevant to 
each of the nodes. 
In addition, while first coding by theme, individual quotations were retained by using 
memos, which were saved separately by theme. This facilitated a bank of salient 
quotations against each theme, which could be referred to and compared and 
accumulated against other quotes by different cases on the same theme on an 
ongoing and iterative process. This meant large amounts of data could be distilled and 
refined, allowing the successful linking of case-orientated with a variable-orientated 
approach, which gains conceptual power that cut across variables can bring (Miles, 
Huberman and Saldana, 2014). As the interviews were semi-structured, they were 
purposely chosen to answer the research question by addressing the relationships 
posed by the research propositions. The coding schedule, shown in Table 8, is in the 
form into which of all the data relating to an item was subsequently entered. Each of 
the Roman numerals in Table 8 relate to a specific dimension that was being coded. 
The coding schedule helps the researcher simplify the principals involved in the 
process of content analysis, and is the first step in funnelling the large amounts of data 
prior to categorisation through the coding manual, as noted by (Bryman and Bell, 
2011). This technique has been used successfully in prior research, including 




Table 8. Coding schedule 
After this process was completed, the cross-case themes could be viewed in groups of 
strips of the relevant text taken from the transcript of each case. The process was 
refined and tested before progressing onto the next stage of the coding drawn from the 
condensed information in the NVivo software repository, where the transcripts were 
uploaded and nodes defined from the content of the interviews. 
5.8 Second round coding 
The second-round coding was done by distilling the contents of the 17 nodes, each 
consisting of a theme derived from the interview transcripts. This further distillation was 
done to dive deeper into the data by classifying it in a consistent manner using a 
coding manual, shown in Table 8. The coding manual, sometimes referred to as the 
content analysis dictionary, is a statement of instruction to coders specifying the 
categories that will be used to classify text based on a set of written rules that will 
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define how the text will be classified  (Bryman and Bell, 2011). This enables replication 
to enhance reliability, ensuring that the process could be carried out again by another 
researcher and get the same results. 
 
Table 9. Coding manual 
The above coding manual in Table 9 indicates the detail by category to be recorded, 
for example, under action response, (xiv): Effective response action has eight 
possibilities in the coding manual, from (1) speed of action through to (8) shortage 
champion. From these options, the frequency of response by the interviewees can be 
collected in a relevant way to ultimately answer the research question, but importantly 
the method is confirmed in the manual for replication in future research.  
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Following on from the coding manual, the contents of the 17 individual nodes were 
analysed using the NVivo query tool, and allows viewing the Word Cloud grouping at 
the exact match to the generalisations level. This produces an image of the most 
frequent 1,000 words which allowed the researcher to pick out the highest frequency 
words relevant to the theme.   
The Word Clouds drawn from each of the nodes were then reviewed along with the 
actual relevant text, to specify the categories within each theme. Then for each case, 
using the NVivo software, their corresponding node content was reviewed and used to 
categorise each node reference content, according to their strip salient words for that 
case. These case categorisations were then accumulated in the contents summary 




Table 10. Contents matrix summary 
Table 10 displays the categories by theme and allows the researcher to review, in 
summary form, the results of the content analysis. It was separated by four overall 
summary sections: 
1. Information about the actor 
2. Actions (Response) 
3. Performance 
4. Advice 
Table 10 shows the typology of the role theme, and displayed that the two most 
frequent roles were head of pharmacy and pharmacy procurement. The length of 
service of the participants was most frequently over 10 years, with 10 out of the 18 
interviewees holding their role for at least this length of time. There was an even 
spread of the hospital numbers within the trusts. The job function of the roles was 
mainly procurement, again with 10 out of the 18 interviewees having this job function, 
with predominately good knowledge, with 14 out of the 18 interviewees meeting this 
standard.  
By reviewing the results in the content summary matrix in these four subdivisions, the 
most frequent categories of each theme can be easily identified, allowing the 
researcher to become further immersed in the data. 
 
Figure 25. Medicine shortages frequency of the interview responses  
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Shortages experienced by the interviewees showed a pattern of ‘frequently’, shown in 
Figure 25. All the interviewees had experienced shortages of at least occasional 
frequency.  
 
        
Figure 26. Shortages as a percentage of the interview responses 
As shown in Figure 26, all the interviewees had experienced shortages of at least 
occasional frequency.  
In the 18 cases interviewed, only two (11%) interviewees reported an occasional 
shortage frequency. There were nine (50%) interviewees that frequently have a 
shortage, and seven (39%) interviewees having a shortage very frequently. This 




Figure 27. Feedback by case 
The feedback by case was captured and summarised, with 11 out of the 18 
interviewees (66.7%) stating they had 'really good' feedback, as shown in Figure 27.  
 
Figure 28. Size of trusts or regional hospital groups 
The size of the hospitals was evenly spread across those interviewed (Figure 28). As 
shown in Figure 28, the standalone hospitals were 27.8%, and between 4 and 5 




Figure 29. Sources of shortages information 
There was an even spread of interviewees who had either limited access to information 
and easy access to multiple sources of information, each comprising 33.3% of the total 
interviewees (Figure 29). This suggests that those charged with managing shortages 
do not have a uniformed standard when it comes to accessing information. However, 
27% of those interviewed did have multiple sources of information, which could 
potentially explain why there was some variation in the level of shortage performance. 
As per information processing capacity (Huber and Daft, 1987), when a disruption 
occurs there can often be a mismatch between the amounts of information available to 
a unit. 
Both buffering and bridging together was the predominant choice as was maintaining 
continuity of supply for the response reason. In the dynamic response, most were 
regularly dynamic with a spread of reasons given. Effective response was using a 
shortage champion (6 of the whole group) and team dynamic and orientation, with 
performance for shortages and patients both scoring highly generally. Vigilant 
orientation was the dominant advice category shown, with 6 of the interviewees 
choosing this category. Although the overall intent is not to quantify qualitative data, 
tallies and frequencies in qualitative research are essentially a supplement to the 




Figure 30. Information about the actor 
Figure 30 sets out the descriptive response findings in one view to give the background 
of the interview respondents. As can be seen in the chart, there is an even spread of 
role titles and a good mix of experience by time in the position. With most of the 
respondents having strong experience, albeit as sometimes explained by the 
respondents that their role has evolved to include wider responsibilities and cross 
functional activities given the limited resources and increased activities of growing 
shortage management due to disruptions. There is an even spread of regions served 
and role function, with the predominant function being in sourcing and procurement 
which was anticipated prior to the findings being obtained. Lastly, the knowledge level 
reported by the interview respondents was overwhelmingly good on shortage 
management which, given the average length of service on the ongoing shortages they 
were experiencing, is consistent with expectations. 
The results are further evaluated in the data analysis in Chapter 8, where the data from 
the contents summary matrix is transposed into a case and variable by variable matrix. 
Interrelationship is one of the foundation principles for methods of explaining change 
and explaining causation. As noted by (Miles, Huberman and Saldana, 2014), a 
variable by variable matrix first explores the interaction and interplay between multiple 
pairs of variables to see whether they apply to particular cases. However, it is 
appreciated by this researcher that good explanations need to link the explanations 
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given by the people we are studying with explanations we develop as researchers, as 
recommended by (Miles, Huberman and Saldana, 2014). It is recognised that this is 
not a straightforward process and, as (Morrison, 2009) advises, researchers should 
consider carefully the nuanced differences between a cause, a reason, and a motive, 
and to keep the primary focus on people's intentions, choices, objectives, values, 
perspectives, expectations, needs, desires, and agency within their particular contexts 
and circumstances.    
The findings from the three focus groups were consolidated under the above six topics. 
As recommended by (Wolcott, 1994), the researcher typically moves through a series 
of analyses episodes that condense more and more data into more and more coherent 
understanding of what, therefore building a solid foundation for later analysing how and 
why. 
The next section describes the findings of the focus groups.  
5.9 Findings from the focus groups 
 
The findings from the three focus groups are consolidated throughout this section 
under the six topics raised in the focus group sessions, which relate back to the 
research question and propositions. There were common outputs across all the focus 
groups, which are extracted in the below narrative. There was a richness of 
perspectives, including the policy and contracting from the CMU and DoH groups, 
however, as the majority of these managers also had either worked directly in the 
pharmacy environment or had deep knowledge of it, there was a common experience 
and knowledge base. 
To first highlight the findings of the three focus groups, a Word Cloud was generated 
using the NVivo programme query selecting the three internal focus groups' transcripts, 
shown in Figure 31. A Word Cloud is a special visualisation of text in which the more 
frequently used words are effectively highlighted by occupying more prominence in the 
representation. Grammatical words and non-frequent words are hidden so that the 
resultant representation cleanly shows the most frequently occurring words of 
importance (McNaught and Lam, 2010). Word clouds, also called tag clouds or a 
weighted list, are a visual depiction of the frequency tabulation of the words in any 
selected written material. Advantages of word clouds include their flexibility and 
capability to create a simple visual image from copious amounts of written material, 
and by highlighting the most frequently used words, allows focus. Disadvantages of 
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word clouds are due to their prioritization of words by frequency, so key concepts may 
be excluded because the words used to describe a concept appear irregularly (Miley 
and Read, 2012). Despite the noted limitations this research uses word clouds for the 
focus groups in combination with the narrative themes. As noted by DeNoyelles and 
Reyes-Foster (2015) it fosters critical thinking and is an ideal way to encourage open 
exploration of a concept or topic without being hindered by a large amount of text. 
 
An initial content analysis can be supported using word clouds to analyse the 
responses to researchers questioning to consider certain words and phrases 
employed. It has been previously used successfully by Sweeney, Grant and Managan 
(2018) in supply chain management research for example in supply chain 
management in practice, where they considered supply chain management particularly 
at a strategic level, through an investigation of the four perspectives taxonomy of the 
relationship between logistics and supply chain management. Word clouds were used 
in particular to furnish some insights into how respondents define the terms logistics 
and supply chain management. Other researchers have used word clouds to  analyse 
themes associated with time in operations management research.Klassen and 
Hajmohammad (2017) for example used words clouds in their research in operations 
management looking at how humans and organizations experience time, termed 
process-time, which was chronicled by events and stages of change. Klassen and 
Hajmohammad (2017) p1609, used the word cloud as a way of offering research 
findings as a “perception of a central tendency, rather than a precise position”. As 
noted by Gottron (2009) and Tidy, Wang and Hall (2016) word clouds are a relatively 
recent way of visualizing the content of documents to make decisions about relevance 
and emphasis. A word cloud does not necessarily illustrate a trend but by preference 
provides an overall visual impression through identification of the most frequently used 
words in a piece of text (Santos, Ma and Judd, 2011), in this way it complements the 
existing narrative and helps explain it rather than replacing it entirely. Results from 
research by Kuo, Hentrich, Good et al. (2007)  further indicate that word clouds are 
effective to give an impression of what information is present in a query result set. 
They draw the conclusion that word clouds are a good visualization technique to 
communicate an ‘overall picture’ of the text contents. However, it is noted that this 
technology and its use in research is still developing, and improvements are continually 
being suggested for example by Heimerl, Lohman, Lange et al. (2014) whose study  
indicated that word clouds are indeed an effective tool for text analysis if equipped with 




 One of the key first observations for the shortage management of medicines post 
supply chain disruption is the largest item of ‘change’.  This was not a surprise to the 
researcher as; having conducted both the exploratory and individual interviews, 
managing the supply chain after disruption is dynamic and not static. As noted in 
previous research (Slack, Chambers, Harland et al., 2001, Ritchie, 2002), the 
pharmaceutical supply chain is different to other organisational supply chains due to 
the scale of the operation and the volume/variety mix of its products. A hospital 
pharmacy buys approximately 4,000 lines of stock from pharmaceutical wholesalers, 
and this is only a part of the range held by these operations. This indicates that the 
range of stock held and the volume of lines processed per day are extremely high in 
the downstream supply chain. 
 
 
Figure 31. Word Cloud from all the focus groups 
Change, clearly, is a constant for the pharmaceutical supply operations manager, and 
the disruptions that the focus groups reported were frequent, or as one participant 
noted from the Wales focus group, "beyond frequent". Some of the other key and most 
frequently mentioned outputs from the focus groups were ‘act’ and ‘actions’, and 
ongoing actions noted from the cloud included both 'bridging' and 'buffering'.  Some of 
175 
 
the significant other factors mentioned in the Word Cloud include communication, 
information, suppliers and management. Managing the supply chain can be difficult 
due to the volume and diversity of products involved, resources, technology, and 
complexity of networks (Lamming, Johnsen, Zheng et al., 2000). Large, complex 
supply networks bring problems to the fore, such as managing information flow which 
is essential to the success of efficient supply chains, potentially leading to investments 
in data capture technology, or information technology for coordinating material and 
information flows (Ritchie, 2002). This also underpins (Bode, Wagner, Petersen et al., 
2011), based on the motivation to act post supply chain disruption, drawing on both 
information theory (Galbraithe, 1977, Tushman and Nadler, 1978) and resource 
dependency theory (Pfeffer and Salancik, 1978). 
The six discussion topics for the focus groups were formulated to address the research 
propositions and, ultimately, the research question to closely examine the 
interrelationships between buffering and bridging that affect performance in shortage 
management post disruption. 
The findings for each of the topics are summarised by topic heading, taking in all the 
focus groups' comments and observations. The common themes for each topic are 
encapsulated with appropriate salient points and corroborated with participant 
quotations. In this qualitative part of the research, the emphasis is on understanding. 
One is not seeking to determine any single causal explanation, to predict, or to 
generalise. The aim, as advocated by Bloomberg and Volpe (2015), is to tell a richly 
detailed story that takes into account and respects a context and that connects 
participants, events, processes, activities, and experiences to larger issues or 
phenomena. With this aim in mind, the focus group findings are presented in a 
narrative form rather than template or thematic chart or by coding.  This later analytical 
approach was rejected by the researcher for this section of the data collected, not only 
because of the problem of losing the context of what was said, but also so that the 
narrative flow of what people say is not lost (Coffey and Atkinson, 1996). The 
emphasis in this section is to let the participants speak for themselves with short 
commentary by way of a thick description (Denzin, 2001). Further scrutiny will be 




5.9.1 Current shortage challenges in pharmaceutical supply  
The focus groups identified multiple challenges in medicines shortages in the current 
environment. These included regulatory, supplier, quality, policy, and in some cases of 
conflicting policy pulling supply chain management of shortages from disruption in 
different directions. For example, participants commented: 
 “From a policy perspective, it is also worth pointing out that we have got things 
such as the Carter Report which was published early in this year [2016], and 
there is a direct recommendation in there for hospitals to reduce their stock 
holdings to around 15 days. Now, of course, that means they are going to have 
less stock available before they run out if there is an issue further up the supply 
chain. So, you have got that one particular policy directive on the one hand 
where hospitals are being asked to reduce their stock holding, and on the other 
hand you have got another policy which, where we have the emergencies 
buffer stock pile, which, of course, seeks to hold stocks in the event of any sort 
of pandemic event or emergency; so, you almost have two different policies 
driving different aspects by hospitals having to keep less stock. On the other 
hand, you have got a policy that advocates the holding of buffer stocks.” 
(Participant A1) 
“Increasing is sort of big regulatory global issues, I am not sure if that we have 
better infrastructure in place with the regulatory or if we just have a better 
relationship with the regulator now, so that what is happening increasingly is 
that an inspector will go into a factory in sort of China, India, Europe, anywhere 
in the world and find an issue and it is not necessarily a UK inspector, because 
we have something called mutual recognition agreements across the EU, and 
to some extent with the FDA and other global regulatory authorities, and they 
will find something wrong with a factory that may manufacture several hundred 
medicines for this country and for Europe and it will shut the factory down.” 
(Participant C1) 
 
In addition, the current state of the pharmaceutical market, a participant commented 
that contracting of medicines that the department has pointed out that where we 
procure medicines in secondary care or generics, they are procured on the basis of a 
commercial perspective, that is to say, for example, paracetamol tablets, there is 
recognition that there will be a hundred different suppliers of paracetamol tablets. 
Whereas participants noted: 
 
“Market failure description, where you have many suppliers of a given product 
in a market (e.g. paracetamol), whereas the same cannot be said of injectable 
medicines which are difficult to manufacture, you are going to have a very 
limited number of manufacturing facilities. In some cases, you are going to 
have a wholly dedicated facility for things like oncology medicines, where you 
can’t just manufacture other product lines for risk of cross contamination, and in 
those incidences, we seek to adopt a more strategic view. We would take a 
more strategic view on the procurement of medicines in that we would seek to 
award to more than one supplier in the market and that is done in recognition 
that if one supplier has an issue or supply disruption, you have at least two or 
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three other suppliers who might be able to help out, so we would not always 
seek to award to the cheapest supplier."  (Participant A1) 
 
The type of medicine and how it affected the severity and the length of impact and the 
subsequent post disruption management response was a predominant theme, 
although there were limited comments that shortages exist across the board. The 
management impact and response was less difficult due to the possibility of 
alternatives. 
Other challenges highlighted included poor supplier engagement, minimum stock 
availability, and pharmaceutical suppliers' processes that were geared towards their 
own commercial considerations rather than the impact of possible disruptions 
potentially causing shortages. Participants expressed the disconnect in the following 
ways: 
“One of our big challenges is the combination of people [suppliers] not telling us 
that they are going to have problems, to companies not giving us advanced 
warning or not giving us enough warning, so that the shortage has already 
happened and so there is not much that can be done in an effective manner. 
So, there is an element about things that go wrong in the supply chain that you 
cannot really be prepared for, there is a kind of, not talking across the board, 
but there is a kind of efficiency challenge with companies themselves where 
they are not holding months’ worth of stock, where there is this almost ‘just in 
time’ manufacturing process, where orders are placed months in advance, and 
so orders arrive that is just enough for the UK. There does not seem to be a lot 
of in-house buffering that is around.” (Participant B1) 
 
A variety of specific examples were given to corroborate the focus groups' participants' 
comments on the supplier issues, including medicine type, for example: 
“We had a shortage recently of an oncology drug, Bleomycin, that was ordered. 
Whenever it did arrive in the UK, one of the potency tests just wasn’t coming up 
to what it should have been according to the product licence, so they had to do 
more testing which was another three or four weeks, and there was just nothing 
the company could do to help. They had only just ordered enough for the UK 
supply and then the manufacture in Japan had a three to four month lead time, 
so I think there is a big combination of things going wrong and there is not a lot 
we can do to respond to it quickly. There is also just a combination of 
companies just not telling us when things are going to go wrong; they are not 
giving us enough notice, so that is one of our big challenges.” (Participant B1) 
 
Many of the participants noted that the shortages caused by the disruptions resulted in 
a lot of extra resources, work, and time: 
 




“Within every trust, there is someone who is almost full-time sorting out 
shortages and making stock available, usually the lead pharmacist." 
(Participant A2) 
On top of the additional drain on resources, a common theme throughout was the 
escalating number of shortage incidences, as well as broader product scope across 
the board from disruptions, which has resulted in both buffering and bridging actions to 
cope: 
“I think the number of shortages we have seen over the last 12 months is 
significantly more than we have seen in the previous decade.”  (Participant A3) 
“For example, dermatological treatments and ointments, that does not seem to 
be a problem in the past, a lot of those we have had problems with in the last 
12 months. We have had to change what we are actually supplying.” 
(Participant C3) 
After the introduction topic of supply chain shortages as a whole, the next topic 
considered was the concept of supply chain disruption orientation to try and 
understand the practitioner’s perspective and to give further insights. 
 
5.9.2 Supply chain disruption orientation 
There was an indication from the groups that each hospital did not react in the same 
way to supply chain disruptions of medicines so an acknowledgement of the supply 
chain disruption orientation concept, one participant mentioned: 
“There are definitely in-house mechanisms that hospitals have built up 
themselves that seem to work really well. Yes, I think hospitals are different in 
the way they respond to it.” (Participant B1) 
 
However, it was not simply that different hospitals were following different written 
procedures, as one participant noted: 
 
“You can kind of tell during a big shortage because some regions we will get a 
lot of noise from and other regions you won’t hear a thing and you know it’s not 
because that region has got more product than the other because there is 
none, so I think it is safe to assume that some are managing the situation better 
or they have the infrastructure in place to know what to do when there isn’t 




So, the actual management of the shortage by hospital units was important in the 
outcome; it was not solely down to something physically available. As another 
contributor commented: 
 
“[Every shortage] has individual circumstances and that’s why it’s really difficult 
to fix because they are all different and they all have different causes, they 
have different effects, and therefore they have different answers, so you can’t 
generalise the response. You have to react.” (Participant A2) 
 
It’s that response reaction which is the essence of the supply chain disruption 
orientation concept. Bode, Wagner, Petersen et al. (2011) explained that supply chain 
disruption orientation is the zeal to learn and dynamic awareness, these sentiments 
were echoed by some of the focus groups' participants', with one commenting on 
coping post disruption: 
“…become quite good at it, in terms of learning in becoming agile and learning 
and where to go to ask for help, they will bend over backwards to do it.” 
(Participant F2) 
It was also then managers with high supply chain disruption orientation who had 
knowledge of where to go for the ‘right’ information. There was an observation of the 
seriousness towards disruption management and the recognition of the opportunity to 
learn:   
“They do think now that a way to potentially manage it is to share the problem 
with their colleagues within their region and include the regional pharmacy 
specialist in their region to see if we have any more information than they 
currently have. And that has been a learning curve process, that is more 
mature in some regions than it is in others.” (Participant C2) 
There was a consensus throughout the focus that not everyone was performing to the 
same level. The question was raised in the deliberation with regards to their disruption 
orientation. This lead on to discussion about whether supply chain disruption 
orientation affects performance and there was a recognition that it did. This led to 
further tangent discussion as to whether it was a particular individual that was 
responsible or a whole team or organisation: 
“I think there are particularly good individuals but I don’t think it's an 
organisational thing, I think it's an individual thing.” (Participant C2) 
Units that use information to influence their environment and that behave proactively 
and assertively so are active rather than passive, as described by Daft and Weick 
(1984), and show a stronger supply chain disruption orientation. This was confirmed in 
the focus groups, with one participant stating:  
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“[The] key thing for me is the communication, once we are aware of what that 
shortage is, what is that initial pathway, and take some leadership on it.” 
(Participant E3) 
 
Again, this points back to the Word Cloud, figure 30 where communication was a 
dominant theme, further supported by participant comments supporting a propensity to 
take quick command of the situation and then act. The different actions taken by the 
actors in hospitals and trusts post disruption were discussed in the next section topic: 
buffering and bridging actions. 
5.9.3 Buffering and bridging actions 
The focus group participants understood and were acquainted with the different 
response actions of buffering and bridging. The reasons why they made those 
decisions was also evident in some of their responses. Information and change were 
key factors mentioned, as highlighted in the Word Cloud, and one contributor 
mentioned: 
“We do use information and data to base a lot of our decisions on but it does 
carry a risk in that the changing environment in which medicines are moved 
around the supply chain does put that at risk to some extent. Certainly, it is 
recognised that there has to be some sort of consistency in terms of the IT 
systems which are used, but the difficulty is you have got so many different 
stakeholders in the system. You have got the DH, you have got CMU, you have 
got the NHS, you have got individual suppliers, you have got third party 
outsource providers all having different IT systems to somehow bring and 
consolidate all of this together to allow information to flow more freely, which is 
what everybody is wanting, but it is just a matter of getting everybody around 
the table, therein lies the biggest challenge of all.” (Participant A1) 
 
So, although decisions were based on information, that information was not uniform or 
consistent, with stakeholder dynamics being an influence. The changing environment 
leading to communication difficulties hampering decisions was also highlighted: 
“Communication issues with a supplier, so you will be told one thing by one part 
of the company and another by another. The other thing that we find, because 
of the way the market works at the moment, is that suppliers are constantly 
changing names or they are merging their divesting products. There seems to 
be a lot of changes within companies, you lost the sort of corporate knowledge 
and contacts, and it is only when there is an issue that you re-establish those 
relationships then it's almost too late.” (Participant A3) 
 
It was pointed out by the focus groups that there was a commercial and cost element 
to the supply decision dynamic to add to the regulatory and organisational challenges 




“For those medicines which have a framework agreement within England, if a 
hospital cannot procure a medicine within 14 days sitting on their shelves, they 
have recourse to source that product from elsewhere from an alternative 
supplier, potentially at list price and then the awarded supplier will have to 
reimburse the difference between the contracted price and the list price of the 
competitor products. So, an individual supplier can stand to lose a substantial 
amount of product within a given amount of time. Now that punitive measure 
can vary from one market to another, but it is the case in the UK that if a 
contracted supplier cannot supply within 14 days of a hospital placing an order, 
they can seek compensation if they have to source an alternative supplier, so it 
can be both a carrot and a stick.” (Participant A1)  
 
Buffering actions were well used, however, there was not a straightforward rationale: 
 
“We all have strategies to build up extra products.” (Participant B4)  
However, even if a buffering response was put in place, some hospitals have limited 
physical space. Participant B1 gave one example of the consequences: 
“You had difficulties at St. Thomas’ [Hospital], you had some stock at which you 
had built up, but the problem is people don’t understand the number of lines a 
hospital pharmacy can hold, so it’s much higher; it's typically 2,000, 3,000 lines, 
so if you run down one of those it can become critical as soon as you can’t get 
it.” (Participant B1) 
So there exists a restriction to the response action on buffering in the pharmaceutical 
supply chain, which has an effect on the decision post disruption, and as such to an 
extent, the interplay potentially between the buffering and bridging decision. However, 
the bridging decision itself also has restrictions at the local level: 
“Bridging is difficult because the personnel within the organisation changes so 
rapidly, so there is a little bit of that, the Department of Health have asked that 
there be somebody in each company [supplier] who is responsible for 
shortages, and they have that named person, and really that’s it and that just 
shows how ridiculous it was before.” (Participant B1) 
So, neither the buffering nor the bridging options for a response decision is an easy 
one, it was evident from the focus groups, and there are restrictions and challenges 
with both. However, all groups recognised, as stated previously, that both of these 
actions were taken, whether that was separately, together, or in changing 
combinations.  
There was also a conflict between which choice to take from a macro policy 
perspective, for example, the Carter Report. There were also seasonal elements to 
take into consideration:  
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“So, what’s happening is this dichotomy situation where we are taught to 
manage our stocks to a minimum but that doesn’t support having extra stock 
just in case.” (Participant B3) 
“There is a bit of an artificial effect at Christmas when we buffer, when we tend 
to hold more.” (Participant B10) 
“And if you use French [suppliers], August.” (Participant B10) 
Buffering actions were used in both a hedging response to buy time to see if the 
medicine in shortage would come back into supply but also as an emergency response 
reflex, as Participant C2 commented regarding drawing back stock from wards: 
“Particularly where there’s more than one indication for a medication, there’s a 
critical indication that you keep the medication for that indication, so it does get 
used so you don’t lose a patient or if you were desperate.” (Participant C2) 
The dynamic nature of decision-making post disruption in shortage management was 
evident throughout the focus groups with regards to buffering and bridging, as the 
below extract highlights: 
“They do change their actions depending on how long it goes on for. Only so 
much that, I mean quite often we would look to specialist pharmaceutical 
industries to supply an unlicensed version of the product [that] can be sourced 
from abroad, where there is no other licensed alternative available in the 
country, and feedback from them is that in many shortage situations they won’t 
get any queries from trusts, or get any interest in using the unlicensed product. 
Which suggests trusts are managing with stocks they have, whether that be 
from a stockpile or from across the region; they are sharing but then every 
shortage sort of goes on. If it is prolonged, they then try to dip into the 
unlicensed source, yes. We then hear we are getting a lot of demand for 
finished stock. That is the type of action which is dynamic, which is anecdotal 
from the suppliers.” (Participant A3) 
 
Unlicensed products are only allowed to be used in secondary acute care when the 
licensed product is not available, both actions are buffering by either stockpiling or by 
reaching out for alternatives, but the decisions are taken at different times subject to 
the circumstances that are changing over time. 
 
Having both the technical expertise but also the awareness of the urgency of the 
situation is crucial: 
“Each hospital will have different degrees of resilience in how they deal with 
disruptions and supply issues, just to supply a bit of context to all of this. It 
certainly is important that whoever deals in shortages has some appreciation 





Again, there was an acknowledgement of the variation of performance and attributes of 
each hospital and trust throughout the focus groups. Considering the effects that 
performance has and the time element in the dynamic action process, the next topic 
looks at Feedback and Dynamics.  
5.9.4 Feedback and Dynamics 
There was consistent input from the groups on feedback and dynamics in the 
management decision processes, with a constant back and forth between the frontline 
pharmacy leads procuring and supplying, and the clinical staff prescribing and 
administering.  
Changing actions over time and an agility to do that was a consistent theme: 
“I think the forecasted length of the shortage and what that's going to be tends 
to change very quickly. So initially you might be told that it's only going to last a 
week but then that stretches to a month and that carries on, so you have to 
adjust your behaviours and actions to that.” (Participant B5) 
“We have already said that people are very good at this, that every shortage is 
different and if every shortage is different then it always morphs over time as 
well. For example, you might be bridging then that product goes out of stock 
and you get a ripple effect where successive products go out of stock so you 
have to keep changing your strategy.” (Participant B2) 
The dynamic actions translate both at a unit level and a national level, according to 
participants: 
“We do have examples where, because we know the shortage of a particular 
drug, that it is going to be an ongoing lengthy problem we come up with criteria 
as to the order of which patient’s medicines should be kept up. So, we look at 
the different indications that the medicines can be used for and tend to rank 
these as to which patient to provide for, and we have had examples where we 
have had to micromanage the supply chain. For example, trusts with cardiac 
surgery, patients will be issued a specific medicine because the other 
indications can be treated with other products, so it's almost like keeping the 
limited resource to the most critical patients so we have had examples of 
having had to do that. And that would be done nationally in collaboration with 
the drug companies.” (Participant B3) 
“But it is also done locally. Trusts can do a similar thing.” (Participant B10) 
Interestingly, as per the attributes of supply chain disruption orientation, there was an 
appreciation by the groups of the self-learning process on shortage management 
actions:  
“You might do that slowly at first, but if that product becomes short again the 
next time round you would have learnt from that process and can intervene 
much earlier.” (Participant B4) 
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“So, you’re learning from yourself.” (Participant B10) 
Regular and ongoing feedback from the clinicians was a key driver to the decision-
making process. The constant understanding at any one time of how the patient was 
doing and what was needed to treat them motivated action to perform to a higher 
standard. As one contributor said: 
“[The] feedback you get is pretty black and white, and if you do not do a good 
job then you get the negative feedback.” (Participant B2) 
High in the minds of the actors procuring the medicines was the feedback:  
“Could the patient be treated or not treated.” (Participant B3 and others) 
The form of the feedback that drove the reaction and led to the highest performance 
was as follows: 
“The most effective feedback is only from the end users [clinicians], whether 
they are happy or not.” (Participant C1) 
“At the end of the day, we get feedback from the end user, and it will be 
negative feedback if we don’t supply that drug.” (Participant C3) 
“You may get initial feedback, ‘Thanks for providing an alternative.’” (Participant 
C6) 
So, the ‘ward’ feedback was the predominant driver and source of pressure, be it 
mainly negative if the drugs weren’t available but also positive if the drug shortage was 
relieved, either by an alternative or by the availability of the drug delivered exactly as 
prescribed. What the pharmacy procurement and supply actors were looking to avoid 
was not being able to supply a critical drug and that having a negative patient outcome, 
which would result in them having to complete an incidence report in the software 
system, for example, Datex. That report would then have to be investigated and 
hopefully closed. Certain cases would have to be reported nationally, for example, if 
the incidence resulted in the death of a patient and would be reported in the National 
Report and Learning System (NRLS). 
The next topic discussed with the three focus groups was the size of the trust, 
specifically the number of hospitals, and the role of the actor making the post 
disruption decisions.   
5.9.5 Size and role 
There was a mixed reaction from the focus groups of the topics of size and role with 
regards to post disruption actions by managers, with some seeing a connection but 
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others not. However, there was an appreciation of speed of action when competing for 
a limited resource as a crucial factor: 
“First come first serve really, if you are at the front of the queue and if you are 
the last one.” (Participant C2) 
“But I haven’t had experience of biggest and loudest will always get what they 
need.” (Participant C1) 
However, as per the above comment by Participant C1, the highest performance in the 
management of a particular shortage was not simply a case of the law of the jungle. 
There were other factors involved, such as resources and aptitude: 
“It might be a case of resource, so larger organisations may have a resource 
dedicated to shortage management.” (Participant B5) 
“On the flip side, smaller organisations can be a bit more agile in their 
response. In terms of their role, sometimes you have to involve different roles to 
adjust choices of drug, depending on what shortage there is.” (Participant B5) 
Clearly, it was not merely the level of the role of the actor involved but also a 
requirement that a combination of actors might be required if a team approach was 
necessary. This team or group involvement, rather than size, was similarly echoed by 
Participant B4: 
“I don’t think it is particularly related to size though, because I see examples of 
large trusts where they don’t really do anything around, like, chase end 
products and a similarly sized trust that gives you regular updates on [the 
shortage]. It could be varied in terms of people and management, and some 
people just put a lot more effort into it.” (Participant B4) 
The recent development of a roles matrix highlighted the cross functionality of many 
roles, with a diversity of titles and functions often masking the true nature of the work 
the individual was tasked to do beyond their job description (see Appendix 3; NHS 
pharmacist roles matrix). This matrix shows 12 separate roles, with 12 different grades, 
with six main skillset categories with 20 class levels. 
The local management and the awareness of the disruption impacts can vary 
depending on the size of the trust and number of hospitals in it. However, larger trusts 
are not necessarily always positive regarding shortages: 
“I was at St. Thomas’ and one of the senior guys wanted to scrap our chasing 
orders guys to redeploy them to another hospital, and it was colossal the 
amount of orders they were chasing. It was thousands even that they were 
having to intervene on. And it was just a management lack of understanding 
that this was a critical service, I think that's how they view it. Some trusts can 
view it differently. But like in a small trust you can walk down the corridor and 
speak to M.I. [Medicines Information], 'Can we just use this product?' And down 
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the corridor to Q.A. [Quality Assessment], get it assessed really quickly, 
compared to it would take you two or three weeks in St Guy's.” (Participant B6) 
Issues on size and role were debated but no consistent answers were given, with 
many participants giving both sides of the argument: 
“If you work in a hospital trust and you've just got more experience in those 
types of things, it does afford that you are going to be more flexible and nimble 
in your approach in dealing with a supply issue. Whereas if you are part of a 
much larger institution made up by a number of hospital trusts, there is a 
possibility that it could be more cumbersome in reaching consensus between a 
group with a greater number of stakeholders within your hospital little patch or 
region to get a feel of which direction one should take in managing a shortage, 
i.e., what sort of clinical alternative might be appropriate. So, you might end up 
with a lot more feedback but it may not always be consistent, with a lot of 
clinicians all telling you different things, whereas if you are in a standalone 
hospital you may just have a single clinician, and you can act upon the single 
advice they have given. It could work both ways, to be honest.” (Participant A1) 
 
However, the larger hospitals may be more likely to bridge due to corporate policies, as 
described in the research by Fennell and Alexander (1987). 
 
On the role, the discussions were predominately around the level of knowledge of 
pharmaceuticals, as in hospitals the supply of medicines also sometimes involves non-
pharmaceutically trained staff, the inference being that without an awareness of the 
impact of the shortage on the actual patient, incorrect/poor decision actions would be 
taken. It was cited by one participant that the role does have an impact on the shortage 
management performance, which may only be evident after that particular person had 
left the hospital: 
 
“There is a teaching hospital close to here, a lady called Sue and she was a 
very experienced pharmacist and contributed all sorts of things to procurement, 
but she has never really been replaced and is one of the ones that contacts me 
and says, 'What do I do?'” (Participant B2) 
The regional specialists that interacted with each of the trusts and hospitals in their 
region described how they could monitor the reaction of each of the managers 
responsible for the shortages in their hospitals by their interaction with them, for 
example, when they were receiving a lot of potentially unnecessary requests on an 
uninformed nature, it gave them insights into how the hospital or trusts were likely to 
perform.   
The last topic for discussion by the focus groups was the shortage management 
performance of the actors responsible for taking post disruption decisions. 
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5.9.6 Shortage management performance 
The focus groups highlighted a number of factors around the performance in shortage 
management, and, as brought to the fore later in the data analysis section 6.1.2, word 
cloud in Figure 41, information and by extension how you interpret and use that 
information is an important factor.  Where the level of movement away from the 
acceptable level of drug supply to patient is a deviation from what the unit deems as 
acceptable, they will act appropriately as described in the information processing 
theory (Daft and Weick, 1984, Kiesler and Sproull, 1982). As highlighted by one 
participant, the information that is received is not always consistent, and so having the 
correct orientation and aptitude in deciphering helps in performance management: 
“If we get regular information from suppliers and they might tell us there is a 
potential we might have an issue six months down the line, that is all well and 
good, the difficulty is how do we use that information to help me to gauge a 
disruption, knowing that disruptions are a movable feast. It is not unheard of 
where we get told by suppliers that they are not going to get any stock for the 
next six months and only three months later for a shedload of stock to arrive. 
And it is how do you use that information to help mitigate these issues.” 
(Participant A1) 
 
Additionally, the reliance of accurate and good quality information was noted as a 
limiting component on performance: 
 
“I think our performance is very determined [and] driven by the information we 
are able to get hold of from the suppliers. We do share information, both on 
contract and non-contract lines, with some of the other devolved 
administrations but we are very reliant on the information we get out from the 
company that has the shortage, and as colleagues have said, the estimated 
time of arrival of stock on a lot of occasions lose, to put it bluntly. So, it is very 
hard then to manage that shortage again with clinical colleagues in making 
short-term decisions and longer term decisions on how you are going to 
manage that population patient group that is exposed to that shortage if you are 
not confident on the robustness of the information you're receiving.” (Participant 
C1) 
Constructive and cooperation were two of the key words picked out by the Word Cloud. 
Suppliers, as part of the bridging strategies used, have an influence on shortage 
performance, with one participant stating: 
“So, the mood music that we like to give out when we hold out our olive branch 





What was apparent from the focus groups was that there were a lot of shortages 
happening and that generated a lot of information and communication. To quantify that, 
an example was given: 
“We did a tally count and we were getting in the region of 500 different 
notifications [of shortages] every other week, so every roughly two weeks, and 
it was roughly 500 different notifications of different products that there is a 
supply issue with.” (Participant A3) 
 
Despite this recognition of high shortage incidence, there was not a definite process of 
measuring how different units perform nationally. This was due to many factors, not 
least of which was how to define the shortage, and also the sheer scale of the task to 
get agreement of the required metric or set of metrics. As one group member 
mentioned: 
 
“So, we don’t have a formalised process or metric to measure would be the 
best statement for that.” (Participant B3) 
There were discussions, however, on this subject, previously including a measure of 
frequency on the contracted medicines: 
“We were hoping that the contract log, every time you intervened regardless of 
whether you claimed or not, could be used as a measure.” (Participant B5) 
Other comments on the measurements to monitor shortages included: 
“We don’t even have a system of grading how severe a shortage is because we 
can’t define it, so we can’t even say its red, amber, green.” (Participant B3) 
“Because what might be a red for you, two trusts along the road is a green 
because they use a different wholesaler. Also, it depends whether it’s being 
managed regionally, nationally, who's involved, how it was discovered. There 
are an awful lot of variables and we haven’t defined them as a single metric and 
haven’t got the time to do it.” (Participant B5) 
What was clear from the focus groups was that it was easier to see what was actually 
in shortage, for example, than why it was in shortage. One participant commented 
regarding the IT system they were using to manage the stock: 
“In terms of managing shortages and managing our own performance, it is 
more subjective than objective really. But, as it is showing ‘out of stock’, you 
haven’t been able to supply something.  Therefore, the item is ‘to follow’. It 
could be down to our poor procurement or the wholesaler’s failure to supply, it 
can be quite difficult to identify what's causing the shortage." (Participant C3) 
The learning curve that the shortage management environment forces onto the units 
did give the managers in the focus groups insights into the best way to manage the 
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shortages but this was not a documented process. As previously described by 
research into supply chain management by Peck (2006), unless managers do learn 





In summary, Chapter 5 provides the data collection and presents the desk research 
and the response rates for both the qualitative and quantitative techniques and 
procedures used, including the first and second round coding of the interviews and the 
findings from the focus groups conducted. Chapter 6 takes the next step in the 
research process, moving on from the data collection and descriptive phase, into the 
















6 Data Analysis 
 
The purpose of this chapter is to analyse, interpret, and synthesise findings from this 
research. The research used different methods of enquiry to collect both quantitative 
data using a survey instrument and qualitative data by conducting in-depth interviews 
and focus group discussions. To explain the data analysis and, following on from the 
descriptive data collection and presentation in the previous chapter, Chapter 6 is 
separated into two main subsections. The first, 6.1, is the qualitative data analysis, 
including the interviews and focus groups research. The second subsection, 6.2 
onwards, is the quantitative data analysis. Appendices 4 and 5 include the summary of 
the quantitative analysis (Table 37) and the condensed list of the diagnostic test tables, 
respectively. 
Section 6.1 analyses the data from the qualitative enquiry, and 6.2 onwards analyses 
the data from the quantitative enquiry, and the last section 6.7 includes the cross-
cutting analysis, bringing together both the qualitative and quantitative analyses 
proposition by proposition to synthesise and triangulate the analysis, leading to further 
and more in-depth discussion in Chapter 7. 
6.1 Data Analysis of the Qualitative  
 
6.1.1 Interviews 
The qualitative descriptions of the enquiries used to collect the data are shown in 
Chapter 5, which were respectively the semi-structured interviews and the focus 
groups. To look at the interrelationships between the variables, the content matrix was 







Table 11. Case by case variable matrix 
This matrix allows the researcher to examine each case against the variable, and then 
examine the variables against each other. A variable by variable matrix by case 
enables the exploration of the interaction and interplay between multiple pairs and sets 
of variables to see whether they apply to selected cases and then to groups of cases. It 
is descriptive ordering, exploratory, and explanatory. As noted by Miles, Huberman and 
Saldana (2014), it matches cases with several variables to encourage the researcher 
to explain why the interrelationship is suggested in the matrix. This presentation 
method was used as it gives a clear path from one variable set to another and to assist 
the navigation through the depth of the data. Miles (1979) has described qualitative 
data as an ‘attractive nuisance’ because of the attractiveness of its richness but the 
difficulty of finding analytic paths through that richness. 
From the variable by variable matrix, it was feasible to draw the possible 
interrelationships and relate them back to the propositions in the research to evaluate 
them. The values in Table 11 were placed from the variable matrix into a pivot table, 
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ordering each case by value, before being compared and considered in relation to the 
research's propositions. 
 
Figure 32. Buffering and bridging response action against performance 
Figure 32 displays the interaction between buffering and bridging actions (from the 
response action column) against the performance of the cases. 
It shows the average of the performance score in shortage management in general 
and also by performance against patient impact. As can be seen in Figure 18 where 
actions of buffering and bridging were both taken in response to a shortage, the 
response action was most effective, the next best response action was for bridging 
action alone and, lastly, the buffering alone had the lowest response action. In 
summary, both buffering and bridging averaged 8.2 for performance (from a possible 
score of 10) for shortage management and 8.0 for performance patient, with 50% of 





Figure 33. Dynamic response action against performance  
Figure 33 displays the dynamic response and performance of the variables. The 
average of 'regular dynamic' and 'always dynamic' was 8.3 for performance shortage 
management and 8.1 for performance patient, with 55.6% of the cases having the 
regular dynamic response action. 
After considering the dynamic response and performance interrelationship shown in 
Figure 33, the next relationship analysed was that between the summary of the advice 
on shortage management given by the interviewees and the performance achieved. 







Figure 34. Advice and performance on shortages 
Figure 34 shows that vigilant orientation averaged 8.0 out of 10 for performance 
shortage and 8.2 for performance patient. Knowledge scored poorest of the advice 
given, whereas feedback, information, and communication all scored an average of 7.0 
out of 10 against performance. 








Figure 35. Feedback against performance in shortage management 
Over half of the cases, 66.7%, gave really good feedback that averaged 8.3 for 
performance shortage and 8.2 for performance patient. From the interviews conducted, 
it shows a very strong relationship between good feedback and performance and, 
conversely, poorer performance for limited or no feedback actions. 
The variable of the role against shortage performance is interpreted in Figure 36. 
 
 
Figure 36. Role against performance in shortage management 
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The head of pharmacy achieved scores of 8.8 out of 10 for performance shortage and 
8.3 for performance patient. This senior role, however, is contrasted by the less 
qualified role of pharmacy technician, which respectively was the lowest scorer, 
achieving 6.00 for both performance shortage and performance patient. 
6.1.2 Focus groups 
Section 6.1.2 gives a summary of the focus group findings, which are then examined in 
a deeper analysis proposition by proposition in the cross-cutting analysis in Section 
6.6. 
The focus groups produced a considerable amount of information for the research and 
were devised to reflect the extension of the framework theory (Bode, Wagner, 
Petersen et al., 2011), which itself was underpinned by two theories; the information 
processing theory (Galbraithe, 1977) and the resource dependency theory (Pfeffer and 
Salancik, 1978). This research study used three main constructs: supply chain 
disruption orientation, supply chain disruption performance, and organisational 
response. Under these three themes, a further nine propositions were produced to 
answer the research question. The focus groups' six topics were designed to contribute 
to this challenge. 
Firstly, to consider the context of the broader phenomena, the current shortage 
challenges in medicine shortage management post disruption incident were discussed 
with every group. Each of the focus groups had their own different perspectives on the 
current shortage situations, but all were in general agreement as to the growth and the 
real practical problems it presented to them and their respective teams on a daily 
basis. Figure 37 is a word cloud generated by the NVivo software and drawn from all 
the responses to the first topic in the focus groups: current shortage challenges. It is 
from all the groups based on the 100 most frequent words used. As well as the central 
phrase ‘just stock shortage’ which sums up the current situation as outlined by the 
groups, supplier issues, manufacturing, market, regulatory, and policy challenges are 





Figure 37. Current shortage challenges 
The focus groups identified and articulated many of the causes of disruptions in 
concert with those identified in the literature review, including regulatory, policy, quality, 
commercial manufacturing, and elongated global supply chains and just in time 
practices. 
Just in time (JIT) practices, it was observed by the groups, have exacerbated an 
already overextended pharmaceutical supply chain. Bridging actions have been used 
to alleviate some of these challenges in response to disruptions, which are not new to 
supply chain practice and theory. Kelle and Miller (1998) also suggest that during the 
transition from a traditional to JIT purchasing system, the purchaser tries to co-operate 
with the vendor with the goal of receiving smaller, more frequent deliveries on time that 
are received with the quality and quantity required. The other side of the coin, however, 
was observed by the focus groups and highlights the problems associated with just in 
time purchasing. As Ansari and Modarress (1986) suggest, the major problems of JIT 
sourcing include: lack of support from suppliers, top management and carrier 
companies, low product quality, and lack of communication. Some of these issues 
were evident in the comments by the focus groups. There were, according to the 




So, whilst the practices are becoming more aligned with JIT principles, the outputs are 
not as productive as potentially anticipated in the face of ongoing disruption 
environments. Although other benefits have been identified within the research 
literature, such as improved relationships with suppliers and improved customer 
service (Yasin and Wafa, 1996), this paradigm was challenged by the focus group 
research commentary.    
The supply chain disruption orientation topic attracted considerable comment, with the 
main thrust of the contributions being that each hospital, trust, and region has its own 
profile, and hence orientation would affect its performance in the management of 
shortages. This topic addressed directly propositions P1a, 1Pc, and P1d under the 
supply chain disruption orientation construct. However, considerable restrictions to the 
management options existed internally and externally. Information and communication 
were both identified as key factors in levels of supply chain orientation from the focus 
groups responses. As shown in the below Figure 38, drawn from topic two, supply 
chain disruption orientation for all the focus groups.  
 
Figure 38. Supply chain disruption orientation 
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In Figure 38, the word cloud generated from the NVivo software, based on word 
frequency of the top 100 words displays a frequency on individual, unit, actions and 
regions, as well as organisations, knowledge and process. There was an 
acknowledgement by all focus groups that differences did exist in the orientation to 
supply chain disruptions. This was not an abstract concept but a real-life management 
phenomenon; a crucial factor and one that influenced success in disruption 
management.  
Change is a dominant theme in the above word cloud, communications was also 
shown in the top 100 words used although less common than change and further to 
the periphery of the word cloud. Both were response choices of the shortage managers 
post disruption with regards to whether to buffer or to bridge, which addressed 
propositions P2f and P2g.  Many group commentators confirmed that both were used 
in a dynamic way. Again, both action paths had challenges, both at internal and 
external levels. For example, conflicting health policy directives pulling actors in 
different directions. Although these phenomena could also be reflected in a private 
company, it’s important to understand the context of this research was conducted in a 
public health environment where the pressures of public scrutiny were evident. For 
example, where communication across various levels of the health service were 
restricted to reduce the possibility of not only internal panic buying, but so as not to 
overly concern the public where necessary. This was highlighted by the focus group 
discussion in the example of the critical Diamorphine shortage in December 2015: 
“One of the problems we have in managing shortages, and one of the reasons 
the Department of Health doesn’t pass everything on to the trusts immediately, 
not only in commercial and in confidence nature of the issue, but unfortunately 
some buyers, in their enthusiasm to protect patients locally, will buy up what 
little stock there is left in the system and make the shortage even more acute.” 
(Participant B4) 
So, in the focus groups, not only were conflicting policy issues discussed that had an 
effect on the choice spectrum, but the buffering and bridging choices they did make 
would have to be carefully considered to prevent knock-on effects, such as panic 
buying. So, decisions made at a local level could translate to a regional and national 
level and vice versa. 
In Figure 38, the query generated in NVivo software produced the following word cloud 






Figure 39. Buffering and Bridging 
The word cloud in Figure 39 shows focus on individual changes of both bridging and 
buffering within units at an organisational and regional level, and highlights the 
challenges of ‘right’ communication. It also highlights the importance of information, 
organisational knowledge, and the interaction of buffering and bridging actions in 
response to events. 
These challenges in free flow communication, however, bring with them the loss of fast 
and direct communication across departments, regions internally, and supplier 
externally. As noted in earlier research, such communication is a critical capability in 
developing and deploying possible mitigating solutions to disruptions (Chadist, 2012). 
Delay in cascading information through various levels of organisations can lead to 
potential miscommunication inherent in relayed communication, causing confusion and 
consequential performance. 
The next topic was feedback and dynamic, which focused on proposition P2e under 
the supply chain disruption performance construct, which is further explored in Figure 






Figure 40. Feedback and Dynamic 
The predominant words, excluding generalisations picked out by the Word Cloud 
query, are ‘change’ and ‘shortage’. Common to all focus groups was an agreement that 
the actions taken by post disruption managers were dynamic in nature, not static but 
rather constantly changing to the situation over time. By varying response actions over 
time, the consensus from the group discussions was that this would be the most 
effective approach, rather than choosing an action and sticking to it, irrespective of a 
change in circumstances. 
The feedback communication was also mentioned as a constant presence in the 
critical management of shortages from disruptions, with every focus group showing a 
high awareness of this. The team dynamic of this was important, with a successful 
team dynamic being described as having valuable feedback interaction from the 
clinical team prescribing the drugs for the patients on the hospital wards.  
Following on from the dynamic and feedback topic, the next topic considered by the 
focus groups was size and role. Under the supply chain disruption orientation 
construct, these topics were reflecting the questions in propositions P1c and P1b, 
respectively. This attracted a varied response from all the groups, with arguments 
given for the possible relationship between role, performance, and size (the number of 
hospitals per trust). 
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The one consistent throughout every focus group was that although both size and role 
did have an influence on the performance of post disruption shortage management, the 
strength and possible causation of that relationship and the direction was not simple to 
quantify. An independent, larger stream of research on cognitive biases in managerial 
decision-making has consistently demonstrated that managers are boundedly rational, 
not perfectly rational (Simon, 1979, Hammond, Keeney and Raiffa, 1998). They cope 
with decision-making complexity by using only a subset of the available information, 
leading to biases in a variety of decision-making contexts (Miller and Chen, 2004, 
Hilary and Menly, 2006, Smith and Winkler, 2006). 
 
Some participants noted that smaller institutions could be more agile, but it was 
dependent on the individual managers. Others pointed towards a team dynamic as a 
key factor, also the city versus provincial location of the trust affected the orientation of 
the team and its development. When presented with a selection of information on 
which to base decisions, it could be limited by the level of the role, however, managers 
made choices that they perceived were in the best interest of the patient at that given 
time according to their reading of the situation. This type of behaviour was also 
previously observed in an investigation of management belief structure, and it was 
highlighted that actors making decisions often demonstrate selectivity and selective 
perception when processing information (Walsh, 1988). 
The final topic of shortage management performance helped illuminate factors and 
influences on many of the propositions and constructs under examination in this 
research, and the focus groups' inputs were centred on the best response actions to 
mitigate the shortage impact on the patients in their hospital wards.  
The groups observed that their relationship with upstream and downstream actors is, 
by definition, one of the key control points in the medicine supply chain. The 
management of each external relationship during the response to a disruptive event 
takes on new priority, and new mechanisms may be established in the context of these 
relationships.  The challenge from a contractual perspective, however, was to: 
“Maintain a competitive market and also to maintain continuity of supply of 
medicines at the same time.” (Participant A1) 
 
This balancing act was itself a high ideal but the reality on the ground (as outlined in 
the focus groups) would often lead to disruptions as individual pharmaceutical vendor 
companies either could not or would not supply an in-demand product, thereby causing 
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a resultant disruption in supply and having a detrimental effect on the supply chain 
performance possibilities, despite the pharmacy procurement team’s best efforts. 
 
“So, you look at Pfizer, if you look at their innovative new medicines, they would 
kill their own grandmother before there was any supply chain disruption 
because in patents they are making a fortune. But in their legacy products, 
which are low value to them, they are not so interested. But you also get huge 
differences from company to company. Other companies like Glaxo 
[GlaxoSmithKline], for example, have invested a lot of time and money into their 
supply chain and generally.” (Participant B2)  
“But you do get companies, particularly generic companies where the margins 
are very low, so they do not invest in their supply chain at all, they will sell it 
when they have got it, when they haven’t got it they don’t see a moral 
separation." (Participant B3) 
The commercial interests of the pharmaceutical companies were an underlying theme 
of the focus groups' commentary, and informed the supply chain environment in which 
they were making decisions in response to disruptions. As highlighted by Lee (2004), 
cost efficiency comes with a huge hidden cost should a major disruption occur, and 
one must balance the notion of cost efficiency with agility, adaptability, and alignment. 
When considering response mitigation actions, the actors in the procurement of the 
medicines in the secondary care hospitals would be pushed potentially to buffer 
(through search for alternative suppliers) and then bridge (to work with the existing 
reliable suppliers) in a dynamic push-pull fashion to get the best outcome for the 
patients at that time. 
 
From the query run in the NVivo software, as shown in Figure 40, a word cloud was 







Figure 41. Shortage management performance 
 
From the word cloud output, as above in Figure 41, shortage and stock information 
from suppliers was described by all the focus groups as key. Despite the public health 
service environment, the pharmaceutical suppliers are commercial concerns, and the 
availability and accuracy of the data itself had an influence on management responses. 
The main themes from the word cloud query, as shown in Figure 41, in successfully 
managing the disruption response performance were feedback and response time, as 
well as systems management and contracts.  
 
Competitors who may play an adversarial role during routine business procedures can 
play a very different role in the risk response, where the event affects multiple supply 
chains and can put either the entire industry or downstream customers under stress. 
The nature of the relationship with competitors has both tactical (event response) and 
strategic (market-shaping) aspects in the events under study. Parallel to the shift from 
normal organisational design to crisis response within the organisation, the focus 
groups observed that most hospital pharmacies were in a permanent state of crisis 
response to disruptions. This is possibly not unique to the pharmacy environment but 
was observed in this research throughout the focus group discussions. This research 
finding echoes another recent drug shortage survey pointing to weaknesses in the 
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pharma industry supply chain management. In January 2017, the Pew Agency for 
Charitable Trusts and the International Society for Pharmaceutical Engineers (ISPE) 
released results of a 10-company survey on the reason for drug shortages. Surveyed 
pharmaceutical companies identified gaps within their supply chains, and many 
respondents said they did not implement best practices in supply chain management, 
such as maintaining back up supplies, sourcing from multiple suppliers, or increasing 
manufacturing shifts, in any standardised or consistent manner (PharmTech, 2017).  
 
6.2 Data Analysis of the Quantitative Survey 
 
The following sections lay out the data analysis of the quantitative survey, beginning 
with the data cleaning and recoding introduction, and then going on to give the 
descriptive statistics analysis for the main variables used in the analysis (6.2.1 to 
6.2.3); relevant contextual variables are then presented. This is followed by the 
normality tests used 6.2.5. Then the summary of the variables used in the analysis 6.3 
and the reliability analysis are presented.  
In addition, 6.4 lays out the justification and explanation of the analysis tests used 
which include the assumptions. Section 6.5 presents the findings and interpretations of 
the variable model tests used in the quantitative survey analysis.  
For clearer understanding of the variables and their summary descriptors used in the 
statistical analysis tables, the summary table of the variables in Table 15 explains the 
variable, dimension, question text and response categories.  
The data file was checked for data entry errors by running the range for each variable 
and checking that values were not outside the range of valid response categories. 
Missing values were defined in SPSS for each variable. Imputation was considered 
unnecessary due to the low level of missing data, which is shown in the tables of 
descriptive statistics for independent and dependent variables.  
6.2.1 Dependent variable  
The measures of performance used were the fill rate both immediate, up to 8 weeks 
after the disruption, and post, between 8-16 weeks after the disruption. This was ‘lines 
fulfilled immediately' (PERF1) and ‘lines fulfilled post’ (PERFPOST 1), and both of 
these are used as dependent variables in all of the regression analyses presented. 
Just under half of respondents (45%) had between 75%-100% of lines fulfilled 
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immediately (as shown in Figures 42 and 43) Looking at ‘post’ in Figure 43, the 
proportion who have 0-25% of lines fulfilled had increased (from 3% to 35%) and the 
proportion who have 51-75% of lines fulfilled had decreased from 36% to 8%. The 
analysis did not further investigate the types of medicines by performance as this was 
not the main focus of this study, but this could be included in future research. 
 


























Figure 44. Percentage of lines fulfilled – immediate and post (n=125) 
Figure 44 clearly summarises the differences between the immediate and post line fill 
rates, and further justifies the selection of both immediate and post measures rather 
than just one of the measures, as differences do exist.  
Supply chain disruption orientation (SCDO) average was the dependent variable in one 
query and an independent variable in other queries; the descriptive statistics for SCDO 
average are shown in Section 6.5.1 
 
6.2.2 Independent variables (nominal and ordinal)  
Bed numbers were used as a control variable in all of the regression analysis 
presented. Table 12 shows the descriptive variables in the analysis. Table 12 also 
includes whether the hospital was in a collaborative hub or federation, as well as the 
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N Valid 125 125 117 116 114 115 
Missing 0 0 8 9 11 10 
Median 2.0000 2.00 4.00 4.00 2.00 4.00 
Mode 2.00 1 5 4 2 4 
Variance .749 .759 1.951 .614 .252 1.033 
Range 3.00 3 4 4 1 3 
Minimum 1.00 1 1 1 1 1 
Maximum 4.00 4 5 5 2 4 
 
Table 12. Descriptive statistics for variables in the analysis (categorical) 
6.2.3 Independent variables  
 
                
Figure 45. Role of respondents 
The largest category in role of respondents was ‘other’ (38%) followed by pharmacist 
















Figure 46. Disruption severity   
For the disruption severity, only 5% of respondents said that the impact had been 
‘extreme’, as shown in Figure 46. However, more than half of respondents said that the 
disruption had had a strong impact highlighting its importance. 
Control variable  
The number of staffed beds served (bed numbers) was used as the control variable in 
the ordinal regression. The number of staffed beds is a key demographic used by both 
global organisations for example OECD (Boscheck, 1996) and local healthcare 
societies and national governments (Siska and Tribble, 2011). It has been used in 
previous shortage impact research in acute care hospitals (Baumer, 2004). In that 
study more, time was spent tracking shortages in hospitals with larger bed numbers for 
example, and more money was spent by larger bed hospitals than smaller bed number 
hospitals on obtaining alternative products of the same therapeutic class. The purpose 
of a control variable in regression is to hold constant the effect of some variable which 
is thought to affect the dependent variable and therefore to ‘control for’ the effect of 
that variable, making it easier to detect the effect of other independent variable, or 
variables, on the dependent variable. 


















Figure 47. Number of staffed beds in respondents’ hospitals   
 
 
Figure 48. Stand alone or part of a trust 
Just under half of respondents (47%) were from standalone hospitals, as shown in 
Figure 48, which along with 2-3 hospitals, formed the majority of the participants.  
6.2.4 Other contextual variables 
Figures 49 and 50 show whether the hospital is a hub or federation, and their hospital's 




Figure 49. Hospital group 
As shown in Figure 49, respondents’ hospitals were almost evenly split between those 
who were in collaborative hubs or federations and those who were not. 
 
Figure 50. Patient budget 
Just over half of respondents were in hospitals with a patient medication budget 
exceeding £10m as shown in Figure 50. 
Independent variables - continuous  
 
Descriptive statistics for continuous independent variables are presented in Table 13. 
All items were measured on five-point Likert scales, where a higher score represented 
a more positive attitude to the statement. All the items (apart from ‘vary response 
internally’ and ‘vary response time’) represent the mean of several items for a 
particular dimension. Means tended to be average or low (around or just above the 
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mid-point of the scale: 2.5). Means were notably higher for ‘vary response internally’ 
and ‘vary response time’. The two items with lowest means were ‘BUFPOST average’ 
and ‘BRI 1 to 7 average’. Standard deviations were low for most items (below a value 
of 1) suggesting low dispersion around the mean. The range was quite small on many 
items (between 2 and 4), again, suggesting that responses were not widely dispersed.  
 
 
Table 13. Descriptive statistics for variables in the analysis (continuous) 
6.2.5 Normality tests 
Normality tests showed, as presented in Table 14, that none of the continuous 
independent variables had a normal distribution (p<.05 on both Kolmogorov-Smirnov 
and Shapiro-Wilk tests). For most queries, this was not a limitation as ordinal 
regression does not require a normal distribution in the independent variable or 
dependent variable (Norusis, 2016). However, for one query, SCDO average was the 
dependent variable and, as it was not normally distributed, this meant that non–
parametric tests had to be used. The Kolmogorov-Smirnov test was selected for the 
test of normality with the Lilliefors correction for the fact that the mean and variance of 
the distribution are being estimated rather than being known. Normality is not a 
requirement for ordinal regression but it was needed to decide if parametric / non- 
parametric tests could be used with SCDO average. It is also a standard descriptive 
statistic to provide as it helps us to be aware of what tests might be valid for any 







Valid 125 119 122 125 125 124 125 125 125
Missing 0 6 3 0 0 1 0 0 0
3.1744 2.9748 3.1475 3.556 2.3659 2.2798 2.901 4.032 3.984
0.03808 0.1208 0.10961 0.02833 0.06227 0.06796 0.08368 0.07615 0.07001
3.1 3 3 3.6667 2.3333 2.1548 3 4 4
3 2.00
a 3 3.67 2.33 2 3.57 4 4
0.42576 1.31782 1.21064 0.31675 0.69622 0.75677 0.93552 0.85134 0.78272
0.181 1.737 1.466 0.1 0.485 0.573 0.875 0.725 0.613
-0.087 0.047 -0.089 -2.228 0.549 0.478 -0.463 -1.177 -0.792
0.217 0.222 0.219 0.217 0.217 0.217 0.217 0.217 0.217
-0.079 -1.122 -0.893 5.662 0.097 -0.314 -0.598 2.031 1.277
0.43 0.44 0.435 0.43 0.43 0.431 0.43 0.43 0.43
2 4 4 2 3.33 3.14 3.71 4 4
2 1 1 2.17 1 1 1 1 1
4 5 5 4.17 4.33 4.14 4.71 5 5
Minimum
Maximum
a.     Multiple modes exist. The smallest value is shown
b.     This is the dependent variable in one query but otherwise all are independent variables only
Variance
Skewness
Std. Error of 
Skewness
Kurtosis





























Tests of Normality 






SCDO_AVERAGE_NEW .089 118 .022 .976 118 .031 
FEEDBACK_REGMGR_NEW .165 118 .000 .906 118 .000 
FEEDBACK_REGOTHER_NE
W 
.158 118 .000 .913 118 .000 
BUF1to6_average .423 118 .000 .614 118 .000 
BUFPOST1to6_average .128 118 .000 .970 118 .010 
BRI1to7_average .108 118 .002 .969 118 .008 
BRIPOST1to7_AVG .100 118 .006 .952 118 .000 
Varyrespintern_NEW .330 118 .000 .788 118 .000 
Varyresptime_NEW .305 118 .000 .817 118 .000 
a. Lilliefors Significance Correction 
 
Table 14. Normality tests for variables in the analysis (continuous) 
In Table 14 the Lilliefors significance correction was used. This ‘correction’ is used to 
adjust the calculation of normality where no specific population mean or standard 
deviation is available (this applies in most cases as we usually do not know what the 
mean or SD of the population we are interested in, i.e. what we are comparing our 
sample to, and so we must use the mean and SD of the sample but this tends to 
overstate the normality of the distribution). If the Lilliefors correction was not applied, 
the calculation of normality would tend to be too ‘lenient’ and some distributions would 
be classified as normal when they were not normal (Internation Business Machines, 
2018).   
6.3 Summary of variables in the analysis  
 
The variables shown in Table 15 are the main variables used in the analysis, (table 










Q51. Of the medicine affected by the disruption, 
what was the percentage of the lines fulfilled 
during the period up to 8 weeks after the 
disruption first occurred? 
0-25% (1)  
26-50% (2)  




PERFPOST 1  Q52. What was the percentage of the lines fulfilled 
during the period 8 weeks to 16 weeks after the 
disruption first occurred?  
0-25% (1)  
26-50% (2)  











SCDO1 Q11. We feel the need to be alert for possible 
supply chain disruptions at all times. 
 
Strongly Disagree (1) 
Disagree (2) 
Neither agree nor 
disagree (3) 
Agree (4) 











SCDO  3 Q13. We recognise that supply chain disruptions 






SCDO  4  Q14. We think a lot about how a supply chain 






SCDO 5 Q15. After a supply chain disruption has occurred, 




 Mean of Feedbackremgr new + Feedbackre other 






Q16. We feedback performance data on the 
alternative response taken to our region. 
 
Strongly Disagree (1) 
Disagree (2) 
Neither agree nor 
disagree (3) 
Agree (4) 
Strongly agree (5) 
Feedback Feedback 
re other new 
 
Q17. We feedback performance data on the 
response alternative taken to all other SHA 
regions. 
 
Strongly Disagree (1) 
Disagree (2) 
Neither agree nor 
disagree (3) 
Agree (4) 






Mean of BRI 1 to 7 (see below)  
Bridging 
(immediate)  
BRI 1 Q37. Since the disruption, to what extent has your 
business unit pursued, or made plans to pursue 
the following 
activities? 
Never (1)  
Seldom (2)  
Sometimes (3)  
Often (4) 
Almost always (5) 
Bridging 
(immediate)  
BRI 2 Q.38. Since the disruption, to what extent has your 






BRI 3 Q39. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your 
business unit pursued, or made plans to pursue 




BRI 4 Q40. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your 











BRI 5 Q41. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your 






BRI 6 Q42. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your 






BRI 7 Q43. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your 






Mean of BRIPOST 1 to 7 (see below)  
Bridging (post) BRIPOST 1 Q44. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your 




Establish a closer relationship with this supplier in 
order to collaborate better in case of supply chain 
 
Never (1)  
Seldom (2)  
Sometimes (3)  
Often (4) 
Almost always (5)  
Bridging (post) BRIPOST 2 Q45. Tighten the control mechanisms on this 
supplier (e.g., more monitoring). 
As above 
Bridging (post) BRIPOST 3 Q46. Cooperate more intensively with this 
supplier. 
As above 
Bridging (post) BRIPOST 4 Q47. Improve information exchange with this 
supplier. 
As above 
Bridging (post) BRIPOST 5 Q48. Engage in risk management activities with 
this supplier (e.g. development of joint 
contingency plans). 
As above 
Bridging (post) BRIPOST 6 Q49. Developed inter-organisational relations 
within your SHA regional area 
As above 
Bridging (post) BRIPOST 7 Q50. Developed inter-organisational relations 






Mean of BUF 1 to 6 (below)   
Buffering  
(immediate) 
BUF 1  Q25. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your 




Make us more independent of this supplier or the 
purchased item. 
Never (1)  
Seldom (2)  
Sometimes (3)  
Often (4) 
Almost always (5) 
Buffering  
(immediate) 
BUF 2 Q26. Increase our protective barriers against 
disturbances in the supply of the purchased item. 
 
As above  
Buffering  
(immediate) 
BUF 3  Q27. Search for or develop one or more 
alternative supplier(s) for the purchased item. 
 
As above  
Buffering  
(immediate) 
BUF 4  Q28. Taken on extra staff or resources to cope 
with such disruptions. 
 
As above  
Buffering  
(immediate) 
BUF 5 Q29 Modified/developed policies (care 
plans/guidelines) 
 
As above  
Buffering  
(immediate) 
BUF 6 Q30. Purchased compounded replacement 
pharmaceuticals. 









Mean of BUFPOST 1 to 6 (see below)   
Buffering (post) BUFPOST 1  Q31. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your 




Make us more independent of this supplier or the 
purchased item. 
 
Never (1)  
Seldom (2)  
Sometimes (3)  
Often (4) 
Almost always (5) 
Buffering (post) BUFPOST 2  Q32. Increase our protective barriers against 
disturbances in the supply of the purchased item. 
 
As above  
Buffering (post) BUFPOST 3 Q33. Search for or develop one or more 
alternative supplier(s) for the purchased item. 
As above  
Buffering (post) BUFPOST 4  Q34. Taken on extra staff or resources to cope 
with such disruptions. 
As above  
Buffering (post) BUFPOST 5 Q35. Modified/developed policies (care 
plans/guidelines) 
As above  
Buffering (post) BUFPOST 6 Q36. Purchased compounded replacement 
pharmaceuticals. 
As above  
Response time  Varyresponsei
ntern  
 
Q18. We vary our response to disruptions 
depending on our business unit needs. 
 
Strongly Disagree (1) 
Disagree (2) 
Neither agree nor 
disagree (3) 
Agree (4) 
Strongly agree (5) 
Response time Vary 
responsetime  
 
Q19. We vary our response to disruptions 
depending on the length of time from initial 
occurrence. 
 
Strongly Disagree (1) 
Disagree (2) 
Neither agree nor 
disagree (3) 
Agree (4) 





Q10. Is your hospital a standalone institute or one 
of several in a trust? 
 
 
Standalone (1)  
2 to 3   (2)  
4 to 5   (3)  







Q23. What was the severity of the disruption? 
 
No impact (1) 
Slight impact (2)  
Moderate impact (3)  
Strong impact (4)  





Q3. What is the number of staffed beds you 
serve? 
 
No impact (1) 
Slight impact (2)  
Moderate impact (3)  
Strong impact (4)  
Extreme impact (5)  









Technician (2)  
Lead Procurement 
Pharmacist Regional (3)  
Pharmacist Specialist (4)  
Other (please specify) (5) 
 
Table 15. Summary of variables used in hypothesis testing 
217 
 
6.3.1 Reliability analysis 
Cronbach's alpha is a widely used measure of scale reliability (National Centre for 
Research Methods, 2016). Specifically, it is a measure of how closely related a set of 
items are as a group (i.e., internal consistency). A value for Alpha of 0.7 or above is 
widely considered as the ‘acceptable’ level. The internal consistency of a group of 
related items is particularly important where items are being aggregated or averaged, 
as they are in this analysis, so that the aggregated variable is a reasonable reflection 
of the components of which it is made.  
6.3.2 Cronbach's alpha 
Alpha was at acceptable levels for all averaged variables except for SCDO 1 to 5 vary 
response, and BUF 1 to 6, where alpha was lower than the commonly accepted 
threshold of 0.7; see Table 16 for value summary. It was not possible to improve alpha 
for SCDO 1 to 5 or vary response. There were no variables which, if deleted, would 
lead to a higher value of alpha. The alpha of BUF 1 to 6 could have been significantly 
improved to .704 by dropping BUF1, but it was considered more important to retain the 
item BUF1 (‘actions immediate independent of supplier/item’).  
Variables Cronbach's alpha 
SCDO 1 to 5 .585 
BUF 1 to 6 .528 
BUFPOST 1 to 6 .704 
BRI 1 to 7 .769 













Ordinal regression (also known as ordered logistic regression) was determined to be 
the most appropriate procedure for all but one of the hypotheses. This was because 
the aim was to look at the effect of a number of independent variables (both 
categorical, ordinal and continuous) on a dependent variable which, in all cases apart 
from one, was ordinal with four levels (Lines fulfilled Immediate - PERF1 in the data 
file, taken as a measure of performance). Multiple linear regression would not have 
been appropriate as this requires the dependent variables to be continuous (interval or 
ratio). Multinomial logistic regression would have been an option but this would have 
been less appropriate as it would not be sensitive to the ‘ordered’ nature of the 
dependent variable and so would have less chance of detecting a relationship between 
the independent variables and the dependent variable. For hypothesis number three 
where the dependent variable was continuous (SCDO average) and the independent 
variable (hospital numbers) was ordinal, it was decided to use one-way ANOVA, 
however, the assumptions of this parametric test were not met, so a non-parametric 
alternative (Kruskal Wallis test) was used instead.  
6.4.1 Assumptions of ordinal regression and associated diagnostic tests 
Independent variables in ordinal regression can be either categorical or continuous or 
a combination of both. The dependent variable must be ordinal; it consists of two or 
more categories which can be meaningfully placed in a hierarchy. Ordinal regression is 
non-parametric and does not assume a normal distribution of the dependent variable, 
the independent variables, or multivariate normality. 
6.4.2 Assumption of proportional odds  
The key assumption in ordinal regression is that the effects of independent variables 
are consistent or proportional across the different thresholds, hence the term 
'assumption of proportional odds' (National Centre for Research Methods, 2016). This 
assumption follows from a more basic assumption that, there is a latent continuous 
outcome variable and that the observed ordinal outcome arises from discretising the 
underlying continuum into J-ordered groups (Norusis, 2016). 
Whether these assumptions are met in SPSS or not can be determined through the 
test of parallel lines where the null hypothesis states that the location parameters 
(slope coefficients) are the same across response categories (i.e., that the assumption 
219 
 
of proportional odds is met). Therefore, p>.05, the test of parallel lines, retains this null 
hypothesis and signifies that the assumption of proportional odds has been met.  
The test of parallel lines is considered to be ‘anti-conservative’ (NCRM 2016), meaning 
that it tends to reject the null hypothesis too readily. It is sensitive to empty cells which 
are very likely to occur when using continuous variables (covariates) in the model. If 
the test is failed (i.e., p<.05), then alternative forms of regression with less restrictive 
assumptions can be considered (e.g., multinomial logistic regression) but for reasons 
stated previously, this is not ideal as multinomial logistic regression is not sensitive to 
the ordered effect in the dependent variable (UCLA, 2016). 
6.4.3 Goodness of fit 
Ordinal regression assumes that there is goodness of fit, namely Whether the 
observed data are consistent with the fitted model (NCRM 2016). SPSS provides a 
goodness of fit test consisting of Pearson's chi-square statistic for the model and a 
second chi-square statistic based on the deviance. The null hypothesis for the 
goodness of fit test is that the fit is good and, therefore, a non-significant result (p>.05) 
indicates that the null hypothesis can be accepted and there is a good fit. However, 
NCRM advise that the goodness of fit test is unreliable in models with a large number 
of categorical independent variables or with continuous independent variables because 
both of these scenarios often result in many empty cells in the analysis. NCRM (2016) 
suggest that, in such cases, one should refer to other indicators of whether the model 
is valid, such as a Pseudo R2 statistic (e.g., Nagelkerke). 
6.4.4 Assessing the effect of independent variables on the dependent variable 
Ordinal regression provides a parameter estimate for each independent variable in the 
model. Ordinal regression parameter estimates refer to 2 Log-likelihood of an increase 
of one level in the dependent variable for a one unit increase in the independent 
variable (for continuous variables) or compared to the reference category (for 
categorical variables). Taking the exponential of the estimate (which is in logits), allows 
an estimate of the actual increase or decrease in the probability of an increase of one 
level in the dependent variable for a one unit increase in the independent variable (for 
continuous variables), or compared to the reference category (for categorical variables) 
when all other independent variables in the model are held constant. This probability is 
known as the cumulative odds.   
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6.5 Findings and Interpretation of the survey data analysis 
 
This section of the quantitative analysis, presents the tests used for each of the nine 
propositions as first described in chapter 5. It begins with an overview of the range of 
the model tests outputs.  
Overview 
In this section, we present an overview of the various models which have been used in 
the analysis and identify which models appear to have the greatest predictive power for 
each of the dependent variables (performance immediate and performance post).  
There was a very considerable range of explanatory power amongst the models (see 
Appendix 4 for a detailed overview in the summary quantitative analysis table) both 
within each dependent variable (performance immediate and performance post) but 
the best models achieved quite impressive levels of Pseudo R2. For performance 
immediate (PERF1) the best models in terms of Pseudo R2 were model number 4 
(43%), model 2 (39.4%), and model 1 (36.6%). There is then a large drop in Pseudo R2 
to reach the next best model, model 5 with 25%, followed by model 8 with 12.6%, and 
model 6 with 10.2%. The remaining two models, 9 and 7, have Pseudo R2 of 8% and 
3.7% respectively. The significant independent variable in models 1 and 2 is SCDO 
independent variables are good predictors of performance immediate (PERF1). It is 
worth noting that while model 4 does show some improvement in Pseudo R2 over 
models 1 and 2, it is not a great amount and one might conclude, therefore, that SCDO  
With regards to performance post (PERFPOST 1), there is a similar range of Pseudo 
R2 amongst the models, with the highest being models 8, 7, and 5 with Pseudo R2 of 
48.4%, 44%, and 41.4%, respectively. There is then a large gap to the next best 
model, model 6 with 34% Pseudo R2, and then a further large gap to model 4 with 
17.4% Pseudo R2, followed by models 2, 1, and 9. This suggests that buffering, 
bridging, and feedback are key to predicting performance post (PERFPOST 1). 
It is very notable that the best models for predicting performance immediate tend to be 
very poor for predicting performance post and vice versa, suggesting that very different 
variables are important in understanding each of these types of performance. In 
summary, a number of models for each dependent variable have been identified which 




6.5.1 Supply chain disruption orientation and performance (1) 
Rationale for the analysis 
The aim was to investigate proposition P1a; whether the stronger the supply chain 
disruption orientation (SCDO) of a unit, the higher the performance in shortage 
management, as described in Chapter 3 under the supply chain disruption orientation 
construct.  
Descriptive statistics 
Descriptive statistics (comparison of means) shows that there is considerable variation 
in the mean of SCDO average according to the categories of the dependent variable 
(performance – lines fulfilled immediate), and that the relationship seems to be positive 
(SCDO means increase through the levels of performance) suggesting that there may 























Table 17. SCDO means by category of performance (immediate)  
The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis).  
Hypothesis/Proposition 
The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone).  
The results of the standard diagnostic test for ordinal regression are presented below. 
222 
 
Goodness of fit 
Since p>.05, we retain the null hypothesis that the model has goodness of fit, Table 18. 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 112.498 140 .958 
Deviance 102.228 140 .993 
 
Table 18. Goodness of fit (1) 
Parallel lines 
The test of parallel lines shows p>.05 and, therefore, we retain the null hypothesis that 
the slope coefficients are the same across response categories of the dependent 
variable, Table 19.  
Test of Parallel Linesa 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Null Hypothesis 147.517       
General 145.289b 2.229c 8 .973 
 
Table 19. Parallel lines (2) 
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model was statistically significant overall (p<.001). Therefore, the null hypothesis 






Intercept Only 197.135       
Final 147.517 49.618 4 .000 
Link function: Logit. 
 
Table 20. Significance (1) 
The various Pseudo R-Squared statistics attempt to emulate the function of R square 
in multiple linear regression but are not exactly equivalent, hence the term ‘Pseudo’. 
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The function is to estimate the amount of variance in the dependent variable which is 
explained by the model (i.e., the independent variables collectively). There is not 
complete consensus on which Pseudo R-Squared (PRS) statistic is the most valid and 
hence SPSS presents all three options, but it is known that the Cox and Snell statistic 
does not give a value of 1, even with a perfect model, and many researchers choose 
the Nagelkerke statistic which is what we shall use in this analysis (Norusis, 2016).  
In logistic or ordinal regression (which share an underlying logic), there is no R2 value 
per se as there is in multiple regression.  However, an assessment of the explanatory 
power of the model can be made by looking at the amount of variance which is 
unaccounted for by the model (the lower the unaccounted-for variance, the higher the 
explanatory power of the model and hence higher Pseudo R2  (Hu, Shao and Palta, 
2006). 
There are three estimates of Pseudo R2  (Cox Snell, Nagelkerke, Mc Fadden) provided 
by SPSS. There is also the Hosmer-Lemeshow but SPSS treats this is a test of 
goodness of fit rather than an attempt to provide a Pseudo r square. Nagelkerke is 
based on the same formula as Cox and Snell but rescaled to give a value between 0 
and 1. 
This is probably why Nagelkerke is most widely used, because it produces a result 
from 0 to 1 and so emulates the Pseudo R2 found in multiple linear regression (which is 
more familiar to most quantitative researchers than is ordinal regression which tends to 
be used relatively infrequently).  
Mc Fadden uses a slightly different formula (comparing a model with no predictors to 
the model with all the predictors in) and while it can in theory produce a zero value for 
R2 it can never produce a value of 1. It is argued by some that Mc Fadden is more 
accurate and that it would tend to give lower values than Negelkerke but there is no 
consensus amongst researchers about which form of pseudo r square is best (Alison, 
2013). As Laerd (2013) notes the three measures (Cox and Snell, Nagelkerke and 
McFadden) are the three most common measures of R2. Conceptually they are 
somewhat the same, so in terms of interpretation they can be seen  as similar to the R2 
in linear regression in that they provide a gauge of the substantive significance of the 





The Nagelkerke value in this model is .366, suggesting that the model has good 
explanatory power, accounting for 36.6% of the variance in the dependent variable 
(performance), Table 21. 
Pseudo R-Squared 
Cox and Snell .328 
Nagelkerke .366 
McFadden .176 
Link function: Logit. 
 
Table 21. PRS (1) 
Ordinal regression coefficients 
Table 22 shows that the independent variable ‘SCDO average’ was statistically 
significant. The exponential of the logits, which are shown in the estimate column, 
gives us the cumulative odds (CO) which shows that, for a one unit increase in SCDO 
average, the probability of going up one level in the dependent variable (performance) 
increases by a factor of 25.48. Hospitals with smaller numbers of beds had an 
increased probability of being at a higher level of performance than the reference 








Table 22. Ordinal regression coefficients 
6.5.2 Supply chain disruption orientation and performance (1x) 
The following analysis refers to the same variables as in section 6.5.1, but with 
PERFPOST1 (8 to 16 weeks) rather than PERF1 (first 8 weeks) as the dependent 
variable. 
Rationale for the analysis 
 The aim was to investigate proposition P1a; whether the stronger the supply chain 
disruption orientation (SCDO) of a unit, the higher the performance in shortage 
management, as described in Chapter 3 in the supply chain disruption orientation 
construct section. 
Descriptive statistics 
Descriptive statistics (comparison of means) shows, as below in Table 23, that there is 
little variation in the mean of SCDO average according to the categories of the 


















6.344 1.624 15.254 1 0 3.16 9.528
[PERF1 = 
2]
8.794 1.665 27.911 1 0 5.532 12.057
[PERF1 = 
3]




3.238 0.534 36.796 1 0 2.192 4.284 25.478 SCDO
[Beds=1.00
]
1.477 0.855 2.986 1 0.084 -0.198 3.153 4.381 B1 (under 100)
[Beds=2.00
]
0.237 0.474 0.25 1 0.617 -0.692 1.166 1.267 B2 (100 to 299)
[Beds=3.00
]







































Table 23. SCDO means by category of performance (POST)  
The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis).  
Hypothesis/Proposition 
The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone).  
The results of the standard diagnostic test for ordinal regression are presented in the 
diagnostic test summary in Appendix 5. Since p>.05, we retain the null hypothesis that 
the model has goodness of fit.  
The test of parallel lines shows p>.05 and, therefore, we retain the null hypothesis that 
the slope coefficients are the same across response categories of the dependent 
variable.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model was statistically significant overall (p<.05) but at p=.043 it is only just below 
the threshold for statistical significance, Table 24. However, the null hypothesis is 




Model Fitting Information 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Intercept Only 198.602       
Final 188.743 9.860 4 .043 
Table 24. Significance (1x) 
The Nagelkerke value in this model is .084, Table 25, suggesting that the model has 
low explanatory power, accounting for just 8.4% of the variance in the dependent 
variable (performance). 
Pseudo R-Squared 




Table 25. PRS (1x) 
Ordinal regression coefficients 
Table 26 shows that no independent variables were statistically significant. The 
exponent of the estimate tells us that for a one unit increase in SCDO average, the 
probability of going up one level in the dependent variable (performance - lines filled 
post) increases by a factor of 1.78, but this was not statistically significant. Hospitals 
with smaller numbers of beds had an increased probability of being at a higher level of 
performance than the reference category (over 500 beds) but not to a statistically 
significant extent. The fact that no independent variables were statistically significant is 
not surprising given the very low level of Pseudo R2 and the fact that the model overall 










Parameter Estimates   
  Estimate Std. 
Error 
Wald df Sig. 95% Confidence Interval   














































Table 26. Ordinal regression coefficients  
 
6.5.3 Role, supply chain disruption orientation, and performance (2) 
Rationale for the analysis 
The aim was to investigate proposition 1b; whether the lower the role of the actor 
responsible for making supply chain disruption action decisions, the lesser the 
shortage management performance, as described in Chapter 3 in the supply chain 
disruption orientation construct section. 
Hypothesis/Proposition 
The null hypothesis is that the coefficients of all the independent variables are equal to 
zero, and the alternate hypothesis is that they are greater than zero. 
The results of the standard diagnostic test for ordinal regression are presented in the 
diagnostic test summary in Appendix 5. Since p>.05, we retain the null hypothesis that 
the model has goodness of fit.  
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The test of parallel lines shows p>.05 and, therefore, we retain the null hypothesis that 
the slope coefficients are the same across response categories of the dependent 
variable.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model is statistically significant overall (p<.001), Table 27 and, therefore, the null 
hypothesis is accepted and the alternate hypothesis is rejected.  






Intercept Only 247.510       
Final 193.022 54.487 8 .000 
 
Table 27. Significance (2) 
The model has good explanatory power (Nagelkerke =.394), Table 28, suggesting that 
the model explains 39.4% of the variance in the dependent variable (performance 
immediate).  
Pseudo R-Squared 
Cox and Snell .353 
Nagelkerke .394 
McFadden .193 
Link function: Logit. 
Table 28. PRS (2) 
Ordinal regression coefficients 
The independent variable SCDO average is statistically significant (p<.001, CO 31.5). 
This indicates that an increase of one unit in SCDO average leads to a 31.5 greater 
probability of going up one level in the dependent variable (performance/lines fulfilled 
immediate), as shown in Table 29. Role has 5 category names included in the 
analysis: pharmacist, lead pharmacy technician, lead procurement, and other, which is 
the reference category that the rest of the categories are compared to, it is the 
benchmark, the baseline which the other categories are interpreted. There are no 
statistically significant effects associated with role or bed numbers, although the 
category ‘under 100 beds’ comes close to being statistically significant compared to the 
230 
 
reference category (over 500 beds, p=.063 CO 5.455) as does the category 300-499 
beds (p=.061 CO 3.023). 
 
Parameter Estimates   
  Estimate Std. 
Error 












Threshold [PERF1 = 
1] 
7.215 1.721 17.577 1 .000 3.842 10.588   
[PERF1 = 
2] 
9.727 1.771 30.162 1 .000 6.256 13.198   
[PERF1 = 
3] 




3.450 .555 38.611 1 .000 2.362 4.538 31.500 SCDO 
average  
[Beds=1.00] 1.697 .912 3.462 1 .063 -.091 3.484 5.455 B1 (under 
100) 
[Beds=2.00] .390 .488 .638 1 .424 -.566 1.346 1.477 B2 (100 to 
299) 
[Beds=3.00] 1.106 .590 3.514 1 .061 -.050 2.263 3.023 B3 (300-499) 
[Beds=4.00] 0a     0        B4 (over 500) 
[Role=1] -.168 .650 .067 1 .795 -1.442 1.105 0.845 Pharmacists 
[Role=2] .832 .529 2.468 1 .116 -.206 1.869 2.297 Lead 
pharmacist 
technician 




[Role=4] .367 .470 .612 1 .434 -.553 1.287 1.444 Pharmacist 
specialist 




Table 29. Results of ordinal regression   
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6.5.4 Role, supply chain disruption orientation, and performance (2x) 
The following analysis refers to the same variables as in section 6.5.3, but with 
PERFPOST1 rather than PERF1 as the dependent variable 
Rationale for the analysis 
The aim was to investigate proposition P1b; whether the lower the role of the actor 
responsible for making supply chain disruption action decisions, the lesser the 
shortage management performance, as described in Chapter 3 in the supply chain 
disruption orientation construct section. 
Hypothesis/Proposition 
The null hypothesis is that the coefficients of all the independent variables are equal to 
zero, and the alternate hypothesis is that they are greater than zero. 
The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis). The results of the standard diagnostic test for ordinal regression are 
presented in the diagnostic test summary in Appendix 5. Since p>.05, we retain the 
null hypothesis that the model has goodness of fit.  
The test of parallel lines shows p>.05 and, therefore, we retain the null hypothesis that 
the slope coefficients are the same across response categories of the dependent 
variable.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model is not statistically significant overall (p>.05), Table 30 and, therefore, the 
null hypothesis is retained and the alternate hypothesis is rejected.  
Model Fitting Information 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Intercept Only 253.865       
Final 240.540 13.325 8 .101 
 
Table 30. Significance (2x) 
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The model has low explanatory power (Nagelkerke=.112), Table 31, suggesting that 








Table 31. PRS (2x) 
Ordinal regression coefficients 
None of the independent variables were statistically significant (p>.05). An increase of 
one unit in SCDO average leads to a 1.817 greater probability of going up one level in 
the dependent variable (performance/lines fulfilled POST) but was not statistically 
significant, as shown in Table 32. There are no statistically significant effects 



















Parameter Estimates   
  Estimate Std.  
Error 















POST1 = 1] 
1.345 1.411 .907 1 .341 -1.422 4.111   
[PERF 
POST1 = 2] 
1.855 1.416 1.718 1 .190 -.919 4.630   
[PERF 
POST1 = 3] 






.597 .421 2.015 1 .156 -.228 1.422 1.817 SCDO 
average  
[Beds=1.00] -.404 .847 .228 1 .633 -2.064 1.256 0.668 B1 (under 
100) 
[Beds=2.00] -.366 .461 .629 1 .428 -1.269 .538 0.694 B2 (100 to 
299) 
[Beds=3.00] .803 .564 2.025 1 .155 -.303 1.909 2.232 B3 (300-499) 
[Beds=4.00] 0a     0       reference 
category  
B4 (over 500) 
[Role=1] .161 .640 .063 1 .801 -1.094 1.416 1.175 Pharmacists 
[Role=2] .154 .483 .101 1 .751 -.793 1.100 1.166 Lead 
pharmacist 
technician 




[Role=4] .716 .443 2.618 1 .106 -.151 1.583 2.046 Pharmacist 
specialist 




Table 32. Results of ordinal regression 
6.5.5 Number of hospitals in the trust and SCDO (3) 
Rationale for the analysis 
The aim was to investigate proposition 1c; whether the larger the number of hospitals 
in a trust, the stronger the supply chain disruption orientation of a unit, as described in 





The hypothesis is that there will be statistically significant differences between the 
means of the groups (levels) within the variable ‘hospital numbers’, the null hypothesis 
is that there will not be statistically significant differences between the means of the 
group within hospital numbers. 
Rationale for test  
In this analysis, there are two variables: independent variable, hospital numbers 
(ordinal), and dependent variable, SCDO (continuous/interval). So again, ANOVA 
would be the obvious choice (if assumptions were met). SCDO is not normal, as 
discussed in the normality tests in Section 6.3.1. Transformations and removal of 
outliers did not improve normality. However, the histogram suggests an approximation 
of normality and as one way ANOVA had considerable robustness, it was decided to 
use that (and also back up with a Kruskal Wallis test).  
ANOVA 
Levene’s test p>.05. showed that there was homogeneity of variance (an assumption 
of ANOVA). The ANOVA was not significant (F=.839, 3,1112, p=.475) showing that 
there was not a statistically significant difference between the means of the categories 
in hospital numbers in respect of the dependent variable, SCDO, Table 33. Therefore, 
the null hypothesis was accepted and the alternate hypothesis was rejected.  
 
Table 33. Significance (3) 
Kruskal-Wallis test 
As the dependent variable was not normally distributed, thus violating one of the 
assumptions of ANOVA, it was decided to also test the hypothesis with a non-
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parametric test (Kruskal-Wallis). This gave a similar result (p=.432) and, again, the null 
hypothesis was accepted and the alternate hypothesis rejected.  
 
6.5.6 Disruption severity, disruption orientation, and performance (4) 
Rationale for analysis 
The aim was to investigate proposition 1d; whether the higher the severity of the 
disruption, the better the managers with higher supply chain disruption orientation 
perform, as described in Chapter 3 under the supply chain disruption orientation 
construct. 
Hypothesis/Proposition 
The null hypothesis in ordinal regression (as in most other forms of regression) is that 
the coefficients of all the independent variables are equal to zero, and the alternate 
hypothesis is that they are greater than zero. 
The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis). The results of the standard diagnostic test for ordinal regression are 
presented in the summary of diagnostic tests in Appendix 5. Since p>.05, we retain the 
null hypothesis that the model has goodness of fit.  
The test of parallel lines shows p<.05 and, therefore, we reject the null hypothesis that 
the slope coefficients are the same across response categories of the dependent 
variable. The assumption of parallel lines is not met.  
However, as the goodness of fit test was passed and the Pseudo R Squared is high, it 
was decided to retain the model. Although clearly there must be a degree of 
uncertainty in the findings, given that the parallel lines test is not passed.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model was statistically significant overall (p<.001), Table 34. Therefore, the null 















Intercept Only 230.442       
Final 173.389 57.053 8 .000 
 
Table 34. Significance (4) 
The model has very good explanatory power of model (Nagelkerke =.430), Table 35, 
meaning that the model explains 43% of the variance in the dependent variable 
(performance immediate).   
Pseudo R-Squared 
Cox and Snell .386 
Nagelkerke .430 
McFadden .213 
Table 35. PRS (4) 
Ordinal regression coefficients 
The statistically significant independent variables are SCDO average (p<.001, CO 
31.668) and disruption severity levels 2, 3, and 4 (slight, moderate, and strong impact 
with p =.044, .014, and .041 respectively and CO of 8.031, 8.755, and 5.637 
respectively). This indicates that a one unit increase in SCDO average is associated 
with a 31.668 times greater probability of going up one category on the dependent 
variable (performance) and that categories 2, 3, and 4 of disruption severity are 
associated with increased probability (ranging from 5.637 to 8.755) of going up one 
level on the dependent variable compared to the reference category (extreme impact), 
as in Table 36. Although the categories relating to smaller numbers of beds showed 
increased probability of going up one level on the dependent variable (performance) 








Parameter Estimates   
  Estimate Std. 
Error 














Threshold [PERF1 = 1] 8.629 1.959 19.400 1 .000 4.789 12.46
9 
  
[PERF1 = 2] 11.120 2.006 30.715 1 .000 7.187 15.05
2 
  










-1.888 2.096 .811 1 .368 -5.996 2.220 0.151 No impact 
[Disruptions
everity=2] 

















[Beds=1.00] 1.370 .930 2.171 1 .141 -.453 3.193 3.936 B1 (under 
100) 
[Beds=2.00] .360 .501 .516 1 .472 -.622 1.342 1.433 B2 (100 to 
299) 
[Beds=3.00] .782 .654 1.432 1 .231 -.499 2.063 2.186 B3 (300-
499) 





Table 36. Results of ordinal regression 
6.5.7 Disruption severity, disruption orientation, and performance (4x) 
The following analysis refers to the same variables as in section 6.5.6, but with 
PERFPOST1 rather than PERF1 as the dependent variable 
Rationale for analysis 
The aim was to investigate proposition 1d; whether the higher the severity of the 
disruption, the better the managers with higher supply chain disruption orientation 





The null hypothesis in ordinal regression (as in most other forms of regression) is that 
the coefficients of all the independent variables are equal to zero, and the alternate 
hypothesis is that they are greater than zero. 
The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis). The results of the standard diagnostic test for ordinal regression are 
presented in the diagnostic test summary in Appendix 5. Since p>.05, we retain the 
null hypothesis that the model has goodness of fit.  
The test of parallel lines shows p>.05 and, therefore, we retain the null hypothesis that 
the slope coefficients are the same across response categories of the dependent 
variable.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model was statistically significant overall (p<.05), Table 37. Therefore, the null 
hypothesis is rejected and the alternate hypothesis is accepted.  
Model Fitting Information 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Intercept Only 236.898       
Final 216.749 20.149 8 .010 
 
Table 37. Significance (4x) 
The model has moderate explanatory power of model (Nagelkerke =.174), Table 38, 
meaning that the model explains 17.4% of the variance in the dependent variable 
(performance post). 
Pseudo R-Squared 




Table 38. PRS (4x) 
Ordinal regression coefficients 
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Disruption severity (moderate impact) was statistically significant, showing a 12 times 
increased probability of going up one level in the dependent variable (performance – 
lines fulfilled post) compared to the reference category (extreme impact). Strong and 
moderate impact also showed a large increased probability of going up one level on 
the dependent variable, compared to the reference category (9.315 and 12.412 
respectively) but not to a statistically significant extent. The exponent of the estimate 
was zero for ‘no impact’, most likely because of the very low number of cases in this 
category. SCDO average was not statistically significant, as shown in Table 39. Again, 
the categories relating to smaller numbers of beds showed increased probability of 
going up one level on the dependent variable (performance) compared to the reference 
category (over 500 beds), but the effect was not statistically significant. 




















[PERFPOST1 = 1] 2.200 1.816 1.468 1 .226 -1.359 5.760   
[PERFPOST1 = 2] 2.766 1.822 2.306 1 .129 -.804 6.337   










-17.231 0.000   1   -17.231 -17.231 0.000 No impact 
[Disruptionseverity
=2] 
















[Beds=1.00] -1.077 .934 1.328 1 .249 -2.908 .755 0.341 B1 (under 
100) 
[Beds=2.00] -.303 .467 .421 1 .517 -1.219 .613 0.739 B2 (100 to 
299) 
[Beds=3.00] .812 .619 1.722 1 .189 -.401 2.025 2.253 B3 (300-
499) 




Table 39. Results of ordinal regression 
6.5.8 Performance and feedback (5) 
Rationale for the analysis 
The aim was to investigate proposition P2e; whether there is a positive relationship 
between the performance feedback given after a supply chain disruption event and 
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higher performance in shortage management, as described in Chapter 3 under the 
supply chain disruption performance construct. 
Hypothesis/Proposition 
The null hypothesis in ordinal regression is that the coefficients of all the independent 
variables are equal to zero, and the alternate hypothesis is that they are greater than 
zero. 
The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis). The results of the standard diagnostic test for ordinal regression are 
presented in the summary of diagnostic tests in Appendix 5. 
The goodness of fit test gave a mixed result, with p<.05 for Pearson (indicating that 
there is not goodness of fit), but p>.05 for deviance (indicating that there is goodness 
of fit). This means that there is some uncertainty about whether the model has 
goodness of fit.  
The test of parallel lines shows p>.05 and, therefore, we retain the null hypothesis that 
the slope coefficients are the same across response categories of the dependent 
variable.   
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model was statistically significant overall (p<.001), Table 40. 
Model Fitting Information 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Intercept Only 167.609    
Final 136.669 30.941 4 .000 
Table 40. Significance (5) 
The model had moderate explanatory power (Nagelkerke =.250), Table 41, suggesting 







Cox and Snell .224 
Nagelkerke .250 
McFadden .112 
Link function: Logit. 
Table 41. PRS(5) 
Ordinal regression coefficients 
Feedback average was a statistically significant independent variable (p<.001, CO 
2.440), suggesting that a one unit increase on feedback is associated with a 2.44 
increased probability of going up one level on performance, as in Table 42. Although 
some levels of bed numbers were associated with increased CO compared to the 
reference category (for example, under 100 beds has CO of 4.233 compared to 
reference category), none of these were statistically significant. 
  Estimate Std. 
Error 












Threshold [PERF1 = 1] -.721 .735 .963 1 .326 -2.162 .719   
[PERF1 = 2] 1.384 .623 4.926 1 .026 .162 2.606   
[PERF1 = 3] 3.324 .688 23.348 1 .000 1.976 4.672   
Location FEEDBACK
_AVG_NEW 
.892 .180 24.500 1 .000 .539 1.245 2.440 Feedbac
k 
average  
[Beds=1.00] 1.443 .878 2.699 1 .100 -.278 3.164 4.233 B1 
(under 
100) 
[Beds=2.00] .238 .468 .258 1 .611 -.679 1.154 1.268 B2 (100 
to 299) 
[Beds=3.00] .695 .573 1.470 1 .225 -.429 1.819 2.004 B3 (300-
499) 




Table 42. Results of ordinal regression 
6.5.9 Performance and feedback (5x) 
The following analysis refers to the same variables as in Section 5.9, but with 
PERFPOST1 rather than PERF1 as the dependent variable 
Rationale for the analysis 
The aim was to investigate proposition P2e; whether there is a positive relationship 
between the performance feedback given after a supply chain disruption event and 
higher performance in shortage management, as described in Chapter 3 under the 




The null hypothesis in ordinal regression is that the coefficients of all the independent 
variables are equal to zero, and the alternate hypothesis is that they are greater than 
zero. 
The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis).  
The results of the standard diagnostic test for ordinal regression are displayed in the 
summary of diagnostic tests in Appendix 5 
The goodness of fit test gave a mixed result, with p<.05 for Pearson (indicating that 
there is not goodness of fit), but p>.05 for deviance (indicating that there is goodness 
of fit). This means that there is some uncertainty about whether the model has 
goodness of fit.  
The test of parallel lines shows p>.05 and, therefore, we retain the null hypothesis that 
the slope coefficients are the same across the response categories of the dependent 
variable.   
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model was statistically significant overall (p<.001), Table 43. 
Model Fitting Information 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Intercept Only 213.029       
Final 152.746 60.283 5 .000 
Table 43. Significance (5x) 
The model had high explanatory power (Nagelkerke = .440), Table 44, suggesting that 
the model explains 44% of the variance in the dependent variable (performance post).  
Pseudo R-Squared 
Cox and Snell .397 
Nagelkerke .440 
McFadden .216 
Table 44. PRS (5x) 
Ordinal regression coefficients 
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Feedback from managers was a statistically significant independent variable (p=.009, 
CO 1.644), suggesting that a one unit increase on feedback is associated (as shown in 
Table 45) with a 1.644 increased probability of going up one level on performance. 
Feedback from ‘other’ was also statistically significant (p<.001, CO 2.386) suggesting 
that a one unit increase on feedback is associated with a 2.386 increased probability of 
going up one level on performance. This indicated that both forms of feedback are 
statistically significant predictors of performance (post) but also that feedback from 
‘other’ seems to be a somewhat more powerful predictor than feedback from 
managers. 
Although some levels of bed numbers were associated with decreased or increased 
CO compared to the reference category, none of these were statistically significant.  
 
Table 45 - Results of ordinal regression  
6.5.10 Buffering, bridging, and performance (6) 
Rationale for hypothesis/proposition 
The aim was to investigate proposition P2f; whether pursuing an initial buffering 














2.76 0.739 13.955 1 0 1.312 4.209
[PERFPOS
T1 = 2]
3.518 0.769 20.96 1 0 2.012 5.025
[PERFPOS
T1 = 3]












-0.597 0.904 0.437 1 0.509 -2.369 1.174 0.55 B1 (under 100)
[Beds=2.00
]
-0.945 0.531 3.166 1 0.075 -1.985 0.096 0.389 B2 (100 to 299)
[Beds=3.00
]














0.869 0.219 15.749 1 0 0.44 1.299









The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone).  
The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis).  
Recoding of variables  
An average was created from all the measures of buffering (BUF1 to BUF6) and 
similarly for bridging (variables BRIPOST 1 to 7). These were the independent 
variables in the regression. The dependent variable was performance (‘lines fulfilled 
immediate’) and bed numbers were included as control variables.  
The results of the standard diagnostic test for ordinal regression are shown in the 
summary of diagnostic tests in Appendix 5. 
The goodness of fit test gave a mixed result with p<.05 for Pearson (indicating that 
there is not goodness of fit) but p>.05 for deviance (indicating that there is goodness of 
fit). This means that there is some uncertainty about whether the model has goodness 
of fit.  
The test of parallel lines (p<.05) shows that the assumption of the slope coefficients 
being the same across response categories was not met. However, this is a very 
conservative test, as we have mentioned earlier, and the model fit is statistically 
significant and there is some explanatory power in the model, as shown in the Pseudo 
R Squared. It was decided to retain the model, therefore, despite this assumption not 
being met.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model is statistically significant overall (p<.05), but not at a high level of statistical 
significance, Table 46. This suggests that the model is weak and shows only a slight 
(though statistically significant) improvement over the intercept alone (as demonstrated 










Intercept Only 240.918       
Final 228.895 12.023 5 .034 
Table 46 - Significance (6) 
The explanatory power of the model is low (Nagelkerke =.102), Table 47. Suggesting 
that the model explains 10.2% of the variance in the dependent variable (performance 
immediate), but still provides some predictive power.  
Pseudo R-Squared 
Cox and Snell .092 
Nagelkerke .102 
McFadden .043 
Link function: Logit. 
Table 47. PRS (6) 
Ordinal regression coefficients 
Table 48 shows that the only independent variable which was statistically significant 
was BRIPOST average (p=.006, CO 1.693) suggesting that a one unit increase in 
BRIPOST leads to a 1.693 increase in the probability of increasing one level on the 
dependent variable (performance) when all other variables are held constant. As with 
some previous analysis, some effect of bed size can be observed (bed levels 1 to 3 all 
have greater CO of being in a higher category of performance than the reference 














0.091 1.987 0.002 1 0.963 -3.803 3.985
[PERF1 = 
2]
2.105 1.953 1.162 1 0.281 -1.723 5.933
[PERF1 = 
3]







0.794 0.84 0.892 1 0.345 -0.853 2.441 2.211 B1 (under 100)
[Beds=2.00
]
0.423 0.455 0.864 1 0.353 -0.469 1.314 1.526 B2 (100 to 299)
[Beds=3.00
]









BRIPOST 1 to 7 
average
0.375 -0.579 1.537 1.615 BUF 1 to 6 average
0.526 0.19 7.665 1 0.006
Threshold
Location
0.479 0.54 0.789 1
Parameter Estimates




Table 48. Results of ordinal regression 
6.5.11 Buffering, bridging, and performance (6x) 
The following analysis refers to the same variables as in Section 6.5.10, but with 
PERFPOST1 rather than PERF1 as the dependent variable 
Rationale for hypothesis/proposition 
The aim was to investigate proposition P2f; whether pursuing an initial buffering 
strategy followed by a bridging strategy enhances performance in shortage 
management 
Hypothesis/Proposition 
The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone). The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis).  
Recoding of variables  
An average was created from all the measures of buffering (BUF1 to BUF6) and also 
for bridging (variables BRIPOST 1 to 7). These were the independent variables in the 
regression. The dependent variable was performance (‘lines fulfilled post’) and bed 
numbers were included as a control variable.  
The results of the standard diagnostic test for ordinal regression are shown in the 
summary of diagnostic tests in Appendix 5. The goodness of fit test gave p>.05 
(indicating that there is goodness of fit).  
The test of parallel lines (p<.05) shows that the assumption of the slope coefficients 
being the same across response categories was not met. However, this is a very 
conservative test and as the model is statistically significant and there is some 
explanatory power in the model, as shown in the Pseudo R Squared, it was decided to 
retain the model, therefore, despite this assumption not being met.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
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The model is statistically significant overall (p<.001), showing a high level of statistical 
significance, Table 49. This suggests that the model is good and shows a significant 
improvement over the intercept alone. 
Model Fitting Information 
Model -2 Log-Likelihood Chi-Square df Sig. 
Intercept Only 255.591       
Final 209.691 45.900 5 .000 
Table 49. Significance (6x) 
The explanatory power of the model is high (Nagelkerke =.340), Table 50, suggesting 
that the model explains 34% of the variance in the dependent variable (performance 
post), but still provides some predictive power.  
Pseudo R-Squared 
Cox and Snell .307 
Nagelkerke .340 
McFadden .157 
Table 50. PRS (6x) 
Ordinal regression coefficients 
Table 51 shows that BRIPOST average (p<.001, CO 3.778) was statistically significant, 
suggesting that a one unit increase in BRIPOST leads to a 3.778 increase in the 
probability of increasing one level on the dependent variable (performance post) when 
all other variables are held constant. BUF was not statistically significant (p=.070). As 
with some previous models, some effect of bed size can be observed (bed levels 1 to 3 
all have greater CO of being in a higher category of performance than the reference 
category of 500 beds), but this effect was statistically significant only in the category of 
300-499 beds which showed a 3.484 times increased probability of going up one level 
on the dependent variable (PERFPOST 1) compared to the reference category.  


















POST1 = 1] 
-.659 2.107 .098 1 .754 -4.788 3.470   
[PERF 
POST1 = 2] 
-.027 2.107 .000 1 .990 -4.157 4.104   
[PERF 
POST1 = 3] 
.434 2.108 .042 1 .837 -3.698 4.567   
Location BUF1to6_aver -1.089 .601 3.285 1 .070 -2.266 .089 0.337 BUF 1 to 6 
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1 .000 .851 1.808 3.778 BRIPOST 
1 to 7 
average  
[Beds=1.00] -.829 .820 1.023 1 .312 -2.436 .777 0.436 B1 (under 
100) 
[Beds=2.00] .093 .485 .037 1 .848 -.857 1.043 1.097 B2 (100 to 
299) 
[Beds=3.00] 1.248 .619 4.064 1 .044 .035 2.462 3.484 B3 (300-
499) 




Table 51. Results of ordinal regression 
6.5.12 Bridging and buffering in response to supply chain disruption (7) 
Rationale for analysis 
The aim was to investigate proposition P2g; whether buffering actions in response to 
supply chain disruption are more effective than bridging actions in shortage 
management performance, as described in Chapter 3 under the supply chain 
disruption performance construct. 
Hypothesis/Proposition 
The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone). The results of the standard diagnostic test for ordinal regression are presented 
in the summary of diagnostic tests in Appendix 5. The goodness of fit test shows that 
there is a good fit between the data and the model (p>.05). 
The test of parallel lines gave p<.05, indicating that the null hypothesis of the test (that 
the location parameters, or slope coefficients, are the same across response 
categories) should be rejected. The assumption of parallel lines is not met. 
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model overall was not statistically significant (p>.05), Table 52. Therefore, we 
accept the null hypothesis (that the coefficients of all the independent variables are 
equal to zero). 










Final 224.031 4.179 5 .524 
Link function: Logit. 
 
Table 52. Significance (7) 
The explanatory power of the model was very low (Nagelerke .037), Table 53, 
suggesting that the model explains just 3.7% of the variance in the dependent variable 








Link function: Logit. 
Table 53. PRS (7) 
Ordinal regression coefficients 
None of the independent variables in the model were statistically significant. BUF 
average shows some increased probability of being at a higher level in the dependent 
variable, as do the lower levels within the variable bed numbers but not to a statistically 
significant extent. As shown in Table 54, BRI shows a negative estimate coefficient (-
.165), which translates into a CO of less than 1 (0.848). This means that, as BRI 
increases, so the probability of being at a higher level in the dependent variable 
decreases, but not to a statistically significant extent. 
Parameter Estimates   
  Estimate Std. 
 Error 














-1.580 2.025 .609 1 .435 -5.550 2.389   
[PERF1 
= 2] 
.352 1.982 .032 1 .859 -3.533 4.238   
[PERF1 
= 3] 













.874 .835 1.094 1 .296 -.763 2.511 2.396 B1 (under 
100) 






.762 .534 2.037 1 .154 -.285 1.809 2.143 B3 (300-499) 
[Beds=
4.00] 




Table 54. Results of ordinal regression 
6.5.13 Bridging and buffering in response to supply chain disruption (7x) 
The following analysis refers to the same variables as in section 6.5.12, but with 
PERFPOST1 rather than PERF1 as the dependent variable 
Rationale for analysis 
The aim was to investigate proposition P2g; whether buffering actions in response to 
supply chain disruption are more effective than bridging actions in shortage 
management performance, as described in Chapter 3 under the supply chain 
disruption performance construct. 
Hypothesis/Proposition 
The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone). The results of the standard diagnostic test for ordinal regression are provided in 
the outline of diagnostic tests in Appendix 3 
The goodness of fit test shows that there is a good fit between the data and the model 
(p>.05). The test of parallel lines gave p>.05 indicating that the null hypothesis of the 
test (that the location parameters (slope coefficients) are the same across response 
categories) should be retained. The assumption of parallel lines is met.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model overall was statistically significant (p<.001), Table 55. Therefore, we reject 
the null hypothesis (that the coefficients of all the independent variables are equal to 
zero). 
Model Fitting Information 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Intercept Only 287.689       




Table 55. Significance (7x) 
The explanatory power of the model is high (Nagelkerke .414), Table 56, suggesting 
that the model explains 41.4% of the variance in the dependent variable (performance 
post). This is not surprising given that the model overall is not statistically significant. 
Pseudo R-Squared 




Table 56. PRS (7x) 
Ordinal regression coefficients 
BUFPOST (p<.001, CO 0.349) and BRIPOST (p<.001, CO 3.730) were statistically 
significant. These statistics indicate that for a one unit increase in BUFPOST there is a 
0.349 times reduced probability of increasing one unit on the dependent variable 
(PERFPOST1, as shown in Table 57). As the CO is less than one, this signifies a 
decreased probability of going up one unit on the dependent variable and implies a 
negative relationship between the BUFPOST and the dependent variable. BRIPOST 
has a positive relationship with the dependent variable (for example, a one unit 
increase in BRIPOST leads to a 3.73 probability of going up one level on the RV). 






Table 57. Results of ordinal regression 
6.5.14 Bridging and buffering in response to supply chain disruption (8) 
Rationale for analysis 
The aim was to investigate proposition 3i; whether the impact of buffering and bridging 
actions in response to supply chain disruption vary over time from the first impact, as 
described in Chapter 3, under the organisational response construct.  
Hypothesis/Proposition 
The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone). The rationale for choice of test (ordinal regression) is discussed in Section 6.4 
(Analysis).  
The results of the standard diagnostic test for ordinal regression are shown in the 
summary diagnostics tests in Appendix 5. As both Pearson and deviance statistics are 
p>.05, the data has goodness of fit with the model. 
The test of parallel lines gave p<.05 showing the null hypothesis of the test (that the 
location parameters, or slope coefficients, are the same across response categories) 
should be rejected. The assumption of proportional odds was not met which means 
that there is some uncertainty about the validity of the results. However, as the model 








0.405 1.033 0.154 1 0.695 -1.619 2.43
[PERFPOST
1 = 2]
1.085 1.037 1.095 1 0.295 -0.948 3.118
[PERFPOST
1 = 3]






[Beds=1.00] -0.651 0.834 0.609 1 0.435 -2.284 0.983 0.522 B1 (under 100)
[Beds=2.00] -0.099 0.501 0.039 1 0.843 -1.08 0.882 0.905 B2 (100 to 299)












1.316 0.241 29.849 1 0 0.844 1.789
-1.052 0.291 13.055 1 0 -1.623
Parameter Estimates




is statistically significant, the goodness of fit was passed, and the model has some 
explanatory power it was decided to retain the model. 
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model overall was statistically significant (p<.05), Table 58, therefore, the null 
hypothesis was rejected and the alternate hypothesis accepted.  
 






Intercept Only 279.012       
Final 264.126 14.885 7 .037 
 
Table 58. Significance (8) 
The model showed low explanatory power (Nagelkerke .126), Table 59, indicating that 




Cox and Snell .113 
Nagelkerke .126 
McFadden .053 
Table 59. PRS (8) 
Ordinal regression coefficients 
The only independent variable which was statistically significant was BRIPOST 
(p=.001, CO 1.922) indicating that for a one unit increase in BRIPOST, the probability 
of going up one level increases by a factor of 1.922. BUF and BUFPOST showed 
positive relationships with the dependent variable (performance), but not to a 
statistically significant extent. BRI was the only independent variable which showed a 
negative relationship with the dependent variable (for a one unit increase in BRI, the 
probability of being at a higher level of the dependent variable decreased slightly), 
although the effect was not statistically significant, as shown in Table 60. Again, a 
smaller number of beds showed a positive relationship with the dependent variable, but 
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not to a statistically significant extent (all categories in bed numbers showed increased 
chances of being at a higher level in the dependent variable of performance than the 




Table 60. Results of ordinal regression 
6.5.15 Bridging and buffering in response to supply chain disruption (8x) 
The following analysis refers to the same variables as in Section 5.16, but with 
PERFPOST1 rather than PERF1 as the dependent variable 
Rationale for analysis 
The aim was to investigate proposition P3i; whether the impact of buffering and 
bridging actions in response to supply chain disruption vary over time from the first 
impact, as described in Chapter 5, under the organisational response construct.  
Hypothesis/Proposition 
The global null hypothesis in ordinal regression is that the coefficients of all the 










-0.662 2.079 0.101 1 0.75 -4.736 3.412
[PERF1 = 
2]
1.302 2.041 0.407 1 0.524 -2.699 5.303
[PERF1 = 
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0.776 0.85 0.834 1 0.361 -0.889 2.442 2.173 B1 (under 100)
[Beds=2.00
]
0.471 0.465 1.022 1 0.312 -0.442 1.383 1.601 B2 (100 to 299)
[Beds=3.00
]










0.653 0.205 10.171 1 0.001 0.252 1.055
-0.307 0.828 1.298 BUFPOST1to6_average
-0.424 0.275 2.383 1 0.123 -0.962
0.654 -0.877 1.397 1.297 BUF1to6_average
0.261 0.29 0.809 1 0.368
Threshold
Location










greater than zero (that the model has greater predictive power than the intercept 
alone). The rationale for choice of test (ordinal regression) is discussed in Section 6.4  
The results of the standard diagnostic test for ordinal regression are summarised in the 
diagnostic tests in Appendix 5. As both Pearson and deviance statistics are p>.05, the 
data has goodness of fit with the model. The test of parallel lines gave p>.05, showing 
the null hypothesis of the test (that the location parameters, or slope coefficients, are 
the same across response categories) should be retained. The assumption of parallel 
lines is met. 
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model overall was statistically significant (p<.001), Table 61, therefore, the null 
hypothesis was rejected and the alternate hypothesis accepted.  
Model Fitting Information 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Intercept Only 288.215       
Final 217.153 71.062 7 .000 
 
Table 61. Significance (8x) 
The model has very high explanatory power (Nagelkerke .484), Table 62, indicating 
that the model explained nearly half (48.4%) of the variance in the dependent variable 
(performance post). 
Pseudo R-Squared 




Table 62. PRS (8x)  
Ordinal regression coefficients 
BRI and BRI post were statistically significant independent variables, but BRI has a 
negative relationship with the dependent variable (PERFPOST 1), being associated 
with a 0.343 probability of going up one level in the dependent variable while BRIPOST 
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has a positive relationship with the dependent variable, being associated with a 5.889 
times increased probability of going up one level in the dependent variable, as shown 
in Table 63. 
Lower levels of beds showed a negative relationship with the dependent variable, but 
not to a statistically significant extent (categories 1 and 2 in bed numbers showed 
decreased chances of being at a higher level in the dependent variable of performance 
than the reference category of over 500 beds). Category 3 of beds showed increased 
chances of going up one level in the dependent variable compared to the reference 
category but again this was not to a statistically significant extent. 
 
 
Table 63. Results of ordinal regression 
6.5.16 Varying response - effect on performance (9) 
Rationale for the analysis 
The aim was to investigate proposition 3h; whether varying a firm’s supply chain 
disruption response actions dynamically post event improves performance in shortage 
management, as described in Chapter 3, under the organisational response construct. 











-3.778 2.31 2.675 1 0.102 -8.306
[PERFPOS
T1 = 2]
-3.102 2.303 1.815 1 0.178 -7.615
[PERFPOS
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-1.026 0.882 1.353 1 0.245 -2.755 0.358 B1 (under 100)
[Beds=2.00
]
-0.153 0.527 0.084 1 0.772 -1.186 0.858 B2 (100 to 299)
[Beds=3.00
]




















-0.614 0.325 3.577 1 0.059
Parameter Estimates






The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone).  
The results of the standard diagnostic test for ordinal regression are summarised in the 
diagnostic tests in Appendix 5. Since p>.05, we retain the null hypothesis that the 
model has goodness of fit. As p<.05, we reject the null hypothesis that the location 
parameters (slope coefficients) are the same across response categories. In addition, 
the assumption of proportional odds is not met. This means that the findings may be 
unreliable, although as mentioned earlier this is a very conservative test.  
The main findings from the ordinal regression are reported below. 
Model significance overall  
The model overall is not statistically significant (p=.098), Table 64. The model does not 
add any predictive power as compared to no model (intercept only). Therefore, we 
accept the null hypothesis and reject the alternate hypothesis.  
Model Fitting Information 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Intercept Only 142.457       
Final 133.161 9.296 5 .098 
Table 64. Significance (9) 
The explanatory power of the model is very low (as we might expect given that the 
model overall is not statistically significant), Table 65. The Nagelkerke value of .080 
suggests that just 8% of the variance in the dependent variable (performance 
immediate) is explained by the model.  
Pseudo R-Squared 
Cox and Snell .072 
Nagelkerke .080 
McFadden .033 
Table 65. PRS (9) 
Ordinal regression coefficients 
Although the model overall was not statistically significant, as shown in Table 66, one 
independent variable (vary response internally) was statistically significant (p=.029, CO 
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1.622), suggesting that a one-unit increase in ‘vary response internally’ leads to a 
1.622 increase in the probability of going up one level on the dependent variable 
(performance). 
 
Table 66. Results of ordinal regression  
6.5.17 Varying response - effect on performance (9x) 
The following analysis refers to the same variables as in Section 6.5.16, but with 
PERFPOST1 rather than PERF1 as the dependent variable 
Rationale for the analysis 
The aim was to investigate proposition P3h; whether varying a firm’s supply chain 
disruption response actions dynamically post event improves performance in shortage 
management, as described in Chapter 3, under the organisational response construct. 
The rationale for choice of test (ordinal regression) is discussed in Section 6.4.  
Hypothesis/Proposition 
The global null hypothesis in ordinal regression is that the coefficients of all the 
independent variables are equal to zero and the alternate hypothesis is that they are 
greater than zero (that the model has greater predictive power than the intercept 
alone).  
The results of the standard diagnostic test for ordinal regression are provided in the 











-0.904 1.14 0.629 1 0.428 -3.139 1.33
[PERF1 = 
2]
1.123 1.071 1.1 1 0.294 -0.975 3.221
[PERF1 = 
3]









1.064 0.835 1.623 1 0.203 -0.573 2.702 2.899 B1 (under 100)
[Beds=2.00
]
0.352 0.445 0.627 1 0.429 -0.519 1.223 1.422 B2 (100 to 299)
[Beds=3.00
]








-0.411 0.528 1.061 Varyresptime_NEW
0.029 0.048 0.919 1.622 Varyrespintern_NEW
0.059 0.239 0.06 1 0.806
Threshold
Location
0.484 0.222 4.739 1
Parameter Estimates





that the model has goodness of fit. As p<.05, we reject the null hypothesis that the 
location parameters (slope coefficients) are the same across response categories and 
the assumption of proportional odds is not met. This means that the findings may be 
unreliable.  
The key findings from the ordinal regression are reported below. 
Model significance overall  
The model overall is not statistically significant (p=.106), Table 67. The model does not 
add any predictive power as compared to no model (intercept only). Therefore, we 
accept the null hypothesis and reject the alternate hypothesis.  
Model Fitting Information 
Model -2 Log-Likelihood Chi-Square df Sig. 
Intercept Only 149.122       
Final 140.042 9.080 5 .106 
Table 67. Significance (9x) 
The explanatory power of the model is very low (as we might expect given that the 
model overall is not statistically significant), Table 68. The Nagelkerke value of .078 
suggests that just 7.8% of the variance in the dependent variable (performance post) is 
explained by the model.  
Pseudo R-Squared 
Cox and Snell .070 
Nagelkerke .078 
McFadden .031 
Table 68. PRS (9x) 
Ordinal regression coefficients 
None of the independent variables were statistically significant which is to be expected 




























-0.642 1.095 0.343 1 0.558 -2.787 1.504
[PERFPOS
T1 = 2]
-0.138 1.093 0.016 1 0.899 -2.281 2.005
[PERFPOS
T1 = 3]









-0.613 0.811 0.571 1 0.45 -2.203 0.976 0.542 B1 (under 100)
[Beds=2.00
]
-0.328 0.447 0.538 1 0.463 -1.203 0.548 0.721 B2 (100 to 299)
[Beds=3.00
]








-0.67 0.298 0.83 Varyresptime_NEW
0.369 -0.241 0.648 1.226 Varyrespintern_NEW
-0.186 0.247 0.567 1 0.451
Threshold
Location
0.204 0.227 0.806 1
Parameter Estimates





6.6 Cross-cutting analysis 
 
The aim of this part of the data analyses is to select triangulation sources that have 
different foci and different strengths so that they can complement each other, as 
recommended by Miles, Huberman and Saldana (2014). Using triangulation enables 
corroboration from diverse sources which enhances the trustworthiness of our 
analysis. However, where conflicting and inconsistent findings are identified due to 
different data facets and data collection methods used, their combined effects build on 
each other to compose a three-dimensional perspective of the phenomena under 
consideration. 
After bringing together the data analysis of both the quantitative and qualitative 
methodologies proposition by proposition, the multi data sources were scrutinised and 
summarised, as below, with each proposition being addressed in turn highlighting the 
analysis foundation. 
Proposition 1a: the stronger the supply chain disruption orientation (SCDO) of a 
unit, the higher the performance in shortage management 
Using information drawn mainly from survey SPSS backed up by the focus group, the 
quantitative analysis showed a statistically significant relationship between SCDO and 
immediate performance, which increases by a factor of 25.48 for every one unit of 
SCDO. Although there was a similar positive relationship with SCDO for post-
performance, it was not statistically significant. From the focus groups, it was noted 
that during the big shortages some units are managing it better than others, not just 
simply the availability of stock in different regions, with the emphasis being on the 
orientation of the team involved. The orientation of the unit with regards to supply chain 
disruptions, according to the focus groups' word cloud outputs, were that it was a 
valuable factor in successful shortage management. In addition, the predominate 
advice given from the interviews by the managers that showed the highest 
performance (+8 out of 10) was the vigilant orientation category (Figure 33).  
Proposition 1b: the lower the role of the actor responsible for making supply 
chain disruption action decisions, the lesser the shortage management 
performance 
From the quantitative analysis, no statistical relationship was shown for role and 
shortage performance with either immediate or post-performance. However, the results 
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from the interviews did show a strong relationship with role, with the stand-out role 
against performance being a senior role and, by contrast, the less qualified role of 
pharmacy technician scoring lowest on both shortage performance and patient 
performance. 
Proposition 1c: the larger the number of hospitals in a trust, the stronger the 
supply chain disruption orientation of a unit  
The one consistent from both the focus groups and interviews was that, although size 
did have influence on the performance of post disruption shortage management, the 
strength and possible causation of that relationship and also the direction was not 
simple to quantify, with mixed explanations in either direction from the qualitative 
research analysis. 
However, the results from the quantitative analysis showed no significant relationships 
between the number of hospitals in a trust and stronger disruption orientation. 
Proposition 1d: the higher the severity of the disruption, the better the managers 
with higher supply chain disruption orientation perform 
From the quantitative analysis, categories 2, 3, and 4 of disruption severity are 
associated with increased probability (ranging from 5.637 to 8.755) of going up one 
level on the dependent variable immediate performance, compared to the reference 
category (extreme impact), as well as a moderate association of disruption severity 
with the post-performance variable. 
The focus groups also indicated that there was a difference in the performance from 
different hospital units, with ‘response complaint noise’ being higher in supply chain 
managers that were not so strongly supply chain orientated. 
Proposition 2e: there is a positive relationship between the performance 
feedback given after a supply chain disruption event and higher performance in 
shortage management 
From the quantitative analysis, there was a significant relationship between both 
immediate and post shortage performance with feedback given. With both immediate 
and post-performance having a statistically significant positive relationship at the 
(p<0.001) level, R squared 2.44. In the case by case qualitative variable analysis, 
during the interviews 66.67% of the cases gave 'really good' feedback, averaging 8.25 
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for performance shortage and 8.17 for performance patient, showing a very strong 
positive relationship.  
Similarly, the focus groups noted the importance of feedback for good performance, 
with a successful team dynamic being described as having good feedback interaction 
from the clinical team prescribing the drugs for the patients on the hospital wards. 
Again, from all the focus groups' query output run on the NVivo software, the word 
cloud had feedback as a dominant theme mentioned. 
Proposition 2f: pursuing an initial buffering strategy followed by a bridging 
strategy enhances performance in shortage management 
From the quantitative analysis, there was a significant relationship between post 
bridging actions and immediate performance, and both buffering immediate and post 
bridging actions in post shortage performance. In the interviews, although there was no 
set pattern of which actions were taken, it was often indicated that the buffering action 
was the first common response. However, in both the interviews and the focus groups, 
a high level of complexity was involved, and the dynamic nature of the response 
spectrum was predominating, with those that dynamically reacted quickly having the 
best performance. 
Proposition 2g: buffering actions in response to supply chain disruption are 
more effective than bridging actions in shortage management performance 
From the quantitative analysis, no association between buffering and bridging actions 
were shown with immediate performance, however there was strong association 
between buffering post and bridging post actions with improved shortage performance, 
and a negative relationship between post buffering and performance and a positive 
relationship between post bridging and post-performance. 
This finding was confirmed by the interviews' cross-case variable analysis, with a 
higher shortage management performance in bridging than buffering (averaging 8 out 
of a possible 10 compared to average 6.3 out of 10 respectively), with the use of 
bridging and buffering in combination scoring highest. 
Proposition 3h: varying a firm’s supply chain disruption response actions 
dynamically post event improves performance in shortage management 
From the interviews, there was a strong relationship between using dynamic actions 
and performance in shortage management, with a dynamic average of 8.30 from a 
264 
 
possible score of 10 for performance shortage management and 8.10 for performance 
patient. Similarly, this was confirmed in the focus groups with change and performance 
being key themes. By varying response actions over time, the general consensus from 
the group discussions was that this would be the most effective approach. 
However, although there was a relationship, there was no statistically significant 
relationship demonstrated by the quantitative analysis. 
Proposition 3i: the impact of buffering and bridging actions in response to 
supply chain disruption vary over time from the first impact  
From the quantitative analysis, there was a significant relationship with bridging actions 
and immediate performance over time, and similarly with bridging actions and post-
performance (R2=0.48), with buffering actions also showing a positive relationship, 
although not a statistically significant one. 
The interviews saw the constant dynamic actions of both buffering and bridging having 
a changing impact, with over 8 out of 10 being constant dynamic actions. In addition, 
the focus groups commented that a buffering action, for example, would change in 
impact in the first 8 weeks compared to the period 8 to 16 weeks because of the 
change in supply availability. 
6.7 Summary 
 
In summary, Chapter 6 presents the data analysis of both the qualitative methodology 
first and then the quantitative methodology in a mixed method approach. It ends by 
considering the joint analysis for each of the 9 propositions in turn.  By ultimately 
combining the results of the analysis in a cross cutting narrative, including conflicts, it 
allows a synthesis of the results to highlight the new empirical contribution through 
insights to the existing post disruption theory framework and understanding.    
 
Chapter 7, following an introduction, discusses these research results and analysis in 
the wider theoretical and management setting. It considers the implications and 
contributions of both the academic and managerial in separate sections and then ends 











This chapter will begin by re-introducing the key research themes identified in Chapters 
1 to 3, the introduction, research background, supply chain review of pharmaceuticals 
and disruptions and the research question, to provide context for this research's 
discussion. It will then discuss and critique the data findings and analysis in Chapters 5 
and 6 and its contribution to the theoretical landscape to give meaning to the research.  
Following this, the next section considers the management implication for this research 
in the intense pressure of the pharmaceutical delivery ‘coal face’.  Lastly, this chapter 
will conclude by providing a summary of the discussions before going on to introduce 
the research conclusions chapter: Chapter 8.  
The heightened interest in the better management of supply chain disruptions has 
been largely due to the rising costs associated with their impact. The need to improve 
supply chains' resilience to these disruptions has prompted the growing importance of 
this research area. Supply chain resilience has been considered in literature from 
multiple perspectives including, but not limited to, crises management (Grewal, 
Johnson and Sarker, 2007), industrial systems and engineering (Ng and Sy, 2014, Li 
and Zhao, 2010), network theory (Greening and Rutherford, 2011, Peck, 2005, 
Turnquist and Vugrin, 2013), risk management and systems theory (Wagner and 
Neshat, 2010, Gaudenzi and Borghesi, 2006, Ho, Zheng, Yildiz et al., 2015). All of 
these approaches have their strengths and weaknesses, for example, the Greening 
and Rutherford (2011) research included an extensive review of 485 articles including 
transaction cost economics (TCE), resource dependency, resource based theory 
(RBT), buyer-seller, economic organisation, network formation, social network, and 
supply chain disruption but no testing of hypothesis.  
Following on from the extensive literature review, this research extends the novel 
framework theory of earlier academic work on understanding the antecedents of 
managers' responses to supply chain disruptions by Bode, Wagner, Petersen et al. 
(2011), jointly based on an information processing theory (Galbraithe, 1973, Tushman 
and Nadler, 1978) and resource dependency theory perspective (Pfeffer and Salancik, 
1978).  The Bode, Wagner, Petersen et al. (2011) research addressed the call to 
augment resource dependency theory with other theoretical lenses (Hillman, Withers 
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and Collins, 2009) and was pioneering in the context of interfirm relationships, with the 
exception of qualitative studies by (Grewal, Johnson and Sarker, 2007, Primo and 
Dooley, 2007). By building resource dependency and information theory background 
and then considering the disruption coping strategies on the response spectrum to be 
buffering and bridging, this built on the prior research work on large American firms 
and environmental and organisational determinants in activities that 'buffer' from the 
social political environment, and activities which 'bridge' with that uncertain 
environment (Meznar and Nigh, 1995). Their research work pulled from previous work 
related to contingency theory (Fisher, 1998), resource dependency theory and 
strategic management.  From the original theory, Bode, Wagner, Petersen et al. (2011) 
framework, supply chain disruption orientation was shown to be a main effect 
subsequent to the occurrence of a disruption in a firms motivation to act, where stability 
is the conjoint driving force for firms to take response actions drawn from both 
information processing theory (Galbraithe, 1977) and resource dependency theory 
(Pfeffer and Salancik, 1978), with supply chain orientation having the greatest effect to 
directly affect bridging and buffering. The Bode, Wagner, Petersen et al. (2011) 
research found that a high supply chain disruption orientation makes a firm more likely 
to craft and execute a specific response for reducing the likelihood and impact of future 
supply chain disruptions. However, although it was suggested that this might lead to 
superior performance and competitive advantage because of earlier work on the 
performance success of information processing approaches to change (Miller and 
Friesen, 1982) and quick and precise responses to environmental changes being 
linked to superior performance (Edmondson, 1996, Dyck, Frese, Baer et al., 2005), 
supply chain disruption orientation was never before empirically tested against post 
disruption performance outcomes. 
This research did test this hypothesis directly and further broke down the performance 
captured into the dynamic output that it is, i.e., into time sections from the disruption 
occurrence. By considering the response actions as dynamic, rather than static and 
‘either or’ and then further examining the resultant post response performance in 
shortage management, this research empirically tested a moving response output to 
specific supply chain disruption events. Other research taking an industrial systems 
and engineering perspective looking at resilience optimisation problems have taken a 
dynamic approach (Ng and Sy, 2014); looking at dynamic transient behaviour when 
system parameters are imprecisely known. This has its theoretical roots in stock 




Sections 7.2 and 7.3 discuss the theoretical and managerial implications of the findings 
and analysis of this research. 
 
7.2 Theoretical Implications from the research 
 
Several important academic implications emerge from the research results, and these 
will be addressed per construct with the main findings from each of the propositions in 
the following sections.  
7.2.1 Supply chain disruption orientation construct 
The first construct considered in the research was supply chain disruption orientation 
through the testing of the propositions (P1a-P1d). Supply chain disruption orientation 
was a new concept introduced into the supply chain management literature by Bode, 
Wagner, Petersen et al. (2011) in considering post disruption response actions. This 
research findings from proposition 1a were that the stronger the supply chain 
disruption orientation (SCDO) of a unit, the higher the performance in shortage 
management, and was indeed confirmed as statistically significant by the quantitative 
methodology. This was true for both immediate shortage management performance 
(up to 8 weeks) and post shortage management performance (8 to 16 weeks). Further, 
it was also supported by both of the qualitative research procedures used; the 
interviews and the focus groups' analysis. 
This supports the normative speculation by Bode, Wagner, Petersen et al. (2011), and 
also previous studies emphasising the importance of firms' orientations and cultural 
traits in enhancing a firm’s capabilities for dealing with adverse events (Edmondson, 
1996, Dyck, Frese, Baer et al., 2005). It also confirms previous work in the risk 
management literature by Autry and Bobbitt (2008), for example, where they 
considered orientation towards risk and operational performance. From information 
processing theory, organisations maybe more active in using information more 
effectively and perform higher to influence its uncertain environment (Galbraithe, 
1973). Further, firms with a high supply chain disruption orientation would be more 
likely to be active in their approach, drawing on the research work by Daft and Weick 
(1984). Active firms are both proactive and assertive, so are less likely to accept the 
environment as a given, so rather than being slower to respond like a passive firm 
would behave, active firms are more likely to be quick to respond. This speed of 
response to supply chain disruptions has been identified as important in previous work 
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in the literature considering factors underlying supply chain disruption response 
(Chadist, 2012, Johnson, 1999, Grewal, Johnson and Sarker, 2007). Based on their 
empirical research, Chadist (2012) proposed four constructs in the relationship 
between response time and factors underlying response; preparation, organisational 
development, partnerships, and appropriate reserves. However, the theory that greater 
response speed can reduce the impact of disruption is a broad statement, and this 
research went deeper into the response alternatives into immediate and post response 
actions and their relative immediate and post performances on shortage management 
in the dynamic post disruption environment. This research found that different actions 
were taken at different stages of the post disruption time gap and different 
performances were the output. The interplay between the response actions over time 
has an effect on performance outcomes, for example, taking post buffering actions on 
their own led to poor performance. So, using reserves by increasing capacity or 
inventory at a certain timeline from the disruption can have an adverse effect on 
performance; the key relationship is that between the supply chain orientation and 
performance. The dynamic decisions made by the higher supply chain orientated firms 
about whether to expand interfirm or intra firm dependencies are more likely, according 
to this research, to have better performance outcomes. 
The research findings of the proposition P1b showed mixed results, with the P1b 
testing that the lower the role of the actor responsible for making supply chain 
disruption actions decisions, the lesser the shortage management performance. The 
results showed no statistically significant relationship from the quantitative 
methodology, but a relationship between higher role and performance in the qualitative 
interviews. This was in contrast to previous quantitative findings on boundary rationality 
bias based on real options theory (Tiwana, Wang, Keil et al., 2007). Proposition P1b 
was included to try and take account of the boundary conditions, based on boundary 
rationality theory (Simon, 1979) in which a firm makes response decisions. Boundary 
rationality encompasses two central concepts: search and satisfying.  The search 
scope is capped by what Simon (1979), describes as an aspirational level that defines 
at the outset of the search process what constitutes a good enough solution. It could 
be argued that the lower the role an individual manager has in an organisation, the less 
scope they would have in the response actions they can take. Prior research confirmed 
this with higher management associated with more bridging actions (Andrews, 1971, 
Freeman, 1984). Mintzberg (1973) also considered managerial roles as how decision 
making choices and their requirements are determined by the manager's role. The 
limits that managers have by their ability to process large amounts of complex data 
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and the access to that data can affect the ultimate outcomes (Hult, Ketchen and Slater, 
2004).  
From the qualitative method of interviews, there was an equal spectrum of respondents 
who had either limited access to information and easy access to multiple sources of 
information, each comprising a third of the total interviewees. This suggests that those 
charged with managing shortages do not have a uniformed standard when it comes to 
accessing information. However, over a quarter of those interviewed did have multiple 
sources of information. This is an explanation of why there was some variation in the 
level of shortage performance. This is in line with previous research but it is only a 
weak result as it is not supported by the quantitative results. 
Proposition 1c, was that the larger the number of hospitals in a trust, the stronger the 
supply chain disruption orientation of a unit. In previous research, system membership 
was reported as an important factor in selecting response actions to uncertainty, 
probably as a result of corporate policies intended to centralise functions and minimise 
costs (Fennell and Alexander, 1987). Size was a salient factor, as noted in previous 
research studies; for example, by Pfeffer and Salancik (1978) who proposed that 
largeness increases organisational power relative to a firms environment, and the 
relationship between a firm and its external environment depends on the firm's scale. 
However, the results from this research were in contrast to prior research and no 
statistically significant relationship was proven in the quantitative tests between the 
larger the number of hospitals in a trust and the supply chain orientation of a unit. 
Although the qualitative methods showed some relationship, the results were mixed, so 
again no strong positive relationship.  However, the qualitative interviews and focus 
groups did give insights as to why this could be, including that each hospital and each 
group of hospitals forming a trust have different functional and managerial priorities, 
such as focuses on surgery or emergency specialities or workloads, but also that the 
staff orientation in a particular hospital was not determined by size. For example, in this 
research one participant who had worked in the different environments of both a large 
urban hospital and a smaller regional hospital had observed a contrasting 
management team supply chain orientation. At odds with the extant literature, it was 
observed by the participant that the smaller regional hospital had a better supply chain 
orientation, including speed of response to supply chain disruptions. The explanation 
given was not only the improved agility in getting actions completed due to the closer 
proximity between departments and short decision management chain, but the overall 
commitment and drive to get the shortage problems relieved was greater in the 
270 
 
regional hospital; whereas in the larger hospital trust, there was less individual 
responsibility taken for actions in response to disruptions. In general, this research 
determined no statistically significant pattern between the variables of size and supply 
chain orientation, in either a positive or a negative direction. This could be due to the 
diversity of the organisations involved or to other factors to be determined by further 
research in this area. 
Proposition 1d of the supply chain disruption orientation construct tested whether the 
higher the severity of the disruption, the better the managers with higher supply chain 
disruption orientation perform. In earlier research on supply chain disruptions by 
Hendricks and Singhal (2005), it was observed that organisations do not perform 
uniformly. (Liu and Cruz, 2012) studied the impact of corporate financial risk and 
economic uncertainty on the values, profit and decisions of supply chains. They found 
that suppliers are willing to sacrifice some profit margins to gain more business from 
manufacturers with lower financial risk and with lower sensitivity to economic 
uncertainty. However, their approach was based on simulated data instead of using 
real data. Prior research also suggested a correlation between increased resilience 
and improved supply chain performance (Pettit, Fiskel and Croxton, 2013). Criticisms 
could be raised on the methodological approach of their single methodology of focus 
group, and their research was also based on a single company in the retail vertical 
over a short period, although it does contain a strong conceptual basis and detailed 
taxonomy. 
This research, based on both quantitative and multiple methods qualitative research, 
found a statistically significant relationship between the higher severity of the 
disruption, the better the managers with higher supply chain disruption orientation 
perform. In the quantitative results, the shortage performance of the highly supply 
chain orientated units were highest on the immediate (up to 8 weeks) performance and 
moderate with the post (8 to 16 weeks) shortage management performance. The 
qualitative methods also produced strong relationships between higher severity 
disruptions and higher shortage performance, particularly from all the focus groups' 
outputs. So, in severe disruption situations the higher units performed better overall, 
which is in agreement with the extant literature on supply chain risk management. 
However, as this concept of supply chain disruption orientation is a new concept, albeit 
based on previous work on active and passive firms, for example Daft and Weick 
(1984), it is the first time it has been tested empirically as a concept. Further, it not only 
tests the concept of supply chain disruption orientation against disruption severity 
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against real data based on real performance, it looks at the changes in performance 
over time from the start of the disruption. This is important as when deploying a 
strategy to mitigate the impact of a supply chain disruption, be it severe or not so 
severe, managers responsible for taking action choices need to know which is the best 
option through the disruption period, not just what to do when the disruption first 
strikes. 
As shown in the results of this research, the higher supply chain disruption orientated 
units perform best in shortage management immediately after the disruption, and 
although this high performance is still better than their peers in the post-performance (8 
to 16 weeks), there is a drop off in level. This could be accounted for perhaps by 
complacency but more likely is that disruption response choices are limited for all 
managers, whether their unit is of high supply chain disruption orientation or not. In 
addition, as the disruption progresses more information becomes available from the 
interfirm relationships (Grewal, Johnson and Sarker, 2007).  However, even in these 
difficult circumstances, the research results show a higher performance for the larger 
severity disruptions both immediately and post the disruption impact. By addressing 
the research gap, this research also addresses the lack of research and practitioner 
based studies in comprehensively addressing the selection of the most appropriate 
strategies in particular scenarios. As noted by Ho, Zheng, Yildiz et al. (2015) in their 
research on supply chain risk management, scholars should evaluate and select the 
best mitigation strategies among various individual and integrated strategies with 
respect to both efficiency and effectiveness.  
7.2.2 Supply chain disruption performance 
The second construct in this research study was supply chain disruption performance 
through the testing of the propositions (P2e-P2g). The first proposition tested was P2e: 
that there is a positive relationship between the performance feedback given after 
supply chain disruption event and higher performance in shortage management. 
Making disruption response decisions that give either a positive or sub optimal 
performance are ‘of the moment’ unless the managers and organisations can learn 
from that performance (Peck, 2005). Choosing the option that seems correct at the 
time may take account of real options but if taken within a managerial vacuum, the 
effect of those decisions and the knowledge gained from those choices will be lost. 
Actors making autonomous response decisions may hold disparate views, and their 
interpretations may overlap without reaching consensus on meaning (Gioia and 
Thomas, 1996). This research extends the previous work on post disruption response 
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decision making, because although the supply chain disruption performance construct 
of this research is grounded in the information processing perspective, as did Bode, 
Wagner, Petersen et al. (2011) and (Bowersox, Closs and Stank, 1999), it also draws 
upon the organisational learning literature. It also refers to the previous work by 
Hedberg (1981), which raised the question of whether firms forget what they have 
learned from previous supply chain disruptions. In summarising the extant literature of 
organisational learning, Hult, Ketchen and Slater (2004) identified four key learning 
elements: knowledge acquisition, information distribution, information interpretation, 
and organisational memory. By including the support of empirical performance 
information from prior and ongoing response decisions, diverse views on concepts can 
be resolved. 
This research found that the proposition P2e between feedback and performance to be 
confirmed as having a significant relationship in the quantitative analysis, with both a 
strong relationship with the immediate (up to 8 weeks) shortage performance and a 
clear relationship with the post (8 weeks to 16 weeks) shortage performance.  Further, 
both the qualitative data collection methods produced positive relationships with both 
the patient and the shortage performances in shortage management through the 
interview analysis and the focus groups' analysis outputs. This is vital, as the results of 
this research are not only empirical based data from post disruption actions but also 
measure the dynamic aspect of post disruption action, taking account of first response 
actions and follow up actions, which reflect the real world dynamic environment. These 
results are in line with expectations from previous work on catastrophic disruptions, 
crisis management, and interfirm relationships. Grewal, Johnson and Sarker (2007) 
found that during response implementation, a feedback loop leads to sense making. 
Although their research was a thorough case study based approach, it was constrained 
to two manufacturing industries, hi-tech and steel, and lacked empirical quantitative 
examination. Nevertheless, it did give interesting insights into positive use of feedback 
loops and the concept of sense making in disruption management.  First on the 
unfolding crisis itself. As the crisis progresses, more information about the crisis event 
and its effect in the interfirm relationships become available. During this unfolding, the 
disruption picture within the interfirm relationship often changes considerably, secondly 
by using an effective feedback loop, potential disruption effects rippling through the 
unit’s interfirm network can be discerned more easily. Managers have the ability then 
to re-evaluate the situation and engage in further sense making through the evolution 
of the disruption by communicating through their interfirm and intrafirm networks. The 
second reason for the feedback loop during the response action repertoire choice is 
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that after a response action has been taken, the unit appraisal of the consequence of 
that choice can be crucial (Dickson, 1992). The uncertainty inherent in disruption 
response is a game of chance, but as the process evolves managers gain more 
information about the effectiveness of the unit's response in stemming damage caused 
by the crisis (Mintzberg, 1990). 
Having a constant feedback loop allows for the adaption of response action in a 
consensus direction; this echoes current thinking on supply chain resilience literature, 
for example, the adaption based supply chain resilience research by Ivanov and 
Sokolov (2013). They take a quantitative approach using control theory balancing 
supply chain protection and adaptability, taking account of managers' risk perceptions, 
risk strategies, and supply chain capability. However, control theory also has its critics 
as not being dynamic enough and too static (Craighead, Blackhurst, Rungtusanatham 
et al., 2007). But non-linear control theory has received support for its adaption 
capabilities in the fast moving consumer goods industry (Spiegler, Potter, Naim et al., 
2016), where a system dynamics approach combining nonlinear control theory (NCT) 
and simulation modelling is applied to evaluate the resilience performance of a 
distribution centre replenishment system. Ivanov and Sokolov (2013) argue this 
mitigates uncertainty and increases the resilience of supply chains from the control 
theoretical perspective – control adaption. This incorporates an adaptive cycle into 
supply chain resilience, as did (Ponomarov and Holcomb, 2011). Further, in the 
additional work on supply chain resilience by (Ivanov, Sokolov and Dolgui, 2014), 
building on Grewal, Johnson and Sarker (2007), they describe the ripple effect, which 
describes the impact of a disruption on supply chain performance and the need for a 
disruption scope of changes in the supply chain structure. They had built on earlier 
works, for example, from socio-ecological systems research, which used the concept 
of resilience, the capacity to buffer change, learn, and develop as a framework for 
understanding how to sustain and enhance adaptive capacity in a complex world of 
rapid transformations. Two useful tools for resilience-building in social-ecological 
systems are structured scenarios and active adaptive management (Folke, Carpenter, 
Elmqvist et al., 2002). Including feedback contingency from performance is a further 










Figure 51. Extended model of organisational responses to supply chain disruptions, including 
action response, output performance and feedback contingency 
 
As shown in the extended model, the information theory and dependency theory that 
underpins the interpretive posture and stability motive, understanding the drivers of 
strategic action selection, is further enhanced by the post disruption outcomes by the 
inclusion of cognition, i.e., the awareness of ‘action and outcome’ building on earlier 
works of the adaptive cycle (Ponomarov and Holcomb, 2011), learning and 
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sense and respond (Lin and Luby, 2005). By including the feedback contingency, it 
allows for back and forth learning in the dynamic environment prevalent in the post 
supply chain disruption process where active variation and combination of strategies is 
more effective in tackling shortages. As shown in the results of this research, the 
feedback contingency allows for better supply chain disruption orientation and shortage 
management performance. 
The next proposition, P2f, investigated by this research was whether pursuing an initial 
buffering strategy followed by a bridging strategy enhances performance in shortage 
management. The examination of the interplay of buffering and bridging in the post 
disruption response environment builds on and extends the Bode, Wagner, Petersen et 
al. (2011) framework beyond the antecedents of response decisions in supply chain 
disruption post environment but considers the action choice effects and efficiencies 
using empirical based performance data. The interaction of different mitigating 
strategies is still not fully understood and could be due to a multitude of supply risk 
factors, for example, because of a lack of vendor diversity, supplier diversity, or sole 
sourcing (Wagner and Neshat, 2010, Ho, Zheng, Yildiz et al., 2015, Tummala and 
Schoenherr, 2011). This research found that in the quantitative analysis, both 
immediate buffering (up to 8 weeks) performance and post bridging performance (8 to 
16 weeks) was positively related in a statistically significant effect. In addition, in the 
qualitative research units that took dynamic actions reached higher performance 
levels. The results that initial buffering actions followed by bridging actions over the 
post disruption dynamic is in keeping with the theory of why this sequence may happen 
(Fennell and Alexander, 1987), where buffering involves trying to keep the environment 
from interfering with internal operations, or trying to insulate itself from external 
interference, then bridging occurs as firms seek to adapt organisational activities to 
conform to external expectations. Bridging implies that the firm actively seeks to 
exceed regulatory requirements in its industry, and promote internal adaption to 
changing external circumstances. However, the effectiveness of this interplay 
sequence is a new insight as called for by (Meznar and Nigh, 1995, Bode, Wagner, 
Petersen et al., 2011). It also reflects other research in supply chain resilience in the 
need to reduce vulnerability in supply chains (Jüttner and Maklan, 2011) and to explore 
relationships between agile and resilient practices to identify synergies, thereby 
allowing unification and integration of the two approaches in supply chain management 
(Carvalho, Barroso, Virginia et al., 2012).   
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The last proposition in the second construct supply chain disruption performance was 
P2g, which considered if buffering actions in response to supply chain disruption are 
more effective than bridging actions in shortage management performance. This 
addressed the research gap in the current research on supply chain risk management, 
for researchers to appraise and select the important mitigation strategies among 
various strategy options with respect to both efficiency and effectiveness (Ho, Zheng, 
Yildiz et al., 2015). Nonetheless, no supply chain strategy is ever likely to be risk free, 
and vigilance is needed even in the best managed supply chain, as well as a dynamic 
approach (Peck, 2006), and managers can only take actions that are available in 
reality, as per real options theory, based on the types of flexibility available (Tiwana, 
Wang, Keil et al., 2007). 
The quantitative research analysis in this study found the proposition P2g as not 
proven, hence the choice of using buffering actions rather than bridging actions per se, 
to enhance shortage performance does not have a positive indication. However, 
conversely the quantitative results did show that using buffering and bridging actions 
together was associated with improved shortage management performance. This is in 
line with previous research speculation by Bode, Wagner, Petersen et al. (2011), that 
post disruption actions of buffering and bridging may not be mutually exclusive, i.e., 
they could be effectively used at the same time. It is also in line with supply chain 
disruption research on interfirm linkages by Grewal, Johnson and Sarker (2007), who 
found that, when forced to react so quickly that their response was instinctive to 
respond to crisis triggering event, managers' choices of actions to take get compressed 
and their sense making occurs in parallel, therefore combining strategies to mitigate a 
problem. This may explain, to some extent, why this happens, but it does concur with 
other current thinking in supply chain resilience literature that combining strategies can 
improve outcomes, reduce vulnerability, and improve resilience (Vlachos, Iakovou, 
Papapanagiotou et al., 2012). Specifically, the data analysis showed that post bridging 
actions and post-performance were associated positively together, whereas in contrast 
using post buffering on its own produced poor shortage management performance. 
This was in line with the qualitative analysis, which showed that there was a higher 
performance in shortages using bridging as opposed to buffering, however, by 
combining bridging and buffering actions together the best overall performance was 
demonstrated. Again, this is in line with existing work on the success of combining 
strategies and not just taking a single static path and demonstrating flexibility to 
enhance supply chain resilience (Sheffi and Rice, 2005, Jüttner and Maklan, 2011, 
Ponis and Kronis, 2012).  
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7.2.3 Organisational Response 
The final construct of organisational response included two further propositions to fully 
answer the research question. These were the propositions (P3h-P3i) to investigate 
the organisational response construct, which incorporates prior work on organisational 
adverse environmental events. Supply chain processes are often measured against 
time (e.g., on time deliveries, picking rates, etc.), as opposed to some other physical 
dimension or quantity (e.g., picking accuracy, product tolerances, etc.), as noted by 
Christopher and Peck (2004). The dynamic management approach to post disruptions 
active management is connected with adjusting the response alternatives over time 
according to the situation presented, and it has been used in resilience optimisation 
from other academic lenses, for example, industrial and systems engineering (Ng and 
Sy, 2014). The first proposition, P3h, addressed the contention that varying a firm’s 
supply chain disruption response actions dynamically post event improves 
performance in shortage management. The results of the quantitative analysis did find 
an association, although not statistically significant. The qualitative analysis did, in 
contrast, support the proposition in both the interview and focus group collection 
methods. The fundamental reason dynamic given in the qualitative reasoning was due 
to the duration of the shortage and the nature of the medicines in shortage. This could 
be explained then by the contextual nature of the industry setting where the disruption 
occurs, in line with the determinist approach to contingency which imposes constraints 
on managers' choices (Burns and Stalker, 1961, Lawrence and Lorsch, 1967). If, for 
example, due to a regulatory shut down of a solitary supplier of a unique medicine 
based overseas and there is no local alternative is available, dynamic response is 
required in the altered environment. Explanations of supply network disruption have 
tended to take a focal firm or a dyadic perspective. These perspectives are adequate 
when considering disturbances (i.e., responses to uncertain demand), which do not 
require any new ties to be made in response to the destruction of existing ties. 
However, in circumstances where either nodes or ties have been removed from the 
network, the surviving actors are compelled to seek new relationships (Greening and 
Rutherford, 2011). In such circumstances, it may not actually improve the shortage 
measurement performance, for example, as measured in the quantitative analysis, the 
fill rate, but it would maintain some or part of the supply back to an even equilibrium. 
This is at the nucleus of supply chain resilience as defined by (Christopher and Peck, 




The last proposition of the organisational response construct was to test whether the 
impact of buffering and bridging actions in response to supply chain disruption vary 
over time from the first impact. The increased focus on mitigating approaches and 
dynamics has been rising in strategic management research, including the 
development of decision support tools for the design of resilient dynamic systems 
when faced with environmental lack of confidence due to disruptions (Ng and Sy, 2014, 
Seferlis, Vlachos, Iakovou et al., 2008, Peck, 2006, Bhattacharya, Geraghty and 
Young, 2009 , Mishra, Sharma, Kumar et al., 2016). This proposition, P3i, however, 
newly examined whether the impact of buffering and bridging actions in response to 
supply chain disruption vary over time from the first impact. The quantitative analysis 
did confirm that both bridging and buffering actions vary over time, and that bridging 
actions enhanced both immediate and post shortage management performance, with 
buffering showing a relationship with performance but not as strong.  
 
Bridging and Buffering Dynamic 
The evidence from both the qualitative collection methods and analysis concurred with 
the quantitative collected data, with respond strategy variation regularly used and 
subsequent changes in shortage performance. This is congruence with earlier 
research by Xu, Wang and Zhao (2014) p106 who stated “an important determinant for 
the changing of supply chain performance is the time when resilient measures take 
effect”. In the Figure 52, below with the accompanying key to the graph, shows the 
performance of lines filled immediately PERFIMM (up to 8 weeks) and lines filled post 
disruption PERFPOST (8 weeks to 16 weeks), measures and the buffering and 
bridging means for both the 8 weeks and 16 week averages. The bridge immediate 
and post, and buffering immediate and post means are taken from the outputs in the 
descriptive statistics variables in the data analysis (Table 13). The lines filled 
immediate performance and lines filled post performance are drawn from the 
descriptive statistics of the quantitative analysis in section 6.2.1 as shown in Figure 42 
and 43 respectively. 
Speed of response and decision making has been found in previous research as noted 
by Pearson and Clair (1998) p.73 “crisis management efforts will be more successful if 
information is disseminated quickly, accurately, directly, and candidly”. However, this 
research highlights that although a high awareness and readiness (through strong 
SCDO) produces higher performance in shortage management, managers must have 
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the insight that mitigating actions should be varied in a dynamic over time since the 
impact. As shown below in the Figure 52, bridging and buffering actions are taken at 
distinct stages (in time) resulting in differing performance outcomes. So just to react 
quickly is not enough, managers need to have the foresight of the complexities of 
processing time. For example, a new supplier might emerge or clinical necessity 
prevents a possible mitigation action being taken. As seen in Figure 52, later time 
period (Post) buffering actions are reduced while bridging actions accelerate. This 
insight can be used when implementing a shortage improvement program, through use 
of SCDO dynamic capabilities, by combining the SCDO program with variation and 
dynamics coupled with dynamic adaption through feedback as will be discussed in the 
proposed supply chain roadmap in section 7.4.  
As shown in the summarising Figure 52 below, the buffering and bridging actions taken 
in the first 8 weeks were different to each other, and they again changed after the 8-
week period for both bridging and buffering in a dynamic affect over time. As seen by 
the shortage performance line, the shortage performance percentage fill rate result at 
the 76-100% level changed and increased from the immediate period to the 8 week to 



















Figure 52. Buffering and bridging dynamic, including shortage performance 
This is an important finding because response strategies in post disruption events 
demonstrated their dynamic versus static nature when developing theoretical 
frameworks to understand both supply chain resilience and the antecedents of 
response actions, whether the motivation to act for stability or interpretative postures, 
and must adopt appropriate underpinning academic theories in line with this dynamic 
nature. Supply chains are not static so theories need to build in dynamic variation, as 
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Mean 3.556 2.365867 2.279762 2.900952 4.48 4.64
Week 0 Week 8 Week 16
BUF 0 3.556 2.365867
BRI 0 2.279762 2.900952
Shortage Performance 0 0.448 0.464
PERFIMM PERFPOST
PERF 76-100% 44.8 46.4
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noted by Fawcett, Waller and Bowersox (2011) p3. “our world is chaotic and dynamic”. 
Supply chain risk based frameworks made prior to a disruption may need to be 
scrapped or adapted in a dynamic environment. Frameworks need to be empirically 
tested, for example, the research work by Ponomarov and Holcomb (2011), where 
research opportunities are abundant but constructs need to be operationalised. This is 
in line with research by Teoh and Zadeh (2013), who produced a strategic 
management resilience model but based the model on a single case study, which has 
limitations because it cannot claim the findings as definitive. Also in congruence with  
Ivanov, Pavlov, Dolgui et al. (2016) whose research looked at dynamic management of 
time critical supply chain under ripple effect using immediate adaption programs, 
although their work was simulation based with an emphasis on costs, revenues and 
profits. Simulation has its drawbacks as shown in a recent study on distinguishing the 
effects of business to business (exchange partnership) on information quality. 
McKnight, Lankton, Nicolaou et al. (2017) conceded that the nature of a laboratory 
experiment could make it hard for respondents to imagine what they would do if they 
were a purchasing manager and having to assume they have a had a continued 
relationship.  
Bridging actions are external to a unit based on resource based theory (Hillman, 
Withers and Collins, 2009, Pfeffer and Salancik, 1978), and buffering actions are 
internal to a unit, according to information processing theory (Galbraithe, 1973), 
however, they both allow for ongoing adjustments. By using adaption to provide an 
integrated approach, as (Stevens, 1989) proposed at an operational level, the supply 
chain is the connected series of activities which is concerned with planning, 
coordinating, and controlling material, parts and finished goods from supplier to 
customer. At a theoretical level neither resource dependency theory or information 
processing theory are singularly able to explain the motivations that drive response 
decisions and need to be integrated to allow for vulnerability in external resource 
provision and internal level effective operation, as suggested by this research's 
empirical experiment outputs. 
7.3 Theoretical Implication Summary 
 
This research looks specifically at post disruption responses and the interaction 
between the alternatives of buffering and bridging actions.  The research question is: 
how do the actions of buffering and bridging in response to supply chain disruption 
events affect the performance of shortage management?  The research used three 
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constructs of supply chain disruption orientation: supply chain disruption performance, 
and organisational response conceptual forms to break the question down into key 
research areas to be explored in-depth.  
To extend the current literature, this research looked through the same lenses of 
information processing theory and research dependency theory as previous research, 
with their mutual roots in the open system paradigm that strives for an orderly and 
reliable pattern of resource flows. However, it looks more closely at the back-and-forth 
between buffering and bridging actions to mitigate disruption post disruption event, and 
included boundary rationality theory and dynamic response action. It further empirically 
tested the original nominal conclusions on performance outcomes of the Bode, 
Wagner, Petersen et al. (2011) theory framework in unique and critical public sector 
service environments in multiple countries to extend the insights into interfirm 
relationships beyond the manufacturing based private sector (active and passive 
firms). In contrast to research based on a preventative approach built on a security 
perspective (Lu, Koufteros and Lucianetti, 2017) of detection, studying what happened 
prior to an event and during disruption episodes, this research looked at how and why 
managers responded to events post disruption; whereas other risk management 
research also found a positive relationship between the mitigating strategies of 
buffering and bridging with supply chain performance in general (Mishra, Sharma, 
Kumar et al., 2016) and that buffering and bridging are not at the opposite ends of a 
continuum (Meznar and Nigh, 1995). This research considered actual supply chain 
post disruption events actions considering supply chain orientation, not standard firm 
typologies and accounting for a new perspective in boundary rationality and dynamic 
action interaction. It further considers other aspects in the existing literature response 
factor spectrum (of prior experience, trust, and dependence) through examining the 
interplay of buffering and bridging with shortage performance, including response 
feedback loop, role, organisational size, impact severity, and the extension of the 
understanding of the newly introduced concept of supply chain disruption orientation. 
In so doing, it illuminates varying patterns of responses over time and action spectrums 
by actors, with outcome performance changing as a result. This is in congruence with 
earlier work on general management behaviour, for example, flexibility (Tomlin, 2006), 
reinforcement theory (Komaki, Coombs and Schepman, 1996) and social cognition 
theory, as noted by Sims and Lorenzi (1992) p234, “A consequence is the result of a 
behaviour; a consequence is contingent upon the behaviour”. But this research 
augments these earlier works and further highlights that there are multiple factors 
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influencing behaviour post supply chain disruption, not just the leadership of the 
organisation itself but the supply chain disruption orientation of the responsible teams 
within the organisation. By including feedback and accounting for dynamic variation in 
post disruption performance, the new concept of supply chain disruption orientation is 
extended and gives further insights and understanding of action mechanisms and their 
interaction with respect to actual shortage management performance. By introducing 
these new variables, the existing theoretical framework is moderated by highlighting 
the modified causal relationships.  Valuably this application of new academic theory 
development provides insights to how to improve post management of supply 
disruptions. 
The extended framework provides insights on how shortage performance can be 
affected by mitigating strategies taken after the supply chain disruption impacts, and 
how feedback, dynamic action and supply chain orientation enhances that 
performance. While many risks are supply chain specific, stemming from for example 
choice of supplier, inventory decisions and dependency of the supplier (Thun and 
Hoenig, 2011). Macroeconomic and wider environmental risks stemming from for 
example political, economic, social, regulatory and natural environment impact all firms 
(Peck, 2005).This framework can be applied to other industries potentially because the 
underlying concepts of for example sense and respond (Haeckel, 1999, Lin and Luby, 
2005), dynamic management (Grewal, Johnson and Sarker, 2007), adaptive resilience 
(Pettit, Fiskel and Croxton, 2013) are not pharmaceutical supply chain specific. Also as 
Breen (2008) found in her risk management research, similarities exist between 
industries in the causal risk factors amongst industries affecting shortages. As this 
framework has indicated positive applicability to the medicines acute care medicines 
supply chain, it is possible those risk factors can be mitigated using this extended 
framework. However, it should be mentioned that even within the same industry 
different response frameworks might be required, and as noted by Breen (2008) the 
pharmaceutical supply chain has a unique criticality not often found in other 
environments. Blair (2012) also highlighted the high level of regulation in the medicines 
supply chain, which could affect the specific circumstances in the performance 
outcomes. Further, Savage, Roberts and Wang (2006) found the relatively low cost of 
logistics to revenue ratio in the pharmaceutical industry compared to other industries, 
and this might influence mitigating response strategy mix  (buffer and or bridge) and 
duration from the impact. Given that the extended framework provides insights into the 
application of shortage management strategies in the drugs supply chain disruption 
management, it provides a new opportunity for testing its generic applicability for future 
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research. A theory helps you identify the limits of generalizations, Corvellec (2013) 
p.12 notes “A theoretical framework specifies which key variables influence on a 
phenomenon of interest and highlights the need to examine how those key variables 
might differ and under what circumstances”.  
The new framework in Figure 51 describes the relationship between the key variable of 
SCDO which the results have shown a positive relationship with shortage performance 
in both time since disruption impact segments. Alternative industry settings could 
potentially improve performance by focusing on this key variable which this framework 
highlights works even when the severity of the disruption is elevated, so could be 
applicable in industries that are subject to severe disruption impacts. With crisis 
readiness research such as Mitroff and Alpaslan (2003) showing that 95% of Fortune 
500 companies are not prepared for an unfamiliar event there is a real need to 
understand disruption response variable interplay, and this new framework provides 
new insights into underlying mechanisms. SCDO from the framework highlights the 
firms that have high awareness and consciousness of supply chain disruptions perform 
better in shortage management, this has also been seen in other industries for 
example in the mobile phone industry. A fire at the Philips microchip plant in 
Albuquerque, New Mexico 2000, caused major disruption downstream to both Nokia 
and Ericsson. Nokia reacted quickly as they were better prepared for the risk of 
disruption and were quickly able to select the correct buffer or bridge technique i.e. 
select an alternative component supplier so customers received product. Ericcson took 
weeks to absorb the information and react causing losses to the company by the end 
of the year of $1.68bn (Latour, 2001).  As found by Supply Chain Council Report 
(2002) reducing disruption impact requires that executives understand the types of 
disruptions present in global supply chain systems and develop methods for 
discovering disruptions in a timely responsive fashion The extended framework, 
describes the importance of the feedback loop contingency, as a constant evaluator of 
the buffer or bridge mitigating strategy choice. Industries with highly developed 
information systems could readily adopt this type of feedback where the adoption of 
the so called ‘internet of things’ or IOT as described by Xu, He and Li (2014), is 
advanced using intelligence monitoring systems for example RFID tags, sensors, and 
wireless communication technology enabling instant feedback. Industries such as the 
food industry for example.  Today’s food supply chain (FSC) is extremely distributed 
and complex. It has large geographical and temporal scale, complex operation 
processes, and large number of stakeholders (Liu, Han, Zhang et al., 2016). Similarly 
in the automotive industry, where multi-tiered supply chains are highly complex and 
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elongated but with well-developed intelligence monitoring systems (Keller, Dang, Fritz 
et al., 2011). Introducing dynamism and variation variables with a combined mitigating 
response strategy through the organizational response construct as shown in the 
extended framework would be more readily applicable in industries in less static 
environments. However research should not suggest all-encompassing solutions that 
ignore the existence or competing position of other theories (Holweg and Bicheno, 
2016). But past approaches have in some cases also ignored the wider institutional 
environment in which companies work (Hines, Wilding and Holweg, 1999). Industries 
that have benefited in the past from  managerial dynamic capabilities  are for example 
fast moving consumer goods (FMCG), (Kunc, 2007). Dynamic capabilities are where 
good processes of managerial decision-making, extend throughout the firm, to 
determine which resources managers identify as strategically important and how they 
combine them. As shown in the extended framework including both the interfirm and 
intrafirm aspects of dynamic capabilities improve shortage performance management. 
The theoretical framework uses then a combination of resilience strategies to mitigate 
disruption impact and this approach has been successfully applied in other industry 
settings indicating possible generic applicability. In the readymade garment industry in 
Bangladesh research by Chowdhury and Quaddus (2015) found in congruence with 
this study that developing and selecting a portfolio of supply chain resilience 
capabilities in order to mitigate the vulnerabilities was the preferred approach including 
back-up capacity, building closer relationships and responsiveness. Similarly multi 
industry research based on  oil and gas, food and beverage, textiles and apparel, wood 
products, paper products, chemical products, rubber and plastic products, basic and 
fabricated products, electrical and optical equipment, automotive and transport and 
furniture by Brandon-Jones, Squirea and Van Rossenberg (2015) found that slack 
resources and visibility can help to mitigate the effects of frequent disruptions on plant 
performance with complex supply chains. This suggests that the extended framework 
which combines the mitigating strategies of buffering and bridging with enhanced 
supply chain disruption orientation and variability with feedback offers significant 
opportunities for generic application building on and giving further insights into the 
theoretical building blocks of existing knowledge of disruption response mechanisms.  





7.4 Managerial Implications 
 
This study is based on the real-world of the pharmaceutical industry, which has been 
experiencing ongoing shortages because of disruptions from both controllable and 
non-controllable factors, such as manufacturing issues and transportation delays, with 
resultant negative patient impact (Breen, 2008). Public health systems, such as the 
NHS, are large, complex organisations with convoluted operational processes that are 
constantly subject to change, and would benefit from operational component 
assessments and benefit from objective benchmarking of processes and performance 
of the pharmaceutical supply chain within the NHS, as called for by previous 
healthcare researchers (Ritchie, 2002). 
The managers who participated and contributed to this research are actively engaging 
in the problem of managing pharmaceutical shortages. Problems caused by medicine 
shortages are serious, threaten patient care in hospitals, and require urgent action. As 
highlighted in a recent survey, medicines are not simple items of commerce; they are 
an essential component of patient care and in the hospital sector they must be 
administered to the patient in a timely manner. This is particularly the case for patients 
taking medicines which have a significant clinical consequence when doses are 
missed, such as anti-psychotics, anti-epileptics, immunosuppressives, and anti-cancer 
drugs (European Association of Hospital Pharmacists, 2014). 
The issues relating to patent and licensing causing shortages due to conflict between 
patient and profit, diversion of manufacturing and exploitation mean that mitigating 
strategies for managers are hampered. Mitigating strategies at the macro level can 
include for example regulations by governments, although this can have negative as 
well as positive outcomes as discussed in more detail in section 2.5.5. Firms can for 
example co-locate with suppliers, which can shorten disruption lengths (Habermann, 
Blackhurst and Metcalf, 2015) although this is not so easy for large public health sites. 
However buffering and bridging strategies can provide some assistance for example by 
holding greater capacity and or through greater information exchange but the 
shortages challenge caused by patent and licensing will be not be easily overcome. 
The industry based steering committee, drawn from the pharmaceutical acute 
secondary care sector, played a vital role in assisting the research study to navigate its 
way through the complex intra and inter organisational supply networks that exist. 
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However, the steering committee and management participants were not initially able 
to recognise the response spectrum frameworks being discussed, not because they 
did not get involved with or take the action choices, but because, at the operational 
level, shortage management is a day-to-day activity and not defined or articulated into 
sets of specific options. There was, however, an earnest appetite from the practitioner 
cohort in learning more and benefiting from insights in improved shortage management 
practice and subsequent performance, not from a self-serving objective but from an 
altruistic driver towards support and care for often very ill patients in their care.  
Understanding how people make decisions can be helpful for explaining and predicting 
their behaviour (Robbins, Judge and Campbell, 2010). Making practitioners and 
managers directly involved with taking operational disruption response decisions and 
those involved in managing these groups at a local, regional, and national level, 
including those departments involved in supplier contracting, regulation and policy, 
would benefit from a response concept awareness either through ongoing training or 
by peer group meeting at an industry or practice association level.  
Focusing on the main insights indicated in this post supply chain disruption response 
research, it is urged that managers take account of the following observations: 
7.4.1 Supply chain disruption orientation 
The study showed that, from the cross cutting analysis, a high supply chain disruption 
orientation was positively related to higher performance in shortage management. 
The suggestion from the research that shortage management performance is 
correlated with the orientation of the unit and managers responsible for making the 
response decisions is a novel management insight. Anecdotally from the qualitative 
discussions, there is an awareness that not all units are performing equally on 
shortage management. Performance inequality in any large organisation on most 
parameters (whether financial, operational, or ethical) is normal, and this research was 
based in three different countries; England, Wales, and Ireland, so this comes as no 
surprise given the different environments in which each hospital unit, trust, or region 
operates. However, like in many large organisations, the explanations or the current 
thinking on why these differences exist could differ widely. This is especially true when 
multiple stakeholders are involved, limited resources are available and where 
management time is caught up in the day to day administration of complex operations 
within highly regulated environments. However, the benefits of considering the key 
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measurement items used to conceptualise supply chain disruption orientation and 
comparing against a current framework by management leadership, potentially using a 
gap analysis, could identify where individual units or groups of units and trust could be 
strengthened. The concept, as articulated in the discussions with the steering group 
and in the focus groups, was not familiar, and furthermore, no set of formalised 
shortage performance measures had been put in place. This may seem surprising 
considering the well-known management axiom that what gets measured gets done, 
and as pointed out by Schlesinger and Heskett (1991), the most important costs those 
derived from poor service rarely get measured. However, in the real world situation of 
pharmaceutical medicine practice where shortages are constant and ongoing, and 
each disruption and every drug therapy is potentially unique, standardising a shortage 
measurement tool (for example, a measurement scorecard) is a complex task, which 
requires not only agreement on definitions of shortages across a wide range of 
stakeholders but also as the acute secondary care service provision is largely in the 
public sector, and so the public gaze, such measurements need to be approved at a 
government and policy level. 
One additional method of introducing the supply chain disruption orientation into the 
consciousness of practitioners and managers is through a method already used in part 
successfully and as a result recognised through the qualitative analysis of this research 
on effective advice to give to other disruption shortage managers; this was to be use a 
vigilant orientation. Those units and managers which implemented and encouraged 
vigilant orientation had the higher performance in shortage management. So, this is 
one attribute which already existed and could be built upon for promoting supply chain 
disruption orientation. Further, that could be implemented more widely to promote 
supply chain disruption orientation concept using the most effective method in 
improving shortage performance, which was the use of a shortage champion.  Not 
every unit has a specific person nominated as shortage champion due to resources as 
well as possibly leadership and priorities, but if this could be encouraged, they could be 
used to deliver the supply chain disruption orientation attributes message.  
7.4.2  Feedback Contingency 
The study results revealed that there was a positive association between performance 




The implication then from the research is that the introduction of improved performance 
feedback would indicate higher shortage management performance could be achieved. 
Feedback whether positive or negative can be used to adjust actions in real time, 
which is an additional observation augmenting the existing (Bode, Wagner, Petersen et 
al., 2011) model of supply chain response based on ‘past experience’. Also, if there an 
alternative that can be approved or need to source another, or a medicine that is off 
license either from own country or abroad for example. Given the positive association 
with improved performance and its relationship to learning organisations, it should 
warrant further interest in evaluating and managing supply risks. It also encourages 
leaders to understand the key lessons learned from the use of live feedback on 
shortage performance. This could be done in an informal way per unit or regional 
practitioner meetings, not necessarily discussing all disruptions to supply, which can 
run into hundreds per week on a consistent basis, but, for example, using weekly or 
monthly contemporary stock reports' aggregated highlights. Ideally, however, the 
feedback dynamic contingency could be formalised into the standard operating 
practices across a set of pilot hospital units to test whether this research’s results do 
indeed result in real world shortage management improvements, with the possibility 
that if the pilot was a success either wholly or in part it could be rolled out on a wider 
basis where practicable and approved by the appropriate regulatory and ethical bodies.  
However, there is, like any large organisation, scepticism about change management 
and new initiatives as found in the qualitative research discussions, one participant 
summarised that: “We are worried; it’s a bit like the banks, we are getting so good at 
dealing with shortages that the [pharmaceutical] companies do not have to worry about 
them. So, there is no onus or pressure on the companies to sort the issue because 
they know that the NHS is good at managing the consequences of their failures”.  
As noted by Nakano and Oji (2017) firms may need a driving department such as a 
supply chain management steering group with the support of top management to build 
these process improvement capabilities. This could be assisted by updating 
practitioner guidelines, where for example the guidelines have no reference to 
feedback contingency but are built on an identify, analyse, plan and execute model like 
the ASPH drug disruption guidelines. 
7.4.3 Buffering and Bridging effective interplay 
The results of this research indicate a positive relationship between sets of scenarios 
of buffering and bridging actions at different time periods from the disruption's first 
impact, namely immediate and post i.e., up to 8 weeks and 8 to 16 weeks. Including, 
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for example, that combining both actions could lead to superior performance in 
shortage management. From a practical aspect within the pharmaceutical industry, this 
could be a challenge to test in a real-world scenario, as unlike a clinical trial phase four 
where the protocol for the medicine has already been tested and approved at each 
stage before, imposing a ‘practice in advance’ would be challenging both from a 
regulatory and ethics perspective. However, this again could be piloted from a 
retrospective secondary data methodology by recording and assimilating what actions 
were taken and what performance outcomes resulted. In this way, patterns could be 
analysed to benchmark this study's findings. Alternatively, simulation modelling could 
be used for the same purposes, and be practically less intrusive and require lesser 
ethical approval. As discussed previously, additional awareness training and 
understanding could be delivered to key stakeholder groups so that managers become 
aware of the study’s findings, although a single research study in the extensive public 
health system, where multiple studies are carried out along with those still pending 
approval, would need the necessary support through the likes of a steering group. 
7.4.4 Varying disruption response actions over time 
Practically, the managers and pharmaceutical delivery practitioners already 
dynamically adjust their response actions over time from disruption impact. However, 
given the research’s findings with positive performance improvement in shortages, it 
would encourage risk managers and management leaders not only to try and record 
and analyse this dynamic effect a practical level and compare it to inventory stock 
management from a risk benefit perspective, but also to identify, whether through 
empirical review of secondary data, for example, action taken against the ‘out of stock’ 
sheets where possible, to foster dynamic feedback in systems format and then review 
it against performance over time. Alternatively, at a management appraisal opportunity 
periodically to investigate whether the individual managers are using a dynamic 
approach or a single approach, whether by pattern over time period or consistently 
irrespective of time from disruption. This research identified through qualitative 
investigation where individual managers only used one particular response option, 
irrespective of the circumstance. This could be because of too close an association 
with a particular supplier, or alternatively no commitment to fostering a partnership or 
collaborative approach. Either way, if this response behaviour could be identified and 
modified, shortage management improvements could possibly be improved in these 
cases, depending on the particular shortage context and medicines and therapies 
involved.   
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7.4.5 Role and shortage disruption performance  
Existing work on role matrix to examine what pharmaceutical practitioner actors 
actually carry out has been and will continue to be carried out in large organisations, 
such as public health systems. This could be from a policy and costs incentive but 
recent internal work on pharmaceutical roles matrix within the England based 
secondary acute care sector (as shown in Appendix 3) shows the diversity of the roles 
themselves and the cross functional responsibilities in their duties and responsibilities 
in that matrix. Given the suggested results from this research, considering boundary 
rationality where the access to information and decision levers could influence 
shortage management performance, this could be taken into account in the next roles 
matrix review. As these reviews take a lot of time and resources to complete, it would 
be encouraged that the shortage management aspect and potential effect on 
performance be included in the considerations of the matrix attributes. The regulatory 
nature of the public health environment, the role titles, related authorities, and access 
as a result of altered responsibilities could give better access to individuals and wider 
boundaries to managers and individuals involved with and responsible for shortage 
management, and potentially improving shortage management performance. As shown 
in the findings of this research, the inevitable slow down due to approval process is 
already a time lag of form filling due to hierarchical and regulatory requirements. This 
slows down response time, hence the need for constant vigilance orientation. Any 
potential to improve this friction in the system through role matrix revision could be 
beneficial. 
7.4.6 Managerial Implications Summary 
In summary of the managerial implications, this research contributes to practice by the 
insights given to practice managers of how supply chain disruption orientation of front 
line teams can influence the positive outcomes in the management of shortages. This 
is vital for practice, as noted by a recent European shortages survey: when a medicine 
cannot be delivered at the instant of patient demand, every stakeholder in the 
healthcare system is affected (Pauwels, Simoens, Casteels et al., 2015).  
The use of feedback and the action – performance dynamic in an operational setting is 
a constructive approach, as is a better understanding of and awareness in the interplay 
of mitigation strategies against actual outcomes in shortage reduction. Insights and 
understanding of varying mitigation strategies over time since the disruption, either in 
combination or as separate tactical interventions in different post disruption time 
continuums, is an effective shortage management strategy. Lastly, individual managers 
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do not work in isolation and further do not work in a vacuum; their access to 
information and knowledge is bounded by their reality, understanding this when 
constructing effective skill set matrixes for role templates can improve shortage 
performance management and overall resource policy.  
The below supply chain road map Figure 53, lays out a process plan to illustrate to 
practice stakeholders and managers how to improve shortage management 
performance at the operational level. 
 
Figure 53 Supply Chain Road Map  
The reason for the inclusion of the roadmap is to draw together the positive elements 
of the research findings. So, when attempting to improve shortage performance after a 
disruption has occurred managers can be not only better prepared to deal with it by 
fostering stronger supply chain disruption orientation, but be more effective in 
performance terms. Management roadmapping was developed by Monomakhoff and 
Blanc (2008) and is a method supported by the roadmap (a pattern for modelling 
organisational capabilities with good practices), and by management mechanisms. It is 
used for transferring good practices, and assessing locally and globally organisational 
capabilities (Rauffet, Cunha and Bernard, 2016). An important matter in organisational 
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learning in distributed organisations is the codification of local innovations, the transfer 
of this knowledge, sometimes called ‘good practices’, and the use of these practices to 
increase the organisational capabilities of each entity. Thus, an organisation must 
share the practices it wants to implement, but it has also to check if these practices are 
understood and correctly used by operational subsidiaries. 
To increase the organisational capabilities organisational learning is required, and 
organisational learning is defined as a “collective endeavour which aims at increasing, 
in a continuous and active way, individual and organisational knowledge and skills” 
(Senge, 1990) p117. The roadmap follows the five step principles of organisational 
adaption as described by Szulanski and Jensen (2006). They explain the different 
transformation stages from a local innovation into a conceptualised organisational 
practice and then into a transferred organisation capability. In the supply chain 
roadmap (Figure 53), the stages that underlies the formation of the pillars stages are: 
step 1 acquisition: an organisational need is identified and knowledge is found locally  
(by expert or operational workers), to address this requirement, step 2 adaptation: 
knowledge is modified and combined, to become organisational knowledge and to be 
adapted to future learners, step 3 application: this adapted knowledge is 
communicated and transferred to the learners, step 4 acceptation: management 
around the applied knowledge must be done so that knowledge is effectively acquired 
by learners and becomes an organisational capability, step 5 appropriation: 
organisation uses the transferred knowledge and skills efficiently. 
The roadmap describes these principles in practice with first three pillars (acquisition & 
adoption) the introduction of a supply chain program, firstly with the assessment of the 
status for example (information and quality) - is there an agreed shortage metric, if not 
define it with an agreed common typology. As noted by Wowak (2016 ) the lynchpin for 
traceability centre on boundary-spanning solutions and coping mechanisms stemming 
from information processing and knowledge that cross functional, ﬁrm, and geographic 
boundaries and considers both supply chain and technology elements . Additionally, 
for example (feedback contingency) - is performance outcome of each shortage 
recorded and feedback, if not capture the outcome data by week, so it can be readily 
available in summary to be feedback to practitioners. Currently many proactive units in 
hospitals record and capture in a weekly shortages report. This includes: date shortage 
was added, name of the drug, strength and pack size, form, brand and manufacturer 
and the expected date of return to stock. The report also contains a list of discontinued 
lines for cross reference. At present however, these reports provide only a running 
294 
 
commentary and are not linked to any formal performance and feedback capture. This 
is a key point of which of the elements need to be emphasised and included in the 
program. The second pillar requires an understanding of the industry and product(s) to 
be included in the programme, and is a generic step irrespective of industry. The 
application principle is represented in the last three pillars in the roadmap. The third 
pillar describes the implementation actors which are listed but these could be replaced 
with other roles depending on country where implemented, and will apply the high 
supply chain orientation and dynamic variation in responses. The last two pillars of the 
road map show the two response mitigating strategies, which can be combined and 
varied during the time from impact in a dynamic and adaptable response to maximise 
shortage management performance in application. The response strategies are 
engaged through the prism of the severity of the impact of the shortage, which will be 
visible through the ongoing capture of the out of stock weekly reports in summary. The 
final element is the flowback of performance to enable the implementation actors to 
interpret dynamically the action behaviour in performance terms as shown by the 
arrows in Figure 53, so that the response mix (Buffer or Bridge or Both) can be 
perfected as necessary, through the time from impact mediated by the severity of the 
impact. This last stage represents the principles of acceptance and appropriation, 
where the improved performance enhances acceptance and the capabilities are 
recognised and transferred successfully to the organisational unit.  By using this 
roadmapping approach the internal resources can be optimally exploited to create 
significant assets for the organisation in a continual lifecycle of capability in line with 
other resource view based research (Helfat and Peteraf, 2003, Pettit, Fiskel and 
Croxton, 2013). 
 
7.5 Overall summary: theory and practice 
 
Bringing together the theoretical and managerial implications in order to better 
understand how the mitigating strategies of buffering and bridging affect shortage 
management performance, there is a need to extend the existing theoretical framework 
of Bode, Wagner, Petersen et al. (2011). The inclusion of a feedback loop linking the 
performance outcomes to the supply chain orientation of the management unit 
improves the shortage management outcomes. As suggested by Sims and Lorenzi 
(1992), effective management strongly suggests a performance orientation, however, it 
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is not just the individual employees linked to overall organisational achievement, rather 
it is predicated on the team action dynamic decision making and post disruption 
variation strategy that will produce enhanced shortage management results. By 
understanding and documenting shortages outcomes in an ‘action and result’ dynamic, 
information processing theory and cognition are combined, and through the 
incorporation of boundary rationality, the stability drivers of dependent resource theory 
are better harnessed for shared value supply chain disruption orientation through self-
management. This research has shown that buffering and bridging actions as 
mitigating strategies in shortage management are effective tools, depending how and 
when they are applied; however, it is noted that they are not the only strategies 
available, which is a potential limitation. Chapter 8 describes the research conclusions, 


















8.1 Research reflections 
 
This research answered the call for more strategic management research on supply 
chain disruptions, in particular the lack of empirical work, which may be due to the lack 
of commonly accepted definitions, lack of a conceptual framework, or the difficulty in 
collecting data around events that are unpredictable (in terms of where and when they 
will occur). This paucity of research is despite an increasing acceptance (reinforced by 
perceived risk) that disruptions will occur, be it, for example, through natural 
phenomena (weather), social political (terrorism) or elongated supply chains (Greening 
and Rutherford, 2011, Ho, Zheng, Yildiz et al., 2015). However, this research has 
made new academic contributions to research by examining post supply chain 
disruptions, extending the theoretical framework of Bode, Wagner, Petersen et al. 
(2011), augmenting the need to balance the larger body of work on prior supply chain 
disruption decisions and risk management. By identifying new factors that moderate or 
mediate key relationships within the existing theoretical framework, the concept of 
supply chain disruption orientation is extended and new causal relationships are 
identified through the expansion of thesis constructs: supply chain disruption 
orientation; supply chain disruption performance and organizational response, 
contributing to extant theory.  
The investigation formulated one research question to address this, and the three 
constructs were used with the subsequent relevant nine research propositions to be 
tested to answer the research problem. Each proposition was used to give novel 
insights into the interplay between response action mitigation strategy options to 
answer the research question: how do the actions of buffering and bridging in 
response to supply chain disruption events affect the performance of shortage 
management. These included an examination of the concept of supply chain disruption 
orientation, giving new insights and concept refinements; additional factors through a 
boundary rationality lens of role and size were incorporated in the buffering and 
bridging interaction considered. Further, original insights were examined in disruption 
severity and feedback contingency, as well as the varying of response action 
empirically tested performance consequences. All the propositions examined the 
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performance outcomes in terms of shortage management in empirical evidence terms, 
rather than the previous nominal only research work. In addition, to account for the 
dynamic nature of supply chain disruption response spectrum and subsequent 
performance over time, each action and performance measurement was categorised 
uniquely into immediately after the disruption and then after a defined period from the 
disruption's initial impact. The interaction of buffering and bridging was examined in the 
context of shortage management in a public health context, which takes into account 
the importance of new settings for supply chain resilience development (Carvalho, 
Barroso, Virginia et al., 2012), rather than the often research-based settings of private 
manufacturers. 
The importance of addressing the current and ongoing practical problems facing 
shortages in pharmaceuticals due to the ongoing supply chain disruptions is vital. As 
noted by Huq, Pawar and Rogers (2016) supply chain disruptions lead to a change in 
strategies at the macro-level (reconfigurations) however, the effect of disturbances at 
the micro-level, in particular on supply chain performance metrics has been little 
studied, this research tackles this gap directly. There are massively increasing 
shortages which effect both practitioners and patients. Acute and chronic shortages of 
various pharmaceuticals and particularly of sterile injectable products are being 
reported on a global scale, prompting evaluation of more effective strategies to 
manage current shortages (Li, Subramanian, Anderson et al., 2015). Wider financial 
implications of not taking steps to improve outcome performance of response actions 
were outside the scope of this study but with a current day to day NHS budget of 
£108bn, any marginal efficiency gains through more effective post disruption 
management would produce cost benefits. Spending is expected to rise to £123 billion 
in 2020/21, of which £111 billion will be for the day to day running of the NHS (Full 
Fact, 2017). However, this is not just a UK and Ireland issue; a recent US based 
survey mentioned 86% of hospital pharmacists reported that medicine shortages are a 
current problem in the hospital they work in in terms of providing the best care to 
patients, and from the hospital pharmacy 66% of respondents said that medicine 
shortages affect their hospital pharmacy on a daily or weekly basis (PharmTech, 
2017). 
 
To meet this significant research problem, this study used a robust triangulated 
methodology rather than singular quantitative methodology, or emerging grounded 
theory, which had been used in previous post disruption research. As noted by Miles, 
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Huberman and Saldana (2014) findings are more dependable when they can be 
buttressed from several independent sources. In addition, commonalities between 
findings of the different data sets revealed a convergence in interpretation. This 
blended method proved effective allowing both the how, what, and the why questions 
to be addressed. Further, by using resource based theory, boundary rationality and 
information processing theory as a lens to construct quantitative collection 
methodology with a multi-country online survey, and combined with a qualitative 
collection methodology using both interviews and targeted focus groups, it provided a 
compelling mixed methodological approach.  
 
8.2 Limitations and future research directions  
 
Several limitations of this research could be considered in the interpretation of its 
results; however, all empirical research has limitations. Despite the encouraging results 
of the tests reported here, some constraints on the data collection include:  
1. Larger response rate for stronger reliability  
2. Only one industry, albeit a large and complex organisation, was included 
3. Only the downstream buyer side of the supplier – buyer dyad, was 
considered  
In addition, the performance timeline from disruption was arbitrary, although based on 
the interaction with the research steering group. Different results could have been 
discovered if shorter or longer periods had been chosen, but generally it was in line 
with the participant’s expectations. However, further research could look at a more 
longitudinal study approach rather than retrospective, in addition to different time slots 
looking at, for example, quantification of the identified drop in shortage performance in 
later buffering in contrast to the rise in later bridging shortage performance. This would 
extend part of this research’s findings, in particular the uneven performance scores 
over time since the supply chain disturbance, and could also build on the existing study 
by capturing the response action and effect dynamic over a longer time period than 12 
months. The medicines in shortage sample was selected by frequency of occurrence 
and recognizability by the target group, and although an ‘other’ medicines option was 
offered, different retrospective timelines could potentially have different drugs in 
shortages with different indications and response actions taken. 
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The research used the UCLH medicine shortage data base as a ready source of which 
drugs had been in shortage, and was highlighted (by the expert steering committee) as 
the most widely used repository for recording drug shortages from across the UK. 
However, limitations to the use of any retrospective database exist including for 
example variation in design, inclusion criteria, consistency and objectivity (Peterson, 
Nau, Cramer et al., 2007). As the ten most frequent medicines selected for the initial 
drug population pool, were then reviewed by the expert practice steering group with a 
specified typology, replacing two of the items which ensured the medicine sample pool 
of five items was relevant and valid. The final sample pool included a range of drug 
types for different therapeutic treatments. The inclusion of specific medicines in the 
survey using a specific medical shortage situation improves the design of the research 
instrument by strengthening  reliability (Doty and Glick, 1998). By specifying the 
medicines and requesting month of occurrence, it improved the trustworthiness of the 
survey answers recorded and transferability of the research process employed, so that 
the results of this research were not unduly affected using the UCLH retrospective 
database as it did not rely solely on the database for the final sample pool. 
This research has shown that buffering and bridging actions as mitigating strategies in 
shortage management are effective tools, depending on how and when then are 
applied; however, it is noted that they are not the only strategies available, which is a 
potential limitation. That said, other strategies were considered; for example, from the 
five operational strategies for managing disruption risk (Wang, Gilland and Tomlin, 
2010), however, many of these are already encapsulated, and those that are not, such 
as demand management, are more ethically challenging to apply in a patient health 
related drug shortage disruption. The underlying theories of information processing and 
resource dependency combined with boundary rationality in the context of post supply 
chain disruption which instigate shortages is a starting point for further investigation 
where the stability motive and motivation to act are bounded by the context of the 
decision maker and the dynamic feedback on performance received. However, this 
researches choice of performance measurement and the importance of the metric 
used could be a potential limitation. Also, the performance was completed as a self-
reported metric in the survey, offering potential self-bias, however, as the data 
collection was completely anonymous, no individual or group gain could have been the 
motivation for incorrect reporting. Moreover transcripts were closely scrutinised and 
coding scheme  employed, to counter potential threats pertaining to bias and reactivity 
common to qualitative research as recommended by Bloomberg and Volpe (2015).   
Performance measures are, however, always difficult to define (Beamon, 1999), and 
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the process of choosing appropriate supply chain performance measures is difficult 
due to the complexity of these systems, though it was widely accepted that fill rate was 
by far the most common method used in the industry and easily recognisable and 
available, hence why it was advised to be used in this research by the practice expert 
steering group. Like all metrics, they can be critiqued but one has to start somewhere 
to deliver insights. In science, we seek to balance curiosity with scepticism (Babyak, 
2004); this said, alternative metrics could be tested and combined to verify the results 
and to add to the research area in future work. Further, post supply chain disruption 
action is suggested to be analysed in terms of financial metrics rather than purely 
operational and patient performance outcomes. 
Other limitations were that, although feedback and performance positively related in 
the quantitative analysis, it was also positively related to other factors. This needs 
further investigation, however, the challenge for all research studies is that they are not 
infinite in time and resource. It does offer the opportunity for further quantitative study 
to validate these outputs for future theoretical frameworks. For example, it could be 
argued other perspectives such as system dynamics and non-linear control theory 
could be applied to feedback contingency in the extended framework model as shown 
in Figure 51. However, these alternatives also have certain limitations. In linear control 
theory analytics linearity requires strong assumptions regarding demand back-ordering 
and negative orders (i.e. physical returns), and imposes heavy burdens on possible 
relationships between parameters (Ivanov and Sokolov, 2013). Although these 
limitations can potentially  be eliminated with the use of system dynamics theory, as 
shown in the study by Villegas and Smith (2006) on the analysis of inventory and order 
oscillation trade-offs. A stochastic modelling approach is an alternative methodology 
that could be explored in future research, however this research focus was on 
empirical field based evidence to test the extended model. Examining empirical 
evidence is a valid approach for identifying building blocks of theories and concepts to 
support the development of new scientific fields. Indeed, “scientific knowledge is often 
rooted in practice: culture and society existed before we had anthropology and 
sociology” (Bouthillier and Shearer, 2002) p.33.  Vahdani et al. (2011) developed a 
hybrid multi-stage predictive model for supply chain collapse recovery analysis in light 
of continuity management. Although these techniques have high practical relevance 
the stabilizing controllers still remain a critical bottleneck (Mayne, Rawlings, Rao et al., 
2000). Another critical issue in applying this type of modelling to supply chain research 
is the centralized controller and its functions. In technical systems, the controller is a 
technical device (e.g., a sensor) that adapts within milliseconds system to behavior 
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based on error identification (Spiegler, Potter, Naim et al., 2016) . The controller in the 
real-world pharmacy is a manager, or more precisely, a number of managers as part of 
a team with possible conflicts of interests, hence the importance of supply chain 
disruption orientation. Even if a deviation in supply chain execution has been identified, 
the model controller will not be able to change anything. The challenge with modelling 
real world behavior is the complexity and range of possible outcomes and the 
sensitivity of those outcomes, especially when assumptions are changed. Relying too 
heavily on stochastic modelling can create a false sense of accuracy and a tendency  
to be less prepared to address downside risk and short-term volatility (Friesen, 2016). 
Ethical constraints in the public health organisation arena meant strict limitations on 
protocols, which then meant only a smaller than expected pool could be approached 
and encouraged to participate, however, from a practical observation such pre-data 
collection preparation actually improves the ultimate response rates due to a clearer 
understanding of participants due to better prepared protocols. In future work, localised 
studies with onsite participation would also produce rich and intense results at the 
operational level, however, would be potentially more difficult to generalise. Future 
work could test the buffering and bridging interplay performance outcomes in 
shortages in different geographies; in private versus public health or other public-sector 
provision, including direct and indirect costs implications.  Moreover, the policy aspect 
of the implications of changed performance could be investigated to consider the 
research gap of post supply chain disruption beyond the operational level. A macro 
level investigation could investigate, for example, best practice across public health 
systems, for example, in potentially a meta-analysis style approach to inform policy 
level decision making managers.  
This research used validated and reliable triangulated methodology with a robust data 
analysis, however, other novel methodological approaches could be used, for example, 
simulation and optimisation modelling to overcome the regulatory and ethical 
constraints within public health services. Triangulation (as for all methods) possesses 
strengths and weaknesses, each of which must be critically acknowledged and 
addressed throughout the analytic process (Farmer, Robinson, Elliot et al., 2006). 
Alternatively, cross industry focus groups could bring together both sides of the 
supplier and buyer spectrum. By including the supplier side an alternative set of 
opinions could have been revealed, with different drivers and were excluded due to the 
time and resource constraints of this research. 
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The research study focused on the downstream part of the whole pharmaceutical 
supply chain very close to end users that being the secondary care acute hospital 
sector as this is where the severe effects of shortages are impacted, and mitigating 
strategies in high demand. However as discussed in section 2.5 there are also 
consequences and impacts in the supplier side, and opportunities to improve 
throughout the end to end supplier chain including government departments at a 
country level and in regional and international levels, as the pharmaceutical supply 
chain has long been a global operation (Booth, 1999, Ni, Zhao, Ung et al., 2017). 
Future researchers could look to extend the scope of this study by including suppliers 
and distributors in an end to end supply chain research investigation to address all of 
the elements in the end to end supply chain as shown in Figure 12, taking a broader 
view of supply chain resilience as recommended by Wright (2013). This would pose 
many challenges  due to the complex nature and multi layers as supply chain involved 
as shown in the Breen (2005) pharmaceutical supply chain map in Figure 7. As noted 
by Kauppi, Longoni, Caniato et al. (2016) today's global supply chain normally contains 
hundreds of members, or even thousands. It is infeasible to get them all work together 
on risk management. A more realistic way would be to let a smaller number of close 
partners cooperate initially. However it could be a promising project, and it could be 
achieved by concentrating on one or two suppliers of a limited amount of specific 
medicines, and study each component end to end from raw material provider to 
contract manufacturer(s) (CMO) of the ingredients (which could be India or China) 
through primary manufacturing process to secondary manufacturing processes of 
packaging, and then through to the downstream supply chain engaging with 
wholesaler, distributors and prewholesalers through to a hospital trusts group and 
individual pharmacy unit in the destination country. Including suppliers in future 
research in disruption response would be useful as suppliers are a critical part of the 
supply chain and product development process, as noted by Chadist (2012) p.279, “ 
the [supplier] relationship and frequent communications are critical to rapid response”. 
Supply resilience has been examined particularly from a global sourcing aspect 
(Goetschalckx, Vidal and Dogan, 2002, Manuj and Mentzer, 2008), but the supply 
chain's exposure to vulnerability can refer only to a part of the supply chain (atomistic 
vulnerability) or to the entire supply chain (holistic vulnerability) (Svensson, 2000). 
Whereas this research only focused on the downstream disruption response part of the 
supply chain, an end to end supply chain would provide further insights into holistic 
vulnerability.   
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Other perspectives could be used to examine the internal relationships and supply 
chain resilience issues considered in this research, for example, from an analytical 
ideology rather than a scientific approach, including an organisational psychological 
approach, a social political or power based approach. Health policy makers in 
particular are attracted to scientific certainty, and demonstrable relationships, but have 
subjected social and economic research to tough criticism for being too academic and 
theoretical, and of minor practical use (Walt, 1996). The inclusion in this research of 
the supply chain road map for practitioners provides a ready point of guidance to 
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Table 70 (continued) 
CRITIQUE DATE AUTHORS TITLE EMPIRICAL
Analytical review 2012 R Andersson Resilience in the supply and demand chain a new management strategy
B Mansson
D Y Hamidi
Analytical review - Early Concept development 2004 M Christopher Building the Resilient Supply Chain
H Peck
Analytical review - Early Concept development 2006 M Christopher Creating Supply Chain Resilience through Agile Six Sigma
C Rutherford
Analytical review - Early Concept development 2005 Y Sheffi The Resilient Enterprise: Overcoming Vulnerability for Competitive Advantage
Analytical review 2005 Y Sheffi A Supply Chain View of the Resilient Enterprise
J Rice
Single method of focus groups was used on 2010 J Pettit Ensuring Supply Chain Resilience : Y
single company in the retail vertical over short period J Fiskel Development of a Conceptual Framework
strong conceptual basis & detailed taxonomy K Croston
Framework requires empirical testing, & contructs 2011 S Ponomorow Understanding the Concept of Supply Chain Resilience
operationalising. Research opportunities abundant  M Holcomb
PERSPECTIVE METHODS THEORY
Quality Management Literature review :5 principles that characterise supply chain resilience:  Total Quality Management, Hendricks & Singhal (1996)
 risk management culture, agility, design-and innovation-led  organisations, collaboration  
& spreading and anchoring of the vision, goal, values and methods
Supply Chain Literature review/UK govt Emergency planning Classic Decision Theory
 'at Risk: vulnerable; likely to be lost or damaged'
Supply Chain - Optimum Leanness Literature review including example manufacturers using Six Sigma Process Control : Lean Six Sigma
for example Motorola & Ford
Strategic Management Literature Review - Including empirical studies of Toyota,J&J,US Navy Vulnerability framework & map
Strategic Management Literature Review Vulnerability framework & map
Company position & responsiveness
Supply Chain Grounded : Focus Groups Supply Chain Resilience Framework (Strategic Management)
Retail & Fashion retailer - Limited Brands Resource based approach to strategy analysis (Grant, 1991)
Logistics Integrative literature review Development  theory of Social Psychology (Conrad et al,1999) , Adaptive Cycle Theory
(Carpenter et al, 2001) & emerging theory of Resilience
FOCUS KEY CONTRIBUTION
Quality Management Philosophy C Quality management philosophy improves the companies’ resilience, 
 due to increased agility & strengthened ability to handle variability 
& risk management
Mitigation - Process control perspective M Framework for improved supply chain risk
identification
Quality control to reduce process variability Q Using Six Sigma approach to reduce internal risk
whilst improving sc efficiency & effectiveness
Enterprise wide M Building in redundancy,flexibility can reduce sc vulnerability
Supply Chain disruption Mitigation M Increasing flexibility to improve resilience
Supply chain resilience C Supply Chain Resilience framework in terms of measureable variables, 
create tool for management, defined 14 capabilities
Concept of resilience multidimensional & C Supply chain resilience framework - Interdisciplinary understanding of the concept






Table 70 (continued) 
CRITIQUE DATE AUTHORS TITLE EMPIRICAL
Understanding of why question in sc vulnerabilities 2005 H Peck Drivers of supply chain vulnerability: an integrated framework Y
lacks practical approach for managers, or full
taxonomy of risk 
Preliminary basis for future simulation 2008 M Falasca A Decision Support Framework to Assess Supply Chain Resilience
optimisation analysis C Zobel
D Cook
Three pronged methodological approach 2007 J Blackhurst An empirically derived agenda of critical research issues for managing Y
Review recognises current early stage of C Craighead supply chain disruptions
disruption research and weaknesses in non dynamic D Elkins
optimisation & control,game theory,simulation tools R Handfield
Novel approach in this context in current literature 2010 M Wagner Assessing the vulnerability of supply chains using graph theory Y
N Neshat
ABS well tested technique, however single 2007 P Datta Agent Based Modelling of Production/Distribution systems to improve Y
industry focus - highly specialised potential M Christopher Resilience
difficulties in generalisation P Allen
Mixed method strong approach but focus on 2005 U Juttner Supply Chain Risk Management : Understanding Business Requirements Y
large companies. Lacks guidance on how managers from a Practitioners Perspective
select from strategies , Manuj & Mentzer (2008) 
PERSPECTIVE METHODS THEORY
Network theory & Complex Exploratory case study - Aerospace (military) Industry Supply chain disruption viewed through the lens of network related
systems theory Validated by cross industry interviews with SC managers from other critical sectors theories ; Dynamic Capabilities (Teece et al,1997;Heide & John, 1990;Heide & Stump,1995)
Normative - Understanding rather than positivist social exchange theory (Anderson & Narus,190)
Supply Chain Design Simulation modelling - Quantitative approach The Resilience Triangle Tierney & Bruneau (2007)
SC disruption management Exploratory Automotive case study, semi structured interviews cross industry Normal Accident Theory (Perrow,1984)
Resource Dependency Theory & focus groups
(Pfeffer et al, 1978) Strategic
Contingency Theory (child,1972)
Risk Management Survey across 8 industries SC Executives Graph Theory (Gibbons, 1985) 
Using Graph Theory to provide supply chain vulnerability indices for industries
Decision making process impacts Case Study - Agent Based Simulation Modelling - Paper Tissue Manufacturer Using ABS to address disturbances & subsequent Forrester affect
Agency Theory
Systematic Supply Chain Exploratory quantitative survey (Cross industry) and qualitative 
practitioners  Focus group with SC managers Supply Chain Risk Management Concept & a structure for research issues in SCRM
FOCUS KEY CONTRIBUTION
Sources & Drivers of sc Vulnerability C & R Conceptual model of a supply chain as an
Networks response to disruption interactive adaptive system.
Assessing sc resilience to disasters I A DS  framework to assess supply chain resilience
3 main determinates - Density, Complexity & Node Criticality
Disruption analysis, mitigation & sc Design P Disruption Discovery, Recovery, Supply Chain Redesign
for Resilience 
Quantification & mitigation of sc vulnerability I Supply Chain Quantification
Modelling the integrated production/distribution P ABS method to understand key issues for understanding operational resilience
system under uncertainty conditions in production distribution systems
Business requirements for sc risk management M Business requirements from practitioner perspective






CRITIQUE DATE AUTHORS TITLE EMPIRICAL
2011 H Calvalho Integrating Lean, Agile, Resilience and Green Paradigms in Supply Chains
C Cruz-Machado
Dynamic monitoring requires implementation of 2009 A Bhattacharya On the Analytical Framework of Resilient Supply-Chain Network Assessing
information system. Conceptual framework J Geraghty Excursion Events
requires validation. P Young
Lacks statistical testing (e.g.SEM) 2006 M Faisal Supply Chain risk mitigation: modelling the enablers Y
generalises on results from Indian Manufacturing D Banwet
R Shankar
Exploratory lacks empirical follow up 2008 L Breen A Preliminary Examination of Risk in the Pharmaceutical Y
Supply Chain (PSC) in the National Health Service (NHS) UK
(UK)
Limitation single focal company & 2006 B Gaudenzi Managing risks in the supply chain using the AHP Method Y
industry vertical (medical/dentistry) A Borgeshi
Robust mixed methodology large heterogeneous 2011 C Bode Understanding responses to supply chain disruptions: Y
sample size (although all manufacturing) K Petersen Insights from Information Processing and Resource Dependence 
with strong statistical analysis & theoretical basis L Ellram Perspectives
PERSPECTIVE METHODS THEORY
Supply Chain Management Literature Review LARG paradigms (Lean -Womack et al (1990),Agility- Christopher (2000),Fan et al. (2007),
Resilient , Christopher & Peck (2004),Carvalho & Machado (2009),ANP, Saaty (2001)
Resilient Strategic Management Descriptive analysis Built on Christopher & Peck (2004) ; Snyder et al. (2006) SC Resilience work
Gestated quantitative decision-support approach New paradigm proposes stochastic dynamic decision making
tools for trade-offs among multiple & conflict criteria to build resilience
Supply Chain Risk Management Interpretive structural modelling (ISM) - Indian SME Manufacturers
Development of ISM (Interpretative structural  modelling (Warfield,
(Identifies & summarises relationships among specific variables to define a problem) 1974; Sage, 1977) with regards to interpreting  SC risk management mitigation
Supply Chain Risk Management Focus groups PSC stakeholders, suppliers & wholesalers Developed study based on earlier work on sc Risk management including
NHS professional & government bodies Blackhurst et al (2008) ; Chopra & Sodhi (2004)
Supply Chain Risk Management Case study using Analytical Process Model to prioritise SC Objectives & identify Risks
Developed study goal of establish the “trade-off” required in complex
decision-making situations, such as consideration of different objectives based on
different criteria Goodwin & Wright (1998)
Dental & Medical Supplies , 4 key managers from focal company
Information Processing & Case study using cross industrial survey of manufacturers Germany,Aus,Switz New holistic theory of organizational responses to sc disruptions ,authors
Resource Dependence integrate organizational informational processing ,Galbraith (1973;Tushman & Nadler


















Table 70 (continued) 
FOCUS KEY CONTRIBUTION
Integrating Multiple Paradigms in SCM I Identification of the conceptual relations among LARG - SCM
Event Excursions I Conceptual analytical framework for resilience of SC Networks
Strategies for Low probability - by assessing excursion events
High Impact disruptions (LPHI) Decision for buffer location in system - 'shock absorbers'
Reducing risk by addressing probability M Presentation of enablers and classification into driver/dependant 
& direct impact category unique in SC Risk Management
Risk management in Pharmaceutical I 35 Prevalent risks identified and categorised - impact, occurance & controllability
Supply Chain
Evaluation method for supply chain risks I Model used for setting up priority hierarchy for risk management
Strategic Disruption Response R
New Theoretical Model - providing insights into the mechanisms






CRITIQUE DATE AUTHORS TITLE EMPIRICAL
Excluded transaction costs in 2009 N Bakshi Co-opetition and Investment for Supply-Chain
analysis P Kleindorfer Resilience
2010 C Colicchiaa Increasing supply chain resilience in a global sourcing context Y
Proven simulation technique with 5,000 replications F Dallaria
Requires combination with cost model for practice M Melacinib
Strong method focus on industrial sector 2011 U Juttner Supply Chain Risk  Effect & Knowledge Management Y
S Maklan
Analytical review 2006 C Tang Robust strategies for mitigating supply chain disruptions
Large scale empirically tested 760 usable responses 2007 S Wagner An empirical investigation into supply chain vulnerability Y
Drawback German based low risk country vs. US/JP C Bode
Extensive simulation but single Automotive based 2012 H Carvalho Supply Chain Redesign for Resilience using Simulation Y




Analytical, ideological rather than scientific approach 2010 M Vickers Resilience in Organizational Actors & Rearticulating Voice Towards 
A Kouzmin a humanistic critic of New Public Management
Analytical, thorough review 2012 S Ponis Supply Chain Resilience: Definition
E Koronis Of Concept And Its Formative Elements
PERSPECTIVE METHODS THEORY
Disruption risk - Security & Disasters The Harsanyi–Selten–Nash bargaining framework is used to model Bargaining theory under incomplete information ,Myers (1979), Principal-agent theory
the supply chain participants’ choice of risk mitigation investments Laffont & Martimort (2001) - Moral Hazard & Information rent (reward for safe suppliers)
Supply Chain Risk Management Mapping of Supply process of a home appliance retailer in Italy Supply Chain Lead time as a proxy for Supply Chain resilience in context of inbound
with suppliers located in China. Monte-Carlo simulation method
supply, building on earlier work by Christopher & Lee (2004); Christopher & Peck (2004):
Scenario analysis using Supply Lead Time (key area of vulnerability selected) Christopher & Rutherford (2004)
Supply Chain Resilience Longitudinal Case Study of 3 supply chains Supply chain risk management concept
Cable,Timber & Chemical Companies (Interviews,workshops)
Supply Chain Strategy Integrative Literature review Total Quality Management,  Hendricks & Singhal (1996),
Apprehension without action, Rice & Caniato (2003); Zsidisin et al. (2000, 2004)
Supply Chain Risk Management Industrial,Service & Trade firms survey (cross section execs SCM) Germany Normal Accident Theory (Perrow, 1984) and High
Testing SC Vulnerability Hypothesis using Ordinary Least Squares (OLS) analysis  Reliability Theory, Roberts (1990) to be further explored to identify further scv factors
Supply Chain Resilience 3 Echelon case - Simulation study (Portuguese Automotive) Designed in resilience building on resilience foundation works based  on mitigating strategies,
Improvement 1st,2nd tier suppliers & outsource entity. Two performance measures  principles and interventions. including Rice & Caniato (2003)
per SC entity - Lead Time ratio & Total Cost Tang (2006);Christopher & Peck (2004);Vlachos & Xanthopoulos (2007) 
Human Actors Resilience Literature Critique Trait theory, Korac-Kakabadse & Kouzmin (1997), Organisational theory, Kouzmin (1980;83); 
with Organisations Dixon & Kouzmin (1984), Public Choice theory, Dixon et al. (1996;98); Kouzmin et al. (1997) 
Psychological Perspective
Supply Chain Resilience Systematic & Structured Literature review Basis of 4 formative elements of supply chain resilience (SCR) based on previous works
on following by element ; (1)Agility based on flexibility :Swafford et al. (2006) & velocity:
Christopher & Peck (2004), (2) Redundancy; Sheffi (2005), (3) Collaboration; 
Lee (2004); Singh and Power ( 2009), (4)Knowledge of supply chain network physical
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FOCUS KEY CONTRIBUTION
Gaming quantification F Framing of mitigating financing before and loss sharing post disruption
Inbound Supply Risk Management I Proposed a  simulation-based framework
(Global Sourcing) a tool for a preliminary evaluation of efficiency of
resilience via dual approaches - Mitigation and Contingency planning
Global Financial Crisis as major demand risk C The conceptualisation of SCRES and the empirical findings
disruptive event regarding its relationship with SCRM and SCV 
SC resilience Capabilities
Flexibility,Visibility,Velocity,Collaboration
Reduction of Impact of Supply Chain Disruptions M Ways to reduce Impact: -  Supply Alliance Network
on Supply Chain Operations
Relationship between SC Vulnerability I Compiled and empirically validated constructs for 
and SC Risk different classes of supply chain risk sources
Evaluate SC Scenarios for improved resilience M Simulation allowed comparison of SC Behaviour post disturbance
How mitigating strategies affect performance under two SC resilience design strategies
How trauma affects Organisations C Trait Theory Development (Korac-Kakabade & Kouzmin,1997)
(personality traits in organisational actors)
Conceptualise SC Resilience & Identify C 4 SC structural Elements as antecedents of SC Resilience
Capabilities to contain disruptions & Flexibility, Redundancy,Collaboration
relationship capabilities to SC Resilience SC Physical & Information Structure
Which are proposed to examined as conceptual 
constructs through their current on-going research
CRITIQUE DATE AUTHORS TITLE EMPIRICAL
Fills gap of lack of empirical case study on 2012 O Khan Aligning product design with the supply chain: a case study Y
product design - sc alignment, triangulated validation,  M Christopher
although opportunity to expand to other industries A Creazza
Analytical wide review, anecdotal 2004 S Chopra Managing Risk To Avoid Supply-Chain Breakdown
M Sodhi
Comprehensive  disruption incident analytical review 2003 C Pickett Strategies for Maximising Supply Chain Resilience Learning from the Past
within time band using mainly desk research to Prepare for the Future
Used appropriate grounded approach to develop 2008 I Manuj Global supply chain risk management Strategies Y
theory due to literature gaps J Mentzer
Novel theory based framework but requires 2012 H Carvalho Agile and resilient approaches to supply chain management:
validation through large empirical research as S Azevedo influence on performance and competitiveness
















Supply Chain Management Longitudinal Case Study - Single Fashion Retailer UK Ulrich and Eppinger (2000): product complexity reduced
through modularity;Sharifi & Pawar (2002);Fine (1998) concurrent engineering
Pero et al. (2010) and Lo and Power (2010): frameworks for aligning product design & sc 
Supply Chain Risk Mitigation Literature review of cross Industry company case studies Risk/Reward trade off, News vendor problem, Chopra & Meindl (2003) 
Kane (2001) Inventory controls, Lee et al. (1997) "Bullwhip Effect in Supply Chains"
Supply Chain Risk Mitigation Literature review of case studies - Case is Organisation impacted Inventory Optimization Theory, Just in Time/ Just in Case trade off, centralizational risk
with regards to disruption event & SC disruption, resilience culture Resilience= visibility + control
Supply Chain Risk Mitigation Strategies Qualitative 14 interviews & focus group cross industry Risk management strategies, Juttner (2003;2005), risk management theory development due to lack of existing theory
Decision making SC managers grounded theory approach  due to lack of existing theory 
Supply Chain Resilience & Agility Literature review induction approach to build theory Merging of agile and resilient approaches in the supply chain management context
in Supply Chain Management
FOCUS FOCUS CODECONTRIBUTION
Product design & supply chain to identify P Product Design alignment with SC has
impacts on a firm’s SC responsiveness positive significant impact on SC resilience & responsiveness
and resilience Benefits of 'design centric' approach in scm
Mitigating strategies to avoid supply chain M Assessing Impact, Trade-off, risk tailored approaches
breakdown
Mode of failure and impact outcomes M Supply Chain Resilience strategy based on failures modes
from experience
Risk Management  Strategies I Identifying the most important antecedents to
in Global Supply Chains selection of risk management strategies and linking the antecedents to appropriate
strategies.
Moderating affect on risk on :Team Composition,Complexity &
Inter-Organisational learning
Relationships between agile & I Identification of the conceptual relationships among
resilient approaches, supply chain competitiveness agile and resilient supply chain practices and performance 
& performance. Conceptual framework facilitates future researchers 
explore the proposed relationships
between the agile and resilient practices to identify
synergies, thereby allowing the unification/integration of the








Table 70 (continued) 
 
 
CRITIQUE DATE AUTHORS TITLE EMPIRICAL
Methodology work for decision support technologies 2013 T Ng A Resilience Optimization Approach for Workplace Inventory Control Dynamics 
S Cy under Uncertainty
Analytical literature review 2010 H Pfohl  State of the art in supply chain risk management research:
H Ko"hler empirical and conceptual findings and a roadmap
David Thomas for the implementation in practice
Used rolling horizon decision making 2008 P. Seferlis An Optimal Control Theory-Based Framework
common method for efficient practical decision D. Vlachos for Supply Chain Resilience
making in a dynamic environment, Chand et al.(2005)  E. Iakovou
A. Xanthopoulos








Industrial Systems & Engineering Dynamic modelling with Eigen value sensitivity analysis Stock management dynamic system model, Sterman (1989), Industrial Dynamics Forrester
(1961), Resilience of workforce inventory systems, Towill (19820 Transfer function models
Supply Chain Risk Management Literature review and integrating summary Capital market theory, Weber et al. (2001), New Institutional Economics, Junginger  (2005)
of conceptual papers & empirical studies
Supply Chain Resilience & Disruption Stochastic modelling (Simulation) using a predictive optimal control scheme Control Theory ,Seferlis & Giannelos  (2004)
Supply Chain Risk Management Literature review including regulations,  and business cases Review highlights the need for integration of SCRM strategies including ;Avoidance
modelled:Mudrageda and Murphy (2007),Wu & Olson (2008),Viswanadham & Raghavan,(2000)
 & Raghavan,(2000); Control:Ellergaard (2008),Sheffi (2007), Cooperation:Cruz (2008):
Flexibility (agility):Tang & Tomlin (2008),Peck (2005), Yu et al.(2009)
Supply Chain Disturbance Management Automotive case study with 4 scenarios' & using Fuzzy Set Theory (FST) Decision Support Systems to address unstructured problems , Spragg & Watson (1986)
 to model uncertainty & effects on SC, & uses discrete event simulation  










Dynamic workforce inventory planning DS Development of decision support tools
for design of resilient dynamic systems under uncertainty
Identification of main principles in I 17 Principles of Supply Chain Risk Management
SC Risk Management & evolutionary steps
for implementation
Quantification of disruption impact & O An optimization based
resilience improvement framework for enhancing resilience of a supply chain
Reduction of vulnerability & resilience M Integration of SCRM strategies to improve Resilience
improvement
Discuss the analysis of the effects of SC disturbances DS Novel approach using SC performance index to select 
& implementation of mitigation/contingency plans best operational policy for improved SC Resilience
using a Fuzzy Decision Support System (FDSS)
CRITIQUE DATE AUTHORS TITLE EMPIRICAL
Used well researched formal quantitative tools 2013 D Ivanov Adaption Based Supply Chain Resilience
combined with operational techniques.But  Control B Sokolov
theory - static not dynamic, Blackhurt et al.(2003) J Kaschel
Analytical research based on extraction of 2010 Y Li Analyzing Deformation of Supply Chain Resilient System based on Cell
theory from ecological resilience, novel L Zhao Resilience Model
but would be strengthened by real world testing
Uses strong academic foundation 2013 J Lambert Multiscale approach to the security of hardware supply chains Y
of previous work in applying it with specific W Wheeler for energy systems
focus on energy hardware, Single  industry centric I Linkov
Four distribution centres and 39 customer locations 2013 M Turnquist Design for resilience in infrastructure distribution networks Y
were included in the simulation, system resilience E Vugrin
explored relevant to infrastructure/engineering sector
Extensive review of 485 articles including TCE, 2011 P Greening Disruptions and supply networks: A multi-level, multi-theoretical Y
Resource dependency, RBT,buyer-seller, C Rutherford relational perspective
economic organization, network formation
social network & scd, but no testing of hypothesis
PERSPECTIVE METHODS THEORY
Supply Chain Planning Quantitative approach using Control Theory Mitigating uncertainty and increasing resilience of supply chains from the control theoretic perspective
balancing SC protection & adaptability taking account of perspective - controlled adaption
managers risk perceptions, risk strategies & SC stability
Systems Engineering Building of Mathematical model of Supply Chain Resilience System with 2 members, Cell resilience model, Zhao (2008)
researched SC deformation rules and quantitative simulation carried out using Matlab 
Energy security Literature review includes editorial on combining Resilience Engineering Design choices for human-automation systems in
& Risk Analysis, drawing upon energy grid case study in FT. Belvoir or abnormal situations 
Caravalho et al.(2012); Huber et al. (2012); Hollnagel et al. (2006) 
Distribution Networks Resilience Optimization computer modelling using example distribution network System resilience, Vugrin et al. (2010)
 airline & 39 customers Design-for-resilience in infrastructure systems 
Little (2002); Fiksel (2003); Petersen & Johansson (2008); Mansouri, et al. (2010)
Supply Chain Disruptions Literature Review ,contextual analysis Supply chain/network disruption - relationship between the nature of a disruption (described 
: Network & relationships by its network context and location) the urgency of response & post disruption network









Mitigating uncertainty & increasing resilience M Adaption based SC Resilience Framework
Resilience analysis Control Theory approach to uncertainty
& Resilience, and insights for decision makers
Changing rules of SC system deformation C Novel approach using cell concept to represent 
under sustained accumulated risk SC system taken from Zhao (2009) 
System deformation gradually  increases with 
certain relationships
Multiscale approach to address modelling & M Defines a multiscale approach for energy hardware sc modelling 
decision-making for energy system hardware SC & model from system scale to granular scale
with associated vulnerabilities
Disruption scenario probabilities & resilience F Framework for network design trade-offs &
capacity with regards to investment alternatives optimal network design  against
a set of uncertain disruptive events (combined contingency/mitigating) 
Network structure post disruption C & R Consideration of disruption as opposed to disturbance
Disruption specific propositions & new conceptual framework
with Network structure influencing recovery time & impact
CRITIQUE DATE AUTHORS TITLE EMPIRICAL
Analytical literature review 2006 T Glickman Security, Visibility, Resilience : the keys to mitigating supply chain
S White vulnerabilities
Thorough case study approach, constrained based 2007 Grewal R Crises in business markets: implications Y
on manufacturing hi-tech and steel. Johnson J for interfirm linkages
Sarker S
Constrained by number of cases used 2007 M Primo Manufacturing firm reaction to Y
& retrospective interview use K Dooley supplier failure and recovery
M Rungtusanatham
Novel approach using two previous models 2012 S Gaonkar Analytical framework for the management of risk in supply chains Y
in combination N Viswanadham
Positive contribution using practical management 2011 A Barroso Supply Chain Resilience Using the Mapping Approach Y
tool from management practice. Further research V Machado
needed on other industries/multi products
PERSPECTIVE METHODS THEORY
Supply Chain vulnerabilities Literature Review
mitigation Conceptual framework
Moberg et al.(2003) Action plans for effective integration
Crises Management Literature  synthesis & qualitative study consisting of in depth Interfirm relations & linkages (Anderson et al.1997; Dwyer et al. 1987; 
interviews with 27 managers from 13 firms; use of  Johnson 1999).  Risk propensity response, Sitkin &  Pablo (1992)
data from two contrasting cases (Hi-Tech & Steel product manufacturer) Crisis management & perception: Abolafia & Kilduff (1988);Milburn et al. (1983)
Supplier failure & recovery Case studies via interviews of 4 US aerospace & electronics manufacturers Critical supply failure Ellram (1991); Bowersox & Closs (1996)
Organizational response Reaction to supplier service failures,Lockshin & McDougall  (1998); Duvarsula
et al., 2000; Pujari, 2004; Yanamandram & White, 2006
Supply Chain Risk Management Mapping of propagation  supplier events due to supplier non performance, develop Optimization model, adapted from the Markowitz model
two mathematical programming-based preventive models for strategic level deviation Credit risk minimisation model
and disruption management
Supply Chain Management Case study Portuguese Automotive based on mapping approach Mitigation policy , Zsidisin et al. (2000);Svensson (2003);Christopher & Peck (2004)






Table 70 (continued) 
 
FOCUS FOCUS CODECONTRIBUTION
Supply Chain activities or  characteristics C Three main key capabilities identified as mitigating
related to the mitigation of SC Vulnerabilities SC disturbances : Security, Visibility & Resilience
Promotes Moberg et al (2003) action plans for effective integration
interorganisational teams, investing in IT & engaging in 
more practical & applied sc research
Organisational responses to M & R A process model of crisis - 5 phases 
crisis & impact on Interfirm relationships that details how crises may play out in Interfirm relationships
propose a typology of crises and crisis management tactics
what is the impact of a supply failure and F & R Supplier failure & recovery impact a manufacturer’s dissatisfaction with a supplier
recovery on manufacturing firm dissatisfaction the antecedent to costs involved with supplier development or switching
with the supplier
Strategic level approach minimize costs F New cost minimization & optimization models 
& supplier choice in disruption management for SC Risk based on Markowitz Model and credit risk
minimization model, combining optimisation & cost
Identifying if supply chain is resilient M Use of mapping approach to support disruption management
to a specific disturbance & supporting decision making and implementation of mitigating policies
managers decisions to adopt mitigating strategies
CRITIQUE DATE AUTHORS TITLE EMPIRICAL
A systematic guide to conducting vulnerability 1999 B Asbjornslett  Assess the vulnerability of your production system
analysis, although excluded empirical work M Rausand
2007 J Blackhurst The Severity of Supply Chain Disruptions:
C Craighead Design Characteristics and Mitigation
M Rungtusanatham Capabilities
R Handfield
Cross industry study used measurement approach based on2010 A Stephenson Benchmark Resilience: A study of the resilience Y
based on similar earlier work in same location, low E Seville in the Auckland Region
response rate but thorough approach J Vargo
would benefit from research in other locations D Roger
Used case study to address the 'how' question 2013 S Teoh Strategic resilience management model Y
Single case study limitation because cannot H Zadeh complex enterprise system upgrade implementation
claim the findings as definitive but basis for future
Only reviewed international journal articles, while 
excluding the conference papers, master and doctoral 
dissertations, textbooks.Solely based on analysis from 
















Production systems vulnerability Vulnerability Analysis using scenarios approach via the input/output model Complex (vulnerable) systems (1984), Input/Output Model
& two step vulnerability analysis Vulnerability of the system, Perrow (1984) Reason (1989, 1990) Meister (1991)
Supply chain risk management Cash study Mitigation & strategy
Organizational Resilience Cross industry web survey & interviews of 68 organisations (7% response rate) Benchmarking, Anderson & Pettersen (1996); Codling (1996)
Resilience measurement tool, McManus (2007) 
Crisis management, organisational beliefs, Mitroff  et al.(1989) 
Resilient Organisations, Seville et al. (2008)
Strategic resilience Management Single Case study of Utility company during a major IT upgrade Resilience management , McManus et al.(2007),
Management mindfulness, Weick & Sutcliffe  (2006), Transactive decision making
(Noble 2000) and Resilience motivation, Gooch & Warburton (2009)
Supply chain risk management Literature Reveiw of 224 journal articles 2003-2013 Chronologicl list from both quantitative and qualitative research
FOCUS FOCUS CODECONTRIBUTION
Vulnerability in relation to production systems C Relationship between threats and vulnerabilities
assessment
Risk Management  Strategies M & R Design management strategies & risk
Test the proposed resilience measurement tool I new  web-based survey tool to measure and benchmark organisational resilience.
& to explore the resilience in the Auckland region
Strategic resilience management development M Inductively derived strategic management resilience
in order to survive the unforeseen challenges model, demystifying threats for more effective 
occurred during a complex ES upgrade process. decision making & executing restoration plans
Risk management strategies M & I Thorough reveiw identifying substantial research gaps for further study
proposed five common risks and new definition
arising across various types of supply chains, including macro risk, demand risk, 
and infrastructural risk (information risk, transportation risk and financial risk)
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CRITIQUE DATE AUTHORS TITLE EMPIRICAL
Based on single respondent in manufacturing with 
considerable non response rate where multicollinearity 
may exist and reluctance of participants to share real risk 
of catastrophe, 2017 G Lu Lucianetti
Supply Chain Security: A Classiﬁcation of Practices and an Empirical Study of 
Differential Effects and Complementarity 
X Koufteros
L  Lucianetti
One country based survey India so cannot be genralised, 
only used single methodology,  single typology not 
generalizable across different industries 2016 D Mishra






Supply chain risk management Survey of 462 firms in US & Italy Supply chain security management
Supply chain risk management Survey of 184 India organisations Social exchange and contigency theory
FOCUS FOCUS CODECONTRIBUTION
Risk and practice from security perspective M & I
 Classiﬁcation of SCSM practices into four classes and particularly the development of 
indicators that reﬂect each category
Probing the relative efﬁcacy of each class of practices to explain variability in SCS 
performance. Evidence suggesting that detection practices are the supreme choice
Risk mitigation M & I
Considers different strategic orientations, prospector,defender and analyser.Considers 
strategic selection and overall supply chain performance
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Section A Characteristics & Overview 
 
This research project investigates supply chain orientation and focuses on post disruption events in the 
supply of pharmaceuticals medicines within an NHS hospital. It is concerned with how actions taken after 
a supply chain disruption, can have on shortage management. Shortage management is a challenge in 
any environment and especially important in the healthcare arena. By participating in this research, new 
insights can be discovered to possibly improve approaches to this problem. Please be advised that 
participation is entirely voluntary and you can withdraw from the study without any penalty or 
consequences; after submitting your answers you will have one week to notify the researcher that you 
wish to withdraw. Please be assured that the data collated from the responses to the questions below will 
be anonymised to protect identity and will remain confidential.  
 




2. This questionnaire is the main method of data collection. To compliment this survey and gain further 
information, limited telephone interviews will be conducted on a random sample basis. To be eligible for 


















Middle & East of England 
Other (please specify) 
 






7. What is the number of Pharmacist FTE’s involved in your units pharmacy execution process 










9. What is your current position title? 
Pharmacist Technician 
Lead Pharmacist Technician 















11. How would you describe your degree of knowledge about disruption management? 












13. We feel the need to be alert for possible supply chain disruptions at all times. 
Strongly Disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly agree 
Not sure/ not applicable 
 
14. Supply chain disruptions show us where we can improve. 
Strongly Disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly agree 
Not sure/ not applicable 
 
15. We recognize that supply chain disruptions are always looming. 
Strongly Disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly Agree 
Not Sure/not applicable 
 
16. We think a lot about how a supply chain disruption could have been avoided. 
Strongly Disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly Agree 
Not sure/not applicable 
 
17. After a supply chain disruption has occurred, it is analysed thoroughly. 
Strongly Disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly Agree 
Not sure/not applicable 
 





Neither agree nor disagree 
Agree 
Strongly Agree 
Not sure/not applicable 
19. We feedback performance data on the response alternative taken to all the other regions managers. 
Strongly Disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly Agree 
Not sure/not applicable 
 
20. We vary our response to disruptions depending on our business unit needs. 
Strongly Disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly Agree 
Not sure/not applicable 
 
21. We vary our response to disruptions depending on the length of time from initial occurrence. 
Strongly Disagree 
Disagree 
Neither agree nor disagree 
Agree 
Strongly Agree 
Not sure/not applicable 
 




Neither agree nor disagree 
Agree 
Strongly Agree 
Not sure/not applicable 
 




Neither agree nor disagree 
Agree 
Strongly Agree 
Not sure/not applicable 
 
Please find below in Question 24 a list of medicines that have experienced disruptions to their 
pharmaceutical supply chain. Please select only one of the medicines, then answer all the 




Section B Medical Shortage 
 
24. Please select one of the following disruptions 
Lidocaine Injection 
Aciclovir Infusion Solution & Powder 
Glycopyrronium Bromide Injection 
Ketamine Injection 
Lorazepam Injection 
Other (please specify) 
 























27. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







28. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following activities? 







29. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







30. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







31. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 










32. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







33. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







34. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







35. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







36. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







37. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 









38. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







39. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 








40. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







41. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following activities? 







42. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







43. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 










44. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 






Medical Shortage (Continued) 
 
45. Actions (Immediately after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







46. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 








47. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







48. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







49. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 









50. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







51. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







52. Actions (8-16 weeks after the disruption) 
Since the disruption, to what extent has your business unit pursued, or made plans to pursue, the 
following 
activities? 







53. Of the medicine affected by the disruption, 







54. What was the percentage of the lines fulfilled during the period 8 weeks to 16 weeks after the 



























































































Appendix 4: Summary of Quantitative Analysis Table  
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Table 71.Quantitative analysis summary  
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Appendix 5: Diagnostic Tests Summary 
 
Supply chain disruption orientation and Performance (2) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 147.500 140 .316 




Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 188.743       
General 180.108b 8.635c 8 .374 
 
 
Role, supply chain disruption orientation, and performance (3) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 208.798 262 .993 




Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 193.022       
General 171.991b 21.031c 16 .177 
 
 







Goodness of Fit  
 
Goodness-of-Fit 
  Chi-Square Df Sig. 
Pearson 266.110 262 .418 




Test of Parallel Linesa 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Null Hypothesis 240.540       
General 209.655b 30.885c 16 .014 
 
 
Disruption severity, disruption orientation, and performance (4) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 174.899 229 .997 




Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 173.389       
General 131.909b 41.480c 16 .000 
 
 











  Chi-Square df Sig. 
Pearson 240.701 229 .285 




Test of Parallel Linesa 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Null Hypothesis 216.749       
General 207.794b 8.955c 16 .915 
 
Performance and feedback (5) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 103.468 77 .024 




Test of Parallel Linesa 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Null Hypothesis 136.669       





Performance and Feedback (5x) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 195.371 142 .002 








Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 152.746       
General 142.200b 10.546c 10 .394 
 
Buffering, bridging, and performance (6) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 279.432 241 .045 




Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 228.895       
General 204.620b 24.275c 10 .007 
 
 
Buffering, bridging and performance (6x)  
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 261.761 241 .171 




Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 209.691       





Buffering, and bridging in response to supply chain disruption (7) 
 






Pearson 257.030 232 .124 












224.031    
General 198.350b 25.681c 10 .004 





Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 323.940 352 .856 




Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 229.172       










Bridging and buffering in response to supply chain disruption (8) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 355.441 362 .587 




Test of Parallel Linesa 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Null Hypothesis 264.126       






Bridging and buffering in response to supply chain disruption (8x) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 353.966 362 .609 





Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 217.153       









Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 121.179 100 .074 
Deviance 89.866 100 .756 
Link function: Logit. 
 
Parallel Lines  
 
 
Test of Parallel Linesa 
Model -2 Log-
Likelihood 
Chi-Square df Sig. 
Null Hypothesis 133.161       
General 107.879b 25.283c 10 .005 
 
Varying response – effect on performance (9x) 
 
Goodness of Fit 
 
Goodness-of-Fit 
  Chi-Square df Sig. 
Pearson 115.675 100 .135 
Deviance 93.739 100 .657 
 
Parallel Lines 
Test of Parallel Linesa 
Model -2 Log-Likelihood Chi-Square df Sig. 
Null Hypothesis 140.042       
General .000b 140.042 10 .000 
 
